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CHAPTER I 
INTRODUCTION AND GOALS 
‘Quid non mortalia pectora cogis, Auri sacra fames!’ 
‘To what do you not drive the hearts of men, accursed hunger for gold!’ 
- Virgil, Aeneid III, 56-57, around 29-19 BC 
 
 
From grave goods to jewelry, ornamentation, and coinage, gold has been considered a 
precious rare metal since time immemorial. While too soft and malleable for the manufacture 
of effective tools and weapons, gold has been treasured for its inherent beauty and luster, 
symbolizing wealth, power, divinity, and eternity.1  
Present in nature in its native form as metallic flakes or nuggets, gold was among the first 
metals known to mankind. The earliest gold artifacts yet discovered date back to the 5th 
millennium BC and were excavated from burial grounds at the Varna Necropolis in Bulgaria.1 
The Egyptians were the first to mine gold and to separate the metal from ores. In ancient 
Egyptian culture, gold was associated with the sun god Ra, and golden adornment was a 
prerogative confined to pharaohs and priests. Yet, gold’s unique durability and density later 
incited its use as a medium of exchange, or money. The minting of gold coins began around 
635 BC in the Lydian kingdom (modern Turkey). The original coins consisted of electrum, an 
alloy of gold and silver. During the reign of King Croesus (560-546 BC), the first coins of pure 
gold and silver were minted by the Lydians, who thereby launched an innovative and 
widespread monetary system for transactions around the Mediterranean basin.2  
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Throughout the evolution of humanity, gold has been venerated as an object of pure value, 
and the relentless desire for gold significantly impacted world history. In the Middle Ages, 
Western alchemists pursued the creation of the so-called Philosophers’ Stone, a legendary 
substance that was believed to be capable of transmuting base metals, such as lead and 
copper, into gold. Despite the fruitless outcome of the quest, these early alchemical 
experiments ultimately laid the foundation for modern chemistry.3 In the 16th century, Spanish 
conquistadors in search for gold explored and conquered Central and South America, which 
led to the fall of the Aztec and Inca empires.2 The lure of gold did not subside over the years, 
and the 19th century was convulsed by a series of major gold rushes. Thousands of miners 
from all over the world traveled to new frontiers where gold had been discovered, including 
the United States, Canada, Australia, and South Africa (Figure 1.1). These events of mass 
migration dramatically accelerated the pace of global integration, revolutionizing industry, 
technology, transportation and communication.4 
 
Figure 1.1. Advertisement for the clipper ship California, which sailed from New York to San Francisco 
during the California Gold Rush in ca. 1850. 
The total amount of gold mined since the beginning of human civilization is estimated to be 
190,400 metric tons.5 This cumulative production corresponds to a gold cube measuring over 
21 m on each side. More than 90% of this gold has been extracted since the California Gold 
Rush in 1849.6 In 2017, the annual global gold mine production was about 3,250 metric tons, 
of which 43% was produced by China, Australia, Russia, the United States and Canada. In 
addition to mining, a significant part of the gold supply came from the recycling of old scrap 
(about 1,200 metric tons). Jewelry is by far the largest processing sector for gold, accounting 
for approximately 60% of the worldwide consumption. The remaining gold is used in industrial 
and medical applications (10%), or is melted into gold bullion and coins (30%).5 
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The interest in gold from an industrial and medical point of view lies in its high corrosion 
resistance. As a noble metal, gold does not react under influence of water or air, and is often 
called chemically “inert”. Therefore, gold is commonly applied in high-end electronic devices, 
e.g., as conductor in phones and computers, and in dental medicine.6-7 At the same time, it 
was this renowned inertness that caused the chemical society to neglect gold for a long time 
as potential metal catalyst. Only in the 1970s and 1980s, the first publications on gold catalysis 
appeared.8 These pioneering works have encouraged other synthetic chemists to explore 
heterogeneous and homogeneous catalysis by gold, and the amount of publications has risen 
almost exponentially in the following decades (Figure 1.2). 
 
Figure 1.2. Number of publications on “gold catalysis” from 1970 to 2018. Data extracted from Web of 
Science.9 
In contrast to what is commonly believed, gold is not the rarest, nor the most expensive of 
metals. Compared to other transition metals frequently used in catalysis, such as rhodium, 
palladium, and platinum, gold is produced in far greater amounts at a similar price (Figure 
1.3).5, 10 Most metal-catalyzed transformations are based on oxidative addition and reductive 
elimination processes, in which the metal cycles between different oxidation states. Gold, on 
the other hand, is reluctant to undergo oxidation, and gold(I)/gold(III) cycles are rarely 
encountered.11 Furthermore, cationic gold species possess superior Lewis acid properties 
compared to other Group 11 metals (silver and copper), and the catalytic reactivity of gold 
typically involves the activation of unsaturated carbon bonds toward nucleophilic addition. The 
gold catalyst is then regenerated through protodeauration with release of the product (Scheme 
1.1).7  
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The peculiar catalytic activity exhibited by gold complexes is attributed to relativistic effects, 
which are maximized in the case of gold. This heavy metal is characterized by an unusually 
large relativistic contraction of the 6s orbital. The stabilization of the 6s shell corresponds to a 
lower-energy lowest unoccupied molecular orbital (LUMO), thus explaining the increased 
Lewis acidity and electrophilicity of gold. In addition, the contracted valence orbitals have a 
shielding effect on the nuclear charge, causing the indirect expansion of the 5d orbitals. As a 
consequence, the 5d electrons are able to delocalize into empty p orbitals and stabilize 
carbocationic intermediates.12 
 
Figure 1.3. Price (in 4th quarter) and annual mine production of precious metals in 2017.5, 10 
 
Scheme 1.1. Most fundamental reactivity pattern in gold catalysis. 
In the following chapters, the unique reactivity of gold as transition metal catalyst is explored 
both as a means and an end.  
In Part I, the gold-catalyzed cyclization of alkynes is envisioned as a key step in the 
construction of fluorescent heterocycles. The ultimate aim of this project is the labeling of plant 
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hormones, most notably strigolactones. Traditionally, five major classes of phytohormones are 
recognized, i.e., auxins, gibberellins, cytokinins, abscisic acid, and ethylene.13 Only recently, 
strigolactones were added to the list, as they were identified as important regulators of plant 
growth and development. While plant physiologists have made a lot of progress in unraveling 
the biochemical processes behind their action, little is still known on the distribution and 
transport of these hormones within plants. A convenient approach to address this interesting 
biological question is the use of traceable analogs. Chapter II introduces the biological 
background of strigolactones, describing their function, molecular structure and signal 
transduction pathway. In Chapter III, an overview is given of how the fluorescent labeling of 
strigolactones has been achieved in the past. The advantages and drawbacks of the different 
tags with respect to fluorescence output and bioactivity are highlighted. Chapter IV is devoted 
to the design and synthesis of a novel type of fluorescent strigolactone analogs with a high 
structural resemblance to the natural hormone. The synthetic compounds are evaluated as 
strigolactone agonists and screened for their fluorescent properties. The most promising 
analog is then selected for a preliminary tracer study in living plants. The chapter is concluded 
with an outlook on the significance of the work in different research domains. 
Whereas gold catalysis is used as a synthetic tool in the first part, Part II revolves around the 
fundamental catalytic properties of gold complexes. Cationic gold is capable of catalyzing a 
wide variety of reactions, often beyond the scope of typical transition metal catalysts. Of 
particular interest is asymmetric gold catalysis, allowing the construction of optically active 
carbocyclic and heterocyclic compounds from relatively simple precursors. Despite the major 
advances made in the past years, this field is still in its infancy. Chapter V provides an update 
on the latest developments in homogeneous enantioselective gold catalysis (ca. 2017-2018). 
The purpose of this overview is dual. On the one hand, it combines recent works into a 
comprehensive review. On the other hand, it allows to profile the different reactivity patterns 
pertinent to cationic gold, and gives the reader an idea of the diverse range of transformations 
that are feasible with gold catalysis. As most chiral gold complexes hitherto employed in 
asymmetric catalysis are based on gold(I) species, Chapter VI focuses on the design of well-
defined chiral gold(III) catalysts. The complexes are composed of a bidentate biphenyl ligand 
to stabilize the high-valent gold center and a chiral phosphorous ligand as the source of 
chirality. The catalysts are screened for their reactivity and selectivity in several typically gold-
catalyzed cyclization reactions, and conclusions are drawn on the applicability of such 
complexes in asymmetric catalysis. 
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CHAPTER II 
THE BIOLOGY OF STRIGOLACTONES 
1. Introduction 
Strigolactones (SLs) are a structurally diverse family of signaling molecules that were only 
recently identified as important players in the regulation of plant growth and development. 
Since their discovery as plant hormones in 2008, new functions of SLs are still being revealed, 
and step by step, their action at a molecular level is untangled. In this chapter, the state of the 
art of these plant hormones is discussed. The focus lies on the multifaceted biological role of 
SLs, their structural features and how these relate to the bioactivity. Finally, the basics of SL 
perception and signal transduction are summarized.  
2. Strigolactone origin and functions 
SLs are a class of ancient signaling molecules that are ubiquitously distributed within the plant 
kingdom. They are biologically derived from carotenoids through enzymatic isomerization and 
successive oxidations.14 Originating in the primeval forms of plant life,15 SLs have evolved into 
host recognition cues to attract beneficial arbuscular mycorrhizal (AM) fungi.16 Molecular data 
and fossil records suggest the importance of this association in the terrestrial migration of 
plants and algae approximately 450 million years ago.17 Today, colonization of plant roots by 
AM fungi is one of the most prevalent symbioses in nature, occurring in over 80% of the higher 
land plants.18 Released by the host plant in the vicinity of the roots, SLs induce hyphal 
branching and root penetration of the germinating fungal spores, promoting the establishment 
of a mutualistic association between plant and fungus.16, 19 The fungal partner delivers mineral 
nutrients, particularly phosphate and nitrogen, to the host, aiding in the plant’s survival in 
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nutrient-deprived soils. In return, the plant provides the obligate symbiotic fungus with carbon, 
necessary for the completion of its life cycle.20 
Over the course of their evolutionary history, SLs have adopted a much broader functional role 
exogenously, i.e., in the soil, as well as endogenously, i.e., in the plant. In the rhizosphere, 
pernicious parasitic plants have availed themselves of the existent signaling molecules to 
locate suitable host plants in close proximity.21 Orobanche and Striga are two genera of 
parasitic weeds that, under influence of SLs, germinate and infest multiple economically 
important crops, including sorghum, rice, sugarcane, and maize, causing devastating 
agricultural losses worldwide (Figure 2.1).22 The potency of SLs to trigger seed germination of 
orobanchaceous root parasites was already discovered in 1966, with the isolation of strigol 
2.1 (Figure 2.3, vide infra) as germination stimulant from the root exudates of cotton.23 
Nevertheless, it took almost 20 years to unambiguously define the molecular structure of this 
first SL representative.24 
 
Figure 2.1. Striga hermonthica infested maize field in sub-Saharan Africa. Photo courtesy of the 
International Institute of Tropical Agriculture (IITA). 
About a decade ago, two studies of branching mutants revealed an important endogenous 
role of SLs in the control of shoot branching.25 While this is by far the best-characterized 
function of SLs in plant development, the downstream signaling events by which the hormone 
represses bud outgrowth are not completely understood yet and two models are currently 
proposed.26 The first model suggests that SLs are second messengers for auxin, and function 
directly in the axillary bud to inhibit growth.27 Alternatively, although not necessarily 
exclusively, they may act systemically, in the main stem, by modulating polar auxin transport 
from the apical meristem, thereby influencing the export of auxin from the buds.28 
Later on, SLs were shown to be involved in a plethora of aboveground developmental 
processes (Figure 2.2), including secondary growth of the stem,29 leaf senescence,30 leaf 
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morphology,31 and shoot gravitropism.32 Moreover, they are suggested to play a role in drought 
and salt stress tolerance, although the current reports are contradictory.33 Hence, additional 
experiments with both SL biosynthetic and signaling mutants are necessary to resolve the 
influence of SLs on plant responses to abiotic stress. 
 
Figure 2.2. Roles of strigolactones in plant development. Reprinted from Waters et al., 2017.34 
Mainly produced in the roots, SLs also affect the plant’s root architecture.35 More interestingly, 
they do so as a function of the nutrient availability in the soil. Under optimal growth conditions, 
endogenous SLs repress the formation of lateral roots, while inducing root hair elongation and 
primary root growth.36 The formation of adventitious roots from nonroot tissues, such as stems 
and leaves, is suppressed as well.37 In contrast, plants growing on phosphate- or nitrate-
deprived soils exhibit significantly elevated SL levels in root tissues and exudates,38 which 
promote the outgrowth of both lateral roots and root hairs.36b, 39 By analogy with signaling 
events in the shoot, changes in the auxin flux have been suggested as key mechanism for 
root development responses to SLs.36b, 37, 40  
Overall, in unfavorable growth conditions, SLs reallocate the resources from shoot to root to 
stimulate nutrient absorption. The formation of new branches is inhibited and leaves are 
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abscised in favor of the expansion of the effective root surface and the establishment of 
symbiosis with AM fungi. The ability of SLs to coordinate the plant’s growth strategy in 
response to nutrient availability makes these phytohormones pivotal for the survival of plants 
in continuously changing environments. Moreover, the gained competitive advantage would 
explain the high conservation of the SL pathway across the plant kingdom.41 
3. Structural diversity 
3.1. Structures of naturally occurring SLs 
To date, over 20 different natural SLs have been isolated from the root exudates of diverse 
plant species. According to their molecular structure, SLs are divided into two major groups, 
which are referred to as canonical and noncanonical SLs.42 Canonical SLs consist of a tricyclic 
lactone (ABC-rings) connected through an enol ether bridge to a second lactone moiety 
(D-ring) (Figure 2.3). They contain various substituents on the A- and B-rings with methyl, 
hydroxyl, and acetyloxy as the most common groups, though oxo- and epoxy-SLs have been 
identified as well. Depending on the orientation of the C-ring, two subclasses of canonical SLs 
are discerned. Strigol-type compounds carry the same β-oriented C-ring as strigol 2.1; 
orobanchol-type compounds have the same α-oriented C-ring as orobanchol 2.5. In addition 
to the bridge heads C-3a and C-8b, a third stereocenter, C-2’, is located at the connection with 
the D-ring. So far, only (2’R)-configured SLs have been found in nature.43  
 
Figure 2.3. Structures of selected canonical SLs. 
BIOLOGY OF STRIGOLACTONES 
13 
In noncanonical SLs, the orthodox ABC-rings are replaced by a variety of structures. Typical 
examples are avenaol 2.944 and heliolactone 2.1045 (Figure 2.4), respectively isolated from 
black oat (Avena strigosa) and sunflower (Helianthus annuus). Also carlactonoic acid (CLA) 
2.11 and the corresponding methyl ester MeCLA 2.12, directly derived from the SL 
biosynthetic precursor carlactone (CL) 2.13 through oxidation,46 have been detected in the 
root exudates of different plants.42b In these structures, the A- and D-rings of the canonical 
SLs can be distinguished. 
 
Figure 2.4. Structures of selected noncanonical SLs. 
3.2. Structure-activity relationship 
As apparent from the different characterized SLs, the invariable α,β-unsaturated furanone ring 
joined to an enol ether unit is a preserved structural feature among all natural SLs, both 
canonical and noncanonical, suggesting its importance for the biological activity. Indeed, 
structure-activity studies designated the enol ether connected D-ring as essential for each of 
the three main functions of SLs, i.e., endogenously as plant growth regulator, and in the 
rhizosphere as signaling molecule for parasitic plants and for AM fungi.47 Nonetheless, each 
system likely uses a distinct mode of perception, as plants, parasitic seeds and fungi respond 
differently to SLs and exhibit slightly different structural requirements (Figure 2.5).48  
 
Figure 2.5. Structure-activity relationship for SLs in plants and fungi. 
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For the hormonal function and the germination stimulating activity, the tricyclic lactone moiety 
as found in canonical SLs is expendable and can be extensively altered or even discarded 
without affecting bioactivity. In addition, compounds lacking both the enol ether bond and the 
ABC tricycle, but containing a good leaving group at the C-2’ position of the D-ring have been 
reported as highly active SL mimics in shoot branching inhibition and parasitic seed 
germination.47b, 49 The C-2’ configuration, which defines the orientation of the D-ring relative to 
the enol ether plane, was shown to modulate the degree of activity. The potency of the natural 
(2’R) isomer often surmounts that of its enantiomer, although the influence strongly depends 
on concentration and species.47a-c, 50 In contrast to plants, AM fungi do not support truncation 
of the tricyclic lactone moiety of canonical SLs to BC- or C-ring systems, while the enol ether 
link in the CD-part can be replaced by an alkoxy ether or oxime bridge without activity loss.47d 
However, removal of the BC-ring structure seems tolerated, as several carlactonoate 
derivatives were shown to induce hyphal branching comparable to canonical SLs.51 
3.3. GR24 as standard in SL research 
Natural SLs are structurally very complex, mainly because of the presence of variable 
functionalities and multiple stereocenters. Nevertheless, total synthetic routes have been 
successfully developed for several derivatives, including strigol 2.1, sorgolactone 2.3, 
orobanchol 2.5 (incorrect stereoisomer), solanacol 2.7 and only recently the noncanonical 
avenaol 2.9.52 These synthetic approaches greatly aided in the elucidation of the molecular 
architecture of SLs, and occasionally led to a revision of the initially assigned structure.53 
However, the reported methods are very lengthy and produce poor yields, which impedes the 
preparation of ample material for bioactivity studies.52a 
For this reason, GR24 2.21, a simplified analog of strigol 2.1 with aromatic A-ring, was 
designed.54 The initial synthetic route was improved to enable the multigram preparation from 
1-indanone 2.14 in six steps (Scheme 2.1).55 First, an ethoxycarbonyl side chain was 
introduced as auxiliary group in α-position of the carbonyl to activate the position for alkylation 
and at the same time protect it from dialkylation. Subsequent reaction with ethyl bromoacetate 
yielded compound 2.15. Acid-catalyzed hydrolysis of the esters, followed by decarboxylation 
afforded carboxylic acid 2.16. After reduction with sodium borohydride, lactonization of the 
crude product 2.17 to the tricyclic lactone 2.18 was accomplished under acidic conditions. 
Formylation and final coupling with bromolactone 2.20 gave GR24 2.21 as a mixture of 
diastereomers, which were separated by chromatography and/or crystallization. Strigol-
configured GR24 (and its enantiomer) was shown to more effectively induce parasitic seed 
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germination in Striga hermonthica and Orobanche crenata than the racemic mixture of 
orobanchol-configured GR24.55 Consequently, the latter two enantiomers are usually 
discarded. Strigol-configured GR24, on the other hand, is now used worldwide in biological 
assays to investigate SL responses,34 and as a reference compound in the evaluation of novel 
SL analogs. It is usually referred to as racemic-GR24 (rac-GR24). 
 
Scheme 2.1. Synthesis of the GR24 stereoisomers. 
4. Strigolactone perception and signaling 
Signaling of SLs in vascular plants occurs through the α/β hydrolase fold protein DWARF14 
(D14).34, 56 Binding of the hormone to the receptor is thought to involve hydrogen bonding and 
hydrophobic interactions with pocket residues of D14 (Figure 2.6). A conserved serine (S), 
histidine (H) and aspartate (D) catalytic triad located at the receptor’s active site was shown 
to catalyze the hydrolysis of rac-GR24, with concomitant release of the formyl tricyclic lactone 
(ABC-rings).57 Recent biochemical data in Pisum sativum and Arabidopsis thaliana indicate 
that the other cleavage product, the butenolide D-ring, remains covalently attached to the 
histidine residue of the catalytic center.57b, 58 While different hypotheses for SL hydrolysis have 
been put forward over the years,59 the current evidence is in favor of the most recently 
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proposed mechanism in which the catalytic serine performs a nucleophilic attack at the 
butenolide carbonyl (Scheme 2.2). A second attack by the imidazole nitrogen of histidine at 
the C-2’ position of the serine-bound aldehyde intermediate is proposed to generate the 
observed covalent complex with the D-ring.57b, 58 
 
Figure 2.6. Catalytic cavity of the D14 receptor with the hydrophobic pocket residues (mainly 
phenylalanine, F) shown in gray and the active site residues in color. Reprinted from Yao et al., 2016.58 
 
Scheme 2.2. Proposed mechanism of SL hydrolysis by the D14 receptor.  
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In vitro experiments revealed the rate of enzymatic cleavage to be rather slow (about 0.3 
molecules min-1). Together with the lack of activity of both hydrolysis products in shoot 
branching, this implies that D14 fulfills a dual role as both enzyme and receptor.57a Moreover, 
the process of hormone cleavage is considered to be imperative to initiate the signaling 
pathway (Figure 2.7). The entrapment of the D-ring inside the D14 binding pocket was shown 
to induce a conformational change of the receptor complex, which in turn triggers the 
interaction of D14 with the F-box protein MORE AXILLARY GROWTH2 (MAX2).57a, 58, 60 As 
MAX2 acts as a substrate recognition unit in an Skp1-Cullin-F-box (SCF) E3 ubiquitin ligase 
complex,61 signal transduction leads to the ubiquitination and subsequent proteolytic 
degradation of target proteins.62 Recently, the rice protein DWARF53 (D53)63 and the co-
orthologous SUPPRESSOR OF MAX2 1 LIKE (SMAX1-LIKE or SMXL) protein family in 
Arabidopsis thaliana64 were identified as downstream targets of SL signaling. Currently, no 
consensus exist on the signaling events downstream of D53/SMXL degradation.34 
 
Figure 2.7. Model of the SL signaling mechanism. Adapted from Waters et al., 2017.34 
5. Outstanding questions 
Many fundamental aspects of how SLs elicit phenotypical outcome are yet to be deciphered.65 
This is further challenged by the variable activities of SLs in different biological systems. In 
vascular plants, the first signaling events, including SL perception, are relatively well 
understood, although crystallographic validation of the receptor-ligand structure is still 
required.66 In contrast, signal transduction down the chain, e.g., the downstream targets of the 
SMXL proteins and crosstalk with other plant hormones, remains elusive. Also, the spatial 
distribution of SLs within the plant and the long-distance transport from root to shoot are 
unresolved topics. 
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The mechanistic basis of SL-promoted AM symbiosis as well as parasitic seed germination is 
largely unexplored. It remains unclear how these organisms can sense minute amounts of SLs 
to identify their host. Furthermore, structure-activity studies revealed a distinct SL specificity 
for the different biological models. Additional data are needed to elucidate the underlying 
mechanism through which parasitic seeds and AM fungi differentiate between various SLs. 
Identification of the putative SL receptors in these species would facilitate the development of 
selective SL analogs, targeting each of the different roles of SLs. Many research efforts are 
currently directed to the design of target-selective SL agonists or antagonists with high 
potential for agricultural applications in weed control and as plant biostimulant.67  
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CHAPTER III 
FLUORESCENT STRIGOLACTONE ANALOGS: 
LITERATURE OVERVIEW 
1. Introduction 
While the biochemical understanding of strigolactone (SL) perception and signaling has 
extensively progressed over the past decade, little is still know about the spatial regulation of 
SL function.68 Fluorescently labeled derivatives are a valuable tool in completing these gaps 
in the current knowledge. They are particularly suited to visualize the spatiotemporal 
distribution within the organism and to locate the receptor site. Indeed, the incorporation of a 
fluorescent tag into plant hormones to study their in vivo molecular action is rapidly gaining 
scientific interest, largely thanks to the advances made in imaging technology over the past 
years.69 
In this chapter, an overview is given of the fluorescent SL analogs presently reported in 
literature. The different probes are grouped according to the labeling method, and their 
synthesis, fluorescent properties and biological activity are discussed. 
2. Dansyl-labeled SL analogs 
Dansyl chloride (5-(dimethylamino)naphthalene-1-sulfonyl chloride) 3.7 is frequently used as 
a derivatization reagent in protein sequencing. It readily reacts with primary amino groups to 
produce fluorogenic sulfonamide adducts, enabling the identification of N-terminal amino acids 
by fluorescent labeling.70 Thuring et al. employed the substance to functionalize the commonly 
accepted SL standard GR24.71 In order to minimize perturbation of the biologically active part, 
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the fluorescent tag was incorporated into the aromatic A-ring. To this end, the tricyclic lactone 
2.18, an intermediate in the synthesis of GR24, was selectively aminated at the 7-position in 
two steps (Scheme 3.1). The amino group in 3.3 was protected as a Schiff base 3.4, upon 
which the enol ether bridge and lactone D-ring were introduced, similarly as described for 
GR24. Finally, 7-amino GR24 3.6, obtained after deprotection of 3.5 during column 
chromatography, was coupled with dansyl chloride 3.7 to afford dansyl-labeled GR24 3.8. 
 
Scheme 3.1. Synthesis of dansyl-labeled GR24. 
The two diastereoisomers of dansyl GR24 3.8 were separated by column chromatography, 
and the strigol-configured isomers were evaluated for their germination stimulating activity on 
seeds of Striga hermonthica and Orobanche crenata (Table 3.1). In Striga, dansyl-labeled 
GR24 3.8 effectively induces seed germination. Moreover, the intrinsic activity of the stimulant 
is higher than that of rac-GR24. In contrast, the analog is completely inactive in Orobanche 
seeds, which perfectly illustrates the distinct selectivity and flexibility of different species 
toward SL perception. As the unsubstituted rac-GR24 2.21 displays substantial germination 
activity, the observed activity loss is completely due to the attached dansyl group. No 
information about the photophysical properties of compound 3.8 were provided.  
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Table 3.1. Germination response of Striga hermonthica and Orobanche crenata seeds after treatment with 
SL analogs at different concentrations. Data are means ± SEM (n = 2). 
Entry Derivative 
Germination of  
S. hermonthica (%) 
Germination of  
O. crenata (%) 
1 mg L-1 0.01 mg L-1 1 mg L-1 0.1 mg L-1 
1 3.8a 70.0 ± 1.9 57.8 ± 3.0 1.5 ± 0.6 0.0 ± 0.0 
2 rac-GR24 40.3 ± 2.4 50.1 ± 2.8 60.7 ± 2.8 27.3 ± 3.6 
a strigol-configured enantiomers. 
Also the group of Prandi et al. employed the dansyl group as a fluorescent tag to create labeled 
SL analogs.72 Unlike Thuring et al., they used an indole-based tricyclic moiety that is somewhat 
different from the common ABC-rings of canonical SLs. In addition, the C-ring consists of a 
cyclic ketone instead of the conventional lactone. The tricyclic scaffold 3.12 was synthesized 
from 1-methylindole 3.9 in three steps involving functionalization of the 2-position and an acid-
induced Nazarov cyclization (Scheme 3.2). The compound (3.12) was selectively brominated 
in the para position with respect to the indole nitrogen, and subsequently subjected to a Suzuki 
coupling reaction with 4-aminophenylboronic ester 3.14. The obtained product 3.15 was 
reacted with dansyl chloride 3.7 under solvent-free conditions on silica as catalytic support. 
Implementation of the enol ether bridge and butenolide D-ring was accomplished as for GR24 
(Scheme 2.1, vide supra), yielding dansyl-labeled 3.17 as a mixture of inseparable 
diastereoisomers. The analog (3.17) displays fluorogenic characteristics, with maximum 
excitation (λex) and emission (λem) wavelengths of 266 nm and 520 nm, respectively. However, 
the low excitation maximum renders the analog unsuited for in vivo imaging. Furthermore, a 
seed germination assay in Orobanche aegyptiaca revealed a complete lack of activity for 
compound 3.17, even at concentrations up to 10-4 M. This is in line with Thuring’s results for 
dansyl-labeled rac-GR24 3.8, which was also inactive in Orobanche seeds.71 The authors 
hypothesized that the sulfonamide functionality, which connects the dansyl group to the SL 
core, exhibits a inhibitory effect.  
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Scheme 3.2. Synthesis of dansyl-labeled SL analog 3.17. 
3. SL analogs with xanthene-based labels 
Rhodamines and fluoresceins belong to the most used fluorophores in all research areas of 
biochemistry and biology.73 They are xanthene-based dyes, containing either aniline (3.18) or 
phenolic (3.19) substituents on the 3- and 6-positions of the tricycle (Figure 3.1). Both classes 
of compounds exist as an equilibrium of two structures: the open, fluorescent quinoid and the 
closed, colorless lactone. The open-closed equilibrium depends on the environment of the 
dye, e.g., solvent polarity and pH, but can also be controlled by functionalizing the nitrogen 
(acylation) and oxygen (acylation and alkylation) substituents of rhodamines and fluoresceins, 
respectively. The absorption and emission spectra of rhodamines are typically redshifted 
relative to fluoresceins.74 
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Figure 3.1. General structures and accepted numbering of rhodamine and fluorescein dyes. 
3.1. Tetramethylrhodamine 
By analogy with dansyl-labeled GR24 3.8, the classic fluorescent dye tetramethylrhodamine 
was used to tag GR24 2.21.75 The intermediate 7-amino GR24 3.6 was prepared following the 
same synthetic pathway as for dansyl GR24 3.8. However, the racemic tricyclic lactone 2.18 
was chromatographically resolved using cellulose triacetate, and the optically pure 
orobanchol-configured lactone (3aS,8bR)-2.18 was used as starting material. Hence, coupling 
of the D-ring in further synthetic steps resulted in two enantiopure diastereoisomers 
(3aS,8bR,2’S)-3.6 and (3aS,8bR,2’R)-3.6, which could be readily separated by column 
chromatography. The 7-amino GR24 (3aS,8bR,2’R)-3.6, displaying the same stereochemistry 
as the natural SL orobanchol 2.5, was retained for subsequent fluorescence labeling (Scheme 
3.3). First, the amino group was reacted with a pentafluorophenyl (PfP) activated ester of 
glycine (Gly), which serves as a spacer between the SL core and the fluorescent reporter 
group. After removal of the Boc protective group, analog 3.20 was coupled with 
tetramethylrhodamine 6-isothiocyanate (6-TRITC) 3.21, yielding rhodamine-labeled GR24 
3.22 as a single isomer. The activity as seed germination inducer was evaluated on seeds of 
Striga hermonthica. The analog (3.22) retained 66% of the activity of a 1:1 diastereomeric 
mixture of GR24 2.21 (at a concentration of 2 x 10-8 M). Hence, despite the use of a spacer, 
the large A-ring substituent negatively affects the potency of the stimulant. The spectroscopic 
properties and in vivo visibility of rhodamine GR24 3.22 were not determined, nor has the 
derivative been used as active tracer in SL research. 
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Scheme 3.3. Synthesis of rhodamine-labeled (3aS,8bR,2’R)-GR24. 
3.2. Fluorescein 
The same SL scaffold of dansyl-labeled 3.17 was used by Prandi et al. to adhere the traditional 
fluorophore fluorescein.72 The first steps of the synthesis, i.e., the generation of the tricyclic 
moiety and connection of a 4-aminophenyl substituent, are identical to those of dansyl analog 
3.17. With the necessary protection and deprotection steps, the enol ether bridge and D-ring 
were introduced to aniline derivative 3.15, following the well-established conditions (Scheme 
3.4). Finally, the fluorescent tag was connected through reaction of the free amino group of 
3.25 with the commercial fluorescein 5-isothiocyanate (5-FITC) 3.26.  
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Scheme 3.4. Synthesis of fluorescein-labeled SL analog 3.27. 
Relative to the fluorescein dianion, displaying excitation and emission maxima at respectively 
491 nm and 510 nm,74 the fluorescent characteristics of the fluorescein-labeled SL analog 3.27 
are significantly shifted to shorter wavelengths. The maximal absorption below 400 nm 
precludes analog 3.27 from application in bioimaging experiments due to technical 
incompatibility with the lasers used in confocal microscopy. Furthermore, the activity of 3.27 
as germination stimulant is poor, with only 7% germination of Orobanche aegyptiaca seeds 
(at a concentration of 10-8 M). For comparison, the unlabeled analog 3.28 (Figure 3.2)76 and 
GR24 2.21 (1:1 diastereomeric mixture) induced 81% (10-8 M) and 72% (10-7 M) germination, 
respectively. From this data it is clear that the inserted fluorescein tag significantly 
compromises the biological activity.  
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Figure 3.2. Structure and activity on Orobanche aegyptiaca seeds of unlabeled SL analogs 3.28 and 3.29. 
4. SL analogs with BF2-chelated labels 
4.1. BODIPY 
BODIPY dyes consist of the general structure of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 
3.30, often abbreviated to boron-dipyrromethene, hence BODIPY (Figure 3.3). This class of 
dyes is characterized by sharp fluorescence peaks with high quantum yields, and usually emits 
yellow to deep red light. The BODIPY fluorophore is extremely versatile, and the spectroscopic 
properties are easily tuned by modification of the substituents on the dipyrromethene 
framework. Furthermore, their absorption and fluorescence emission spectra are relatively 
insensitive to the temperature, pH and polarity of the environment. BODIPY dyes are widely 
used to generate fluorescent conjugates of proteins and DNA.77 
 
Figure 3.3. General structure and accepted numbering of BODIPY dyes. 
The formal charges on boron and nitrogen are not depicted in further schemes. 
The indole-based tricycle, which already served as SL base structure for the dansyl- and 
fluorescein-tagged analogs 3.17 and 3.27, was subjected to BODIPY labeling (Scheme 3.5).72 
The 1,3,5,7-tetramethylated BODIPY core 3.33 was prepared through condensation of 
2,4-dimethylpyrrole 3.31 and glutaric anhydride 3.32, followed by complexation with BF3·Et2O. 
The generated free carboxylic acid substituent in the meso position was activated as 
pentafluorophenyl (PfP) ester 3.34, and subsequently coupled with the para-aminophenyl SL 
analog 3.25. 
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Scheme 3.5. Synthesis of BODIPY-labeled SL analog 3.35. 
BODIPY derivative 3.35 exhibits satisfactory spectroscopic properties. The long maximum 
excitation and emission wavelengths, as well as the high fluorescence quantum yield (φf) are 
consistent with the requirements for in vivo imaging applications. Preliminary observations by 
means of confocal microscopy demonstrated the visibility of the BODIPY analog 3.35 as a 
green fluorescence in root hairs of Medicago truncatula (barrelclover). The compound was 
evaluated as germination stimulant on seeds of Orobanche aegyptiaca, inducing 57% 
germination at a concentration of 10-8 M. While a reduced biological activity is observed 
compared to the unsubstituted analog 3.28 (81% germination at 10-8 M),76 the decline is more 
confined relative to the dansyl- and fluorescein-labeled SL analogs 3.17 and 3.27, which are 
practically inactive in Orobanche seeds. Presumably, the flexible C3 linker between the 
BODIPY unit and the bioactive part of the molecule allows better accommodation of the SL 
analog into the receptor binding pocket. 
Owing to the second stereocenter at the methyl substituent on the C-ring in addition to the 
racemic C-2’ connection of the D-ring, BODIPY analog 3.35 exists as a diastereomeric 
mixture. As the different diastereoisomers could not be separated, a similar BODIPY-labeled 
analog 3.40 solely chiral at the D-ring was prepared (Scheme 3.6).78 Formation of the tricyclic 
scaffold 3.38, lacking the C-ring substituent, started from indole-3-propionic acid 3.36 and 
involved ring closure using polyphosphoric acid (PPA) as a dehydrating agent. The synthesis 
of the corresponding para-aminophenyl SL analog 3.39 proceeded analogously to the methyl-
substituted variant 3.25. The free amino group was then coupled with the BODIPY-labeled 
ester 3.34, generating derivative 3.40 as racemate.  
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Scheme 3.6. Synthesis of BODIPY-labeled SL analog 3.40, lacking the C-ring methyl substituent. 
Not surprisingly, the spectroscopic properties of BODIPY-labeled SL analog 3.40 are very 
similar to BODIPY derivative 3.35 containing a methyl substituent on the C-ring. Furthermore, 
BODIPY-labeled 3.40 exhibits equal germination stimulating activity as 3.35 on seeds of 
Orobanche aegyptiaca (57% at a concentration of 10-8 M).  
The optically pure enantiomers of BODIPY analog 3.40, obtained through separation by chiral 
HPLC, were used to study the distribution and movement of SLs in Arabidopsis thaliana.79 The 
analog (3.40) was found to be mainly located in the cytoplasm of root epidermal cells. A 
multidirectional flow, i.e., both shoot- and root-ward, of primarily (2’R)-configured 3.40 was 
observed. However, due to the large structural difference between BODIPY SL 3.40 and 
natural SLs, these results may be merely applicable to synthetic and/or exogenous SLs and 
differ from the behavior of natural SLs. Furthermore, cellular influx and efflux of 3.40 were 
indicated to be active, ATP-dependent processes. 
4.2. Salicylaldimine BF2 complexes 
As a variation on BODIPY dyes, salicylaldimine derivatives coordinated to BF2 were developed 
as fluorogenic labels for SL analogs.78 In these complexes, the N,N-bidentate dipyrromethene 
ligand of the BODIPY dye is replaced by a N,O-chelate forming a six-membered ring with the 
boranyl fragment.80 The para-aminophenyl SL analogs 3.25 and 3.39, respectively with and 
without methylated C-ring, were treated with different derivatives of salicylic aldehyde 3.41 
(Scheme 3.7). The imine intermediates were then chelated with BF3·Et2O, with the formation 
of boranyl derivatives 3.42 and 3.43. 
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Scheme 3.7. Synthesis of boranyl-labeled SL analogs 3.42 and 3.43. 
While both boranyl-labeled compounds 3.42 and 3.43 emit green fluorescent light, with 
maximal emission wavelengths above 500 nm, the absorption characteristics are very 
dissimilar. The nitrated analog 3.43 is maximally excited at 336 nm, which is far below the 
minimum wavelength of the lasers used for in vivo imaging. Boranyl derivative 3.42, on the 
other hand, shows an absorption maximum that is ca. 120 nm redshifted from that of the 
nitrated analog 3.43, and is thus suitable for visualization studies in plants. Despite the 
structural similarities, the compounds display reverse activities as germination stimulant on 
Orobanche aegyptiaca seeds. Boranyl derivative 3.42 (R2 = H) induces 68% germination, 
while derivative 3.43 (R2 = NO2) is nearly inactive with only 4% germination of the parasitic 
seeds (at a concentration of 10-8 M). For both derivatives, the introduction of the fluorophore 
abated the biological activity to a lesser or greater extent, as the corresponding unlabeled SL 
analogs 3.28 (R1 = CH3)76 and 3.29 (R1 = H, Figure 3.2)81 respectively trigger 81% and 88% 
germination of Orobanche aegyptiaca seeds (10-8 M). These data indicate that substitution of 
the C-ring only minimally affects the bioactivity, and that the inactivity of boranyl analog 3.43 
is predominantly due to the nitro substituent on the fluorophore. 
5. SL analogs with extended aromatic systems 
The group of Prandi also prepared several SL analogs with various aromatic substituents on 
the A-ring, using the same nitrogen-based tricyclic core as for their other labeled derivatives.81 
By extending the conjugated system of the aromatic A- and B-rings, a series of fluorescent 
analogs with different spectroscopic properties was obtained. 
The synthesis starts from the commercially available 1-methylindolin-2-one 3.44 (Scheme 
3.8). The compound was brominated (3.45) and coupled with different aromatic rings (para-
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methoxyphenyl (PMP), para-(dimethylamino)phenyl (PMAP), 2-thienyl, and 6-methoxy-2-
naphthyl (PMN)) via a Suzuki reaction (3.46). The corresponding triflates 3.47 were generated 
in the presence of phenyl triflimide under alkaline conditions. Coupling with the ethoxydienyl 
boronic ester 3.48 and subsequent Nazarov cyclization yielded the tricyclic structures 3.51. 
The bioactiphore was introduced under the usual conditions, and derivatives 3.52a-d were 
isolated as diastereomeric mixtures.  
 
Scheme 3.8. Synthesis of fluorescent SL analogs with extended aromatic system. 
The methoxylated aromatic substituents PMP (3.52a) and PMN (3.52d) have similar effects 
on the photoemission properties of the compounds, with emission maxima at 480 nm and 
quantum yields around 10% (Table 3.2). Derivatives containing the aromatic cores PMAP 
(3.52b) and 2-thienyl (3.52c) are characterized by poor quantum yields, similar to the 
unsubstituted analog 3.28.76 While the different aromatic groups caused a bathochromic shift 
of the emission maxima (λem), the excitation maxima (λex) hardly changed to longer 
wavelengths compared to analog 3.28, which is adverse for imaging purposes by confocal 
microscopy. A germination assay on seeds of Orobanche aegyptiaca showed that the SL 
analogs 3.52a-d are far less potent stimulants than the standard GR24. Furthermore, the 
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results demonstrate that even the conjugation of a small aromatic substituent to the 
strigolactone A-ring is enough to negatively affect the bioactivity. In conclusion, neither the 
desired fluorescent properties nor a strong bioactivity was achieved by extending the aromatic 
system of the basic tricyclic scaffold, and the fluorescent derivatives 3.52a-d are unsuited as 
tracer molecules. 
Table 3.2. Fluorescent properties of SL analogs 3.52a-d and germination response of Orobanche 
aegyptiaca seeds after treatment with a 10-8 M solution of the compounds. Data of unlabeled analog 3.28 
and GR24 are given for comparison. 
Entry Derivative λex (nm) λem (nm) φf (%) 
Germination of  
O. aegyptiaca (%) 
1 3.52a 335 480 10 30 
2 3.52b 300 560 3 55 
3 3.52c 325 506 6 36 
4 3.52d 335 480 12 33 
5 3.28 320 425 4 81 
6 GR24a - - - 72 
a 1:1 mixture of two racemic diastereoisomers at a concentration of 10-7 M. 
6. Turn-on probes 
Turn-on probes differentiate themselves from the previously discussed fluorescent SL analogs 
in that they only illuminate after cleavage of the butenolide D-ring by the SL receptor. In other 
words, the emitted fluorescence is indicative of active SL signal perception and transduction. 
6.1. Fluorescein-based probes 
As mentioned before, the fluorogenic open structure of fluorescein 3.19 is in equilibrium with 
the nonfluorescent closed form. This unique feature easily lends itself to the design of 
fluorescence turn-on probes. The closed lactone configuration is promoted by alkylation or 
acylation of the phenolic oxygen. However, to fully squelch fluorescence, two masking groups 
are required, one for each hydroxy substituent. Another strategy is to block conversion 
between both configurations and modulate fluorescence by the electronic character of the 
xanthene ring.74 
Japanese researchers applied both strategies to develop the profluorescent SL mimics 
Yoshimulactone Green (YLG) 3.54 and Yoshimulactone Green Double (YLGW) 3.55 (Scheme 
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3.9), named after their inventor and the green-fluorescent light they emit upon hydrolysis.82 
For the synthesis of YLG 3.54, the carboxylic acid functionality of fluorescein 3.19, which is 
engaged in the open-closed equilibrium, was first protected as ethyl ester 3.53. Subsequently, 
the lactone D-ring was attached to the phenolic oxygen, yielding the nonfluorescent 3.54. The 
preparation of YLGW 3.55 comprised double alkylation of the phenolic oxygens of fluorescein 
3.19 with bromobutenolide 2.20. 
 
Scheme 3.9. Synthesis of the fluorescence turn-on probes YLG and YLGW. 
The biological activity and in vivo visibility of the turn-on probes 3.54 and 3.55 was validated 
in Arabidopsis thaliana. The analogs were able to restore the reduced shoot branching 
phenotype in SL deficient mutants, and demonstrated active perception by the D14 receptor, 
resulting in fluorescent emission in primary and lateral roots. Furthermore, YLG 3.54 proved 
to be a potent germination stimulant, inducing 61% seed germination in Striga hermonthica, 
compared to 69% germination induction by GR24 (at a concentration of 10-7 M). YLGW 3.55 
exhibits reduced activity, triggering 33% Striga germination at 10-6 M. 
By virtue of the improved signal resolution of YLGW 3.55 relative to YLG 3.54, the former was 
used to investigate SL perception in seeds of the parasitic plant Striga hermonthica. The 
ShHTL clade of α/β hydrolase fold proteins, which produced a green fluorescence upon 
treatment with YLG(W), was identified as SL receptors mediating seed germination in Striga. 
Germination was shown to be instigated by a transient burst of YLGW hydrolysis in the radicle 
tip, which propagated toward the cotyledon of the embryo and triggered awakening of the 
entire Striga seed. Subsequent root elongation was accompanied by a second, more 
sustained phase of hydrolysis.82 
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6.2. Coumarin-based probes 
Derivatives of 7-hydroxycoumarin 3.56 and 7-aminocoumarin 3.57 (Figure 3.4) are bright, 
blue-fluorescent dyes that are often used in multicolor fluorescence applications, as their 
contrasting color is easily distinguished from the green to red light generated by the more 
common, longer-wavelength probes, e.g., fluorescein, rhodamine and BODIPY.83  
 
Figure 3.4. General structure and accepted numbering of coumarin dyes. 
Marina Blue, consisting of 6,8-difluoro-7-hydroxy-4-methylcoumarin 3.63 (DiFMU), was 
designed for its enhanced fluorescent signal and photostability compared to the parent dye 
7-hydroxycoumarin 3.56. Fluorination of the phenolic ring results in a more acid character of 
the hydroxyl group, which stimulates deprotonation and maximizes fluorescence.84 The DiFMU 
fluorophore 3.63 is prepared from 2,3,4,5-tetrafluoronitrobenzene 3.58 through the 
regiospecific synthesis of 2,4-difluororesorcinol 3.62, followed by condensation with ethyl 
acetoacetate in strong acidic medium (Scheme 3.10).84-85 This fluorogenic core was used by 
de Saint Germain and coworkers to create the profluorescent SL mimics 3.65 and 3.66 through 
attachment of a mono- or dimethylated lactone D-ring.57b Similarly to YLG 3.54, substitution of 
the phenolic oxygen quenches the fluorescence, which is again released upon hydrolysis. 
 
Scheme 3.10. Synthesis of the fluorescence turn-on probes 3.65 and 3.66. 
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The coumarin-derived turn-on probes were evaluated for shoot branching regulating activity in 
Pisum sativum (pea). Both 3.65 and 3.66 effectively suppressed shoot outgrowth in SL-
deficient plants, with 3.66 (R = CH3) being more active than 3.65 (R = H) and rac-GR24. The 
compounds were also shown to inhibit hypocotyl elongation in Arabidopsis thaliana, acting via 
the D14 receptor. 
Due to its higher bioactivity and stability, the dimethylated SL mimic 3.66 was employed to 
analyze the hydrolysis kinetics of SL receptors in pea. In vitro experiments with RAMOSUS3 
(RMS3), the pea ortholog of D14, incubated with the profluorescent probe 3.66 revealed a 
quick onset of fluorescence, followed by a plateau phase. With a constant concentration of 
3.66, the height of the plateau was dependent on the amount of enzyme, which indicates that 
RMS3 was inactivated following the hydrolysis of 3.66, being unable to hydrolyze the 
remaining substrate. Accordingly, addition of a second amount of RMS3 after reaching the 
plateau resulted in a rapid increase in fluorescence. The suggestion that the RMS3 forms a 
stable intermediate with one of the hydrolysis products was confirmed by mass spectrometry 
analysis of the protein incubated with 3.66 or rac-GR24, revealing a mass shift corresponding 
to the respective D-ring. Digestion of RMS3-D-ring complex demonstrated the D-ring to be 
covalently linked to the histidine residue of the catalytic triad, which in vitro leads to irreversible 
product inhibition. 
7. Conclusion 
The fluorescent SL analogs reported in literature can be divided in two main categories. In the 
first category, involving the majority of the analogs, fluorescent labeling is achieved through 
the conjugation of a known fluorescent dye to the canonical SL base structure consisting of 
the ABC-tricycle and enol ether linked D-ring. The most common tags are dansyl, rhodamine, 
fluorescein and BODIPY dyes. However, this approach proved rather cumbersome. The 
spectroscopic properties were often inadequate for imaging purposes in living organisms. In 
terms of biological activity, the large fluorescent substituent significantly reduced the potency 
of the labeled analogs as germination stimulant, whereas the influence on the regulation of 
other plant developmental processes has not been assessed. Within this abundant class of 
fluorescent SL analogs, only the BODIPY-labeled derivatives 3.35 and 3.40 arose as suitable 
tracers, exhibiting an appropriate combination of bioactivity and fluorescence. Derivative 3.40 
was used as a molecular probe to visualize transport and distribution in Arabidopsis thaliana. 
However, the observed phenomena might not be pertinent to natural SLs due to the large 
discrepancy between both molecular structures.  
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The second category of labeled analogs comprises so-called turn-on probes, as fluorescence 
is only generated after hydrolysis by the SL receptor. This class of analogs was only developed 
in the last few years, but already presented great advances in the insight of SL perception by 
different organisms. The fluorescein-based probes YLG 3.54 and YLGW 3.55 led to a major 
breakthrough in resolving SL perception in parasitic plants. The long-sought SL receptors in 
Striga could be identified and light was shed on the parasitizing mechanism of the seeds. The 
molecular mechanism through which SLs are perceived in higher plants was unraveled with 
the aid of coumarin derivatives 3.65 and 3.66. The receptor was shown to act as a single-
turnover enzyme, forming a covalent complex with the lactone D-ring upon SL hydrolysis.  
The past accomplishments show that fluorescently labeled SL analogs are powerful tools for 
a better understanding of the behavior and action of SLs. Both types of labeling contribute to 
the elucidation of different aspects of SL signaling, and the potential of this research approach 
is expected to be further exploited in the future.  
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CHAPTER IV 
DEVELOPMENT OF CYANOISOINDOLE-BASED 
FLUORESCENT STRIGOLACTONE ANALOGS 
1. Introduction 
As evident from the previous chapter, fluorescence turn-on probes of strigolactones (SLs) 
have been successfully developed and applied, whereas genuine tracer molecules are often 
troubled with poor in vivo visibility and reduced biological activity. As for the latter, the 
attachment of a voluminous fluorogenic side group to the canonical SL framework is the 
conspicuous culprit. The substantial increase in molecular weight and steric hindrance 
potentially results in a decreased mobility, solubility and/or receptor affinity of the labeled 
derivatives. To avoid these issues, a noncanonical type of fluorescent SL analogs was 
developed, where the fluorophore substitutes the biologically redundant tricyclic system of 
canonical SLs, thus avoiding significant changes in the global shape of the hormone. In this 
chapter, the rational design, synthesis, biological activity and spectroscopic properties of this 
novel class of labeled SL analogs are discussed. The chapter is concluded with preliminary 
visualization experiments in planta and a future outlook on the potential use of these 
fluorescent hormones in SL and other biochemical research. 
2. Design of noncanonical fluorescent SL analogs 
The fluorescent backbone chosen to replace the tricyclic system of canonical SLs comprises 
a 1-cyanoisoindole motif. This nitrogen-containing aromatic structure has long been known for 
its remarkable fluorescent properties.86 The first derivative of this fluorescent series, 
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cyanoisoindole strigolactone analog 1 (CISA-1, 4.1, Figure 4.1), has previously been designed 
by our research group.87 The butenolide D-ring and α,β-unsaturated ester, required for activity 
in both plants and fungi, are retained and connected to the nitrogen atom of the cyanoisoindole 
core. Evaluation of the biological activity in Orobanche aegyptiaca (root parasitic seed 
germination), Arabidopsis thaliana (adventitious root formation, axillary bud outgrowth) and 
garden pea (axillary bud outgrowth) proved the potency of CISA-1 4.1 to be comparable to the 
commonly used standard rac-GR24 (2.21, Scheme 2.1, vide supra).87-88 Despite modifications 
of the ABC-rings, CISA-1 4.1 even mildly induced hyphal branching of the AM fungus 
Gigaspora rosea.88 In contrast to the favorable biological activity, the inferior spectroscopic 
properties precluded the use of CISA-1 4.1 as tracer in bioimaging studies, as its fluorescence 
could not be distinguished from background signals originating from the plant matrix.87 
However, these first results revealed a promising lead compound for the further design of 
small-sized fluorescent SL analogs. 
Building on the first analog CISA-1 4.1, two different strategies were employed to boost the 
fluorogenic characteristics while maintaining the level of bioactivity. The first strategy involved 
the extension of the fluorescent isoindole ring with simple substituents, including both electron-
withdrawing (fluorine, chlorine) and electron-donating (methylenedioxy, methoxy) groups 
(Type I analogs, Figure 4.1). Secondly, comparison of the 1-cyanoisoindole core to known 
fluorescent dyes as ethidium bromide (λex = 486 nm, λem = 606 nm, phenanthridine-based dye) 
and norharmane (λex = 355 nm, λem = 460 nm, φf = 58%) provided inspiration to construct 
nitrogen-containing extended aromatic systems with improved spectroscopic properties (Type 
II analogs, Figure 4.1).89 In total, six novel SL analogs 4.2a-f with modified isoindole core 
structure were proposed as potential molecular probes. 
 
Figure 4.1. General and specific structure of the 1-cyanoisoindole-based SL analogs. 
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3. Synthetic pathway 
The route toward the CISA series of fluorescent analogs can be divided into two major parts 
(Scheme 4.1). First, different 1-cyanoisoindole ring structures 4.4 were synthesized from a 
variety of ortho-brominated arylaldehydes 4.3. Subsequently, the obtained fluorophores were 
elaborated into functional SL analogs 4.2 through the incorporation of the enol ether bridge 
and the lactone D-ring. 
 
Scheme 4.1. Overview of the CISA synthesis. 
3.1. Substituted arylaldehydes as basis for fluorescent diversity 
The derivatization of CISA-1 4.1 to obtain an array of CISA analogs with variable fluorescent 
moieties is not a late-stage modification, but rather occurs at the very start of the synthetic 
pathway. In particular, different ortho-brominated arylaldehydes form the basis of the structural 
diversity found in the final fluorophores. For derivatives 4.2a-e, the corresponding 
arylaldehydes 4.3a-e are commercially available (Figure 4.2). The precursor of 
cyanopyrrolo[3,4-b]indole analog 4.2f was synthesized from indole-2-carboxylic acid 4.5 
(Scheme 4.2). 
 
Figure 4.2. Structure of commercially available arylaldehydes 4.3a-e. 
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Scheme 4.2. Synthesis of indole-2-carbaldehyde 4.3f. 
3.1.1. Conversion of the carboxylic acid into an aldehyde 
In the first step, indole-2-carboxylic acid 4.5 was transformed into the corresponding aldehyde 
4.7 through reduction with LiAlH4 and subsequent partial oxidation with MnO2.90 The addition 
of 1.1 equivalents of LiAlH4 led to the quantitative reduction of the acid to the corresponding 
alcohol. However, isolation of this intermediate 4.6 proceeded with difficulty as the product 
tended to oligomerize both during the reaction and the following purification steps. Generally, 
indoles are known to oligomerize under various acidic conditions. Especially the C-3 position 
is highly reactive toward electrophilic substitution due to its increased electron density. Regular 
acid-catalyzed dimerization involves nucleophilic addition to the iminium moiety of the 3-
protonated species.91 In the case of indole-2-methanol 4.6, a second appropriate electrophilic 
site is present. Similar to benzylic and allylic systems,92 the carbon bearing the alcohol is highly 
activated through either a partial or entire positive charge, and can be readily intercepted by 
intermolecular reaction with a second indole ring.93 By means of LC MS, dimers (11%), trimers 
(3%) and even tetramers (2%) of indole-2-methanol 4.6 were identified under the initial 
reaction conditions. Different measures were taken to reduce this side reaction. First, to avoid 
dimerization during the reaction, the mixture in dry THF was diluted fivefold from 0.31 M to 
0.062 M and the reaction time was kept to the minimum (1.5 h) instead of overnight stirring. 
Secondly, the initial acidic quench of the reaction mixture in aqueous 1 M HCl was replaced 
by a neutral aqueous quench. Finally, as also column chromatography significantly promoted 
oligomerization, possibly catalyzed by the acidic nature of the silica gel, no additional 
purification step was performed. Instead, during solvent extraction with ethyl acetate, a 
saturated aqueous solution of the mild base NaHCO3 was used to remove any remaining 
starting material from the organic phase. Under the optimized conditions, oligomerization was 
completely suppressed during the reaction and extraction steps, as was revealed by LC MS. 
Yet, in the final product, up to 10% of dimer was found (LC MS, 220 nm). Consequently, 
CYANOISOINDOLE-BASED FLUORESCENT STRIGOLACTONES 
41 
dimerization was also induced during solvent evaporation, when temporarily high 
concentrations are attained. Indole-2-methanol 4.6 was isolated as brown-red crystals in 46% 
yield, corrected for the dimer present. 
The following oxidation of the primary alcohol with activated MnO2 was evaluated in different 
solvents and at different concentrations (Table 4.1). The starting material consisted of a 9:1 
mixture of indole-2-methanol 4.6 and its dimer, which can be oxidized to the corresponding 
aldehyde as well. Toluene significantly stimulated the dimerization process, leading to a 
substantial increase of the dimer to monomer ratio in the oxidized product (66:34) compared 
to the starting material (entry 1). To assess if the concentration was the determining factor, 
the reaction was repeated in diluted reaction conditions (entry 2). However, significant 
dimerization was still observed, and toluene was considered unsuitable as solvent for this 
reaction. When the reaction was performed in THF or ethyl acetate, no additional dimers were 
formed at concentrations up to 0.06 M (entries 3, 4 and 5). Yet, the reaction in THF proceeded 
less cleanly and column chromatography was required to purify compound 4.7. Ethyl acetate, 
on the other hand, generally yielded pure material after removal of the oxidant over celite and 
evaporation of the solvent, resulting in higher isolated yields. 
Table 4.1. Oxidation of indole-2-methanol 4.6 to indole-2-carbaldehyde 4.7 with MnO2. 
 
Entry Solvent Concentration (M) t (h) M:Da Yield (%)b 
1 toluene 0.06 1 34:66 - 
2 toluene 0.03 1 38:62 - 
3 THF 0.03 17 9:1 34 
4 EtOAc 0.03 17 9:1 55 
5 EtOAc 0.06 4 9:1 82 
a determined by LC MS (220 nm). b isolated yield. 
Furthermore, the suitability of ethyl acetate as a solvent for the oxidation reaction provided a 
solution to the problem of dimerization during solvent evaporation in the previous step. Instead 
of evaporation to dryness, the volume of the organic phase after extraction of indole-2-
methanol 4.6 with ethyl acetate was only partially reduced until a concentration of 
approximately 0.06 M was reached. The resulting solution was then treated with five 
equivalents of MnO2 and heated to reflux until completion of the oxidation. After removal of the 
solid particles by filtration, indole-2-carbaldehyde 4.7 was obtained as pure crystals in 75% 
CHAPTER IV 
42 
isolated yield. No oligomers were observed throughout the reaction sequence. In contrast, 
only 38% overall yield was obtained over the two steps when the intermediate alcohol 4.6 was 
isolated. 
3.1.2. Methylation of the indole nitrogen 
With the aldehyde in hand, the indole nitrogen was alkylated with methyl iodide in the presence 
of sodium hydride to avoid acid-base reactions at the N-H center in later synthetic steps.94 A 
small methyl group was chosen over larger substituents to minimize deviation from the natural 
hormone structure. Although N-methylation of 4.7 using 1.1 equivalents of both reagents 
proceeded very fast in dry DMF, attaining full conversion after 2 h at room temperature, dry 
THF was preferred as solvent because of its easy removal after reaction. The transformation 
in THF was evaluated at different concentrations with variating amounts of NaH and MeI 
(Table 4.2). Using a slight excess (1.1 equivalents) of base and methyl halide, the 
N-methylated indole 4.8 was isolated in high yield (90%) after 72 h stirring at room temperature 
(entry 1). In an attempt to improve the conversion rate, the amount of both reagents was 
increased to 1.7 equivalents. While all starting material was consumed after 41 h, 29% of side 
product 4.9 was obtained, resulting from sodium hydride reduction of the aldehyde followed 
by methylation. The presence of methyl ether 4.9 was confirmed by 1H NMR as well as mass 
spectrometry. The activity of NaH as reducing agent is rather exceptional. Indeed, the 
reduction of π-electrophiles, such as carbonyls, nitriles, and imines, is commonly performed 
using complex hydrides, e.g., LiAlH4 and NaBH4. Alkali metal hydrides, including NaH, are 
almost exclusively employed as strong Brønsted bases.95 However, the reductive methylation 
of ketones when exposed to a mixture of NaH and MeI has been reported earlier.96 The 
presence of dissolved iodide ions is pivotal for the observed hydride-donor activity of NaH, 
and the combination of NaH with LiI or NaI was shown to also effectively reduce nitriles, 
amides and imines.97 In the case of aldehyde 4.7, this side reaction could be restrained by 
limiting the amount of hydride base to 1.1 equivalents. Doubling the amount of alkylating 
reagent from 1.1 to two equivalents drove the isolated yield of the desired product 4.8 to the 
maximum (entry 3). By increasing the concentration, the required reaction time was 
significantly reduced from four days to several hours (entry 4). The product (4.8) was obtained 
as pure crystals after extraction and evaporation of the solvent. For comparison, reaction in 
DMF required purification by column chromatography to remove solvent traces, resulting in a 
slightly reduced isolated yield of 88%.  
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Table 4.2. N-alkylation of indole-2-carbaldehyde 4.7 in the presence of sodium hydride. 
 
Entry Concentration (M) Equiv NaH Equiv MeI t (h) 4.8 (%)a,b 4.9 (%)a 
1 0.04 1.1 1.1 72 95 (90) 0 
2 0.04 1.7 1.7 41 71 29 
3 0.08 1.1 2 96 100 (quant.) 0 
4 0.16 1.1 2 15 100 (quant.) 0 
a conversion determined by 1H NMR (CDCl3). 
b isolated yield between brackets. 
3.1.3. Bromination of the indole ring 
As mentioned before, indoles readily react with electrophiles at the C-3 position.91 Accordingly, 
derivative 4.8 was easily halogenated at this center using the electrophilic brominating agent 
N-bromosuccinimide (NBS). The reaction was performed in 2-methyltetrahydrofuran, 
commonly considered a greener alternative to THF, although some solvent guides still 
discommend its use in terms of health, safety and environmental hazards.98 The reaction 
proceeded smoothly with five equivalents of NBS and full conversion was reached within 2 h 
at room temperature. Bromoindole 4.3f was obtained in 90% yield after recrystallization in 
hexane.  
In summary, 3-bromo-1-methyl-1H-indole-2-carbaldehyde 4.3f was synthesized from indole-
2-carboxylic acid 4.5 in four steps in 68% overall yield. The reaction sequence is easy, robust 
and time efficient as gram-scale synthesis can be achieved in 24 h without the need for silica 
gel purification of the intermediates after the usual work-up. 
3.2. Sonogashira coupling with ethynyltrimethylsilane 
The first step of the three-step synthetic pathway to convert the different ortho-brominated 
arylaldehydes 4.3a-f into the corresponding fluorophores is a Sonogashira cross-coupling 
reaction with ethynyltrimethylsilane.99 The coupling reaction was performed under mild 
conditions in the presence of 2 mol% of a Pd/Cu catalytic system. The added Pd(PPh3)2Cl2 is 
a palladium(II) precatalyst and is activated in situ by reduction to palladium(0) before entering 
the classical catalytic cycle of oxidative addition and reductive elimination.100 Copper(I) iodide 
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functions as a co-catalyst, and is proposed to deliver the terminal alkyne to the palladium 
catalyst through transmetallation. As copper can also catalyze the homocoupling of terminal 
alkynes in the presence of oxygen, a reaction known as the Glaser or Hay coupling,101 the 
Sonogashira cross-coupling was performed under inert argon atmosphere. Amine bases are 
usually added in excess to facilitate the catalytic process by neutralizing the hydrogen halide 
released in the copper cycle with the formation of copper acetylide.102 In addition, they might 
also play a role in the generation of the active palladium(0) species.102c In this case, 
triethylamine was employed as solvent. Though Sonogashira coupling is typically achieved at 
ambient temperature, a short period of reflux was necessary for most derivatives 4.3 to push 
the coupling with ethynyltrimethylsilane to completion (Table 4.3). The catalyst was removed 
over a plug of celite and the obtained TMS-protected alkynylarenes 4.10a-f were subjected to 
desilylation without additional purification. Potassium carbonate in methanol proved a 
successful deprotection strategy, provided that the base was added at low temperature (0 °C) 
and that heat sources were avoided at all times. For analogs 4.10a-e, TMS removal was 
complete after 1 h at room temperature. In the case of indole derivative 4.10f, cooling was 
maintained during the complete desilylation step, as also ambient temperature promoted the 
formation of (unknown) side products. Alternatively, the TMS group of 4.10f was removed 
using 1.05 equivalents of TBAF in THF (30 min at room temperature), however, the isolated 
yield (51%) was significantly lower compared to K2CO3-effected deprotection. Finally, the 
terminal alkynes 4.11a-f were purified via column chromatography on silica gel and obtained 
in good to excellent yields.  
Table 4.3. Sonogashira cross-coupling and silyl deprotection of analogs 4.3a-f. 
 
Entry Derivative R1 R2 t1 (h) t2 (h) Yield (%)a 
1 4.3a H F 1 1.5 69 
2 4.3b H Cl 1 0 79 
3 4.3c -OCH2O- 1 1.5 73 
4 4.3d OCH3 OCH3 1 2 67 
5 4.3e naphthaleneb 1.5 1 78 
6 4.3fc indoleb 19 2 quant.d 
a isolated yield after column chromatography. b for the complete structure, see section 3.1. 
c desilylation (step 2) was performed by stirring at 0 °C for 3 h. d no purification was needed. 
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For type I analogs 4.10a-d, containing electron-donating and -withdrawing substituents on the 
aromatic ring, the deprotection side product at elevated temperatures (> 25 °C) was identified 
as dihydroisobenzofuran 4.12 (Scheme 4.3). Isotopic labeling experiments with deuterated 
MeOH-d4 confirmed interaction of the solvent with the aldehyde. More specifically, at increased 
temperatures, the methoxy anions generated from potassium carbonate and methanol 
performed a nucleophilic attack on the carbonyl with in situ formation of a transient hemiacetal 
anion. Subsequent 5-exo-dig annulation of the deprotonated hemiacetal on the triple bond, 
followed by solvent-mediated protonation eventually gave cyclic acetal 4.12.103 Analogous to 
deprotection at ambient temperature, the TMS group was removed as well. Accordingly, 
deuterium labels were identified in the methoxy and methylene moieties (4.13). 
Interestingly, ortho-alkynylbenzaldehydes with electron-withdrawing substituents, such as 
chlorine (4.10b), were found to be more susceptible to this tandem addition/annulation side 
reaction than derivatives with electron-donating substituents, e.g., the dimethoxy analog 
4.10d. After 20 min at 40-50 °C, 4.10b was completely converted to dihydroisobenzofuran 
4.12b, while 4.10d mostly displayed TMS deprotection, with only a minor fraction (11%) of 
cyclized side product 4.12d. The reason for this reactivity difference can be found in the 
electron density of the triple bond. In 4.10d, the electron-donating substituent renders the triple 
bond more electron rich, reducing its reactivity toward nucleophilic attack. On the other hand, 
the chlorine substituent is electron withdrawing and might slightly activate the triple bond for 
cyclization. Dihydroisobenzofuran 4.12b was isolated in 30% yield after column 
chromatography on silica gel with 10:1 hexane/ethyl acetate as eluent, supplemented with 1% 
Et3N. The latter was necessary to neutralize the acidity of the silica gel to avoid acid-catalyzed 
acetal decomposition.  
 
Scheme 4.3. Domino nucleophilic addition/annulation and desilylation of TMS-protected 
alkynylbenzaldehydes with potassium carbonate in methanol. 
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3.3. Strecker synthesis of α-amino nitriles 
Following the implementation of the terminal alkyne, a Strecker reaction was carried out to 
convert the aldehyde into an α-amino nitrile group. The Strecker synthesis, originally reported 
by Adolph Strecker in 1850, is a two-step reaction sequence to prepare α-amino acids from 
aldehydes or ketones.104 The first step involves the generation of an α-amino nitrile adduct 
4.18 through condensation of carbonyl compound 4.14 with ammonia and a cyanide source. 
Subsequent acid hydrolysis of the nitrile functionality affords the corresponding α-amino acid 
4.19.105 In the early years after the initial report, two mechanistic pathways were proposed for 
the formation of Strecker adduct 4.18 (Scheme 4.4). The first mechanism involves nucleophilic 
displacement of the hydroxyl group of cyanohydrin intermediate 4.16 by the incoming amine,106 
while the opposed route suggests cyanide addition to Schiff base intermediate 4.17.107 The 
second route is also supported by more recent mechanistic studies.108  
 
Scheme 4.4. Proposed mechanisms for the Strecker α-amino acid synthesis. 
3.3.1. Reaction design 
3.3.1.1. Catalyst 
Formation of the Strecker adduct (4.18) is usually performed under homogeneous or 
heterogeneous catalysis, and a myriad of Lewis and Brønsted acids, organocatalysts, metal 
complexes, and even ionic liquids have been proposed to promote the three-component 
Strecker reaction.109 Moreover, various chiral catalysts have been designed to induce 
enantioselective cyanation of the imine intermediate (4.17), and the catalytic asymmetric 
Strecker reaction has become a popular method for the synthesis of optically pure α-amino 
nitriles and α-amino acids.110 For the Strecker reaction of aryl aldehydes 4.11a-f, 
2,2,2-trifluoroethanol (TFE) was chosen as nonconventional acid catalyst to activate the 
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carbonyl for nucleophilic addition.111 TFE is a strong hydrogen donor, as the hydroxyl group is 
characterized by a high acidity due to the electron-withdrawing nature of the CF3 group. 
Furthermore, TFE shows excellent solvent features. Compared to its nonfluorinated 
counterpart, ethanol, it exhibits a high polarity, and poor nucleophilic and hydrogen bond 
accepting properties similar to nonalcoholic solvents.112 As such, a dual role was attributed to 
TFE as solvent and catalyst. 
3.3.1.2. Cyanide source 
The most commonly used cyanide sources in the Strecker synthesis are gaseous HCN, the 
alkaline metal cyanides KCN and NaCN, acetone cyanohydrin, and trimethylsilyl cyanide 
(TMSCN), with the latter often applied as reference cyanating agent in the evaluation of new 
catalytic systems.109 In addition to its proven efficiency with a variety of different carbonyls, 
amines and catalysts, the reduced toxicity compared to HCN and the cyanide salts rendered 
TMSCN the cyanide source of choice for the conversion under consideration. Moreover, the 
trimethylsilyl cation can serve as a dehydrating agent during the condensation of the carbonyl 
4.14 with the amine, providing a driving force for further iminium formation in accordance with 
Le Chatelier’s principle (Scheme 4.5). The water is trapped as trimethylsilanol, likely during 
the hydrolysis of the cyanosilylated intermediate 4.21, which is produced through direct 
addition of TMSCN across the C-N double bond of iminium derivative 4.20 (route a).113 
Alternatively, the released water can immediately react with the highly oxophilic silicon atom 
of TMSCN with the formation of a hypervalent pentacoordinate silicate species 4.22, 
characterized by an enhanced nucleophilic character compared to TMSCN (route b).114 
Liberation and addition of the cyanide anion or direct condensation with iminium derivative 
4.20 affords then the final α-amino nitrile 4.23 and trimethylsilanol by-product. 
 
Scheme 4.5. Proposed mechanism of the acid-catalyzed one-pot Strecker reaction with TMSCN. 
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3.3.1.3. Amine 
In view of the following cyclization step, involving a Claisen-type rearrangement,115 an allylic 
substituent ought to be connected to the nitrogen in the α-amino nitrile backbone. The other 
N-substituent was chosen as a function of the structural requirements for active SL analogs 
and is an α-positioned ester. The required secondary amine 4.25 was generated from ethyl 
2-bromoacetate 4.24 and allylamine according to a procedure of Hong et al. (Scheme 4.6).116 
The alkyl halide 4.24 was added dropwise to an excess of allylamine in cooled diethyl ether to 
suppress overalkylation toward tertiary amines and quaternary ammonium salts. During the 
reaction, a white precipitate was formed, which was identified as the hydrogen bromide salt of 
allylamine and removed by filtration. Ethyl N-allylglycinate 4.25 was obtained in 67% yield after 
vacuum distillation.  
 
Scheme 4.6. Preparation of the secondary allylic amine as reagent for the Strecker reaction. 
3.3.2. Strecker reaction of type I analogs 4.11a-d 
To a solution of aldehydes 4.11a-d in TFE, two equivalents of the amine 4.25 were added. 
The mixture was stirred for 15 minutes to promote iminium formation, followed by the slow 
addition of two equivalents of TMSCN. α-Amino nitrile formation was tedious at room 
temperature for all derivatives, with reaction times up to several days. The slow conversion 
rate is probably due to the bulky nature of the amine 4.25. One-pot Strecker reactions are 
mostly carried out with aldehydes and primary amines, mainly anilines and benzylamines. 
Whenever ketones or secondary amines are used, the increased steric hindrance results in 
longer reaction times and/or dropped yields.117 In an attempt to boost the condensation 
process, the reaction was run at reflux temperature. Within a few hours, the starting material 
4.11a-d was completely consumed. In addition to the α-amino nitrile adducts 4.26a-d, even 
traces of the desired 1-cyanoisoindole ring structures 4.4a-d were observed. Hence, TFE is 
not only an effective catalyst for imine and α-amino nitrile formation in the Strecker reaction, it 
can also activate the triple bond for the ensuing nitrogen-induced cyclization. Based on this 
observation, we investigated the feasibility of a one-pot Strecker reaction/cyclization 
sequence. After almost two days at reflux temperature, full conversion of aldehydes 4.11a-d 
to cyanoisoindoles 4.4a-d was accomplished (Table 4.4). The mechanistic details of the 
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cycloisomerization process are discussed in section 3.4. The fluorophores 4.4a-d were purified 
by column chromatography on silica gel. Occasionally, the cyanoisoindole was not fully 
separated from the excess amine reagent 4.25 present in the crude mixture. In this case, the 
remaining amine impurities were removed by washing a solution of the product in ethyl acetate 
with aqueous 0.5 M HCl. 
Table 4.4. α-Amino nitrile formation of aldehydes 4.11a-d and subsequent cyclization in TFE. 
 
Entry Derivative R1 R2 t (h) Yield (%)a 
1 4.11a H F 41 53 
2 4.11b H Cl 41 54 
3 4.11c -OCH2O- 44 43 
4 4.11d OCH3 OCH3 44 63 
a isolated yield after column chromatography. 
3.3.3. Strecker reaction of type II analog 4.11e 
Similar to the type I analogs 4.11a-d, the Strecker reaction of type II analog 4.11e with the 
secondary amine 4.25 and TMSCN proceeded very slow in TFE at room temperature. While 
increasing the temperature was a successful strategy for derivatives 4.11a-d, an unidentified 
cyclization product 4.27 was obtained when 4.11e, amine 4.25 and TMSCN were refluxed for 
approximately two days (Scheme 4.7). Furthermore, the conversion was incomplete, and next 
to 18% of the expected isoindole 4.4e and 56% of unknown side product 4.27, 26% of starting 
material 4.11e was still present. Separation of the mixture by preparative TLC (7:1 
hexane/ethyl acetate) allowed the isolation of the different compounds. Based on 1H and 
13C NMR spectra and the detected m/z of 306 (M + H+), the main product 4.27 was identified 
as a C20 compound, comprising a tricyclic aromatic structure with an allylamine and ethyl 
carboxylate substituent. However, the exact molecular structure could not be determined. 
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Scheme 4.7. Reaction of naphthaldehyde 4.11e with amine 4.25 and TMSCN at reflux temperature. 
Because of the unforeseen high reactivity toward undesired cyclization, the Strecker reaction 
of 4.11e was constrained to room temperature. Other parameters were varied in order to drive 
the reaction to completion, including the order of addition of the amine and the cyanide source. 
Indeed, the sequence in which the starting reagents are added has been shown to directly 
influence the yield of the target α-amino nitriles.113 In fact, this should come to no surprise. 
Depending on which mechanistic pathway is followed, the cyanohydrin or imine pathway, one 
order of addition favors the formation of the appropriate intermediate while the other might 
induce side reactions. Both possibilities were investigated for the reaction under consideration 
(Table 4.5). 
Table 4.5. Reaction conditions for the condensation of naphthaldehyde 4.11e with amine 4.25 and TMSCN 
at room temperature. 
 
Entry 
Catalyst 
(equiv) 
Order of 
reagents 
Equiv 
4.25 
Equiv 
TMSCN 
t (h) 
4.11e 
(%)a 
4.26e 
(%)a,b 
4.28 
(%)a 
4.29 
(%)a 
1 
TFE 
(solvent) 
B, A 1.5 5 x 2 144 10 83 (66) 6 1 
2 
TFE 
(solvent) 
A, B 1.5 2 144 3 96 (90) 1 0 
3c 
Mg(ClO4)2 
(0.1) 
A, B 1.1 1.5 4.5 0 10 0 90 
a conversion determined by 1H NMR (CDCl3). 
b isolated yield between brackets. c in dry Et2O (0.05 M). 
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First, the cyanohydrin pathway was assumed and TMSCN was added to a solution of 
naphthaldehyde 4.11e in TFE (entry 1). After premixing for 1 h at room temperature, a 
substantial amount of cyanohydrin 4.28 (37%, LC MS, 220 nm) was observed. Subsequently, 
the amine 4.25 was added and stirring was continued. At several points in time when the 
reaction rate was dropping, another two equivalents of TMSCN were added. Finally, 90% 
conversion was reached after six days (144 h), and both the cyanohydrin 4.28 (6%) and the 
silylated counterpart 4.29 (1%) were detected in the reaction mixture. The desired α-amino 
nitrile 4.26e was isolated in 66% yield after column chromatography on silica gel with 10:1 
hexane/ethyl acetate as eluent. Secondly, the order of the reagents was reversed and the 
amine 4.25 was allowed to react for 15 minutes with the starting material 4.11e to stimulate 
iminium formation, before two equivalents of TMSCN were added dropwise (entry 2). In 
contrast to the previous reaction setup (entry 1), no extra portions of the cyanide source were 
added. Nonetheless, a similar conversion of 97% was reached within the same time. 
Furthermore, less cyanohydrin 4.28 was present in the final mixture (1% instead of 6%), and 
silyl ether 4.29 was not detected at all during the reaction. Presumably, the generation of side 
product 4.29 in TFE requires the presence of a large excess of silylating reagent. The product 
4.26e was isolated in 90% yield after column chromatography. The faster rate of condensation 
and the reduced amount of remaining cyanohydrin 4.28 when TMSCN is added to an 
equilibrium mixture of amine and aldehyde suggest that the iminium is indeed the Strecker 
intermediate in our reaction setup. The formation of cyanohydrin is merely a side reaction, 
delaying the overall reaction progress. Several authors propose that the conversion of 4.28 to 
the α-amino nitrile product 4.26e involves dissociation to the carbonyl compound 4.11e and 
HCN, followed by the imine pathway.108a, 118  
Finally, the reaction was repeated with the nontoxic Lewis acid Mg(ClO4)2 as catalyst instead 
of TFE (Table 4.5, entry 3).119 Mg(ClO4)2 is seemingly more effective than TFE in activating 
the aldehyde and accelerating the reaction, as full conversion was obtained after 4.5 h. 
However, mainly nucleophilic addition of the cyanide to the carbonyl was promoted, despite 
the prior mixing of amine 4.25 and aldehyde 4.11e in the presence of Mg(ClO4)2. Attempts to 
purify the cyanohydrin TMS ether 4.29 on silica gel resulted in the recovery of the starting 
aldehyde 4.11e, which supports the hypothesized reversibility of cyanohydrin formation. 
In conclusion, TFE is also the catalyst of choice for the Strecker synthesis of α-amino nitrile 
4.11e, and premixing the carbonyl and amine before addition of the cyanide source was shown 
to give the best results.  
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3.3.4. Strecker reaction of type II analog 4.11f 
The optimized conditions for the Strecker reaction, as found for naphthalene derivative 4.11e, 
were applied to convert indole-2-carbaldehyde 4.11f into the corresponding α-amino nitrile 
4.26f (Scheme 4.8). However, the conversion of 4.11f proceeded two to four times slower 
compared to 4.11e, and it took as much as 13-24 days, depending on the reaction scale, to 
reach 90% consumption of the starting material (Figure 4.3). In addition to the desired product 
4.26f, four side products were identified and quantified by 1H NMR, based on the appearance 
of characteristic CH peaks derived from the original aldehyde function (Table 4.6). 
 
Scheme 4.8. Synthesis of α-amino nitrile 4.26f through condensation of indole-2-carbaldehyde 4.11f with 
amine 4.25 and TMSCN at room temperature. 
 
Figure 4.3. Progress of the Strecker reaction (determined by 1H NMR, in CDCl3) of aldehyde 4.11f 
(0.4 mmol), amine 4.25 and TMSCN in TFE. Proof for the conversion of the intermediate 4.32 into the 
product 4.26f is shown in gray.  
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Table 4.6. Structure and peak assignment of the detected side products during the Strecker reaction of 
indole-2-carbaldehyde 4.11f with amine 4.25 and TMSCN. 
 
Entry 
Characteristic 
CH peak in 
1H NMR (ppm)a 
Other peaks in 
1H NMR 
Observed 
mass in LC 
MS (m/z)b 
Assigned 
structure 
MW 
(g mol-1) 
1 6.05 TMS 283 4.31 282 
2 6.06 no TMS -c 4.30 210 
3 6.15 no TMS -c 4.32 326 
4 6.45 
allyl signals 
integrate double 
433 4.33 432 
a in CDCl3. 
b ions were produced by electrospray ionization (M + H+). c not detected in LC MS.  
Given the product distribution observed for the Strecker reaction of 4.11e, nucleophilic addition 
of cyanide to the aldehyde, with formation of cyanohydrins 4.30 and 4.31, was anticipated. 
The TMS-protected cyanohydrin 4.31 was unambiguously identified by mass spectroscopy 
(LC MS). The structure was confirmed by 1H NMR, as the singlet at 6.05 ppm (in CDCl3) was 
systematically accompanied by a large peak around 0 ppm integrating for nine protons, 
consistent with a TMS group (vide infra) (entry 1). In contrast, cyanohydrin 4.30 was never 
observed by LC MS. Presumably, 4.30 rapidly dissociates to the initial aldehyde under these 
conditions. Based on spectroscopic data from literature120 and the proton spectra of the 
naphthalene-based cyanohydrins 4.28 and 4.29, the characteristic proton of 4.30 is less than 
0.05 ppm downfield shifted from that of 4.31. As such, the singlet at 6.06 ppm (in CDCl3) was 
assigned to 4.30 (entry 2). The characteristic peak around 6.15 ppm (in CDCl3) was mainly 
observed in 1H NMR during the first part of the reaction, after which it gradually diminished. 
This decrease directly resulted in formation of the α-amino nitrile 4.26f (Figure 4.3). Along with 
its disappearance in aqueous conditions, e.g., after aqueous work-up or during LC MS 
analysis with a water/acetonitrile mixture as eluent, the structure was tentatively assigned as 
the hemiaminal intermediate 4.32 (entry 3). Compound 4.33 was easily identified upon 
integration of the peaks in 1H NMR. Six protons were counted for the allylic double bond, while 
only four aromatic protons, one N-methyl and one ethoxy group were distinguished, together 
with a singlet at 6.45 ppm (in CDCl3) integrating for one proton. The molecular structure was 
confirmed by mass spectrometry (LC MS), including a retention time similar to α-amino nitrile 
4.26f (entry 4). The product is formed by nucleophilic addition of the (excess) amine 4.25 onto 
CHAPTER IV 
54 
the ester moiety of the end product 4.26f, and was only observed after prolonged stirring (> six 
days, Figure 4.3). For both the small (0.4 mmol) and big (4.4 mmol) scale Strecker reaction of 
4.11f at ambient temperature, 77% of the desired product 4.26f was detected when 90% of 
the starting material was converted. The remaining 13% consisted of intermediate 4.32 (2%), 
cyanohydrin 4.30 (3%), and side product 4.33 (8%). The α-amino nitrile 4.26f was isolated 
from the mixture by reversed-phase column chromatography in 24-28% yield. 
Although simple stirring of the three-component mixture furnished α-amino nitrile 4.26f, the 
indolent reaction rate urged to screen for improved conditions. As formation of the iminium 
intermediate is a crucial step in the synthesis of the Strecker adduct, the reaction might benefit 
from an increased amount of amine. Therefore, the reaction was repeated on a 0.2 mmol scale 
using a large excess of amine 4.25 (Scheme 4.9). The mixture was supplemented with two 
equivalents of TFE, while the amount of TMSCN was unchanged. Nevertheless, full 
conversion of the starting material 4.11f was only reached after 13 days, which constitutes no 
improvement compared to the previous reaction conditions. In addition, the reaction mixture 
contained a substantial amount of 4.33, which was the sole product after 19 days. Hence, 
increasing the amount of amine reagent does not enhance the reaction rate, but instead 
promotes conversion of α-amino nitrile 4.11f into the undesired side product 4.33. 
 
Scheme 4.9. Strecker reaction of indole-2-carbaldehyde 4.11f with TMSCN and a large excess of amine 
4.25. 
Consequently, other approaches were required to advance the transformation at hand. 
Besides the general accelerating effect of temperature on a chemical process, different 
alternative methods have been reported to specifically activate sterically hampered Strecker 
reactions, including microwave conditions,121 ultrasound,122 elevated pressure,123 and 
mechano-chemical activation.124 Based on practical feasibility, conventional heating as well as 
microwave and ultrasonic irradiation were selected for evaluation in the synthesis of α-amino 
nitrile 4.26f. In each case, the amine 4.25 and aldehyde 4.11f were equilibrated beforehand 
for 15-30 minutes in the presence of the chosen catalyst, as this was established to be the 
most expedient procedure for the three-component condensation process. 
CYANOISOINDOLE-BASED FLUORESCENT STRIGOLACTONES 
55 
3.3.4.1. Temperature 
Similar to the previous analogs 4.11a-e, a first attempt to stimulate the conversion involved 
raising the reaction temperature. The starting material 4.11f was completely consumed after 
six days at 74 °C, however, neither the desired α-amino nitrile 4.26f nor the derived isoindole 
4.4f were detected. Instead, a cyclization product 4.34, analogous to 4.27 in the Strecker 
reaction of 4.11e under reflux conditions, was obtained (Scheme 4.10). The NMR and MS 
spectral data, recorded after purification of the product by reversed-phase column 
chromatography, revealed an aromatic indole-based C19 compound, containing an allylamine 
and ethyl carboxylate substituent (m/z 309, M + H+). Again, complete structure elucidation was 
not achieved. Consequently, the indole derivative 4.11f was affected by the same annulation 
side reaction as derivative 4.11e at elevated temperature. 
 
Scheme 4.10. Reaction of indole-2-carbaldehyde 4.11f with amine 4.25 and TMSCN at reflux temperature. 
Presumably, the free terminal alkyne is involved in the observed cyclization process. In this 
case, a possible approach to circumvent side product formation at high temperatures is to 
apply the Strecker conditions to the TMS-protected analog 4.10f. The reaction was examined 
at both 50 °C and 74 °C. Apart from a small fraction of cyanohydrin immediately after TMSCN 
addition, which dissociated again as the reaction proceeded, no side products were observed 
at either temperature. However, when monitoring the reaction by 1H NMR, a decrease in 
α-amino nitrile 4.35 relative to the starting material 4.10f was measured after 55 h at 50 °C, 
and already after 3 h at 74 °C. Since no degradation products were present, this suggests that 
cyanide addition to the iminium intermediate is a reversible process, and that α-amino nitrile 
4.35 and aldehyde 4.10f are interconvertible. It is proposed that in the presence of warm or 
boiling solvent, cyanide is carried away with the solvent vapors in the form of HCN gas. 
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Especially under a constant nitrogen flow, applied to prevent moisture from entering the 
reaction set-up, rapid cyanide depletion of the mixture is probable. In accordance to Le 
Chatelier’s principle, this cyanide deficiency is suggested to induce decomposition of product 
4.35 into aldehyde 4.10f with release of HCN. To provide evidence for this hypothesis, the 
reaction was repeated in the presence of 1-methylnaphthalene (bp 240-243 °C) as nonvolatile 
internal standard, and the response to the addition of TMSCN following a decrease in product 
4.35 was examined (Table 4.7). As evidenced from the obtained data, the amount of starting 
material started to rise again after 3 h at reflux temperature, which coincided with a drop in 
α-amino nitrile 4.35. The addition of another two equivalents of TMSCN after 7 h immediately 
reinstated the formation of Strecker product 4.35, confirming the reversibility of the process. 
Therefore, while the synthesis of Strecker adduct 4.35 would benefit from reflux conditions, it 
is important to perform the reaction in a closed system, e.g., a pressure tube, to avoid loss of 
the cyanide source as HCN gas. 
Table 4.7. Reaction of indole-2-carbaldehyde 4.10f with amine 4.25 and TMSCN at reflux temperature. 
Reversion of the reaction (product dissociation) is denoted by an asterisk. 
 
t (h) 4.10f (%)a 4.35 (%)a 
1 86 13 
3 68 31 
6 77* 22* 
7 78* 20* 
 + 2 equiv TMSCN 
8.5 65 33 
23.5 50 35 
a 1H NMR yield (CDCl3) determined using 1-methylnaphthalene as internal standard. 
3.3.4.2. Microwave irradiation 
In the last two decades, the application of microwaves instead of conventional heating as 
energy source in organic synthesis has gained a lot of interest. Microwave irradiation has 
proven to significantly accelerate reaction rates, improve yields and reduce the generation of 
side products in a wide range of synthetic transformations.125 The observed enhancements 
are ascribed to thermal effects, resulting from the fast heating rate, the creation of hot spots 
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(superheating) and the selective heating of polar substances in a microwave setting. The 
existence of a nonthermal effect related to the electromagnetic field is generally refuted 
nowadays.126  
For the condensation reaction of indole-2-carbaldehyde 4.11f with the secondary amine 4.25 
and TMSCN, low temperature (up to 50 °C) microwave experiments were conducted, as to 
avoid undesired heat-triggered cyclization. In addition to TFE, other catalysts commonly used 
in Strecker reactions were evaluated as well. These include the organocatalysts guanidine 
hydrochloride127 and oxalic acid,128 the Brønsted acid sulfamic acid,129 and the Lewis acids 
LiClO4130 and Mg(ClO4)2119 (Table 4.8). The reactions were carried out in polar solvents, in 
order to maximize absorption of the microwave energy and heat generation by dipolar 
polarization.131 In accordance with solvent polarity, the efficiency for dielectric heating 
increases from diethyl ether to acetonitrile, and to the alcohols TFE and methanol.132 
Microwave irradiation clearly had a positive effect on the Strecker reaction of 4.11f in TFE. 
After 2 h at 30 °C, 33% of α-amino nitrile 4.26f was detected in the reaction mixture (entry 1). 
This constitutes a spectacular acceleration compared to room temperature, where the same 
degree of conversion (39%) was only reached after approximately six days. Furthermore, only 
a limited amount of side products (6%) was formed. Increasing the temperature to 40 °C and 
50 °C did not further improve the conversion rate (39% in 3 h), nor the level of the cyanohydrin 
side products 4.30 and 4.31 (4-6%) (entry 2). The use of guanidine hydrochloride as a catalyst 
was unsuccessful, and the desired product 4.26f was not observed at all (entry 3). Mainly 
cyanide addition to the carbonyl was promoted, with the formation of both the cyanohydrin 
4.30 (23-29%) and the corresponding TMS ether 4.31 (3%). The same is true for oxalic acid, 
although the catalyst proved to be very efficient in activating the carbonyl, as full and selective 
conversion to the side product 4.31 was observed within 2 h at 40-50 °C (entry 4). Sulfamic 
acid only moderately induced α-amino nitrile formation, with a limited amount of 4.26f (16%) 
after 2 h under low temperature microwave irradiation (entry 5). The reaction was presumably 
impeded by the slow dissociation of transient hemiaminal 4.32 into the corresponding iminium. 
Both Lewis acids LiClO4 and Mg(ClO4)2 were considerably active as catalysts under 
microwave heating, and respectively 81% and 67% of the starting material was consumed 
after 2 h at 40-50 °C (entries 6 and 7). However, side product formation was substantial, 
leading to only low quantities of the Strecker adduct 4.26f. LiClO4 mainly generated 
cyanohydrins 4.30 and 4.31 (up to 77%) with only trace amounts of 4.26f (4%) (entry 6). The 
Strecker reaction catalyzed by Mg(ClO4)2 also yielded 11% of the product typically obtained 
under reflux conditions (4.34). Nevertheless, the amount of desired product was about fivefold 
higher (21%) compared to LiClO4-catalyzed conversion (entry 7). 
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Table 4.8. Screening of catalysts for the Strecker reaction of indole-2-carbaldehyde 4.11f with amine 4.25 
and TMSCN under microwave (MW) conditions. 
 
Entrya 
Catalyst 
(equiv) 
Solvent T (°C) t (h) 
4.11f 
(%)b 
4.26f 
(%)b 
4.32 
(%)b 
4.30 
(%)b 
4.31 
(%)b 
4.34 
(%)b 
1 (solvent) TFE 30 2 61 33 3 0 3 0 
2 (solvent) TFE 40 1 85 11 0 4 0 0 
   40 1 69 25 0 6 0 0 
   50 1 61 35 0 4 0 0 
3 
guanidine HCl 
(0.3) 
MeOH 30 1 68 0 0 29 3 0 
   50 1 74 0 0 23 3 0 
4 
oxalic acid 
(0.1) 
CH3CN 40 1 8 0 0 3 89 0 
   50 1 0 0 0 0 100 0 
5 
NH2SO3H 
(0.05) 
MeOH 40 1 66 6 27 1 0 0 
   50 1 43 16 39 2 0 0 
6 
LiClO4  
(0.1) 
Et2O 40 1 23 2 0 14 61 0 
   50 1 19 4 0 17 60 0 
7 
Mg(ClO4)2 
(0.1) 
Et2O 40 1 39 17 0 5 29 10 
   50 1 33 21 0 5 30 11 
a for each entry, one sample (0.1 mmol) was successively submitted to the different conditions. 
b conversion determined by 1H NMR (CDCl3). 
As can be deduced from this screening experiment, TFE is once again the preferred catalyst 
for the Strecker synthesis. Although its activity is only moderate compared to the other 
catalysts, TFE-catalyzed conversion is characterized by the least formation of side products, 
and consequently yields the highest amounts of product. Furthermore, the application of low 
temperature microwave irradiation proved a successful strategy to reduce the required 
reaction time for the formation of α-amino nitrile 4.26f. 
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3.3.4.3. Ultrasound 
In sonochemistry, high-power ultrasound is used to enhance chemical transformations. The 
driving force relies on cavitation within the liquid phase and the energy released during the 
sudden collapse of these cavities. This leads to the creation of so-called hot spots, retaining 
extreme conditions in terms of temperature and pressure.133 A literature example, where 
ultrasonic irradiation is applied to the Strecker reaction of γ-piperidone derivatives with primary 
amines and KCN, reports higher yields and significantly shortened reaction times, from days 
to hours, compared to prolonged stirring.122a In the case of indole-2-carbaldehyde 4.11f, 
sonication was able to double and triple the rate of aminocyanation for small (0.4 mmol) and 
big (4.4 mmol) scale reactions, respectively, inducing > 90% conversion of the starting 
material in 7-8 days compared to 13-24 days under regular stirring (Scheme 4.11, Figure 4.4). 
In addition to the formation of hot spots, the sonication process also caused a small 
temperature rise of the reaction mixture to a steady-state temperature of 40 °C. Although the 
rate was significantly improved, ultrasonic irradiation highly promoted condensation of the 
formed end product 4.26f with unreacted amine 4.25, and next to 67% of α-amino nitrile 4.26f, 
the final reaction mixture contained 19% of 4.33. The other impurities were identical to the 
room temperature variant of the reaction and included the hemiaminal intermediate 4.32 (2%), 
the cyanohydrin 4.30 (6%), and the starting material 4.11f (6%). As a consequence, the 
isolated yield after column chromatography (20%) was slightly lower upon the application of 
ultrasound to activate the reaction compared to prolonged stirring at ambient temperature 
(28%). 
 
Scheme 4.11. Synthesis of α-amino nitrile 4.26f through condensation of indole-2-carbaldehyde 4.11f with 
amine 4.25 and TMSCN under ultrasonic irradiation. 
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Figure 4.4. Formation of the Strecker adduct 4.26f under regular stirring and ultrasonic irradiation of the 
reaction mixture of aldehyde 4.11f, amine 4.25 and TMSCN in TFE (determined by 1H NMR, in CDCl3). 
3.3.4.4. Overview 
Different methods were evaluated to synthesize α-amino nitrile 4.26f from indole-2-
carbaldehyde 4.11f. For each method, the best conditions and corresponding outcome are 
summarized in Table 4.9. At room temperature, the Strecker reaction proceeded tremendously 
slow (entry 1). However, the amount of side products remained within acceptable boundaries, 
and 77% of product 4.26f was present in the reaction mixture after 13-24 days. Both 
conventional heating (entry 2) and ultrasonic irradiation (entry 5) were able to significantly 
improve the conversion rate, but at the cost of α-amino nitrile formation. Ultrasound stimulated 
addition of the excess amine reagent to the formed end product 4.26f, leading to a substantial 
level of waste products (27%) in the final mixture (entry 5). Under reflux conditions, the desired 
product 4.26f was not detected at all, and only an unidentified annulated side product was 
obtained (entry 2). This was resolved when the TMS-protected derivative 4.10f was heated 
(entry 3). Only the desired product 4.35 was detected, and conversion was significantly faster 
compared to room temperature. However, α-amino nitrile 4.35 was shown to revert to starting 
aldehyde 4.10f, most likely in response to the loss of cyanide as HCN gas at the elevated 
temperature. The use of a closed reaction system instead of an open flask could provide a 
solution to cyanide depletion of the reaction mixture. Obviously, TMS deprotection is still 
required when this method is applied. Microwave irradiation combined the advantages of both 
the room temperature and reflux approach, as fast reaction rates were obtained for the de-
protected analog 4.11f at medium-low temperature (entry 4). In addition, the formation of side 
products was limited, and reversion of the reaction was prevented as microwave irradiation is 
commonly applied in a closed reaction vessel. Therefore, the application of microwaves is by 
far the most convenient method for a fast and controlled synthesis of α-amino nitrile 4.26f. 
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Table 4.9. Overview of the different methods for the Strecker reaction of indole-2-carbaldehyde  
4.11f or 4.10f. 
 
Entry Method R T (°C) t (d) 
4.11f or 
4.10f 
(%)a 
4.26f or 
4.35 
(%)a,b 
Side 
products 
(%)a 
Remarks 
1 
room 
temperature 
H 20 13-24 10 77 (28) 13  
2 
conventional 
heating 
H 74 6 0 0 100 
annulated side 
product 
3 
conventional 
heating 
TMS 74 3 h 68 31 1 
reaction is 
reversible 
4c 
microwave 
irradiation 
H 30 2 h 61 33 6  
5 ultrasound H 40 7-8 6 67 (20) 27 
condensation of 
product 4.26f 
with amine (19%) 
a conversion determined by 1H NMR (CDCl3). 
b isolated yield between brackets. c 8 equivalents of amine 4.25. 
3.4. Isoindole formation through 5-exo-dig cyclization 
The fluorescent 1-cyanoisoindole cores of the different SL analogs were generated through 
annulation of the amino moiety with the earlier introduced terminal alkyne. Alkyne activation is 
traditionally achieved using Brønsted acids or iodine, with as major difference the incorporation 
of H or I in the final product.134 Another versatile method involves carbophilic activation by 
π-acid catalysts, such as gold or platinum complexes. Both late transition metals have been 
extensively employed to catalyze a myriad of inter- and intramolecular addition processes to 
alkenes and alkynes.135 As mentioned before, cyclization of the α-amino nitrile derivatives 
4.26a-d was successfully induced by TFE, and cyanoisoindoles 4.4a-d were directly obtained 
from benzaldehydes 4.11a-d through tandem aminocyanation and annulation (Table 4.4, vide 
supra). In the case of the naphthalene analog 4.26e, the simple salt AuCl3 was chosen as mild 
and nontoxic catalyst, with high tolerance toward different functional groups. The cyclization 
reaction of 4.26e was evaluated in different solvents at a 0.1 mmol scale, with a catalyst 
loading of 1 mol% (Table 4.10). In each solvent, the conversion proceeded very cleanly, 
without the formation of degradation or side products. The reaction rate, on the other hand, 
differed significantly between the different media, and fast conversion was only achieved in 
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acetonitrile (entry 4). Scaling up the reaction to 1.5 mmol, however, considerably slowed down 
the annulation process, even in acetonitrile. By increasing the amount of AuCl3 to 3 mol% and 
doubling the concentration to 0.02 M, a reasonable conversion time of 44 h was attained. 
Removal of the catalyst by filtration over a plug of celite and evaporation of the solvent 
furnished pure isoindole 4.4e in 96% yield.  
Table 4.10. Solvent screening for the synthesis of benzo[e]isoindole 4.4e in the presence of AuCl3. 
 
Entry Solvent t (h) 4.26e (%)a 4.4e (%)a 
1 toluene 21 81 19 
2 2-MeTHF 21 76 24 
3 CH2Cl2 21 53 47 
4 CH3CN 0.25 0 100 
a conversion determined by 1H NMR (CDCl3). 
Unfortunately, the results obtained for the naphthalene-based α-amino nitrile 4.26e could not 
be extrapolated to the indole-based analog 4.26f. AuCl3 was rather inactive as catalyst in the 
annulation process of 4.26f, despite the use of different solvents with diverse properties (Table 
4.11, entries 1-7). In the halogenated solvents dichloromethane (entry 1) and 1,2-dichloro-
ethane (entry 2), AuCl3 only yielded trace amounts of the cyclized structure 4.4f after several 
hours of stirring. The apolar solvents toluene (entry 3) and 1,2-dimethoxyethane (entry 4) did 
not deliver any product at all. Moreover, appreciable degradation of the starting material was 
observed in DME. Also, the more polar solvent acetone proved to be unsuited for the gold-
mediated cyclization of 4.26f, as only starting material was recovered after 22 h (entry 5). 
Solely in acetonitrile, the optimal solvent for the cycloisomerization of 4.26e, AuCl3 moderately 
catalyzed ring closure of 4.26f (38% in 2 h). However, this activity was accompanied by a 
substantial degree of product degradation, resulting in a hard-to-purify mixture (entry 6). The 
application of microwave heating to a temperature of 120 °C did not affect the cyclization rate, 
generating 18% of product 4.4f in 1 h, though it visibly accelerated degradation (entry 7). 
Computational and experimental studies of gold-catalyzed reactions showed that proton 
transfer agents, such as the solvent or other nucleophiles present in the reaction mixture, are 
important for facilitating catalyst regeneration via protodeauration.136 To exclude inefficient 
proton transfer as restricting factor in the cyclization of 4.26f, methanol was added as a proton 
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shuttle after 24 h to the reaction mixtures in DCE, toluene, DME and acetone (entries 2-5), 
with a final concentration of 10% (v/v). Yet, no change in conversion was observed (data not 
displayed). As a consequence, AuCl3 was considered inapt to efficiently catalyze the 
annulation of 4.26f, and other catalysts were evaluated, including AuCl (entry 8),137 the Lewis 
acids AgNO3 (entry 9)138 and ZnCl2 (entry 10),139 the transition metal complexes 
(CuOTf)2·toluene (entry 11)140 and Pd(OAc)2 (entry 12),141 and the strong Brønsted acid 
CF3SO3H (entry 13).142 None of the aforementioned catalysts were able to surmount the 
activity of the AuCl3/acetonitrile system, with as notable exception CF3SO3H. Apparently, only 
a superacid, like triflic acid, is sufficiently strong to activate the carbon-carbon triple bond of 
4.26f toward nucleophilic addition, inducing quantitative cycloisomerization within 1 h (entry 
13). Despite the strong acidity, the other functional groups, in particular the ester moiety, 
remained largely untouched, and only minor impurities were observed after the reaction. The 
mixture was quenched in a saturated aqueous solution of NaHCO3 to neutralize the acid. After 
extraction, chromatographic purification delivered pyrroloindole 4.4f as pale yellow crystals in 
67% yield. 
Table 4.11. Catalyst and solvent screening for the synthesis of pyrrolo[3,4-b]indole 4.4f. 
 
Entry Catalyst Solvent T (°C) t (h) 4.26f (%)a 4.4f (%)a,b 
1 AuCl3 CH2Cl2 20 3 95 5 
2 AuCl3 DCEc 20 22 96 4 
3 AuCl3 toluene 20 22 100 0 
4 AuCl3 DMEd 20 22 100e 0 
5 AuCl3 acetone 20 22 100 0 
6 AuCl3f CH3CN 20 2 62e 38e 
7 AuCl3 CH3CN 120g 1 82e 18e 
8 AuCl CH3CN 20 3 97 3 
9 AgNO3 CH3CN 20 3 100 0 
10 ZnCl2 CH3CN 20 3 100 0 
11 (CuOTf)2·C7H8 CH2Cl2 20 3 97 3 
12 Pd(OAc)2 CH3CN 20 3 100 0 
13 CF3SO3H CHCl3 20 1 0 100 (67) 
a conversion determined by 1H NMR (CDCl3). 
b isolated yield between brackets. c 1,2-dichloroethane. 
d 1,2-dimethoxyethane. e degradation observed. f 1 mol% of catalyst. g microwave irradiation. 
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Independent of the chosen catalyst, annulation reactions with alkyne substrates start with 
coordination of the electrophile to the triple bond. The result is a decrease in the electron 
density of the alkyne carbons, which renders the system susceptible to attack by a 
nucleophile.134 Based on the reaction outcome, the rearrangement of the N-allylic α-amino 
nitriles 4.26a-f is proposed to proceed through a cascade 5-exo-dig cyclization and migratory 
isomerization (Scheme 4.12).115, 143 Intramolecular nucleophilic addition of the tertiary nitrogen 
onto the proximate alkyne carbon delivers intermediate 4.36a-f, which readily undergoes a 
[3,3]-sigmatropic Claisen rearrangement with formation of intermediate 4.37a-f. Consecutive 
aromatization furnishes the desired 1-cyanoisoindole motif. Although feasible according to the 
Baldwin rules,144 no 6-endo-dig cyclization was encountered for any of the substrates with any 
catalyst. 
 
Scheme 4.12. Proposed mechanism of the cyclization reaction of N-allylic α-amino nitriles 4.26a-f. 
3.5. Introduction of the enol ether bridge 
With the different fluorescent cores in hand, the biologically essential features of SLs were 
introduced. First, the enol ether bridge was incorporated, enabling ensuing attachment of the 
butenolide D-ring. The envisioned strategy involves α-formylation of the ester functionality with 
ethyl formate in the presence of a suitable base. As commercial ethyl formate (bp 54 °C) is 
commonly contaminated with its hydrolysis products formic acid (bp 101 °C) and ethanol (bp 
78 °C), the reagent was distilled prior to use. 
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3.5.1. α-Formylation of type I analogs 4.4a-d 
Initially, the reaction was evaluated for type I analogs 4.4a and 4.4b with electron-withdrawing 
substituents (i.e., fluorine and chlorine), using sodium hydride as a non-nucleophilic base to 
abstract the proton adjacent to the ester’s carbonyl (Table 4.12). To a solution of the starting 
material in dry THF, two equivalents of sodium hydride and ethyl formate were added, and the 
mixture was heated to reflux. Surprisingly, despite the moisture-free system, significant 
amounts of carboxylic acid 4.39 were detected in both reaction mixtures by LC MS. In the case 
of the chlorinated isoindole 4.4b, the desired formyl ester 4.38b was only scarcely generated 
under the applied conditions. However, the addition of an exorbitant amount of 20 equivalents 
of ethyl formate, together with another two equivalents of base, led to a threefold increase in 
the amount of 4.38b in 1.5 h at reflux temperature. 
Table 4.12. Base-mediated α-formylation of ethyl 2-(isoindol-2-yl)acetates 4.4a-b  
with ethyl formate in dry THF. 
 
Entry R t (h) 4.4 (%)a 4.38 (%)a 4.39 (%)a 
1 F 2.5 0 56 44 
2 Cl 3 7 3 90 
a conversion determined by LC MS (254 nm).  
Since increasing the amount of ethyl formate proved beneficent for the α-formylation process, 
the reaction was repeated under solvent-free conditions, using instead a large excess of the 
electrophile to solubilize the reagents (Table 4.13). The reaction was stirred at room 
temperature for 1 h, followed by reflux conditions (54 °C). This approach turned out to 
successfully suppress the previously encountered side reaction, as no carboxylic acid 4.39 
was detected for both derivatives 4.4a and 4.4b. In order to decrease the required conversion 
time, a second portion of sodium hydride was added during the course of the reaction. The 
applied conditions were also pertinent for type I analogs 4.4c and 4.4d with electron-donating 
substituents (i.e., methylenedioxy and methoxy), promoting quantitative conversion to formyl 
esters 4.38c-d within 24 h. All products 4.38a-d were isolated in high yields after purification 
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via column chromatography on silica gel using a mixture of hexane and ethyl acetate as mobile 
phase, supplemented with 2.5% of methanol to ensure reasonable elution times. 
Table 4.13. Base-mediated α-formylation of ethyl 2-(isoindol-2-yl)acetates 4.4a-d with ethyl formate under 
solvent-free conditions. 
 
Entry Derivative R1 R2 t (h) Yield (%)a 
1 4.4a H F 18 89 
2 4.4b H Cl 19 83 
3 4.4c -OCH2O- 23 98 
4 4.4d OCH3 OCH3 21 86 
a isolated yield after column chromatography. 
Apart from being an efficient method for the α-formylation of ethyl 2-(isoindol-2-yl)acetates 
4.4a-d, the use of ethyl formate as solvent also shed light on the mechanism behind the 
formation of carboxylic acid side product 4.39. The total absence of side product under these 
conditions suggests that more is at play than simple base-catalyzed ester hydrolysis as a result 
of the reaction of sodium hydride with water traces present in the reagents. Indeed, since both 
reactions were carried out with the same starting materials, following the same procedure to 
instate dry conditions, comparable water contents are expected. The only factor that could 
create a difference is the presence or absence of solvent. However, Karl Fischer titration using 
an automated coulometric titrator (Mettler Toledo C10S) indicated that the employed dry THF 
contained only 30 ppm of water, which is less than 1 mol% of the amount of starting material 
at the used concentration of 0.15 M. Consequently, hydroxide-mediated ester hydrolysis 
cannot account for more than trace amounts of carboxylic acid 4.39, and an alternative 
mechanism is proposed (Scheme 4.13). In diluted conditions, carbanion 4.40a-b, generated 
through reaction of 4.4a-b with sodium hydride, presumably collapses to ketene 4.41a-b with 
elimination of the ethoxy group.145 Subsequent aqueous work-up causes hydrolysis of the 
highly reactive ketene 4.41a-b into the detected carboxylic acid 4.39a-b. In contrast, when 
ethyl formate is used as solvent, the negative charge is readily trapped, with no opportunity 
for the side reaction to occur. Hence, the resonantly stabilized carbanion functions as central 
intermediate and is converted into different products, depending on the abundance of a 
suitable electrophile.  
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Scheme 4.13. Plausible mechanisms for the formation of carboxylic acid side products 4.39a-b from 
ethyl 2-(isoindol-2-yl)acetates 4.4a-b. 
3.5.2. α-Formylation of type II analogs 4.4e-f 
As with the Strecker reaction, the type II analogs 4.4e and 4.4f containing extended aromatic 
systems behaved differently under the optimal reaction conditions established for the merely 
substituted analogs 4.4a-d. In the case of the naphthalene-derived compound 4.4e, sodium 
hydride was found unsuited as base to promote reaction at the ester’s α-carbon (Table 4.14). 
Consecutive addition of sodium hydride and ethyl formate to a solution of 4.4e in dry THF, 
followed by 3 h heating to reflux, did not yield formyl ester 4.38e, regardless the addition of an 
extra portion of both reagents halfway the reaction time (entry 1). Increasing the temperature 
and duration of the deprotonation step did not promote product formation either (entry 2). In 
both cases, only traces (4-6%) of the carboxylic acid side product 4.39e were observed. These 
detected amounts are within the feasible levels of hydroxide-induced ester hydrolysis. At a 
concentration of 0.01 M in solvent retaining 30 ppm of water, up to 15% of the starting material 
can theoretically be hydrolyzed. 
The inertness of ethyl 2-(benzo[e]isoindol-2-yl)acetate 4.4e to sodium hydride prompted a 
switch to the strong base lithium diisopropylamide (LDA). The base was either generated from 
diisopropylamine and nBuLi, or added as a commercial 2.0 M solution in THF/heptane/ethyl-
benzene. The starting material was reacted with an excess of LDA at -78 °C for 1 h. This step 
was characterized by a change in color of the reaction mixture from light yellow to dark brown. 
Subsequently, a large amount of ethyl formate was added and the mixture was slowly warmed 
to room temperature. After overnight stirring, 87% of carboxylic acid 4.39e was detected, while 
no desired product 4.38e was formed (entry 3). Incitement of the deprotonation step, by 
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exposing the mixture of 4.4e and LDA in dry THF to room temperature (entry 4) or reflux 
temperature (entry 5) for prolonged time, only evoked increased formation of the side product 
4.39e (91% and 99%, respectively). In all three cases employing LDA, large quantities of 
carboxylic acid 4.39e were obtained, which cannot be ascribed to water-dependent hydrolysis. 
This suggests that a ketene intermediate is once again involved. As formation of this reactive 
species requires the generation of a carbanion, LDA is demonstrated to adequately 
deprotonate the α-position of the ester. As a matter of fact, the color change of the reaction 
was a visual indication of this interaction. Importantly, this implies that the lack of product 
formation emanates from inefficient trapping of the electrophile. Thereupon, the amount of 
ethyl formate was drastically increased. In addition, the prior mixing of starting material and 
LDA was discarded, as this likely favors contraction of the carbanion to the ketene. Although 
the side reaction was kept under control, only scant amounts (5%) of formyl ester 4.38e were 
observed after 16 h at room temperature (entry 6). Apparently, reaction of the carbanion with 
ethyl formate remained troublesome, and a similar approach to the α-formylation of 4.4a-d 
was followed, where the electrophile adopts the role of solvent (entry 7). LDA was added at 
0 °C to a solution of ester 4.4e in ethyl formate, and the resulting mixture was stirred overnight 
at ambient temperature. This resulted in quantitative formation of formyl ester 4.38e, without 
a single trace of the carboxylic acid side product 4.39e. Product 4.38e was isolated in 71% 
yield after reversed-phase column chromatography. 
Table 4.14. Base-mediated α-formylation of ethyl 2-(benzo[e]isoindol-2-yl)acetate 4.4e with ethyl formate. 
 
Entry Base 
Equiv 
base 
Tdepr (°C) 
tdepr 
(h) 
Equiv 
EtOC(O)H 
Tform (°C) 
tform 
(h) 
4.4e 
(%)a 
4.38e 
(%)a,b 
4.39e 
(%)a 
1 NaH 1.1 + 1.1c 20 - 2 + 1.5 66 3 96 0 4 
2 NaH 1.1 + 1.1 66 3 1 + 1 20 19 94 0 6 
3d LDA 4.3 -78 1 7.3 -78 → 20 17 13 0 87 
4d LDA 4.3 -78 → 20 2 17.8 -78 → 20 18 9 0 91 
5 LDA 2.1 
0 → 20 
→ 66 
19 
2 
6.5 20 18 1 0 99 
6 LDA 1.1 0 - 16 + 16 
0 
→ 20 
2 
16 
91 5 4 
7e LDA 2 0 - 
solvent 
(0.04 M) 
0 → 20 19 0 
100 
(71) 
0 
a conversion determined by LC MS (254 nm). b isolated yield between brackets. c second portion added during formylation step. 
d concentration 5 mM. e no dilution in dry THF. 
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For the α-formylation of ethyl 2-(pyrrolo[3,4-b]indol-2-yl)acetate 4.4f, no additional screening 
was performed, and the reaction was immediately carried out using ethyl formate as solvent 
and LDA as a powerful base (Table 4.15). Indeed, dilution of the reaction mixture in dry THF 
was detrimental for the α-formylation reaction of all analogs 4.4a-e, and LDA proved effective 
for the α-deprotonation of compound 4.4e. However, the reaction proceeded more sluggishly, 
and after 23 h at room temperature, only 24% of formyl ester 4.38f was obtained (entry 1). 
Therefore, the reaction was successively submitted to different activation methods in order to 
improve the reaction rate. Conventional heating of the reaction to 50 °C, as well as the 
application of ultrasonic irradiation exhibited an accelerating effect on the conversion. The 
latter was selected as strategy for the large scale α-formylation of 4.4f (entry 2). Nearly full 
conversion was attained after 23 h, and formyl ester 4.38f was isolated in 85% yield after 
column chromatography on reversed-phase silica gel. In neither case the side reaction toward 
the corresponding carboxylic acid occurred. 
Table 4.15. Base-mediated α-formylation of ethyl 2-(pyrrolo[3,4-b]indol-2-yl)acetate 4.4f with ethyl 
formate. 
 
Entry T (°C) t (h) 4.4f (%)a 4.38f (%)a,b 
1c 20 23 76 24 
 50 3 66 34 
 20, )))e 68 3 97 
2d 20, )))e 23 1 99 (85) 
a conversion determined by LC MS (254 nm). b isolated yield between brackets. c reaction scale 0.05 mmol. 
d reaction scale 0.33 mmol. e application of ultrasound. 
3.5.3. Configuration of the formyl ester double bond 
Due to conjugation with the carbonyl function of the ester, the formyl group attached in 
α-position adopts the enol form. The presence of a free hydroxyl group was confirmed for each 
derivative by both IR and 1H NMR spectral analysis. Consequently, the formylated esters 
4.38a-f can be obtained as two possible isomers, displaying a different relative orientation of 
the hydroxyl group to the isoindole and ester substituents at the opposite side of the double 
bond (Figure 4.5). However, a strong preference for one of both configurations prevailed, as 
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the compounds 4.38a-f were isolated as mainly single stereoisomers (Table 4.16, vide infra). 
Based on the observed chemical shifts of the olefinic proton Ho and the magnetic anisotropy 
effect of the nearby ester group, a tentative structure was assigned. 
 
Figure 4.5. Different possible isomers of formyl esters 4.38a-f. 
The carbonyl functionality is known to exhibit a strong deshielding effect (+δ) on protons lying 
in the same plane. The result is a strong downfield shift of those protons situated proximate to 
the carbonyl, as is evidenced by several literature examples (Figure 4.6).146  
 
Figure 4.6. Influence of the anisotropy of the carbonyl function on the 1H NMR chemical shift (ppm) of 
neighboring protons. 
In the case of formyl esters 4.38a-f, the olefinic proton Ho in the (Z) geometry is affected by 
the anisotropy of the ester’s carbonyl, experiencing a downfield shift, whereas the (E)-
configured olefinic proton Ho is not. As the major isomers are upfield shifted from the minor 
isomers (Table 4.16), the isolated formyl esters 4.38a-f were inferred to mainly exist in the (E) 
enol configuration. Moreover, this configuration favors further stabilization by intramolecular 
hydrogen bonding between the enolic proton and the adjacent ester functionality.  
CYANOISOINDOLE-BASED FLUORESCENT STRIGOLACTONES 
71 
Table 4.16. Observed chemical shifts of the olefinic proton Ho, the isomer ratio and tentative structure 
assignment of formyl esters 4.38a-f. 
Entry Derivative R1 R2 
1H NMR shift Ho (ppm)a Isomer 
ratioa,b Major Minor 
1 4.38a H F 7.53 8.21 95:5 
2 4.38b H Cl 7.53 8.23 88:12c 
3 4.38c -OCH2O- 7.50 8.16 96:4 
4 4.38d OCH3 OCH3 7.51 8.17 96:4 
5 4.38e benzo[e]isoindole 7.57 8.38 97:3c 
6 4.38f pyrrolo[3,4-b]indole 7.57 8.22 94:6 
a in CDCl3. 
b determined by 1H NMR. c determined by 13C NMR due to overlapping signals in 1H NMR. 
 
3.6. Connection of the butenolide D-ring 
3.6.1. Synthesis of the D-ring precursor 
The precursor of the D-ring, the halogenated butenolide 2.20, was prepared via allylic radical 
bromination of the commercially available 3-methyl-furan-2-5H-one 4.48 as originally reported 
by MacAlpine and coworkers.147 A solution of the starting material in CCl4 was treated with 
N-bromosuccinimide (NBS) in the presence of a catalytic amount of the radical initiator benzoyl 
peroxide (BPO) and light (Scheme 4.14). Since both NBS and the formed succinimide 
byproduct are nearly insoluble in CCl4 and possess a different relative density compared to 
the solvent, the progress of the allylic bromination of 4.48 was easily visually monitored. NBS, 
denser than CCl4, sinks below the solvent level, while succinimide floats on top of the reaction 
mixture. As such, the reaction was complete after 20 h, when no solid particles remained on 
the bottom of the flask. The product 2.20 was isolated in 76% yield after filtering off the solids. 
The double brominated side products 4.49 and 4.50 were identified as impurities.  
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Scheme 4.14. Synthesis of bromobutenolide 2.20. 
3.6.2. Coupling reaction of formyl esters 4.38a-f with bromobutenolide 2.20 
To couple formyl esters 4.38a-f with bromobutenolide 2.20, a solution of 4.38a-f in dry THF 
was treated with sodium hydride for 15 minutes to form the corresponding enolates. 
Subsequently, bromolactone 2.20 was added and the mixture was heated to reflux. 
Nucleophilic substitution of the lactone halogen delivered the SL analogs 4.2a-f as racemic 
mixtures. The compounds were isolated in moderate to good yields after purification via 
column chromatography on reversed-phase silica gel (Table 4.17). 
Table 4.17. Coupling of formyl esters 4.38a-f with bromobutenolide 2.20. 
 
Entry Derivative R1 R2 t (h) Yield (%)a 
1 4.38a H F 5 56 
2 4.38b H Cl 3 56 
3 4.38c -OCH2O- 4 58 
4 4.38d OCH3 OCH3 4 55 
5 4.38e benzo[e]isoindole 5 37 
6 4.38f pyrrolo[3,4-b]indole 9 65 
a isolated yield after reversed-phase column chromatography. 
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3.7. Nature of the CISA isomers 
The different CISA analogs 4.2a-f were obtained as inseparable mixtures of two isomers. 
Whereas most proton and carbon nuclei of both isomers display similar chemical shifts in 1H 
and 13C NMR, respectively, the enol ether proton experiences a significantly disparate 
electronic environment in each isomer, resulting in a shift difference of approximately 0.3 ppm 
(in CDCl3). Therefore, a mixed geometry of the double bond was initially considered. However, 
upon chromatographic enrichment, interconversion of the isomers was observed at room 
temperature, which seems rather unlikely for E/Z isomerization. Alternatively, hampered 
rotation around the N-C bond between the isoindole and enol ether planes could give rise to 
atropisomers, with either an (E)- or (Z)-configured double bond. In collaboration with the 
Center for Molecular Modeling (CMM, Ghent University), computational methods were applied 
to determine the exact nature of the isomers, using the unsubstituted analog CISA-1 4.1 as 
model.148 For each configuration of the double bond, (E) and (Z), both axially chiral isomers, 
P and M, were considered (Figure 4.7). Due to the stereocenter in the lactone ring, each 
isomer occurs in fact as an enantiomeric pair: (Z)-P-R and (Z)-M-S, (Z)-M-R and (Z)-P-S, (E)-
P-R and (E)-M-S, and (E)-M-R and (E)-P-S.  
 
Figure 4.7. Plausible isomers of the SL analog CISA-1. 
The stability of the isomers and their interconversion barriers were calculated using the M06-
2X/6-31+G(d,p) level of theory for geometry optimizations.149 Solvent effects were taken into 
account by means of a polarizable continuum model (PCM) (εTHF = 7.4257).150 The obtained 
relative Gibbs free energies for the different isomers show that the (Z) isomers (0.00-1.10 kcal 
mol-1) are definitely more stable than the (E) isomers (2.54-3.90 kcal mol-1, depending on the 
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enantiomeric pair). This is presumably due to repulsion between the enol ether and ester 
oxygen atoms in the (E) configuration. Next, the interconversion between the P and M 
atropisomers was studied. As rotation can take place in two possible directions, where either 
the enol ether or ester moiety passes the alkenyl group, two transition states, TS-a and TS-b 
respectively, were computed. The resulting Gibbs free energy profiles for the (E)- and (Z)-
configured isomers are displayed in Figure 4.8.  
 
Figure 4.8. Gibbs free energy profiles for the atropisomerization of the (a) (E)-configured and (b) (Z)-
configured CISA-1 isomers (PCM ε = 7.4257, M06-2X/6-31+G(d,p), energies in kcal mol-1).  
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The activation barriers for rotation are remarkably lower for the (E) isomer (15.68-
17.17 kcal mol-1) than for the (Z) isomer (23.30-25.15 kcal mol-1). This logically emanates from 
the decreased steric hindrance when the lactone ring is oriented away from the rotational axis. 
The calculated activation energies give rise to half-life times of less than a second for the (E) 
isomer and several hours for the (Z) isomer. The very fast interconversion of the former would 
imply that it is impossible to distinguish both isomers by HPLC. However, HPLC analysis of 
the isolated CISA derivatives clearly shows two partially separated peaks. Together, these 
findings indicate that the observed isomers are in fact the more stable (Z)-configured rotamers. 
For completeness, the Gibbs free activation energies for E/Z isomerization were calculated as 
well and found to exceed 50 kcal mol-1, excluding interconversion at room temperature.  
To validate the deduced structure, 1H NMR chemical shifts were calculated for the enol ether 
proton of CISA-1 4.1 in the (E) and (Z) configuration,151 and compared with the experimental 
data. The conformations of the different isomers were reoptimized in chloroform, using the 
same approach as before (M06-2X/6-31+G(d,p) level of theory, PCM εCHCl3 = 4.7113). For 
each conformer, NMR shielding tensors were calculated with the gauge-including atomic 
orbital (GIAO) method152 at the B3LYP/6-311+G(2d,p) level of theory,153 and translated into 
chemical shifts using a linear regression approach.154 The obtained shift values for the (Z) 
isomers are in very good agreement with the experimental data, while the correspondence is 
significantly less for the (E) isomers (Table 4.18). Therefore, the double bond geometry can 
be unambiguously assigned as (Z), which is in line with the energetic considerations.  
Table 4.18. Calculated and experimental 1H NMR chemical shift values of the enol ether proton of CISA-1 
(4.1) (PCM ε = 4.7113, M06-2X/6-31+G(d,p), B3LYP/6-311+G(2d,p)). 
 
1H NMR shift (ppm)a,b 
Minor Major 
Calculated   
(E) isomer 7.03 (0.78) 7.24 (1.06) 
(Z) isomer 7.77 (0.24) 8.09 (0.26) 
Experimental   
 7.87 8.16 
a in CDCl3. 
b mean absolute error between brackets. 
Consequently, the CISA derivatives 4.2a-f possess the same spatial orientation of the double 
bond as natural SLs, e.g., strigol 2.1,24 and previously reported SL analogs, including GR24 
2.21,54-55 and the structurally related Nijmegen-1 4.51155 (Figure 4.9). Despite the geometrical 
similarity, the 1H NMR chemical shift of the enol ether proton of the CISA derivatives 4.2a-f 
(major δ 8.09-8.19 ppm; minor δ 7.80-7.92 ppm, in CDCl3) is relatively high compared to the 
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other SL analogs, especially for the major isomer. This likely results from electronic 
interactions with the isoindole and/or nitrile moieties. Furthermore, the occurrence of 
atropisomers has never been reported before for SL analogs. While this could lead to a 
divergence in biological activity for slowly interconverting isomers, the isomerization rate of the 
CISA analogs is sufficiently high to warrant full bioavailability. 
 
Figure 4.9. Structure of related SLs and analogs and the 1H NMR chemical shift (ppm, in CDCl3) of the 
enol ether proton.  
Additionally, the unequivocal proof for the (Z) configuration of the CISA analogs 4.2a-f 
provides underlying support for the structure assignment of formyl esters 4.38a-f. The 
chemical shift of the olefinic proton (Ho) of their minor isomers, previously assigned as (Z)-
configured, corresponds well to the shifts observed for the enol ether proton of derivatives 
4.2a-f. 
3.8. Summary 
In total, six new cyanoisoindole-based SL analogs 4.2a-f (Figure 4.10) were prepared in good 
overall yields (10-20%) via parallel synthetic routes, starting from a selection of ortho-
brominated arylaldehydes 4.3a-f (Scheme 4.15). First, the fluorescent cores 4.4a-f were 
constructed in 19-67% yield through consecutive Sonogashira cross-coupling with 
ethynyltrimethylsilane, silyl deprotection (4.11a-f), Strecker reaction toward the corresponding 
α-amino nitriles (4.26e-f) and electrophile-induced ring closure (4.4a-f). The second part of the 
synthesis involved the incorporation of the biologically essential features of SLs; the ester 
moieties of 4.4a-f were formylated in α-position, and the resulting enol ethers 4.38a-f were 
coupled with the lactone D-ring precursor 2.20. As a general trend, the synthesis of the type II 
analogs 4.2e-f, with enlarged aromatic systems, required far more optimization efforts than 
the synthesis of the type I analogs 4.2a-d, bearing simple substituents. Often, harsh conditions 
and/or longer reaction times were required, which were frequently accompanied by reduced 
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yields. Due to steric hindrance between the fluorescent core and the lactone D-ring, the CISA 
analogs 4.2a-f exist as inseparable mixtures of two atropisomers. 
 
Figure 4.10. Structure and overall yield of the CISA analogs 4.2a-f. 
 
Scheme 4.15. Overview of the synthesis of the cyanoisoindole-based SL analogs 4.2a-f.  
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4. Evaluation of the biological activity 
In collaboration with the VIB Center for Plant Systems Biology (Ghent, Belgium), the potency 
of the CISA analogs 4.2a-f to elicit SL-like responses was evaluated in both parasitic and 
autotrophic plants. Also, different molecular assays were performed to confirm that the 
observed phenotypical outcomes are the result from signal transduction through the natural 
SL pathway. Furthermore, the relative instability of the different SL analogs in aqueous 
medium was assessed to estimate their life span in natural, moist environments, e.g., the soil 
and plant cells. 
4.1. Chemical stability assay 
The chemical stability of the CISA analogs 4.2a, 4.2c, 4.2e and 4.2f was evaluated in a 
methanol/water (1:3) mixture at a biologically relevant pH of 7.4 (Figure 4.11a), and compared 
to the commonly accepted SL standard rac-GR24 (2.21, Scheme 2.1, vide supra). The 
aqueous solutions were stored at 22 °C and analyzed at distinct time intervals by HPLC. All 
experiments were performed in triplicate. One-phase exponential decay curves provided an 
excellent data fit, with goodness of fit measures (R2) between 0.968 and 0.999 (Figure 4.12).  
 
Figure 4.11. Chemical stability of CISA analogs 4.2a, 4.2c, 4.2e, 4.2f and rac-GR24 in (a) methanol/water 
1:3 at pH 7.4, data are means ± SEM (n = 3); and (b) methanol (n = 1). 
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Figure 4.12. One-phase exponential decay fits to the experimental degradation data of CISA analogs (a) 
4.2a, (b) 4.2c, (c) 4.2e, (d) 4.2f and (e) rac-GR24 in methanol/water 1:3 at pH 7.4. 
Under the evaluated conditions, GR24 displays a half-life time of 3.11 h. CISA analogs with 
electron-withdrawing and -donating substituents are slightly less stable than GR24 with half-
life times of 2.13 h (4.2a) and 2.41 h (4.2c), respectively. Fused tricycles 4.2e and 4.2f show 
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a significantly increased resistance to hydrolysis with half-life times of 7.79 h and 4.47 h, 
respectively. The results are in line with the previously published data for CISA-1 and GR24 
(at pH 7.4; CISA-1 t1/2 = 22 h; GR24 t1/2 = 4 h).87 Remarkably, no appreciable degradation was 
observed in pure methanol over a time span of 17 h (Figure 4.11b). This suggests that 
aqueous conditions are necessary for the degradation of the compounds. The inherent 
instability of SLs to moist conditions is well known, as is the accelerating effect of alkaline pH 
on the degradation process.87, 156 In addition, while innocuous as pure solvent, the presence 
of methanol in alkaline aqueous conditions further decreases the stability of the analogs 
through nucleophilic degradation, accounting for the relatively short half-life times compared 
to previously reported values in literature.47d, 88 
4.2. Parasitic weed seed germination assay 
Parasitic weed seed germination is one of the most abundantly used assays to evaluate the 
SL-like activity of new analogs. The main incentives are the limited time and space required 
to perform the test, and the high sensitivity of parasitic seeds to germination stimulants.157 The 
germination inducing activity of the CISA analogs 4.2a-f was evaluated at different 
concentrations on seeds of the root parasite Phelipanche ramosa. Racemic GR24 was used 
as positive control (Figure 4.13). 
 
Figure 4.13. Dose-dependent Phelipanche ramosa seed germination, five days after treatment with CISA 
analogs 4.2a-f and rac-GR24. Data are means ± SEM (n = 3). Within the same concentration, different 
letters (a-d) indicate significant differences at P < 0.05 (Tukey’s HSD test). 
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All treatments had a significant effect on the germination of P. ramosa (P < 0.05, versus 
control). GR24 was significantly more potent than the CISA analogs in stimulating seed 
germination at concentrations above 1 nM. However, except for analog 4.2b, no significant 
differences in activity with GR24 were observed at 0.1 nM. Nevertheless, the germination 
assay revealed a high potency of the analogs 4.2a-f as germination stimulants. P. ramosa was 
previously shown to be responsive to both (2’R) and (2’S) SL isomers at concentrations above 
1 nM, with increasing selectivity for the (2’R) isomer at lower concentrations.158 Therefore, both 
(2’R) and (2’S) isomers of the CISA analogs are likely to contribute to the observed activity, 
especially at higher concentrations. 
4.3. Hypocotyl elongation assay 
SLs are involved in various plant developmental processes through perception by the α/β fold 
hydrolase D14.159 Additionally, the D14 paralog KARRIKIN INSENSITIVE2 (KAI2), an α/β fold 
hydrolase primarily accommodated to perceive smoke-derived karrikins, is often associated 
with SL responses.160 KAI2 was initially identified in a screen for light signaling mutants and is 
therefore also referred to as HYPOSENSITIVE TO LIGHT (HTL).161 While not engaged in 
natural SL signaling, KAI2/HTL is responsive to non-natural (2’S) SL stereoisomers, producing 
typical karrikin-related phenotypic outcomes, such as shortened hypocotyls in seedlings.50 In 
contrast, naturally (2’R)-configured SLs strongly control hypocotyl length through the original 
D14 receptor.47c, 50 Accordingly, rac-GR24, a racemic mixture of naturally and non-naturally 
configured GR24, was shown to repress hypocotyl growth in both a D14- and KAI2-dependent 
manner.160 Particularly for chemically synthesized SL analogs, such as the CISA analogs 
4.2a-f, the pronounced stereoselectivity of both receptors toward the different C-2’ isomers is 
a valuable tool to untangle the response to both components in a racemic mixture. For this 
reason, a hypocotyl elongation assay was performed in Arabidopsis thaliana seedlings, treated 
with compounds 4.2a-f and rac-GR24 as positive control (Figure 4.14). In addition to 
Columbia-0 (Col-0) wild-type plants, different mutant lines (d14, htl-3 and d14/htl-3) were used 
to separate D14- and KAI2/HTL-dependent regulation. In the d14 and htl-3 single-mutants, 
one of both receptors remains functional for signal transduction; in the double-mutant 
d14/htl-3, both signaling pathways are disabled. The elongated hypocotyls of the KAI2/HTL-
defective mutants htl-3 and d14/htl-3 compared to wild-type plants reveal KAI2/HTL as the 
dominant receptor in hypocotyl growth regulation. 
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Figure 4.14. Arabidopsis thaliana seedling hypocotyl elongation responses to 1 µM of CISA analogs 4.2a-f 
and rac-GR24. Data are means ± SEM (n = 3). Asterisks indicate significant differences relative to the 
control treatment (Tukey’s HSD test; * P < 0.05, ** P < 0.01, *** P < 0.001). 
In wild-type seedlings (Col-0) and both mutant lines d14 and htl-3, the CISA analogs 4.2a-f 
significantly inhibited hypocotyl elongation compared to the mock treatment (P < 0.001). 
Except for compound 4.2b in the wild-type plant, no significant differences with rac-GR24 were 
observed in any mutant (P > 0.05). As the active pathway in the htl-3 mutant operates through 
the common D14 receptor, the observed activity likely emanates from the corresponding (2’R) 
isomers and can be extrapolated to the normal SL responses in adult plants. Hence, the data 
suggest that the CISA (2’R) isomers are equally capable as naturally configured GR24 in 
activating the D14-mediated signaling pathway and thus regulating different vegetal 
processes, e.g., shoot outgrowth. The potency of the CISA (2’S) isomers to signal through the 
KAI2/HTL receptor, as expressed by the strongly reduced hypocotyl of the d14 mutant, is 
especially relevant for karrikin-derived responses, such as hypocotyl growth inhibition and 
germination recruitment.162 The non-natural CISA isomers are of less practical significance for 
naturally SL-controlled processes, though some scattered reports indicate substantial shoot 
growth regulating activity for (2’S)-configured SLs in garden pea and Arabidopsis.47b, 50, 57b The 
d14/htl-3 double-mutant was generally insensitive to the tested analogs, in spite of a trend 
toward a small reduction in hypocotyl length, which was only statistically significant for analogs 
4.2a, 4.2e and 4.2f. Since none of the analogs 4.2a-f displayed a significant difference among 
each other or to the standard rac-GR24 (P > 0.05), the minor deviation of 4.2a, 4.2e and 4.2f 
from the control treatment in the double-mutant is likely the result of off-target effects. The 
overall unresponsiveness of the d14/htl-3 mutant to SL treatment suggests that the CISA 
analogs 4.2a-f signal through the same pathway as rac-GR24. 
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4.4. SMXL6 protein degradation assay 
The SMXL6, SMXL7, and SMXL8 proteins, co-orthologs of rice D53,63 were recently identified 
as key components in the SL-dependent regulation of shoot branching and other 
developmental processes in Arabidopsis thaliana. Ubiquitination and degradation of the SMXL 
proteins were shown to proceed in a MAX2- and D14-dependent manner, and are triggered 
by perception of the SL analog rac-GR24.64a, 64b To verify if analogs 4.2a-f indeed initiate the 
SL signaling cascade, CISA-induced degradation of SMXL6 was investigated in Arabidopsis 
thaliana seedlings by means of confocal microscopy. To this end, transgenic Arabidopsis 
plants were generated by transformation of Col-0 wild-type plants with the 35S:SMXL6-GFP 
reporter construct. The green fluorescent protein (GFP) signal was examined in the primary 
root of 5-day old seedlings treated for 30 minutes with a 10 µM solution of rac-GR24 or CISA 
analogs 4.2a-f (Figure 4.15). In contrast to the mock treatment, application of rac-GR24 
resulted in the virtual loss of GFP signal, which indicates the rapid degradation of the GFP-
fused SMXL6 proteins. Similarly, strongly reduced SMXL6-GFP signal was observed after 
treatment with compounds 4.2a-f. This demonstrates that the CISA analogs 4.2a-f activate the 
SL pathway and validates their action as true SL analogs. 
 
Figure 4.15. SMXL6 degradation in Arabidopsis thaliana roots in response to SL analogs. SMXL6-GFP 
confocal images (a) before and (b-i) after 30 minutes treatment with (b) 0.01% (v/v) acetone, or 10 µM of 
(c) rac-GR24, (d) 4.2a, (e) 4.2b, (f) 4.2c, (g) 4.2d, (h) 4.2e, (i) 4.2f. Scale bars, 50 µm.  
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4.5. Yeast two-hybrid assay 
Proteasome-mediated degradation of the SMXL proteins is preceded by the formation of a 
MAX2-D14-SMXL complex. The downstream targets SMXL6 and SMXL7 were shown to 
physically interact with the receptor protein D14 in a SL-enhanced manner.47c, 64b, 64c In 
addition, SL perception triggers interaction of D14 with the F-box protein MAX2, which 
suggests that D14 acts as a bridge to bring both components together for ensuing target 
ubiquitination by the SCFMAX2 complex.64c  
By means of a yeast two-hybrid (Y2H) assay, the protein-protein interaction between D14 and 
SMXL7 in response to the CISA analogs 4.2a-f was studied. The premise behind the technique 
is the reconstitution of an operational transcription factor, which is validated by the expression 
of a downstream reporter gene (Figure 4.16). The functional domains of the transcription 
factor, the DNA binding domain (BD) and the activation domain (AD), are separately fused to 
the proteins of interest, D14 and SMXL7 in this case, creating two systems of hybrid proteins 
(of which one is depicted in Figure 4.16). The BD and AD constructs are referred to as bait 
and prey, respectively. The bait binds the upstream activation sequence (UAS) of the 
promotor. Interaction between the bait and prey protein leads to the recruitment of the 
transcriptional activation domain (AD). Hence, both functional domains of the transcription 
factor are brought into close proximity, driving expression of the reporter gene.163 In the current 
assay, the Escherichia coli gene LacZ was selected as a reporter. LacZ encodes the enzyme 
β-galactosidase, which in many bacteria is responsible for the hydrolysis of the disaccharide 
lactose into the monosaccharides galactose and glucose. In molecular biology assays, 
β-galactosidase activity is revealed by the artificial substrate 5-bromo-4-chloro-3-indolyl-β-D-
galactoside (X-Gal), whose indole cleavage product spontaneously dimerizes and oxidizes to 
produce a deep blue colored precipitate.164 
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Figure 4.16. Molecular basis of the yeast two-hybrid technique. In the presence of SL, protein-protein 
interaction between D14 and SMXL7 brings the DNA binding domain (BD) and the transcriptional 
activation domain (AD) in close proximity, resulting in the expression of the reporter gene. 
The Y2H experiment was performed in the Saccharomyces cerevisiae yeast strain EGY48, 
which is auxotrophic for uracil, histidine and tryptophan, but equipped with a β-galactosidase 
reporter plasmid with URA3 marker gene. The yeast was co-transformed with bait and prey 
plasmids, retaining respectively the HIS3 and TRP1 gene as selection marker. The yeast 
transformants were plated on control medium, i.e., a synthetic defined growth medium lacking 
the nutrients uracil, tryptophan and histidine (−UTH), and selective medium additionally 
containing X-Gal (−UTH + X-Gal). The plates were supplemented with 10 µM of the CISA 
analogs 4.2a-f. Positive and negative control experiments were performed in the presence 
and absence of rac-GR24, respectively. Positive protein interactions were identified based on 
the blue staining of the yeast colonies on X-Gal containing medium (Figure 4.17).  
 
Figure 4.17. Yeast two-hybrid analysis of the interaction between D14 and SMXL7 in the presence of 
10 µM of CISA analogs 4.2a-f or rac-GR24. C, control treatment with 0.01% (v/v) acetone. 
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Both rac-GR24 and the CISA analogs 4.2a-f induced a physical interaction between D14 and 
SMXL7, whereas no interaction was observed in the absence of SL analogs. Especially 
derivatives 4.2b, 4.2e and 4.2f generated a high level of β-galactosidase activity compared to 
rac-GR24, as revealed by the intense coloration, which indicates that interaction of D14 with 
SMXL7 was exceedingly triggered. In general, weaker protein interactions were obtained when 
the D14 protein was used as bait instead of SMXL7. The difference between both hybrid 
systems likely results from the divergent size and folding of the chimeric proteins, which might 
affect interaction. Overall, the Y2H assay provides additional evidence at a molecular level 
that the CISA analogs 4.2a-f initiate the SL signaling pathway and thus confirms the results of 
the SMXL6 protein degradation experiment. 
5. Evaluation of the spectroscopic properties 
With all CISA analogs 4.2a-f being highly capable of eliciting SL-like responses in different 
organisms, their functionality as a tracer molecule is decided by their fluorescent properties. 
First, the spectroscopic characteristics of the different analogs 4.2a-f were determined in 
solution. Subsequently, the most promising compound was selected for in vivo imaging in 
plants. 
5.1. Fluorescence measurements in solution 
The local environment of the fluorophore is known to considerably affect the emission spectral 
properties of the compound. The correlations are complex, however, solvent polarity is 
deemed an important factor.165 The internal volume of plant cells, where the compounds are 
ideally visualized, consists for 70-80% of water.166 As the CISA analogs 4.2a-f are not water-
soluble, methanol was chosen as substitute solvent to conduct the fluorescence 
measurements. Indeed, both water and methanol are polar protic solvents with comparable 
dipole moments (μ = 1.85 and 1.70 Debye, respectively) and high dielectric constants (ε = 78 
and 33, respectively).167 Furthermore, chemical degradation of the compounds was observed 
in aqueous medium, but not in methanol solutions (Figure 4.11, vide supra).  
Excitation and emission spectra were recorded in the range of 250-700 nm (Figure 4.18). All 
analogs 4.2a-f show wide, multipeaked excitation bands with maxima in the near ultraviolet 
region (320-380 nm). The emission spectra are more uniformly shaped, displaying maxima in 
the violet (380-450 nm, analogs 4.2a-e) and green regions (495-570 nm, analog 4.2f) of the 
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visible spectrum. A summary of the obtained maxima can be found in Table 4.19, together 
with other determined spectroscopic properties as the Stokes shift, the luminescence lifetime 
(τ) and the quantum yield (φf). 
 
Figure 4.18. Normalized excitation (left) and emission (right) spectra in function of the wavelength (nm) 
for the different CISA analogs 4.2a-f (10-4 M in methanol). The maxima are highlighted (▼). 
Table 4.19. Selected spectroscopic properties of the different CISA analogs 4.1 and 4.2a-f 
(10-4 M in methanol). 
Entry Derivative λex (nm)a λem (nm)b 
Stokes 
shift (nm) 
τ (ns)c φf (%)d 
1e 4.1 355 384 29 ND ND 
2 4.2a 334 394 60 1.36 1.1 
3 4.2b 338 397 59 1.85 0.9 
4 4.2c 355 399 44 0.92 1.3 
5 4.2d 321 404 83 1.0 0.7 
6 4.2e 345 380 35 1.94 1.1 
7 4.2f 369 525 156 3.42 24.4 
a excitation maximum. b emission maximum. c luminescence lifetime. d absolute fluorescence quantum yield. 
e data from literature, measured in a 10-5 M solution in methanol.87 
The Stokes shift is defined as the difference between the emission and the excitation 
maximum. This spectroscopic parameter is preferably large, as to allow separation of the 
fluorescence emission signal from Rayleigh-scattered excitation light and autofluorescence of 
the plant tissue. The unsubstituted analog CISA-1 (4.1) has a Stokes shift of only 29 nm (entry 
1), which explains its poor visibility during in vivo fluorescence tests.87 The introduction of 
substituents with different electronical properties onto the cyanoisoindole core has a positive 
influence on the Stokes shift. Electron-withdrawing substituents (4.2a-b) double the Stokes 
shift to 60 nm (entries 2 and 3). Electron-donating substituents (4.2c-d) even increase the 
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Stokes shift up to 83 nm (entries 4 and 5). Expansion of the aromatic core of CISA-1 with an 
additionally fused benzene ring (4.2e) has a limited influence on both the excitation and the 
emission maximum, and consequently on the Stokes shift (entry 6). However, the increased 
conjugation of CISA-7 (4.2f) results in a strong redshifted emission maximum, yielding a 
substantially increased Stokes shift of over 150 nm (entry 7). CISA-7 (4.2f) also differentiates 
itself when it comes to fluorescence efficiency. Whereas analogs 4.2a-e possess low quantum 
yields (φf) of about 1%, CISA-7 (4.2f) performs far superior with a quantum yield of 24%. This 
coincides with an increased decay time of 3.42 ns compared to 1-2 ns for compounds 4.2a-e. 
Based on these observations, cyanopyrrolo[3,4-b]indole analog 4.2f is obviously the most 
promising candidate for visualization in plants. 
5.2. Confocal microscopy in Arabidopsis thaliana roots 
Confocal microscopy is a frequently applied technique to measure fluorescence in labeled 
cells and tissues. The light to illuminate the designated specimen is usually generated by 
lasers operating at specific wavelengths. The minimum excitation wavelength in standard 
confocal equipment is 405 nm, which poses an important limitation to the fluorescent probes 
that can be visualized by confocal microscopy. While compounds 4.2a-e cannot be excited 
above 400 nm, the selected fluorescent analog CISA-7 (4.2f) shows an adequate excitation 
capacity up to 450 nm and is therefore the sole compatible compound.  
Five-day old Arabidopsis thaliana seedlings were grown overnight on medium supplemented 
with 100 µM of analog 4.2f. The treated sample was excited using a 405 nm UV diode laser. 
A lambda scan in the range from 445 nm to 605 nm revealed maximal fluorescence at about 
500 nm, which is very close to the measured emission maximum at 525 nm in methanol. 
Adequate fluorescent signal was observed from 455 nm up to 555 nm, which was set as the 
emission window to visualize compound 4.2f in plant tissue. Confocal images of the primary 
root of the treated seedlings show a strong green fluorescence (Figure 4.19a), whereas 
untreated roots remain invisible, apart from some light scattering at the root tip surface (Figure 
4.19b). This demonstrates that CISA-7 (4.2f) can be successfully visualized within living plant 
cells without interfering background signals emitted from the matrix. Staining of the cell walls 
with propidium iodide (PI), a red-fluorescent dye which is not permeant to live cells, evidences 
the presence of analog 4.2f inside the root cells of the seedling, more specifically in the 
cytoplasm. Moreover, the fluorescence intensity gradually diminished when moving along the 
root away from the root tip, demonstrating the effective absorption of CISA-7 (4.2f) by the 
plant’s root system and its translocation toward tissues more distant from the root tip. 
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Figure 4.19. Fluorescence confocal images of the primary root of a 5-day old Arabidopsis thaliana 
seedling (a) after 20 h pre-incubation with 100 µM of CISA analog 4.2f (green) or (b) without treatment, 
followed by propidium iodide (PI) staining of the cell walls (red). Scale bars, 50 µm.  
6. Conclusion 
An innovative class of labeled SL analogs was developed, in which the original ABC-rings are 
exchanged for a fluorescent core. The applied strategy stands in sharp contrast with the earlier 
reported methods, which rely on the attachment of an external fluorescent moiety to the 
canonical SL scaffold. The main advantage of this novel approach is the minimal divergence 
from the natural shape of the hormone.  
The 1-cyanoisoindole motif was selected as base structure for the fluorophore. Through 
various substitution patterns and the fusion of 5- or 6-membered aromatic rings, the 
fluorescent properties of the compound series were modulated. All cyanoisoindole-based 
strigolactone analogs (CISA) were shown to emit fluorescent light in solution, but the 
remarkable luminescent properties of the pyrrolo[3,4-b]indole analog CISA-7 (4.2f) also 
enabled visualization in living plants. Biological evaluation as parasitic seed germination 
stimulant and hypocotyl elongation repressor demonstrated the high efficacy of the CISA 
analogs to elicit SL-like responses. Furthermore, protein degradation and interaction 
experiments provided evidence at a molecular level that the CISA analogs operate through 
the natural SL signaling pathway. Overall, a potent series of SL agonists was developed, 
including a promising molecular probe to track the fate of SLs in plants and fungi. 
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7. Perspectives 
The high level of bioactivity in both parasitic and autotrophic plants combined with eminent in 
vivo visibility renders CISA-7 (4.2f) a powerful tool for both basic and applied SL research. 
Moreover, the 3-cyano-4H-pyrrolo[3,4-b]indole fluorescent core is unprecedented in literature 
and its relevance can be extended to the labeling of a wide range of biologically active small 
molecules and macromolecules. 
7.1. Molecular probe for basic SL research 
The fluorescent analog CISA-7 (4.2f) fills a gap in the spectrum of available molecular probes 
for fundamental research on SL signaling. In contrast to bioactive turn-on probes, which only 
emit fluorescence upon cleavage by the SL receptor, CISA-7 is a permanently visible tracer. 
Whereas turn-on probes are used to locate the SL receptor and visualize the perception 
dynamics, probes that can be tracked from the initial uptake process to the place of action are 
particularly suited to study the spatiotemporal distribution and translocation of SLs. However, 
functional tracers belonging to the latter group are currently sparse, and the few analogs which 
are visible in plants are characterized by a strongly reduced biological activity due to the large 
fluorescent tag. In addition, the significantly increased three-dimensional volume of the labeled 
analogs compared to endogenous SLs might lead to altered behavior in plants, which 
questions the relevance of the obtained data. CISA-7, on the other hand, strongly resembles 
natural SLs in overall shape, size and molecular weight (Figure 4.20). Consequently, the 
compound is expected to display physicochemical properties more similar to the natural 
hormone, which would endorse its use as tracer to deduce conclusions concerning the spatial 
regulation of SLs in plant tissues. More specifically, topics as subcellular localization and 
transport, cellular export and import, long-distance transport between different organs and 
exudation from the roots might be unraveled with the aid of CISA-7.  
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Figure 4.20. Similarity in overall size and shape between CISA-7 4.2f (blue) and strigol 2.1 (orange). 
7.2. Agricultural applications in weed control 
Parasitic weeds of the genera Striga and Orobanche belong to the most destructive and 
intractable pests to agricultural production, affecting millions of farmers in tropical and 
subtropical areas of Africa and Asia. One of the major endeavors to prevent parasitism toward 
crops is artificial germination induction in the absence of a host. The germinated seeds are 
unable to survive, which eventually results in the depletion of the field’s seed bank.168 SL 
analogs and mimics have been reported before as effective suicidal germination agents.169 In 
addition to a high intrinsic activity on a broad spectrum of parasitic seeds, an adequate stability 
of the agent in the soil is important to ensure efficient treatment of the farmland. With respect 
to the CISA analogs, extension of the cyanoisoindole system with an additional 5- or 6-
membered aromatic ring was shown to greatly enhance the resistance to moist and alkaline 
conditions. At a pH of 7.4, the corresponding analogs CISA-7 (4.2f) and CISA-6 (4.2e) 
respectively displayed a 1.5- and 2.5-fold increased half-life time compared to the standard 
GR24. The improved stability together with shown activity in Phelipanche ramosa seeds 
suggests their applicability as suicidal germination stimulants. Further research efforts are 
required to determine the scope of parasitic seeds that germinate under influence of 
compounds 4.2e and 4.2f, and the potential occurrence of unwanted effects on AM fungi. Key 
aspects to consider when pursuing field trials are the optimal working concentration, the 
formulation of the compound and the application technique.  
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7.3. Fluorescent dye in biochemical research 
Being convenient for the preparation of fluorescent SL analogs, the 3-cyano-4H-pyrrolo-
[3,4-b]indole fluorescent core might also be applicable to the labeling of biomolecules, such 
as peptides, proteins, antibodies, sugars, polysaccharides, nucleic acids, oligonucleotides, 
etc. Fluorescent bioconjugates, consisting of a biomolecule covalently linked to a fluorogenic 
substance, are widely applied in immunochemistry, fluorescence in situ hybridization assays, 
cellular imaging, and flow cytometry.170  
Coupling of the target molecule with the fluorescent tag relies on spontaneously reactive 
functional groups in both compounds. Most commonly, the fluorophore is equipped with an 
amine-reactive functionality, which allows the labeling of nearly all peptides and proteins, along 
with amine-modified nucleic acids and oligonucleotides.170-171 In the case of fluorophore 4.4f, 
the ester function is specifically suited as point of attachment, as it can be easily transformed 
into activated succinimidyl or tetrafluorophenyl esters 4.52 (Scheme 4.16). Upon reaction with 
free amino groups in the respective biomolecules, strong peptide bonds are produced. 
 
Scheme 4.16. Labeling of amino-functionalized biomolecules with the 3-cyano-4H-pyrrolo[3,4-b]indole 
fluorescent core. 
Hydroxyl-reactive functionalities, such as isocyanates, are particularly useful to label sugars 
and polysaccharides. They can also be applied to form bioconjugates with nucleic acids 
through reaction with the nucleotide sugar units.170-171 The required isocyanate 4.54 can be 
prepared from the carboxylic acid 4.39f through formation of the acyl azide 4.53, followed by 
a Curtius rearrangement (Scheme 4.17). Reaction of 4.54 with a hydroxyl group forms a stable 
urethane bond between the biomolecule and fluorescent tag. 
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Scheme 4.17. Labeling of hydroxyl-functionalized biomolecules with the 3-cyano-4H-pyrrolo[3,4-b]indole 
fluorescent core. 
Fluorescence microscopy experiments in plants with SL analog 4.2f demonstrated that the 
fluorophore can be excited with short-wavelength light of 405 nm and fluoresces in the 
450-550 nm range. The fluorophore is optimally suited for multicolor experiments with two or 
more molecular probes, as the excitation and/or emission bands are separated from those of 
many commercially available dyes, such as fluorescein (λex = 494 nm, λem = 518 nm), BODIPY 
FL (λex = 505 nm, λem = 513 nm), tetramethylrhodamine (λex = 555 nm, λem = 580 nm), and 
Texas red (λex = 595 nm, λem = 615 nm).171 This allows the simultaneous monitoring of different 
biochemical functions. The feasibility of isolating the signal from other fluorophores was proven 
for the green-fluorescent protein GFP (section 4.4) and the red-fluorescent dye propidium 
iodide (section 5.2).  
7.4. Tuning of the spectroscopic properties 
Many options exist to further optimize the fluorescent properties of the 3-cyano-4H-
pyrrolo[3,4-b]indole core. The introduction of different substituents on the six-membered ring 
as well as the indole nitrogen might shift the excitation and emission spectra to longer, less 
energetic wavelengths, and boost the fluorescence intensity.  
A modified indole core is proposed to be obtained via Fischer indole synthesis with variously 
substituted phenylhydrazines 4.55 (Scheme 4.18, step 1).172 In a next step, the indole nitrogen 
can be protected with cleavable groups exhibiting divergent electronic properties (4.58), or 
arylated with different aryl halides in the presence of a copper(I) catalyst via an Ullmann-type 
coupling reaction (4.59) (step 2).173 Subsequent formation of aldehyde 4.60 and bromination 
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of the C-3 position (4.61) is inferred to proceed similarly to the original pathway (step 3). 
Indoles which are brominated on the benzene ring can be subjected to a regioselective Suzuki 
coupling reaction, which allows the extension of the indole core with a wide range of aromatic 
rings (4.62) (step 4).174 Finally, after formation of the fluorescent core 4.63 with the appropriate 
variations (step 5), the indole nitrogen might be deprotected (4.64) if substituted with an acid-
labile group (step 6). With respect to the synthetic route of the plain 3-cyano-4H-pyrrolo[3,4-b]-
indole framework, the addition of one to three steps enables extensive diversification of the 
fluorescent core, providing innumerable possibilities to tune the spectroscopic properties as a 
function of the biological application. 
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Scheme 4.18. Diversification of the 3-cyano-4H-pyrrolo[3,4-b]indole fluorescent core.  
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8. Experimental details 
8.1. General methods 
Unless otherwise noted, all commercial reagents were used without further purification. 
Tetrahydrofuran and diethyl ether were dried by passage through an activated alumina column 
under nitrogen (MBraun 5-Solvent Purification System) or by distillation from 
sodium/benzophenone. Anhydrous acetonitrile was obtained by distillation and storage over 
4 Å molecular sieves. Anhydrous methanol was obtained by heating methanol with dried 
magnesium turnings and iodine for two hours before distillation. Microwave experiments were 
conducted in a CEM Discover microwave reactor model with a continuous power output (0 to 
300 W). The reactions were run in a closed 10 mL microwave Pyrex vessel under continuous 
stirring. Ultrasonic conditions were created with a Hielscher UP100H compact ultrasonic 
laboratory device (100 W, 30 kHz). Thin layer chromatography (TLC) analysis of reaction 
mixtures was performed using Merck silica gel 60 F254 TLC plates, and visualized under UV 
light (254 nm) or by using ceric ammonium molybdate, KMnO4 or vanillin stain. Flash column 
chromatography was carried out on Davisil LC 60 Å 70-200 µm chromatographic silica. 
Automated flash chromatography was performed on a Grace Reveleris flash system using 
prepacked columns (40 µm C18 silica cartridges). Melting points were determined on a Kofler 
heating bench system of Wagner & Munz (type WME, accuracy ± 1 °C). Infrared spectra were 
obtained on a Shimadzu IRAffinity-1S FT-IR apparatus or a Perkin-Elmer BX FT-IR 
spectrometer. Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AVIII 
HD 400 spectrometer at 25 °C, unless otherwise stated. 1H and 13C chemical shifts are 
reported in ppm downfield of tetramethylsilane and referenced to the (residual) solvent peak 
(CDCl3 δH = 7.26 and δC = 77.16). Coupling constants (J) are reported in Hertz (Hz). 
Multiplicities are listed using the following abbreviations: s = singlet, d = doublet, t = triplet, q 
= quartet, p = quintet, h = sextet, m = multiplet, br = broad resonance. Peaks were assigned 
with the aid of DEPT and 2D spectra (COSY, HSQC, HMBC). LC and LC MS analyses were 
performed on an Agilent 1200 Series HPLC system with Supelco Ascentis Express C18 
(30 mm x 4.6 mm x 2.7 µm) column, connected to a UV-DAD detector and an Agilent 1100 
Series mass spectrometer using a mass selective single quadrupole detector (ESI mode, 
70 eV, 4000 V). GC MS analysis was performed on a Hewlett-Packard 6890/5973N gas 
chromatograph/mass spectrometer equipped with an Agilent J&W DB-5MS (30 m x 0.25 mm 
x 0.25 µm) column and quadrupole mass analyzer (EI mode, 70 eV). High resolution mass 
spectral (HRMS) data were collected on an Agilent 6220A time-of-flight mass spectrometer 
(ESI/APCI mode, 2000 V). 
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8.2. Safety 
Based on the European Regulation (EC) No 1272/2008 on classification, labeling and 
packaging of substances and mixtures (EU-GHS/CLP), chemicals are classified according to 
their hazardous properties with respect to human health and environment. A brief overview of 
the category 1 chemicals, the most harmful category in each hazard class, employed in this 
research is given below, along with the hazards and precautions for that class. The information 
was retrieved from the respective safety data sheets (SDS), which can be found on the website 
of the supplier. 
Allylamine. Fatal in contact with skin. Wear protective gloves and clothing. 
Benzoyl peroxide. Organic peroxide. Explosive when dry. May cause an allergic skin 
reaction. Very toxic to aquatic life with long lasting effects. Keep away from heat, hot surfaces, 
sparks, open flames and other ignition sources. Avoid release to the environment. Wear 
protective gloves and clothing. 
Carbon tetrachloride. May cause an allergic skin reaction. Causes damage to organs through 
prolonged or repeated exposure. Harms public health and the environment by destroying 
ozone in the upper atmosphere. Avoid inhalation. Avoid release to the environment. Wear 
protective gloves and clothing. 
Chloroform. Causes damage to organs through prolonged or repeated exposure. Avoid 
breathing vapors. Wear protective gloves and clothing. 
1,2-Dichloroethane. May cause cancer. Wear protective gloves and clothing. 
1,2-Dimethoxyethane. May damage fertility. May damage the unborn child. May form 
explosive peroxides. Wear protective gloves and clothing. 
Ethyl 2-bromoacetate. Fatal in contact with skin. Wear protective gloves and clothing. 
Inorganic acids and bases (HCl, H2SO4, NaOH). May be corrosive to metals. Cause severe 
skin burns and eye damage. Wear protective gloves and clothing. 
Iodomethane. May cause an allergic skin reaction. May cause allergy or asthma symptoms 
or breathing difficulties if inhaled. Avoid breathing vapors. Wear protective gloves and clothing. 
Lithium aluminum hydride. In contact with water releases flammable gases which may ignite 
spontaneously. Causes severe skin burns and eye damage. Keep away from any possible 
contact with water, because of violent reaction and possible flash fire. Handle and store under 
inert gas. Protect from moisture. Wear protective gloves and clothing. 
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Lithium diisopropylamide. Catches fire spontaneously if exposed to air. Causes severe skin 
burns and eye damage. Do not allow contact with air. Handle and store under inert gas. Wear 
protective gloves and clothing.  
Methanol. Causes damage to organs (eyes). Wear protective gloves and clothing.  
N-bromosuccinimide. Causes severe skin burns and eye damage. Wear protective gloves 
and clothing. If in eyes, rinse cautiously with water for several minutes. Immediately call a 
poison center. 
Organic acids and bases (triflic acid, Et3N). Cause severe skin burns and eye damage. 
Wear protective gloves and clothing. 
Oxalic acid. Causes serious eye damage. Wear protective gloves, protective clothing, eye 
and face protection. If in eyes, rinse cautiously with water for several minutes. Immediately 
call a poison center. 
Potassium permanganate. Causes severe skin burns and eye damage. Very toxic to aquatic 
life with long lasting effects. Wear protective gloves and clothing. 
Sodium hydride. In contact with water releases flammable gases which may ignite 
spontaneously. Handle under inert gas. Protect from moisture. Store in a dry place in a closed 
container. 
Solvents in general. (Highly) flammable liquid and vapor. Harmful if swallowed, in contact 
with skin or if inhaled. Keep away from heat, hot surfaces, sparks, open flames and other 
ignition sources. Avoid inhalation. Wear protective gloves and clothing. 
Toluene. May be fatal if swallowed and enters airways. Do not breathe dust, fume, gas, mist, 
vapors, spray. Wear protective gloves and clothing. 
Transition metal salts. May cause an allergic skin reaction. Cause severe skin burns and 
eye damage. May cause respiratory irritation. Very toxic to aquatic life (with long lasting 
effects). Wear protective gloves and clothing. 
2,2,2-Trifluoroethanol. Causes serious eye damage. May damage fertility. Wear protective 
gloves, protective clothing, eye and face protection. If in eyes, rinse cautiously with water for 
several minutes. Immediately call a poison center. 
Trimethylsilyl cyanide. Fatal if swallowed, in contact with skin or if inhaled. Do not breathe 
dust, fume, gas, mist, vapors, spray. Wear respiratory protection. Contact with water liberates 
toxic gas (HCN). 
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8.3. Synthetic procedures and spectral data 
8.3.1. Synthesis of bromoindole 4.3f from indole-2-carboxylic acid 4.5 
8.3.1.1. Synthesis of indole 4.7 
 
The title compound 4.7 was synthesized via a modification of a procedure reported by Suzuki 
et al..90 A flame-dried 250 mL round-bottom flask equipped with a Teflon-coated magnetic 
stirrer was charged with a solution of indole-2-carboxylic acid 4.5 (2.00 g, 12.410 mmol) in dry 
tetrahydrofuran (200 mL, 0.062 M) and placed under argon atmosphere. Lithium aluminum 
hydride (1.0 M solution in THF, 13.7 mL, 13.651 mmol) was carefully added at 0 °C and the 
resulting mixture was stirred at room temperature (20 °C) for 1.5 h. Subsequently, the reaction 
was quenched by sequential addition of water (50 mL) and a saturated aqueous solution of 
NaHCO3 (20 mL). The aqueous layer was extracted with ethyl acetate (4 x 50 mL) and the 
combined organic phases were washed with a saturated aqueous solution of NaCl (2 x 30 mL), 
dried over MgSO4 and concentrated in vacuo until approximately 200 mL of solvent was 
remaining to avoid polymerization. 
The obtained solution of (1H-indol-2-yl)methanol 4.6 (12.410 mmol) in ethyl acetate (200 mL, 
0.062 M) was cooled to 0 °C and manganese dioxide (activated, 5.39 g, 62.051 mmol) was 
added. The suspension was refluxed (77 °C) for 2 h, after which the precipitates were removed 
by vacuum filtration over a celite bed. The filtrate was evaporated to dryness under reduced 
pressure, yielding compound 4.7 as off-white crystals (1.35 g, 75%). 
(1H-Indol-2-yl)methanol 4.6. Brown-red crystals. Rf (SiO2) = 0.29 (hexane/EtOAc 1:1). Mp 65 °C. IR 
(neat, cm-1): 3374 (N-H), 3246 (O-H), 1454, 1416, 1339, 1290, 1230, 1136, 1055, 
1006, 977, 790, 774, 736, 631, 620. 1H NMR (400 MHz, CDCl3): δ 8.41 (br s, 1H, NH), 
7.59 (dd, J = 7.8, 1.1 Hz, 1H, C4H), 7.32 (dd, J = 8.1, 1.0 Hz, 1H, C7H), 7.19 (ddd, J = 
8.1, 6.9, 1.1 Hz, 1H, C6H), 7.11 (ddd, J = 7.8, 6.9, 1.0 Hz, 1H, C5H), 6.40 (d, 4JH-NH = 2.1 Hz, 1H, C2H), 
4.79 (s, 2H, C9H), 3.00 (br s, 1H, OH). 13C NMR (101 MHz, CDCl3): δ 137.6 (C1), 136.5 (C8), 128.2 (C3), 
122.3 (C6), 120.8 (C4), 120.1 (C5), 111.1 (C7), 100.7 (C2), 58.8 (C9). MS (ESI, 70 eV) m/z (%): 148 (M + 
H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C9H9NO + H+ 148.0757, found 148.0757. The spectroscopic 
data are in agreement with the previously reported literature values.175  
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1H-Indole-2-carbaldehyde 4.7. Off-white crystals, yield 75% (2 steps). Rf (SiO2) = 0.19 (hexane/EtOAc 
10:1). Mp 140 °C. IR (neat, cm-1): 3175 (N-H), 1650 (C=O), 1526, 1427, 1340, 1252, 
1126, 821, 740. 1H NMR (400 MHz, CDCl3): δ 9.86 (s, 1H, C9H), 9.26 (br s, 1H, NH), 
7.76 (dddd, J = 8.1, 1.1, 1.0 Hz, 5JH-NH = 1.0 Hz, 1H, C4H), 7.47 (dddd, J = 8.4, 1.0, 1.0, 
1.0 Hz, 1H, C7H), 7.40 (ddd, J = 8.4, 6.9, 1.1 Hz, 1H, C6H), 7.29 (dd, 4JH-NH = 2.1 Hz, J = 1.0 Hz, 1H, 
C2H), 7.19 (ddd, J = 8.1, 6.9, 1.0 Hz, 1H, C5H). 13C NMR (101 MHz, CDCl3): δ 182.3 (C9), 138.2 (C8), 
136.1 (C1), 127.49 (C6), 127.46 (C3), 123.6 (C4), 121.4 (C5), 115.0 (C2), 112.6 (C7). MS (ESI, 70 eV) m/z 
(%): 146 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C9H7NO – H+ 144.0455, found 144.0461. The 
spectroscopic data are in agreement with the previously reported literature values.176  
8.3.1.2. Synthesis of indole 4.8 
 
The title compound 4.8 was synthesized via a modification of a procedure reported by Han et 
al..94 A flame-dried 100 mL round-bottom flask equipped with a Teflon-coated magnetic stirrer 
was charged with a solution of 1H-indole-2-carbaldehyde 4.7 (1.79 g, 0.0123 mol) in dry 
tetrahydrofuran (77 mL, 0.16 M) and placed under argon atmosphere. Sodium hydride (60% 
dispersion in mineral oil, 543 mg, 0.0136 mol) was added slowly at 0 °C and the resulting 
suspension was stirred at room temperature (20 °C) for 0.5 h. Subsequently, methyl iodide 
(1.54 mL, 0.0247 mol) was added and the stirring was continued at room temperature (20 °C) 
for 15 h. The reaction was poured onto crushed ice (50 mL) and extracted with ethyl acetate 
(4 x 50 mL). The combined organic phases were washed with a saturated aqueous solution of 
NaCl (2 x 30 mL), dried over MgSO4 and concentrated in vacuo, yielding compound 4.8 as off-
white crystals (1.96 g, quant.). 
1-Methyl-1H-indole-2-carbaldehyde 4.8. Off-white crystals, quant. yield. Rf (SiO2) = 0.30 
(hexane/EtOAc 20:1). Mp 80 °C. IR (neat, cm-1): 1661 (C=O), 1610, 1518, 1469, 1396, 
1354, 1182, 1115, 911, 846, 801, 752, 739, 619. 1H NMR (400 MHz, CDCl3): δ 9.89 (s, 
1H, C9H), 7.74 (ddd, J = 8.1, 1.0, 1.0 Hz, 1H, C4H), 7.46 – 7.38 (m, 2H, C6H, C7H), 7.25 
(d, J = 0.8 Hz, 1H, C2H), 7.18 (ddd, J = 8.1, 6.3, 1.7 Hz, 1H, C5H), 4.10 (s, 3H, C10H). 13C NMR (101 
MHz, CDCl3): δ 183.1 (C9), 141.0 (C8), 135.8 (C1), 127.1 (C6), 126.4 (C3), 123.5 (C4), 121.1 (C5), 117.6 
(C2), 110.5 (C7), 31.7 (C10). MS (ESI, 70 eV) m/z (%): 160 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. 
for C10H9NO + H+ 160.0757, found 160.0755. The spectroscopic data are in agreement with the 
previously reported literature values.177  
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8.3.1.3. Synthesis of 3-bromoindole 4.3f 
 
The title compound 4.3f was synthesized via a modification of a procedure reported by Barraja 
et al..178 To a stirred solution of 1-methyl-1H-indole-2-carbaldehyde 4.8 (815 mg, 5.120 mmol) 
in 2-methyltetrahydrofuran (102 mL, 0.05 M) in a 250 mL round-bottom flask was added 
portion wise at 0 °C N-bromosuccinimide (NBS, 4.56 g, 25.599 mmol). After 2 h stirring at 
room temperature (20 °C), the reaction mixture was diluted with ethyl acetate (100 mL). The 
organic phase was consecutively washed with aqueous 2 M NaOH (3 x 70 mL) and a 
saturated aqueous solution of NaCl (2 x 30 mL), dried over MgSO4 and concentrated. The 
crude residue was recrystallized from hexane, yielding compound 4.3f as yellow crystals 
(1.10 g, 90%). 
3-Bromo-1-methyl-1H-indole-2-carbaldehyde 4.3f. Yellow crystals, yield 90%. Rf (SiO2) = 0.15 
(hexane/EtOAc 10:1). Mp 88 °C. IR (neat, cm-1): 1660 (C=O), 1611, 1505, 1468, 1393, 
1348, 1328, 1238, 1180, 1122, 869, 738. 1H NMR (400 MHz, CDCl3): δ 10.13 (s, 1H, 
C9H), 7.69 (ddd, J = 8.1, 1.1, 1.0 Hz, 1H, C4H), 7.47 (ddd, J = 8.6, 6.8, 1.1 Hz, 1H, 
C6H), 7.38 (ddd, J = 8.6, 1.0, 0.9 Hz, 1H, C7H), 7.25 (ddd, J = 8.1, 6.8, 0.9 Hz, 1H, C5H), 4.08 (s, 3H, 
C10H). 13C NMR (101 MHz, CDCl3): δ 182.8 (C9), 139.5 (C8), 130.1 (C1), 128.2 (C6), 126.2 (C3), 121.8 
(C5), 121.7 (C4), 110.7 (C7), 106.1 (C2), 32.0 (C10). MS (ESI, 70 eV) m/z (%): 238 (M + H+, 100), 240 (M 
+ H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C10H8BrNO + H+ 237.9862, found 237.9859. The 
spectroscopic data are in agreement with the previously reported literature values.179 
8.3.2. Sonogashira coupling of bromoarenes with ethynyltrimethylsilane 
Bromoarenes 4.3a-e are commercially available, and were purchased from TCI Europe or 
Merck and used without further purification. 
8.3.2.1. Synthesis of 5-fluorobenzaldehyde 4.11a 
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The title compound 4.11a was synthesized via a modification of a procedure reported by Vasu 
et al..180 A flame-dried 100 mL round-bottom flask equipped with a Teflon-coated magnetic 
stirrer and a reflux condenser was charged with 2-bromo-5-fluorobenzaldehyde 4.3a (1.50 g, 
7.389 mmol) and placed under argon atmosphere. The starting material was dissolved in 
triethylamine (30 mL, 0.25 M), and Pd(PPh3)2Cl2 (104 mg, 0.148 mmol) and CuI (28 mg, 
0.148 mmol) were added. Subsequently, ethynyltrimethylsilane (1.25 mL, 8.867 mmol) was 
added dropwise over 15 minutes. The resulting suspension was stirred at room temperature 
(20 °C) for 1 h and then heated to reflux (89 °C) for 1.5 h. After completion of the reaction, the 
solvent was evaporated and the residue was dissolved in ethyl acetate (100 mL). The catalyst 
was removed by vacuum filtration over a celite bed and the clear organic phase was washed 
with water (25 mL), a saturated aqueous solution of NaCl (2 x 25 mL) and dried over MgSO4. 
After filtration, the solvent was evaporated under reduced pressure and a crude solid was 
obtained. 
To remove the trimethylsilyl protecting group, the resulting solid was dissolved in methanol 
(75 mL, 0.1 M). K2CO3 (1.23 g, 8.867 mmol) was added at 0 °C, and the mixture was allowed 
to warm to 20 °C by removing the ice bath. Proper temperature control was pivotal to prevent 
the formation of side products, and elevated temperatures (> 25 °C) were avoided at all times. 
After 1 h, complete TMS deprotection of the alkyne group was observed and the solvent was 
partially removed at ambient temperature under reduced pressure. The remaining mixture was 
diluted with water (100 mL), extracted with ethyl acetate (4 x 50 mL) and the combined organic 
phases were dried over MgSO4, filtered and concentrated. The product was purified by flash 
column chromatography on silica gel with hexane/ethyl acetate 99:1 as eluent, yielding 
compound 4.11a as off-white crystals (759 mg, 69%). 
2-Ethynyl-5-fluorobenzaldehyde 4.11a. Off-white crystals, yield 69%. Rf (SiO2) = 0.16 (hexane/EtOAc 
99:1). Mp 97 °C. IR (neat, cm-1): 3237 (≡C-H), 2100 (C≡C), 1690 (C=O), 1601, 1481, 1420, 
1221, 1150, 899, 831, 785, 665, 615, 567. 1H NMR (400 MHz, CDCl3): δ 10.49 (d, 5JHF = 
3.2 Hz, 1H, C9H), 7.62 (dd, J = 8.3 Hz, 4JHF = 5.0 Hz, 1H, C4H), 7.60 (dd, 3JHF = 8.3 Hz, J 
= 2.8 Hz, 1H, C7H), 7.28 (ddd, 3JHF = 8.1 Hz, J = 8.3, 2.8 Hz, 1H, C5H), 3.44 (s, 1H, C1H). 
13C NMR (101 MHz, CDCl3): δ 190.3 (d, 4JCF = 1.8 Hz, C9), 162.8 (d, 1JCF = 253.3 Hz, C6), 138.8 (d, 3JCF 
= 6.7 Hz, C8), 136.1 (d, 3JCF = 7.7 Hz, C4), 121.7 (d, 4JCF = 3.6 Hz, C3), 121.4 (d, 2JCF = 22.9 Hz, C5), 
113.9 (d, 2JCF = 23.1 Hz, C7), 84.2 (d, 6JCF = 1.8 Hz, C1), 78.3 (C2). 19F NMR (376 MHz, CDCl3): δ -
107.83 – -107.93 (m). MS (EI, 70 eV) m/z (%): 120 ([M - CO]+, 100), 148 (M+•, 92). The spectroscopic 
data are in agreement with the previously reported literature values.181  
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8.3.2.2. Synthesis of 5-chlorobenzaldehyde 4.11b 
 
The title compound 4.11b was synthesized from 2-bromo-5-chlorobenzaldehyde 4.3b 
(750 mg, 3.417 mmol) following the same procedure as outlined for compound 4.11a. The 
product 4.11b was purified by flash column chromatography on silica gel with hexane/ethyl 
acetate 99:1 as eluent and was obtained as white crystals (442 mg, 79%). 
5-Chloro-2-((trimethylsilyl)ethynyl)benzaldehyde 4.10b. Brown oil, quant. yield. IR (neat, cm-1): 2158 
(C≡C), 1695 (C=O), 1587, 1470, 1385, 1250, 1213, 1179, 1109, 837, 758, 677, 644, 
554. 1H NMR (400 MHz, CDCl3): δ 10.48 (s, 1H, C9H), 7.86 (dd, J = 1.7, 1.1 Hz, 1H, 
C7H), 7.51 – 7.49 (m, 2H, C4H, C5H), 0.28 (s, 9H, C10H). 13C NMR (101 MHz, CDCl3): 
δ 190.6 (C9), 137.4 (C8), 135.5 (C6), 134.9 (C4), 133.8 (C5), 127.0 (C7), 125.1 (C3), 
103.8 (C1), 99.1 (C2), -0.2 (C10). MS (ESI, 70 eV) m/z (%): 237 (M + H+, 100). 
5-Chloro-2-ethynylbenzaldehyde 4.11b. White crystals, yield 79%. Rf (SiO2) = 0.09 (hexane/EtOAc 
99:1). Mp 118 °C. IR (neat, cm-1): 3248 (≡C-H), 1692 (C=O), 1585, 1472, 1395, 1194, 895, 
831, 723, 675. 1H NMR (400 MHz, CDCl3): δ 10.47 (s, 1H, C9H), 7.90 (d, J = 2.0 Hz, 1H, 
C7H), 7.58 – 7.51 (m, 2H, C4H, C5H), 3.50 (s, 1H, C1H). 13C NMR (101 MHz, CDCl3): δ 
190.2 (C9), 137.8 (C8), 136.0 (C6), 135.2 (C4), 133.9 (C5), 127.4 (C7), 123.8 (C3), 85.4 (C1), 
78.4 (C2). MS (EI, 70 eV) m/z (%): 136 ([M - CO]+, 100), 164 (M+•, 81). The spectroscopic data are in 
agreement with the previously reported literature values.143c 
8.3.2.3. Synthesis of 1,3-benzodioxole-5-carbaldehyde 4.11c 
 
The title compound 4.11c was synthesized from 6-bromo-2H-1,3-benzodioxole-5-
carbaldehyde 4.3c (2.0 g, 8.733 mmol) following the same procedure as outlined for 
compound 4.11a. The product 4.11c was purified by flash column chromatography on silica 
gel with hexane/ethyl acetate 99:1 to 90:10 as eluent and was obtained as off-white crystals 
(1.11 g, 73%). 
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6-Ethynyl-2H-1,3-benzodioxole-5-carbaldehyde 4.11c. Off-white crystals, yield 73%. Rf (SiO2) = 0.20 
(hexane/EtOAc 95:5). Mp 147 °C. IR (neat, cm-1): 3289 (≡C-H), 1674 (C=O), 1599, 
1489, 1427, 1404, 1350, 1271, 1155, 1051, 1030, 928, 889, 860, 785, 664, 621, 565. 
1H NMR (400 MHz, CDCl3): δ 10.37 (s, 1H, C10H), 7.34 (s, 1H, C8H), 6.99 (s, 1H, C4H), 
6.08 (s, 2H, C6H), 3.37 (s, 1H, C1H). 13C NMR (101 MHz, CDCl3): δ 189.9 (C10), 152.4 
(C5), 149.2 (C7), 133.2 (C9), 122.2 (C3), 112.8 (C4), 106.2 (C8), 102.6 (C6), 83.2 (C1), 79.2 (C2). MS (EI, 
70 eV) m/z (%): 146 ([M - CO]+, 14), 174 (M+•, 100). The spectroscopic data are in agreement with the 
previously reported literature values.143c 
8.3.2.4. Synthesis of 4,5-dimethoxybenzaldehyde 4.11d 
 
The title compound 4.11d was synthesized from 2-bromo-4,5-dimethoxybenzaldehyde 4.3d 
(2.0 g, 8.161 mmol) following the same procedure as outlined for compound 4.11a. The 
product 4.11d was purified by flash column chromatography on silica gel with hexane/ethyl 
acetate 95:5 to 80:20 as eluent and was obtained as off-white crystals (1.04 g, 67%). 
4,5-Dimethoxy-2-((trimethylsilyl)ethynyl)benzaldehyde 4.10d. Light-brown solid, quant. yield. Mp 
112 °C. IR (neat, cm-1): 2143 (C≡C), 1684 (C=O), 1589, 1503, 1464, 1439, 1396, 
1350, 1279, 1250, 1217, 1107, 1003, 839, 756, 706, 583. 1H NMR (400 MHz, 
CDCl3): δ 10.39 (s, 1H, C11H), 7.38 (s, 1H, C9H), 6.98 (s, 1H, C4H), 3.96 (s, 3H, 
C6H), 3.94 (s, 3H, C7H), 0.28 (s, 9H, C12H). 13C NMR (101 MHz, CDCl3): δ 190.7 
(C11), 153.6 (C5), 150.0 (C8), 130.7 (C10), 121.5 (C3), 114.7 (C4), 108.1 (C9), 100.9 (C1), 100.2 (C2), 56.4 
(C6), 56.2 (C7), -0.1 (C12). MS (ESI, 70 eV) m/z (%): 263 (M + H+, 100). The spectroscopic data are in 
agreement with the previously reported literature values.182 
2-Ethynyl-4,5-dimethoxybenzaldehyde 4.11d. Off-white crystals, yield 67%. Rf (SiO2) = 0.16 
(hexane/EtOAc 9:1). Mp 153 °C. IR (neat, cm-1): 3235 (≡C-H), 1674 (C=O), 1587, 
1504, 1462, 1396, 1346, 1277, 1217, 1094, 993, 868, 752, 702, 633, 577. 1H NMR 
(400 MHz, CDCl3): δ 10.39 (s, 1H, C11H), 7.40 (s, 1H, C9H), 7.02 (s, 1H, C4H), 3.96 
(s, 3H, C6H), 3.95 (s, 3H, C7H), 3.38 (s, 1H, C1H). 13C NMR (101 MHz, CDCl3): δ 
190.3 (C11), 153.6 (C5), 150.2 (C8), 131.1 (C10), 120.2 (C3), 115.0 (C4), 108.3 (C9), 83.0 (C1), 79.3 (C2), 
56.4 (C6), 56.3 (C7). MS (ESI, 70 eV) m/z (%): 191 (M + H+, 100). The spectroscopic data are in 
agreement with the previously reported literature values.143c 
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8.3.2.5. Synthesis of 2-naphthaldehyde 4.11e 
 
The title compound 4.11e was synthesized from 1-bromo-2-naphthaldehyde 4.3e (2.0 g, 
8.508 mmol). As for the Sonogashira coupling reaction (step 1), the same procedure as 
outlined for compound 4.11a was followed. To remove the trimethylsilyl protecting group (step 
2), the obtained solid was dissolved in methanol (170 mL, 0.05 M) and K2CO3 (1.41 g, 
10.209 mmol) was added. After 1 h at room temperature (20 °C), the solvent was partially 
removed under reduced pressure. The remaining mixture was diluted with water (100 mL), 
extracted with ethyl acetate (3 x 50 mL) and the combined organic phases were dried over 
MgSO4, filtered and concentrated. The product 4.11e was purified by flash column 
chromatography on silica gel with hexane/ethyl acetate 15:1 as eluent and was obtained as 
yellow crystals (1.20 g, 78%). 
1-Ethynyl-2-naphthaldehyde 4.11e. Yellow crystals, yield 78%. Rf (SiO2) = 0.30 (hexane/EtOAc 15:1). 
Mp 140 °C. IR (neat, cm-1): 3247 (≡C-H), 1669 (C=O), 1617, 1590, 1457, 1430, 1375, 
1333, 1230, 813, 756, 718, 659. 1H NMR (400 MHz, CDCl3): δ 10.79 (d, J = 0.8 Hz, 
1H, C13H), 8.57 – 8.52 (m, 1H, C5H), 7.97 (d, 3JAB = 8.7 Hz, 1H, C11H), 7.91 (d, 3JAB = 
8.7 Hz, 1H, C10H), 7.91 – 7.87 (m, 1H, C8H), 7.70 – 7.65 (m, 2H, C6H, C7H), 3.92 (s, 
1H, C1H). 13C NMR (101 MHz, CDCl3): δ 192.1 (C13), 135.8 (C9), 135.4 (C12), 133.5 (C4), 129.63 (C10), 
129.57 (C7), 128.6 (C8), 128.0 (C6), 127.2 (C5), 126.2 (C3), 122.0 (C11), 90.2 (C1), 77.3 (C2). MS (ESI, 
70 eV) m/z (%): 181 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C13H8O + H+ 181.0648, found 
181.0646. The spectroscopic data are in agreement with the previously reported literature values.183  
8.3.2.6. Synthesis of indole-2-carbaldehyde 4.11f 
 
The title compound 4.11f was synthesized from 3-bromo-1-methyl-1H-indole-2-carbaldehyde 
4.3f (500 mg, 2.100 mmol). As for the Sonogashira coupling reaction (step 1), the same 
procedure as outlined for compound 4.11a was followed. To remove the trimethylsilyl 
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protecting group (step 2), the obtained solid was dissolved in methanol (42 mL, 0.05 M) and 
K2CO3 (348 mg, 2.520 mmol) was added at 0 °C. After 3 h at 0 °C, the solvent was partially 
removed at ambient temperature under reduced pressure. The remaining mixture was diluted 
with water (50 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic phases 
were dried over MgSO4, filtered and concentrated, yielding product 4.11f as yellow-brown 
crystals (385 mg, quant.). 
1-Methyl-3-((trimethylsilyl)ethynyl)-1H-indole-2-carbaldehyde 4.10f. Yellow solid, quant. yield. 
1H NMR (400 MHz, CDCl3): δ 10.20 (s, 1H, C9H), 7.83 (d, J = 8.1 Hz, 1H, C4H), 
7.46 (dd, J = 8.4, 7.5 Hz, 1H, C6H), 7.38 (d, J = 8.4 Hz, 1H, C7H), 7.25 (dd, J = 8.1, 
7.5 Hz, 1H, C5H), 4.08 (s, 3H, C10H), 0.31 (s, 9H, C13H). 13C NMR (101 MHz, 
CDCl3): δ 182.6 (C9), 139.5 (C8), 136.2 (C1), 128.0 (C3), 127.9 (C6), 122.4 (C4), 
121.8 (C5), 111.9 (C2), 110.6 (C7), 102.9 (C12), 95.6 (C11), 31.9 (C10), 0.2 (C13). The spectroscopic data 
are in agreement with the previously reported literature values.184 
3-Ethynyl-1-methyl-1H-indole-2-carbaldehyde 4.11f. Yellow-brown crystals, quant. yield. Rf (SiO2) = 
0.21 (hexane/EtOAc 15:1). Mp 114 °C. IR (neat, cm-1): 3252 (≡C-H), 1668 (C=O), 
1612, 1475, 1412, 1336, 1206, 892, 747, 710, 658, 634. 1H NMR (400 MHz, CDCl3): δ 
10.22 (s, 1H, C9H), 7.85 (ddd, J = 8.1, 1.1, 1.0 Hz, 1H, C4H), 7.47 (ddd, J = 8.5, 6.9, 
1.1 Hz, 1H, C6H), 7.40 (ddd, J = 8.5, 1.0, 1.0 Hz, 1H, C7H), 7.26 (ddd, J = 8.1, 6.9, 1.0 
Hz, 1H, C5H), 4.10 (s, 3H, C10H), 3.53 (s, 1H, C12H). 13C NMR (101 MHz, CDCl3): δ 182.4 (C9), 139.4 
(C8), 136.6 (C1), 128.1 (C3), 127.9 (C6), 122.2 (C4), 122.0 (C5), 110.7 (C7), 110.4 (C2), 84.8 (C12), 74.9 
(C11), 32.0 (C10). MS (ESI, 70 eV) m/z (%): 184 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C12H9NO 
+ H+ 184.0757, found 184.0758. 
8.3.2.7. Synthesis of dihydroisobenzofuran 4.12b 
 
To a stirred solution of 5-chloro-2-((trimethylsilyl)ethynyl)benzaldehyde 4.10b (150 mg, 
0.634 mmol) in methanol (6 mL, 0.1 M) was added K2CO3 (105 mg, 0.761 mmol). The reaction 
mixture was heated to 50 °C for 20 minutes, after which the solvent was partially removed 
under reduced pressure. The remaining mixture was diluted with water (10 mL), extracted with 
ethyl acetate (3 x 10 mL) and the combined organic phases were dried over MgSO4, filtered 
and concentrated. The product was purified by flash column chromatography on silica gel with 
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hexane/ethyl acetate 10:1 + 1% Et3N as eluent, yielding compound 4.12b as a pale yellow 
solid (38 mg, 30%). 
5-Chloro-3-methoxy-1-methylene-1,3-dihydroisobenzofuran 4.12b. Pale yellow solid, yield 30%. Rf 
(SiO2) = 0.18 (hexane/EtOAc 10:1 + 1% Et3N). Mp 39 °C. IR (neat, cm-1): 1667 (C=C), 
1468, 1352, 1194, 1096, 1065, 968, 891, 876, 833, 797, 727, 637, 606, 446. 1H NMR 
(400 MHz, CDCl3): δ 7.46 – 7.37 (m, 3H, C4H, C5H, C7H), 6.30 (s, 1H, C9H), 4.63 (d, 
2JAB = 2.5 Hz, 1H, C1Hb), 4.61 (d, 2JAB = 2.5 Hz, 1H, C1Ha), 3.47 (s, 3H, C10H). 13C NMR 
(101 MHz, CDCl3): δ 158.2 (C2), 139.8 (C8), 135.4 (C6), 132.9 (C3), 130.4 (C5), 123.6 (C7), 121.8 (C4), 
105.8 (C9), 81.5 (C1), 54.9 (C10). MS (EI, 70 eV) m/z (%): 165 ([M - OCH3]+, 100), 181 ([M - CH3]+, 21), 
196 (M+•, 76). 
8.3.3. Strecker synthesis of α-amino nitriles from aldehydes 
8.3.3.1. Synthesis of amine 4.25 
 
The title compound 4.25 was synthesized via a procedure reported by Hong et al..116 To a 
stirred solution of allylamine (52.40 mL, 0.698 mol) in dry diethyl ether (175 mL, 4.0 M) at 0 °C 
under nitrogen atmosphere was added dropwise over 2 h ethyl 2-bromoacetate 4.24 
(38.72 mL, 0.349 mol). Following the addition, the ice-water bath was removed and the 
reaction was stirred at room temperature (20 °C) overnight. After 19 h at 20 °C, the reaction 
mixture was filtered through a glass frit to remove the precipitated allylamine hydrobromide 
salt. The precipitate was washed with diethyl ether (100 mL) and the combined filtrates were 
concentrated under reduced pressure. The crude liquid was vacuum distilled (13 mbar, bp 
68-70 °C) to give the desired product 4.25 as a colorless oil (33.56 g, 67%). 
Ethyl N-allylglycinate 4.25. Colorless oil, yield 67%. 1H NMR (400 MHz, CDCl3): δ 5.86 (ddt, 3Jtrans = 
17.2 Hz, 3Jcis = 10.2 Hz, J = 6.0 Hz, 1H, C2H), 5.19 (ddt, 3Jtrans = 17.2 Hz, 2Jgem 
= 1.6 Hz, J = 1.4 Hz, 1H, C1Ha), 5.11 (ddt, 3Jcis = 10.2 Hz, 2Jgem = 1.6 Hz, J = 
1.4 Hz, 1H, C1Hb), 4.19 (q, J = 7.1 Hz, 2H, C6H), 3.39 (s, 2H, C4H), 3.26 (dt, J 
= 6.0, 1.4 Hz, 2H, C3H), 1.65 (br s, 1H, NH), 1.27 (t, J = 7.1 Hz, 3H, C7H). 13C NMR (101 MHz, CDCl3): 
δ 172.5 (C5), 136.2 (C2), 116.6 (C1), 60.8 (C6), 51.9 (C3), 50.0 (C4), 14.3 (C7). The spectroscopic data 
are in agreement with the previously reported literature values.116  
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8.3.3.2. Synthesis of α-amino nitrile 4.26e 
 
A flame-dried 50 mL round-bottom flask equipped with a Teflon-coated magnetic stirrer was 
charged with 1-ethynyl-2-naphthaldehyde 4.11e (300 mg, 1.665 mmol) and placed under 
nitrogen atmosphere. The starting material was dissolved in 2,2,2-trifluoroethanol (17 mL, 
0.1 M), and ethyl N-allylglycinate 4.25 (358 mg, 2.497 mmol) was added. After 15 minutes 
stirring at room temperature (20 °C), trimethylsilyl cyanide (0.44 mL, 3.330 mmol) was added 
dropwise over 5 minutes and the reaction mixture was stirred at room temperature (20 °C) for 
6 days. Subsequently, the solution was diluted with water (30 mL) and extracted with 
dichloromethane (3 x 40 mL). The combined organic phases were dried over MgSO4, filtered 
and the solvent was removed under reduced pressure. The product 4.26e was purified by flash 
column chromatography on silica gel with hexane/ethyl acetate 10:1 as eluent and was 
obtained as pale yellow oil (496 mg, 90%). 
Ethyl N-allyl-N-(cyano(1-ethynylnaphthalen-2-yl)methyl)glycinate 4.26e. Pale yellow oil, yield 90%. 
Rf (SiO2) = 0.20 (hexane/EtOAc 10:1). IR (neat, cm-1): 3284 (≡C-H), 1732 
(C=O), 1420, 1375, 1264, 1195, 1098, 1026, 974, 928, 821, 777, 749, 679, 
660. 1H NMR (400 MHz, CDCl3): δ 8.41 (dd, J = 8.4, 1.4 Hz, 1H, C5H), 7.92 
(d, 3JAB = 8.6 Hz, 1H, C10H), 7.87 (dd, J = 8.2, 1.4 Hz, 1H, C8H), 7.78 (d, 3JAB 
= 8.6 Hz, 1H, C11H), 7.62 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H, C6H), 7.57 (ddd, J = 
8.2, 6.9, 1.4 Hz, 1H, C7H), 5.93 – 5.81 (m, 2H, C13H, C19H), 5.32 (dd, 3Jtrans = 17.2 Hz, 2Jgem = 1.6 Hz, 
1H, C18Hb), 5.21 (dd, 3Jcis = 10.1 Hz, 2Jgem = 1.6 Hz, 1H, C18Ha), 4.10 (q, J = 7.1 Hz, 2H, C16H), 3.85 (s, 
1H, C1H), 3.55 (dd, 2JAB = 13.7 Hz, 3JAX = 5.8 Hz, 1H, C20Ha), 3.49 (s, 2H, C14H), 3.38 (dd, 2JAB = 13.7 
Hz, 3JBX = 7.3 Hz, 1H, C20Hb), 1.22 (t, J = 7.1 Hz, 3H, C17H). 13C NMR (101 MHz, CDCl3): δ 170.3 (C15), 
134.8 (C12), 134.1 (C19), 133.8 (C4), 133.1 (C9), 129.6 (C10), 128.3 (C8), 127.8 (C6), 127.5 (C7), 126.7 
(C5), 125.2 (C11), 120.6 (C3), 119.6 (C18), 116.9 (C21), 89.2 (C1), 78.7 (C2), 60.8 (C16), 56.7 (C13), 55.2 
(C20), 51.6 (C14), 14.2 (C17). MS (ESI, 70 eV) m/z (%): 333 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. 
for C21H20N2O2 + H+ 333.1598, found 333.1600.  
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8.3.3.3. Synthesis of α-amino nitrile 4.26f 
 
A flame-dried 100 mL round-bottom flask equipped with a Teflon-coated magnetic stirrer was 
charged with 3-ethynyl-1-methyl-1H-indole-2-carbaldehyde 4.11f (800 mg, 4.367 mmol) and 
placed under nitrogen atmosphere. The starting material was dissolved in 2,2,2-
trifluoroethanol (44 mL, 0.1 M), and ethyl N-allylglycinate 4.25 (1.25 g, 8.733 mmol) was 
added. After 15 minutes stirring at room temperature (20 °C), trimethylsilyl cyanide (1.2 mL, 
8.733 mmol) was added dropwise over 5 minutes and the reaction mixture was stirred at room 
temperature (20 °C) for 24 days. Subsequently, the solution was diluted with water (80 mL) 
and extracted with dichloromethane (3 x 80 mL). The combined organic phases were dried 
over MgSO4, filtered and the solvent was removed under reduced pressure. Purification by 
automated flash chromatography on C18 silica with water/acetonitrile as eluent (gradient from 
30% to 100% CH3CN in H2O over 25 column volumes) yielded product 4.26f as yellow crystals 
(415 mg, 28%). 
Ethyl N-allyl-N-(cyano(3-ethynyl-1-methyl-1H-indol-2-yl)methyl)glycinate 4.26f. Yellow crystals, 
yield 28%. Rf (SiO2) = 0.30 (hexane/EtOAc 5:1). Mp 112 °C. IR (neat, cm-1): 
3294 (≡C-H), 2100 (C≡C), 1740 (C=O), 1476, 1418, 1202, 1188, 1153, 1123, 
1099, 1024, 991, 932, 845, 748, 660, 588, 571, 430. 1H NMR (400 MHz, 
CDCl3): δ 7.74 (ddd, J = 8.0, 1.0, 1.0 Hz, 1H, C4H), 7.38 – 7.31 (m, 2H, C6H, 
C7H), 7.23 (ddd, J = 8.0, 6.3, 1.7 Hz, 1H, C5H), 5.78 (dddd, 3Jtrans = 17.4 Hz, 
3Jcis = 10.1 Hz, 3JBX = 7.8 Hz, 3JAX = 5.4 Hz, 1H, C15H), 5.68 (s, 1H, C9H), 5.30 (dd, 3Jtrans = 17.4 Hz, 
2Jgem = 1.4 Hz, 1H, C14Hb), 5.23 (dd, 3Jcis = 10.1 Hz, 2Jgem = 1.4 Hz, 1H, C14Ha), 4.10 (qd, J = 7.1, 1.3 
Hz, 2H, C12H), 3.94 (s, 3H, C19H), 3.58 – 3.45 (m, 4H, C10H, C16Ha, C17H), 3.28 (dd, 2JAB = 13.8 Hz, 3JBX 
= 7.8 Hz, 1H, C16Hb), 1.22 (t, J = 7.1 Hz, 3H, C13H). 13C NMR (101 MHz, CDCl3): δ 170.2 (C11), 137.1 
(C8), 133.6 (C15), 132.3 (C1), 128.2 (C3), 124.3 (C6), 121.2 (C5), 120.5 (C4), 120.1 (C14), 114.6 (C20), 
109.9 (C7), 99.8 (C2), 84.2 (C17), 75.6 (C18), 61.0 (C12), 54.5 (C16), 50.8 (C10), 50.1 (C9), 30.8 (C19), 14.2 
(C13). MS (ESI, 70 eV) m/z (%): 336 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C20H21N3O2 + H+ 
336.1707, found 336.1707.  
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8.3.3.4. Synthesis of cyclization product 4.27 
 
The title compound 4.27 was synthesized from 1-ethynyl-2-naphthaldehyde 4.11e (75 mg, 
0.416 mmol) following the same procedure as outlined for compound 4.26e, except that the 
reaction mixture was heated to reflux (74 °C) for 41 h. Subsequently, the solution was diluted 
with water (15 mL) and extracted with dichloromethane (3 x 10 mL). The combined organic 
phases were dried over MgSO4, filtered and the solvent was removed under reduced pressure. 
The product 4.27 was purified by preparative TLC using hexane/ethyl acetate 7:1 as eluent 
and was obtained as yellow crystals (57 mg, 45%). However, the molecular structure could 
not be unambiguously defined. 
Unidentified compound 4.27. Yellow crystals, yield 45%. Rf (SiO2) = 0.31 (hexane/EtOAc 7:1). MS 
(ESI, 70 eV) m/z (%): 306 (M + H+, 100). 
1H NMR (400 MHz, CDCl3): 
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13C NMR (101 MHz, CDCl3): 
 
8.3.3.5. Synthesis of cyclization product 4.34 
 
The title compound 4.34 was synthesized from 3-ethynyl-1-methyl-1H-indole-2-carbaldehyde 
4.11f (91 mg, 0.497 mmol) following the same procedure as outlined for compound 4.26f, 
except that the reaction mixture was heated to reflux (74 °C) for 6 days. Subsequently, the 
solution was diluted with water (15 mL) and extracted with dichloromethane (3 x 15 mL). The 
combined organic phases were dried over MgSO4, filtered and the solvent was removed under 
reduced pressure. Purification by automated flash chromatography on C18 silica with 
water/acetonitrile as eluent (gradient from 40% to 90% CH3CN in H2O over 35 column 
volumes) yielded product 4.34 as yellow oil (34 mg, 22%). However, the molecular structure 
could not be unambiguously defined.  
CHAPTER IV 
112 
Unidentified compound 4.34. Yellow oil, yield 22%. MS (ESI, 70 eV) m/z (%): 309 (M + H+, 100). 
1H NMR (400 MHz, CDCl3): 
 
13C NMR (101 MHz, CDCl3): 
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8.3.4. One-pot Strecker synthesis and ring closure reaction of ethynyl benzaldehydes 
8.3.4.1. Synthesis of isoindole 4.4a 
 
A flame-dried 100 mL round-bottom flask equipped with a Teflon-coated magnetic stirrer and 
a reflux condenser was charged with 2-ethynyl-5-fluorobenzaldehyde 4.11a (672 mg, 
4.536 mmol) and placed under argon atmosphere. The starting material was dissolved in 
2,2,2-trifluoroethanol (30 mL, 0.15 M), and ethyl N-allylglycinate 4.25 (1.30 g, 9.073 mmol) 
was added. After 15 minutes stirring at room temperature (20 °C), trimethylsilyl cyanide 
(1.2 mL, 9.073 mmol) was added dropwise over 5 minutes and the reaction mixture was 
heated to reflux (74 °C) for 41 h. Upon complete conversion, the solution was diluted with 
water (30 mL) and extracted with dichloromethane (3 x 25 mL). The combined organic phases 
were washed with a saturated aqueous solution of NaCl (2 x 25 mL) and dried over MgSO4. 
The crude product was purified by flash column chromatography on silica gel with hexane/ethyl 
acetate 9:1 to 8:2 as eluent. Residual ethyl N-allylglycinate 4.25 was removed by washing a 
solution of the product in ethyl acetate (15 mL) with aqueous 0.5 M HCl (2 x 5 mL). Upon 
evaporation of the solvent, isoindole 4.4a was obtained as a brown solid (721 mg, 53%). 
Ethyl 2-(1-(but-3-en-1-yl)-3-cyano-5-fluoro-2H-isoindol-2-yl)acetate 4.4a. Brown solid, yield 53%. Rf 
(SiO2) = 0.16 (hexane/EtOAc 9:1). Mp 68 °C. IR (neat, cm-1): 2191 (C≡N), 1732 
(C=O), 1638 (C=C), 1427, 1371, 1219, 1196, 1150, 1018, 916, 866, 787, 745, 569, 
496, 430. 1H NMR (400 MHz, CDCl3): δ 7.57 (dd, J = 9.2 Hz, 4JHF = 4.9 Hz, 1H, 
C3H), 7.20 (dd, 3JHF = 9.4 Hz, J = 2.2 Hz, 1H, C6H), 6.87 (ddd, 3JHF = 9.1 Hz, J = 
9.2, 2.2 Hz, 1H, C4H), 5.78 (ddt, 3Jtrans = 17.1 Hz, 3Jcis = 10.2 Hz, J = 6.8 Hz, 1H, 
C14H), 5.06 (ddt, 3Jtrans = 17.1 Hz, 2Jgem = 1.5 Hz, J = 1.4 Hz, 1H, C13Hb), 5.04 (ddt, 3Jcis = 10.2 Hz, 2Jgem 
= 1.5 Hz, J = 1.4 Hz, 1H, C13Ha), 5.02 (s, 2H, C9H), 4.29 (q, J = 7.2 Hz, 2H, C11H), 3.02 (t, J = 7.7 Hz, 
2H, C16H), 2.39 (tdt, J = 7.7, 6.8, 1.4 Hz, 2H, C15H), 1.31 (t, J = 7.2 Hz, 3H, C12H). 13C NMR (101 MHz, 
CDCl3): δ 166.4 (C10), 161.7 (d, 1JCF = 246.0 Hz, C5), 136.1 (C14), 132.4 (C1), 131.2 (d, 3JCF = 11.8 Hz, 
C7), 122.8 (d, 3JCF = 10.3 Hz, C3), 120.1 (C2), 116.9 (C13), 114.4 (C17), 114.0 (d, 2JCF = 28.3 Hz, C4), 
101.3 (d, 2JCF = 24.6 Hz, C6), 93.8 (d, 4JCF = 8.0 Hz, C8), 62.7 (C11), 48.1 (C9), 33.6 (C15), 25.0 (C16), 
14.2 (C12). 19F NMR (376 MHz, CDCl3): δ -113.6 – -113.7 (m). MS (ESI, 70 eV) m/z (%): 301 (M + H+, 
100). HRMS (ESI, 2 kV): m/z calcd. for C17H17FN2O2 - H+ 299.1201, found 299.1200. 
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8.3.4.2. Synthesis of isoindole 4.4b 
 
The title compound 4.4b was synthesized from 5-chloro-2-ethynylbenzaldehyde 4.11b 
(339 mg, 2.060 mmol) following the same procedure as outlined for compound 4.4a. The 
product was purified by flash column chromatography on silica gel with hexane/ethyl acetate 
9:1 to 8:2 as eluent. Residual ethyl N-allylglycinate 4.25 was removed by washing a solution 
of the product in ethyl acetate (15 mL) with aqueous 0.5 M HCl (2 x 5 mL). Upon evaporation 
of the solvent, isoindole 4.4b was obtained as a brown solid (352 mg, 54%). 
Ethyl 2-(1-(but-3-en-1-yl)-5-chloro-3-cyano-2H-isoindol-2-yl)acetate 4.4b. Brown solid, yield 54%. 
Rf (SiO2) = 0.19 (hexane/EtOAc 9:1). Mp 58 °C. IR (neat, cm-1): 2191 (C≡N), 1736 
(C=O), 1423, 1348, 1215, 1061, 1018, 901, 860, 800. 1H NMR (400 MHz, CDCl3): 
δ 7.61 (d, J = 1.8 Hz, 1H, C6H), 7.52 (d, J = 9.0 Hz, 1H, C3H), 7.01 (dd, J = 9.0, 1.8 
Hz, 1H, C4H), 5.77 (ddt, 3Jtrans = 17.0 Hz, 3Jcis = 10.2 Hz, J = 6.7 Hz, 1H, C14H), 
5.08 – 5.00 (m, 4H, C9H, C13H), 4.28 (q, J = 7.1 Hz, 2H, C11H), 3.02 (t, J = 7.7 Hz, 
2H, C16H), 2.38 (td, J = 7.7, 6.7 Hz, 2H, C15H), 1.31 (t, J = 7.1 Hz, 3H, C12H). 13C NMR (101 MHz, 
CDCl3): δ 166.3 (C10), 136.0 (C14), 132.5 (C5), 132.3 (C1), 131.2 (C7), 123.7 (C4), 121.9 (C3), 121.0 (C2), 
117.01 (C6), 116.97 (C13), 114.2 (C17), 93.3 (C8), 62.8 (C11), 48.0 (C9), 33.6 (C15), 24.9 (C16), 14.1 (C12). 
MS (ESI, 70 eV) m/z (%): 317 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C17H17ClN2O2 - H+ 
315.0906, found 315.0912. 
8.3.4.3. Synthesis of isoindole 4.4c 
 
The title compound 4.4c was synthesized from 6-ethynyl-2H-1,3-benzodioxole-5-
carbaldehyde 4.11c (1.04 g, 5.954 mmol) following the same procedure as outlined for 
compound 4.4a. The product 4.4c was purified by flash column chromatography on silica gel 
with hexane/ethyl acetate 9:1 to 7:3 as eluent and obtained as off-white solid (844 mg, 43%). 
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Ethyl 2-(5-(but-3-en-1-yl)-7-cyano-6H-[1,3]dioxolo[4,5-f]isoindol-6-yl)acetate 4.4c. Off-white solid, 
yield 43%. Rf (SiO2) = 0.26 (hexane/EtOAc 8:2). Mp 128 °C. IR (neat, cm-1): 2185 
(C≡N), 1738 (C=O), 1503, 1462, 1420, 1369, 1204, 1159, 1022, 951, 910, 845. 
1H NMR (400 MHz, CDCl3): δ 6.86 (d, J = 0.8 Hz, 1H, C7H), 6.80 (d, J = 0.8 Hz, 
1H, C3H), 5.95 (s, 2H, C5H), 5.78 (ddt, 3Jtrans = 17.0 Hz, 3Jcis = 10.1 Hz, J = 6.9 Hz, 
1H, C15H), 5.06 (ddt, 3Jtrans = 17.0 Hz, 2Jgem = 1.5 Hz, J = 1.5 Hz, 1H, C14Hb), 5.03 
(ddt, 3Jcis = 10.1 Hz, 2Jgem = 1.5 Hz, J = 1.5 Hz, 1H, C14Ha), 4.92 (s, 2H, C10H), 4.27 (q, J = 7.1 Hz, 2H, 
C12H), 2.90 (t, J = 7.6 Hz, 2H, C17H), 2.34 (tdt, J = 7.6, 6.9, 1.5 Hz, 2H, C16H), 1.30 (t, J = 7.1 Hz, 3H, 
C13H). 13C NMR (101 MHz, CDCl3): δ 166.9 (C11), 149.2 (C6), 146.2 (C4), 136.4 (C15), 130.7 (C1), 128.7 
(C8), 118.8 (C2), 116.7 (C14), 115.0 (C18), 101.1 (C5), 95.8 (C3), 94.5 (C7), 93.7 (C9), 62.6 (C12), 47.8 
(C10), 33.6 (C16), 24.9 (C17), 14.2 (C13). MS (ESI, 70 eV) m/z (%): 327 (M + H+, 100). HRMS (ESI, 2 kV): 
m/z calcd. for C18H18N2O4 + H+ 327.1339, found 327.1343. 
8.3.4.4. Synthesis of isoindole 4.4d 
 
The title compound 4.4d was synthesized from 2-ethynyl-4,5-dimethoxybenzaldehyde 4.11d 
(974 mg, 5.121 mmol) following the same procedure as outlined for compound 4.4a. The 
product 4.4d was purified by flash column chromatography on silica gel with hexane/ethyl 
acetate 9:1 + 2% MeOH to 8:2 + 2% as eluent and obtained as off-white crystals (1.10 g, 63%). 
Ethyl 2-(1-(but-3-en-1-yl)-3-cyano-5,6-dimethoxy-2H-isoindol-2-yl)acetate 4.4d. Off-white crystals, 
yield 63%. Rf (SiO2) = 0.22 (hexane/EtOAc 8:2 + 2% MeOH). Mp 145 °C. IR 
(neat, cm-1): 2191 (C≡N), 1736 (C=O), 1504, 1423, 1369, 1204, 1165, 1032, 
910, 858, 810, 789. 1H NMR (400 MHz, CDCl3): δ 6.86 (s, 1H, C8H), 6.76 (s, 1H, 
C3H), 5.81 (ddt, 3Jtrans = 17.0 Hz, 3Jcis = 10.1 Hz, J = 6.7 Hz, 1H, C16H), 5.07 (ddt, 
3Jtrans = 17.0 Hz, 2Jgem = 1.5 Hz, J = 1.3 Hz, 1H, C15Hb), 5.04 (ddt, 3Jcis = 10.1 Hz, 
2Jgem = 1.5 Hz, J = 1.3 Hz, 1H, C15Ha), 4.95 (s, 2H, C11H), 4.27 (q, J = 7.2 Hz, 2H, C13H), 3.95 (s, 3H, 
C6H), 3.91 (s, 3H, C5H), 2.95 (t, J = 7.8 Hz, 2H, C18H), 2.37 (tdt, J = 7.8, 6.7, 1.3 Hz, 2H, C17H), 1.30 (t, 
J = 7.2 Hz, 3H, C14H). 13C NMR (101 MHz, CDCl3): δ 166.9 (C12), 151.4 (C7), 148.2 (C4), 136.5 (C16), 
130.3 (C1), 127.6 (C9), 117.7 (C2), 116.6 (C15), 115.4 (C19), 98.0 (C3), 96.3 (C8), 92.7 (C10), 62.4 (C13), 
56.1 (C6), 56.0 (C5), 47.7 (C11), 33.5 (C17), 24.8 (C18), 14.2 (C14). MS (ESI, 70 eV) m/z (%): 343 (M + H+, 
100). HRMS (ESI, 2 kV): m/z calcd. for C19H22N2O4 + H+ 343.1652, found 343.1641. 
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8.3.5. Ring closure reaction of α-amino nitriles 
8.3.5.1. Synthesis of benzoisoindole 4.4e 
 
To a stirred solution of ethyl N-allyl-N-(cyano(1-ethynylnaphthalen-2-yl)methyl)glycinate 4.26e 
(486 mg, 1.462 mmol) in acetonitrile (73 mL, 0.02 M) was added AuCl3 (13 mg, 0.0439 mmol). 
The resulting suspension was stirred at room temperature (20 °C) for 44 h. Subsequently, the 
amount of solvent was reduced in vacuo and the catalyst was removed by vacuum filtration 
over a celite bed. Upon evaporation of the solvent, isoindole 4.4e was obtained as a yellow 
solid (466 mg, 96%). 
Ethyl 2-(1-(but-3-en-1-yl)-3-cyano-2H-benzo[e]isoindol-2-yl)acetate 4.4e. Yellow solid, yield 96%. 
Mp 100 °C. IR (neat, cm-1): 2197 (C≡N), 1746 (C=O), 1713, 1421, 1397, 1372, 
1199, 1022, 916, 806, 748, 699. 1H NMR (400 MHz, CDCl3): δ 8.14 (dd, J = 8.3, 
1.3 Hz, 1H, C4H), 7.82 (dd, J = 8.1, 1.4 Hz, 1H, C7H), 7.57 (ddd, J = 8.3, 7.2, 1.4 
Hz, 1H, C5H), 7.55 (d, 3JAB = 8.9 Hz, 1H, C10H), 7.51 (d, 3JAB = 8.9 Hz, 1H, C9H), 
7.47 (ddd, J = 8.1, 7.2, 1.3 Hz, 1H, C6H), 5.92 (ddt, 3Jtrans = 17.0 Hz, 3Jcis = 10.2 
Hz, J = 6.7 Hz, 1H, C18H), 5.16 (ddt, 3Jtrans = 17.0 Hz, 2Jgem = 1.6 Hz, J = 1.3 Hz, 1H, C17Hb), 5.12 (ddt, 
3Jcis = 10.2 Hz, 2Jgem = 1.6 Hz, J = 1.3 Hz, 1H, C17Ha), 5.06 (s, 2H, C13H), 4.29 (q, J = 7.1 Hz, 2H, C15H), 
3.29 (t, J = 8.0 Hz, 2H, C20H), 2.52 (tdt, J = 8.0, 6.7, 1.3 Hz, 2H, C19H), 1.31 (t, J = 7.1 Hz, 3H, C16H). 
13C NMR (101 MHz, CDCl3): δ 166.9 (C14), 136.3 (C18), 133.4 (C1), 131.5 (C8), 130.5 (C11), 129.6 (C7), 
128.4 (C3), 128.3 (C9), 127.4 (C5), 125.2 (C6), 122.7 (C4), 117.5 (C10), 117.4 (C2), 116.9 (C17), 114.3 
(C21), 95.9 (C12), 62.7 (C15), 47.8 (C13), 32.3 (C19), 26.6 (C20), 14.2 (C16). MS (ESI, 70 eV) m/z (%): 333 
(M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C21H20N2O2 + H+ 333.1598, found 333.1596. 
8.3.5.2. Synthesis of pyrroloindole 4.4f 
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To a stirred solution of ethyl N-allyl-N-(cyano(3-ethynyl-1-methyl-1H-indol-2-yl)methyl)-
glycinate 4.26f (319 mg, 0.951 mmol) in chloroform (19 mL, 0.05 M) was added 
trifluoromethanesulfonic acid (4.2 µL, 0.0476 mmol). The reaction mixture was stirred at room 
temperature (20 °C) for 1 h, and subsequently diluted with a saturated aqueous solution of 
NaHCO3 (30 mL). The aqueous layer was extracted with dichloromethane (3 x 20 mL) and the 
combined organic phases were dried over MgSO4, filtered and evaporated. Purification by 
automated flash chromatography on C18 silica with water/acetonitrile as eluent (gradient from 
40% to 100% CH3CN in H2O with steps of 5% per 2 column volumes) yielded product 4.4f as 
pale yellow crystals (214 mg, 67%). 
Ethyl 2-(1-(but-3-en-1-yl)-3-cyano-4-methyl-4H-pyrrolo[3,4-b]indol-2-yl)acetate 4.4f. Pale yellow 
crystals, yield 67%. Rf (SiO2) = 0.26 (hexane/EtOAc 5:1). Mp 122 °C. IR (neat, 
cm-1): 2184 (C≡N), 1740 (C=O), 1641 (C=C), 1599, 1465, 1432, 1371, 1352, 
1201, 1025, 912, 745. 1H NMR (400 MHz, CDCl3): δ 7.69 (d, J = 7.6 Hz, 1H, C4H), 
7.33 (dd, J = 7.8, 7.6 Hz, 1H, C6H), 7.21 (d, J = 7.8 Hz, 1H, C7H), 7.13 (t, J = 7.6 
Hz, 1H, C5H), 5.86 (ddt, 3Jtrans = 16.9 Hz, 3Jcis = 10.1 Hz, J = 6.8 Hz, 1H, C16H), 
5.10 (dd, 3Jtrans = 16.9 Hz, 2Jgem = 1.6 Hz, 1H, C15Hb), 5.03 (dd, 3Jcis = 10.1 Hz, 2Jgem = 1.6 Hz, 1H, C15Ha), 
4.85 (s, 2H, C11H), 4.27 (q, J = 7.1 Hz, 2H, C13H), 3.78 (s, 3H, C20H), 3.00 (t, J = 7.7 Hz, 2H, C18H), 2.51 
(td, J = 7.7, 6.8 Hz, 2H, C17H), 1.31 (t, J = 7.1 Hz, 3H, C14H). 13C NMR (101 MHz, CDCl3): δ 167.7 (C12), 
145.8 (C8), 142.6 (C9), 136.5 (C16), 130.5 (C1), 124.4 (C6), 120.6 (C3), 120.3 (C4), 119.4 (C5), 116.6 
(C15), 115.4 (C19), 114.4 (C2), 108.6 (C7), 80.4 (C10), 62.4 (C13), 47.3 (C11), 33.1 (C17), 30.8 (C20), 26.5 
(C18), 14.3 (C14). MS (ESI, 70 eV) m/z (%): 336 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for 
C20H21N3O2 + H+ 336.1707, found 336.1719. 
8.3.6. α-Formylation of esters 
8.3.6.1. Synthesis of enol 4.38a 
 
The title compound 4.38a was synthesized via a modification of a procedure reported by 
MacAlpine et al..147 A flame-dried 50 mL round-bottom flask equipped with a Teflon-coated 
magnetic stirrer and a reflux condenser was charged with ethyl 2-(1-(but-3-en-1-yl)-3-cyano-
5-fluoro-2H-isoindol-2-yl)acetate 4.4a (472 mg, 1.572 mmol) and placed under argon 
atmosphere. The starting material was dissolved in freshly distilled ethyl formate (6 mL, 
CHAPTER IV 
118 
0.25 M), and sodium hydride (60% dispersion in mineral oil, 126 mg, 3.143 mmol) was added 
portion wise at room temperature (20 °C). The reaction mixture was stirred at room 
temperature (20 °C) for 1 h and then heated to reflux (54 °C). A second portion of sodium 
hydride (60% dispersion in mineral oil, 126 mg, 3.143 mmol) was added after 2 h at 54 °C. 
After a total reflux time of 18 h, the reaction was quenched in a saturated aqueous solution of 
NH4Cl (20 mL) and acidified to pH 1 using aqueous 3 M HCl. The aqueous layer was extracted 
with ethyl acetate (3 x 20 mL) and the combined organic phases were dried over MgSO4, 
filtered and concentrated in vacuo. Purification by flash column chromatography on silica gel 
with hexane/ethyl acetate 3:1 + 2.5% MeOH to 1:1 + 2.5% as eluent yielded product 4.38a as 
a viscous brown oil (458 mg, 89%; E/Z 95:5, solution in CDCl3 at 25 °C, based on the 
integration of the vinylic proton C18H in 1H NMR). 
Ethyl (2E)-2-(1-(but-3-en-1-yl)-3-cyano-5-fluoro-2H-isoindol-2-yl)-3-hydroxyacrylate 4.38a. 
Viscous brown oil, yield 89%. Rf (SiO2) = 0.16 (hexane/EtOAc 2:1 + 2.5% 
MeOH). IR (neat, cm-1): 3075 (O-H), 2195 (C≡N), 1715 (C=O), 1636 (C=C), 
1483, 1369, 1190, 1142, 1063, 1016, 914, 841, 797, 731, 615. 1H NMR (400 
MHz, CDCl3): δ 11.81 (br s, 1H, OH), 7.60 (dd, J = 9.2 Hz, 4JHF = 4.9 Hz, 1H, 
C3H), 7.53 (s, 1H, C18H), 7.19 (dd, 3JHF = 9.4 Hz, J = 2.2 Hz, 1H, C6H), 6.89 (ddd, 
3JHF = 9.1 Hz, J = 9.2, 2.2 Hz, 1H, C4H), 5.73 (ddt, 3Jtrans = 16.9 Hz, 3Jcis = 10.3 Hz, J = 6.7 Hz, 1H, 
C14H), 5.01 (ddt, 3Jtrans = 16.9 Hz, 2Jgem = 1.6 Hz, J = 1.3 Hz, 1H, C13Hb), 5.00 (ddt, 3Jcis = 10.3 Hz, 2Jgem 
= 1.6 Hz, J = 1.3 Hz, 1H, C13Ha), 4.37 – 4.21 (m, 2H, C11H), 3.01 (ddd, 2JAB = 14.8 Hz, 3JAX = 8.2, 6.8 
Hz, 1H, C16Ha), 2.91 (dt, 2JAB = 14.8 Hz, 3JBX = 7.7 Hz, 1H, C16Hb), 2.34 (tdt, 3JAX,BX = 7.7 Hz, J = 6.7, 
1.3 Hz, 2H, C15H), 1.22 (t, J = 7.1 Hz, 3H, C12H). 13C NMR (101 MHz, CDCl3): δ 168.1 (C10), 164.9 (C18), 
161.8 (d, 1JCF = 246.8 Hz, C5), 136.2 (C14), 134.3 (d, 5JCF = 1.7 Hz, C1), 131.2 (d, 3JCF = 11.7 Hz, C7), 
123.2 (d, 3JCF = 10.3 Hz, C3), 119.9 (C2), 116.7 (C13), 114.35 (d, 2JCF = 28.5 Hz, C4), 114.34 (C17), 106.6 
(C9), 101.3 (d, 2JCF = 24.5 Hz, C6), 96.1 (d, 4JCF = 8.1 Hz, C8), 62.5 (C11), 33.6 (C15), 25.1 (C16), 14.2 
(C12). 19F NMR (376 MHz, CDCl3): δ -113.0 – -113.1 (m). MS (ESI, 70 eV) m/z (%): 329 (M + H+, 100). 
HRMS (ESI, 2 kV): m/z calcd. for C18H17FN2O3 - H+ 327.1150, found 327.1157. 
Characteristic peaks for the (Z) isomer: 1H NMR (400 MHz, CDCl3): δ 8.21 (s, 1H, C18H). 13C NMR (101 
MHz, CDCl3): δ 156.9 (C18). 
8.3.6.2. Synthesis of enol 4.38b 
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The title compound 4.38b was synthesized from ethyl 2-(1-(but-3-en-1-yl)-5-chloro-3-cyano-
2H-isoindol-2-yl)acetate 4.4b (825 mg, 2.604 mmol) following the same procedure as outlined 
for compound 4.38a. Purification by flash column chromatography on silica gel with 
hexane/ethyl acetate 3:1 + 2.5% MeOH to 1:1 + 2.5% as eluent yielded product 4.38b as a 
brown foam (744 mg, 83%; E/Z 88:12, solution in CDCl3 at 25 °C, based on the integration of 
the vinylic carbon C18 in 13C NMR). 
Ethyl (2E)-2-(1-(but-3-en-1-yl)-5-chloro-3-cyano-2H-isoindol-2-yl)-3-hydroxyacrylate 4.38b. Brown 
foam, yield 83%. Rf (SiO2) = 0.10 (hexane/EtOAc 2:1 + 2.5% MeOH). IR (neat, 
cm-1): 3076 (O-H), 2197 (C≡N), 1713 (C=O), 1665 (C=C), 1622 (C=C), 1479, 
1441, 1368, 1285, 1225, 1171, 1067, 912, 795, 770, 731. 1H NMR (400 MHz, 
CDCl3): δ 11.78 (br s, 1H, OH), 7.61 (dd, J = 1.8, 0.8 Hz, 1H, C6H), 7.55 (dd, J 
= 9.0, 0.8 Hz, 1H, C3H), 7.53 (s, 1H, C18H), 7.02 (dd, J = 9.0, 1.8 Hz, 1H, C4H), 
5.72 (ddt, 3Jtrans = 17.9 Hz, 3Jcis = 9.6 Hz, J = 6.7 Hz, 1H, C14H), 5.01 (ddt, 3Jtrans = 17.9 Hz, 2Jgem = 1.5 
Hz, J = 1.3 Hz, 1H, C13Hb), 5.00 (ddt, 3Jcis = 9.6 Hz, 2Jgem = 1.5 Hz, J = 1.3 Hz, 1H, C13Ha), 4.36 – 4.21 
(m, 2H, C11H), 3.01 (ddd, 2JAB = 14.8 Hz, 3JAX = 8.2, 6.7 Hz, 1H, C16Ha), 2.90 (dt, 2JAB = 14.8 Hz, 3JBX = 
7.8 Hz, 1H, C16Hb), 2.37 – 2.30 (m, 2H, C15H), 1.22 (t, J = 7.1 Hz, 3H, C12H). 13C NMR (101 MHz, 
CDCl3): δ 168.0 (C10), 164.9 (C18), 136.2 (C14), 134.2 (C1), 132.8 (C5), 131.3 (C7), 124.0 (C4), 122.2 (C3), 
120.7 (C2), 117.2 (C6), 116.8 (C13), 114.1 (C17), 106.6 (C9), 95.7 (C8), 62.5 (C11), 33.6 (C15), 25.1 (C16), 
14.2 (C12). MS (ESI, 70 eV) m/z (%): 345 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C18H17ClN2O3 
+ H+ 345.1000, found 345.0991. 
Characteristic peaks for the (Z) isomer: 1H NMR (400 MHz, CDCl3): δ 8.23 (s, 1H, C18H). 13C NMR (101 
MHz, CDCl3): δ 157.3 (C18). 
8.3.6.3. Synthesis of enol 4.38c 
 
The title compound 4.38c was synthesized from ethyl 2-(5-(but-3-en-1-yl)-7-cyano-6H-
[1,3]dioxolo[4,5-f]isoindol-6-yl)acetate 4.4c (793 mg, 2.430 mmol) following the same 
procedure as outlined for compound 4.38a. Purification by flash column chromatography on 
silica gel with hexane/ethyl acetate 3:1 + 2.5% MeOH to 1:1 + 2.5% as eluent yielded product 
4.38c as a brown foam (842 mg, 98%; E/Z 96:4, solution in CDCl3 at 25 °C, based on the 
integration of the vinylic proton C19H in 1H NMR). 
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Ethyl (2E)-2-(5-(but-3-en-1-yl)-7-cyano-6H-[1,3]dioxolo[4,5-f]isoindol-6-yl)-3-hydroxyacrylate 
4.38c. Brown foam, yield 98%. Rf (SiO2) = 0.11 (hexane/EtOAc 2:1 + 2.5% 
MeOH). IR (neat, cm-1): 3076 (O-H), 2191 (C≡N), 1715 (C=O), 1670 (C=C), 
1489, 1423, 1395, 1364, 1244, 1213, 1140, 1059, 1032, 959, 934, 827. 
1H NMR (400 MHz, CDCl3): δ 11.76 (br s, 1H, OH), 7.50 (s, 1H, C19H), 6.86 
(d, J = 0.7 Hz, 1H, C7H), 6.81 (d, J = 0.7 Hz, 1H, C3H), 5.96 (d, 2JAB = 1.1 Hz, 
1H, C5Ha), 5.95 (d, 2JAB = 1.1 Hz, 1H, C5Hb), 5.73 (ddt, 3Jtrans = 17.0 Hz, 3Jcis 
= 10.2 Hz, J = 6.8 Hz, 1H, C15H), 5.01 (ddt, 3Jtrans = 17.0 Hz, 2Jgem = 1.5 Hz, J = 1.4 Hz, 1H, C14Hb), 5.00 
(ddt, 3Jcis = 10.2 Hz, 2Jgem = 1.5 Hz, J = 1.4 Hz, 1H, C14Ha), 4.35 – 4.22 (m, 2H, C12H), 2.89 (ddd, 2JAB = 
14.8 Hz, 3JAX = 8.1, 6.8 Hz, 1H, C17Ha), 2.78 (dt, 2JAB = 14.8 Hz, 3JBX = 7.8 Hz, 1H, C17Hb), 2.29 (tdt, 
3JAX,BX = 7.8 Hz, J = 6.8, 1.4 Hz, 2H, C16H), 1.22 (t, J = 7.1 Hz, 3H, C13H). 13C NMR (101 MHz, CDCl3): 
δ 168.5 (C11), 164.8 (C19), 149.3 (C6), 146.2 (C4), 136.5 (C15), 132.6 (C1), 128.8 (C8), 118.5 (C2), 116.4 
(C14), 114.9 (C18), 106.8 (C10), 101.1 (C5), 96.0 (C9), 95.9 (C3), 94.3 (C7), 62.2 (C12), 33.6 (C16), 25.0 
(C17), 14.2 (C13). MS (ESI, 70 eV) m/z (%): 355 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for 
C19H18N2O5 + H+ 355.1288, found 355.1290. 
Characteristic peaks for the (Z) isomer: 1H NMR (400 MHz, CDCl3): δ 11.39 (br s, 1H, OH), 8.16 (s, 1H, 
C19H). 13C NMR (101 MHz, CDCl3): δ 156.9 (C19). 
8.3.6.4. Synthesis of enol 4.38d 
 
The title compound 4.38d was synthesized from ethyl 2-(1-(but-3-en-1-yl)-3-cyano-5,6-
dimethoxy-2H-isoindol-2-yl)acetate 4.4d (1.05 g, 3.078 mmol) following the same procedure 
as outlined for compound 4.38a. Purification by flash column chromatography on silica gel with 
hexane/ethyl acetate 2:1 + 2.5% MeOH to 1:2 + 2.5% as eluent yielded product 4.38d as a 
brown solid (983 mg, 86%; E/Z 96:4, solution in CDCl3 at 25 °C, based on the integration of 
the vinylic proton C20H in 1H NMR). 
Ethyl (2E)-2-(1-(but-3-en-1-yl)-3-cyano-5,6-dimethoxy-2H-isoindol-2-yl)-3-hydroxyacrylate 4.38d. 
Brown solid, yield 86%. Rf (SiO2) = 0.10 (hexane/EtOAc 1:1 + 2.5% MeOH). 
IR (neat, cm-1): 3287 (O-H), 2189 (C≡N), 1717 (C=O), 1676 (C=C), 1632 
(C=C), 1506, 1425, 1396, 1369, 1246, 1223, 1171, 1134, 1065, 1030, 910, 
812. 1H NMR (400 MHz, CDCl3): δ 11.77 (br s, 1H, OH), 7.51 (s, 1H, C20H), 
6.85 (s, 1H, C8H), 6.76 (s, 1H, C3H), 5.76 (ddt, 3Jtrans = 17.0 Hz, 3Jcis = 10.2 
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Hz, J = 6.8 Hz, 1H, C16H), 5.03 (ddt, 3Jtrans = 17.0 Hz, 2Jgem = 1.5 Hz, J = 1.4 Hz, 1H, C15Hb), 5.01 (ddt, 
3Jcis = 10.2 Hz, 2Jgem = 1.5 Hz, J = 1.4 Hz, 1H, C15Ha), 4.35 – 4.22 (m, 2H, C13H), 3.96 (s, 3H, C6H), 3.92 
(s, 3H, C5H), 2.94 (dt, 2JAB = 14.8 Hz, 3JAX = 7.6 Hz, 1H, C18Ha), 2.83 (dt, 2JAB = 14.8 Hz, 3JBX = 7.6 Hz, 
1H, C18Hb), 2.32 (tdt, 3JAX,BX = 7.6 Hz, J = 6.8, 1.4 Hz, 2H, C17H), 1.22 (t, J = 7.1 Hz, 3H, C14H). 13C NMR 
(101 MHz, CDCl3): δ 168.5 (C12), 164.8 (C20), 151.6 (C7), 148.4 (C4), 136.7 (C16), 132.2 (C1), 127.8 (C9), 
117.5 (C2), 116.3 (C15), 115.2 (C19), 106.7 (C11), 98.1 (C3), 96.2 (C8), 95.1 (C10), 62.2 (C13), 56.1 (C6), 
56.0 (C5), 33.5 (C17), 25.0 (C18), 14.2 (C14). MS (ESI, 70 eV) m/z (%): 371 (M + H+, 100). HRMS (ESI, 2 
kV): m/z calcd. for C20H22N2O5 + H+ 371.1601, found 371.1607. 
Characteristic peaks for the (Z) isomer: 1H NMR (400 MHz, CDCl3): δ 11.38 (br s, 1H, OH), 8.17 (s, 1H, 
C20H). 13C NMR (101 MHz, CDCl3): δ 156.7 (C20). 
8.3.6.5. Synthesis of enol 4.38e 
 
A flame-dried 50 mL round-bottom flask equipped with a Teflon-coated magnetic stirrer was 
charged with ethyl 2-(1-(but-3-en-1-yl)-3-cyano-2H-benzo[e]isoindol-2-yl)acetate 4.4e 
(206 mg, 0.620 mmol) and placed under argon atmosphere. The starting material was 
dissolved in freshly distilled ethyl formate (15 mL, 0.04 M), and lithium diisopropylamide (2.0 M 
solution in THF/heptane/ethylbenzene, 0.6 mL, 1.239 mmol) was added at 0 °C. The reaction 
mixture was allowed to warm to room temperature (20 °C) and stirred for 19 h. Subsequently, 
the reaction was quenched in a saturated aqueous solution of NH4Cl (20 mL) and acidified to 
pH 1 using aqueous 3 M HCl. The aqueous layer was extracted with ethyl acetate (3 x 20 mL) 
and the combined organic phases were dried over MgSO4, filtered and concentrated in vacuo. 
Purification by automated flash chromatography on C18 silica with water/acetonitrile as eluent 
(gradient from 30% to 70% CH3CN in H2O over 25 column volumes) yielded product 4.38e as 
a yellow foam (159 mg, 71%; E/Z 97:3, solution in CDCl3 at 25 °C, based on the integration of 
the vinylic carbon C22 in 13C NMR). 
Ethyl (2E)-2-(1-(but-3-en-1-yl)-3-cyano-2H-benzo[e]isoindol-2-yl)-3-hydroxyacrylate 4.38e. Yellow 
foam, yield 71%. IR (neat, cm-1): 3052 (O-H), 2200 (C≡N), 1713 (C=O), 1671 
(C=C), 1641 (C=C), 1620, 1552, 1419, 1400, 1273, 1230, 1175, 1141, 1077, 
1042, 909, 806, 729. 1H NMR (400 MHz, CDCl3): δ 11.73 (br s, 1H, OH), 8.15 
(dd, J = 8.2, 1.2 Hz, 1H, C4H), 7.83 (dd, J = 8.0, 1.4 Hz, 1H, C7H), 7.59 (ddd, J 
= 8.2, 7.1, 1.4 Hz, 1H, C5H), 7.57 (s, 1H, C22H), 7.55 (d, 3JAB = 9.1 Hz, 1H, 
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C10H), 7.53 (d, 3JAB = 9.1 Hz, 1H, C9H), 7.49 (ddd, J = 8.0, 7.1, 1.2 Hz, 1H, C6H), 5.89 (ddt, 3Jtrans = 17.0 
Hz, 3Jcis = 10.2 Hz, J = 6.6 Hz, 1H, C18H), 5.12 (ddt, 3Jtrans = 17.0 Hz, 2Jgem = 1.6 Hz, J = 1.5 Hz, 1H, 
C17Hb), 5.09 (ddt, 3Jcis = 10.2 Hz, 2Jgem = 1.6 Hz, J = 1.5 Hz, 1H, C17Ha), 4.36 – 4.23 (m, 2H, C15H), 3.32 
(ddd, 2JAB = 14.9 Hz, 3JAX = 9.3, 6.3 Hz, 1H, C20Ha), 3.13 (ddd, 2JAB = 14.9 Hz, 3JBX = 9.3, 7.2 Hz, 1H, 
C20Hb), 2.52 – 2.40 (m, 2H, C19H), 1.21 (t, J = 7.1 Hz, 3H, C16H). 13C NMR (101 MHz, CDCl3): δ 168.5 
(C14), 165.3 (C22), 136.5 (C18), 135.4 (C1), 131.5 (C8), 130.5 (C11), 129.6 (C7), 128.5 (C9), 128.4 (C3), 
127.5 (C5), 125.4 (C6), 123.0 (C4), 117.6 (C10), 117.2 (C2), 116.5 (C17), 114.2 (C21), 106.5 (C13), 98.1 
(C12), 62.4 (C15), 32.5 (C19), 26.6 (C20), 14.2 (C16). MS (ESI, 70 eV) m/z (%): 361 (M + H+, 100). HRMS 
(ESI, 2 kV): m/z calcd. for C22H20N2O3 + H+ 361.1547, found 361.1552. 
Characteristic peaks for the (Z) isomer: 1H NMR (400 MHz, CDCl3): δ 8.38 (s, 1H, C22H). 13C NMR (101 
MHz, CDCl3): δ 161.3 (C22). 
8.3.6.6. Synthesis of enol 4.38f 
 
The title compound 4.38f was synthesized from ethyl 2-(1-(but-3-en-1-yl)-3-cyano-4-methyl-
4H-pyrrolo[3,4-b]indol-2-yl)acetate 4.4f (112 mg, 0.334 mmol) following the same procedure 
as outlined for compound 4.38e. In addition to magnetic stirring, the reaction mixture was 
sonicated for the total reaction time. Purification by automated flash chromatography on C18 
silica with water/acetonitrile as eluent (gradient from 25% to 100% CH3CN in H2O with steps 
of 5% per 2 column volumes) yielded product 4.38f as yellow crystals (103 mg, 85%; E/Z 94:6, 
solution in CDCl3 at 25 °C, based on the integration of the vinylic proton C21H in 1H NMR). 
Ethyl (2E)-2-(1-(but-3-en-1-yl)-3-cyano-4-methyl-4H-pyrrolo[3,4-b]indol-2-yl)-3-hydroxyacrylate 
4.38f. Yellow crystals, yield 85%. Mp 187 °C. IR (neat, cm-1): 2984 (O-H), 2193 
(C≡N), 1711 (C=O), 1674 (C=C), 1638 (C=C), 1599, 1464, 1406, 1260, 1221, 
1148, 1069, 1030, 903, 797, 743. 1H NMR (400 MHz, CDCl3): δ 11.77 (br s, 
1H, OH), 7.71 (d, J = 7.6 Hz, 1H, C4H), 7.57 (s, 1H, C21H), 7.36 (dd, J = 7.7, 
7.6 Hz, 1H, C6H), 7.23 (d, J = 7.7 Hz, 1H, C7H), 7.15 (t, J = 7.6 Hz, 1H, C5H), 
5.81 (ddt, 3Jtrans = 17.0 Hz, 3Jcis = 10.2 Hz, J = 6.8 Hz, 1H, C16H), 5.06 (dd, 3Jtrans 
= 17.0 Hz, 2Jgem = 1.6 Hz, 1H, C15Hb), 5.00 (dd, 3Jcis = 10.2 Hz, 2Jgem = 1.6 Hz, 1H, C15Ha), 4.29 (q, J = 
7.1 Hz, 2H, C13H), 3.79 (s, 3H, C20H), 2.97 (dt, 2JAB = 14.7 Hz, 3JAX = 7.6 Hz, 1H, C18Ha), 2.87 (dt, 2JAB 
= 14.7 Hz, 3JBX = 7.6 Hz, 1H, C18Hb), 2.46 (td, 3JAX,BX = 7.6 Hz, J = 6.8 Hz, 2H, C17H), 1.23 (t, J = 7.1 
Hz, 3H, C14H). 13C NMR (101 MHz, CDCl3): δ 169.2 (C12), 165.5 (C21), 145.8 (C8), 142.8 (C9), 136.7 
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(C16), 132.2 (C1), 124.7 (C6), 120.6 (C4), 120.5 (C3), 119.6 (C5), 116.4 (C15), 115.3 (C19), 114.4 (C2), 
108.7 (C7), 106.8 (C11), 82.5 (C10), 62.1 (C13), 33.1 (C17), 30.8 (C20), 26.4 (C18), 14.3 (C14). MS (ESI, 70 
eV) m/z (%): 364 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C21H21N3O3 + H+ 364.1656, found 
364.1648. 
Characteristic peaks for the (Z) isomer: 1H NMR (400 MHz, CDCl3): δ 8.22 (s, 1H, C21H). 13C NMR (101 
MHz, CDCl3): no peaks observed. 
8.3.7. Coupling reaction with bromobutenolide 2.20 
8.3.7.1. Synthesis of bromobutenolide 2.20 
 
The title compound 2.20 was synthesized via a procedure reported by MacAlpine et al..147 To 
a solution of 3-methyl-furan-2-5H-one 4.48 (1.0 g, 10.194 mmol) in tetrachloromethane 
(40 mL, 0.25 M) were added N-bromosuccinimide (NBS, 2.0 g, 11.213 mmol) and benzoyl 
peroxide (BPO, 75 wt. % with 25 wt. % H2O, 33 mg, 0.102 mmol). The mixture was heated to 
reflux (77 °C) overnight while being exposed to a light source (fluorescent spiral lamp, 26 W). 
After 20 h, the reaction mixture was filtered and the solvent was removed to yield the product 
2.20 as a pale yellow oil (1.37 g, 76%). The compound 2.20 was obtained as a racemic mixture 
in sufficient purity (86% by 1H NMR) for further reaction. 
5-Bromo-3-methyl-5H-furan-2-one 2.20. Pale yellow oil, yield 76%. 1H NMR (400 MHz, CDCl3): δ 7.20 
(dq, J = 1.7, 1.5 Hz, 1H, C2H), 6.83 (qd, J = 1.7, 1.7 Hz, 1H, C1H), 2.01 (dd, J = 1.7, 1.5 
Hz, 3H, C5H). 13C NMR (101 MHz, CDCl3): δ 170.8 (C4), 147.6 (C2), 130.9 (C3), 74.9 (C1), 
10.6 (C5). MS (EI, 70 eV) m/z (%): 97 ([M - Br]+, 100). The spectroscopic data are in 
agreement with the previously reported literature values.185 
8.3.7.2. Synthesis of strigolactone analog 4.2a 
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The title compound 4.2a was synthesized via a modification of a procedure reported by 
MacAlpine et al..147 A flame-dried 50 mL round-bottom flask equipped with a Teflon-coated 
magnetic stirrer and a reflux condenser was charged with ethyl (2E)-2-(1-(but-3-en-1-yl)-3-
cyano-5-fluoro-2H-isoindol-2-yl)-3-hydroxyacrylate 4.38a (253 mg, 0.771 mmol) and placed 
under argon atmosphere. The starting material was dissolved in dry tetrahydrofuran (15 mL, 
0.05 M), and sodium hydride (60% dispersion in mineral oil, 62 mg, 1.541 mmol) was added 
portion wise at room temperature (20 °C). The reaction was stirred at room temperature 
(20 °C) for 15 minutes. Subsequently, 5-bromo-3-methyl-5H-furan-2-one 2.20 (273 mg, 
1.541 mmol) was added and the mixture was heated to reflux (66 °C) for 5 h. Upon full 
conversion, the reaction mixture was quenched in water (20 mL). After phase separation, the 
aqueous layer was extracted with ethyl acetate (3 x 20 mL), and the combined organic phases 
were dried over MgSO4, filtered and concentrated under reduced pressure. The product 4.2a 
was obtained as brown-yellow foam (183 mg, 56%) after purification by automated flash 
chromatography on C18 silica with water/acetonitrile as eluent (gradient from 30% to 100% 
CH3CN in H2O with steps of 5% per 2 column volumes). The compound 4.2a was 
characterized as a mixture of two interconverting atropisomers as a result of the hindered 
rotation around the N-C9 bond between the isoindole and enol ether moiety (maj./min. 61:39, 
solution in CDCl3 at 25 °C, based on the integration of the enol ether proton (C18H) in 1H NMR). 
Ethyl (2Z)-2-(1-(but-3-en-1-yl)-3-cyano-5-fluoro-2H-isoindol-2-yl)-3-((4-methyl-5-oxo-2,5-dihydro-
furan-2-yl)oxy)acrylate 4.2a. Brown-yellow foam, yield 56%. IR (neat, cm-1): 
2195 (C≡N), 1786 (C=O), 1717 (C=O), 1659 (C=C), 1638 (C=C), 1483, 1445, 
1369, 1285, 1188, 1142, 1080, 1049, 951, 860, 799, 741, 615, 430. 1H NMR 
(400 MHz, CDCl3): δ 8.15 (s, 1H, C18H, maj.), 7.86 (s, 1H, C18H, min.), 7.60 
(ddd, J = 9.2, 0.7 Hz, 4JHF = 5.0 Hz, 1H, C3H, min.), 7.58 (ddd, J = 9.2, 0.7 
Hz, 4JHF = 5.0 Hz, 1H, C3H, maj.), 7.181 (ddd, 3JHF = 9.4 Hz, J = 2.2, 0.7 Hz, 
1H, C6H, min.), 7.176 (ddd, 3JHF = 9.4 Hz, J = 2.2, 0.7 Hz, 1H, C6H, maj.), 7.01 (dq, J = 1.8, 1.6 Hz, 1H, 
C20H, min.), 6.90 (dq, J = 1.8, 1.6 Hz, 1H, C20H, maj.), 6.86 (ddd, 3JHF = 9.2 Hz, J = 9.2, 2.2 Hz, 1H, 
C4H, min.), 6.84 (ddd, 3JHF = 9.2 Hz, J = 9.2, 2.2 Hz, 1H, C4H, maj.), 6.26 (dq, J = 1.8, 1.4 Hz, 1H, C19H, 
maj.), 6.22 (dq, J = 1.8, 1.4 Hz, 1H, C19H, min.), 5.80 – 5.63 (m, 1H, C14H, maj. + min.), 5.05 – 4.97 (m, 
2H, C13H, min.), 5.00 – 4.92 (m, 2H, C13H, maj.), 4.33 – 4.22 (m, 2H, C11H, maj. + min.), 2.97 – 2.87 (m, 
1H, C16Ha, maj. + min.), 2.86 – 2.76 (m, 1H, C16Hb, maj. + min.), 2.33 (tdt, J = 7.7, 6.9, 1.3 Hz, 2H, C15H, 
min.), 2.29 (tdt, J = 7.7, 6.9, 1.3 Hz, 2H, C15H, maj.), 2.04 (dd, J = 1.6, 1.4 Hz, 3H, C23H, min.), 1.93 (dd, 
J = 1.6, 1.4 Hz, 3H, C23H, maj.), 1.30 (t, J = 7.1 Hz, 3H, C12H, maj.), 1.26 (t, J = 7.1 Hz, 3H, C12H, min). 
13C NMR (101 MHz, CDCl3): δ 169.9 (C22, maj.), 169.7 (C22, min.), 162.42 (C10, maj.), 162.38 (C10, min.), 
161.62 (d, 1JCF = 246.1 Hz, C5, maj.), 161.59 (d, 1JCF = 246.1 Hz, C5, min.), 155.1 (C18, maj.), 151.9 (C18, 
min.), 141.2 (C20, min.), 140.9 (C20, maj.), 136.7 (C21, min.), 136.4 (C14, min.), 136.3 (C14, maj.), 135.5 
(C21, maj.), 133.4 (d, 5JCF = 1.7 Hz, C1, maj.), 133.1 (d, 5JCF = 1.7 Hz, C1, min.), 131.4 (d, 3JCF = 11.7 
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Hz, C7, maj.), 131.3 (d, 3JCF = 11.7 Hz, C7, min.), 123.3 (d, 3JCF = 10.4 Hz, C3, maj.), 123.2 (d, 3JCF = 
10.4 Hz, C3, min.), 119.9 (C2, maj.), 119.8 (C2, min.), 116.3 (C13, min.), 116.2 (C13, maj.), 114.4 (C17, 
maj.), 114.2 (C17, min.), 113.83 (d, 2JCF = 28.3 Hz, C4, min.), 113.77 (d, 2JCF = 28.3 Hz, C4, maj.), 111.8 
(C9, min.), 111.3 (C9, maj.), 101.2 (d, 2JCF = 24.4 Hz, C6, min.), 101.13 (d, 2JCF = 24.4 Hz, C6, maj.), 
101.12 (C19, maj.), 99.6 (C19, min.), 94.0 (d, 4JCF = 8.2 Hz, C8, min.), 93.8 (d, 4JCF = 8.2 Hz, C8, maj.), 
62.1 (C11, maj. + min.), 33.2 (C15, min.), 33.1 (C15, maj.), 25.3 (C16, min.), 25.2 (C16, maj.), 14.18 (C12, 
maj.), 14.16 (C12, min.), 10.7 (C23, min.), 10.6 (C23, maj.). 19F NMR (376 MHz, CDCl3): δ -113.4 – -113.5 
(m). MS (ESI, 70 eV) m/z (%): 425 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C23H21FN2O5 + H+ 
425.1507, found 425.1502. 
8.3.7.3. Synthesis of strigolactone analog 4.2b 
 
The title compound 4.2b was synthesized from ethyl (2E)-2-(1-(but-3-en-1-yl)-5-chloro-3-
cyano-2H-isoindol-2-yl)-3-hydroxyacrylate 4.38b (361 mg, 1.047 mmol) following the same 
procedure as outlined for compound 4.2a. The product 4.2b was obtained as brown-yellow 
foam (257 mg, 56%) after purification by automated flash chromatography on C18 silica with 
water/acetonitrile as eluent (gradient from 30% to 100% CH3CN in H2O with steps of 5% per 
2 column volumes). The compound 4.2b was characterized as a mixture of two interconverting 
atropisomers as a result of the hindered rotation around the N-C9 bond between the isoindole 
and enol ether moiety (maj./min. 65:35, solution in CDCl3 at 25 °C, based on the integration of 
the enol ether proton (C18H) in 1H NMR). 
Ethyl (2Z)-2-(1-(but-3-en-1-yl)-5-chloro-3-cyano-2H-isoindol-2-yl)-3-((4-methyl-5-oxo-2,5-dihydro-
furan-2-yl)oxy)acrylate 4.2b. Brown-yellow foam, yield 56%. IR (neat, cm-1): 
2197 (C≡N), 1784 (C=O), 1717 (C=O), 1659 (C=C), 1624 (C=C), 1479, 1443, 
1366, 1285, 1207, 1165, 1084, 1051, 951, 858, 797, 768, 741. 1H NMR (400 
MHz, CDCl3): δ 8.14 (s, 1H, C18H, maj.), 7.85 (s, 1H, C18H, min.), 7.61 – 7.59 
(m, 1H, C6H, maj. + min.), 7.56 (dd, J = 9.0, 0.8 Hz, 1H, C3H, min.), 7.54 (dd, 
J = 9.0, 0.8 Hz, 1H, C3H, maj.), 7.01 (dq, J = 1.8, 1.6 Hz, 1H, C20H, min.), 
7.00 (dd, J = 9.0, 1.8 Hz, 1H, C4H, min.), 6.99 (dd, J = 9.0, 1.8 Hz, 1H, C4H, maj.), 6.90 (dq, J = 1.8, 1.6 
Hz, 1H, C20H, maj.), 6.25 (dq, J = 1.8, 1.4 Hz, 1H, C19H, maj.), 6.22 (dq, J = 1.8, 1.4 Hz, 1H, C19H, min.), 
5.79 – 5.63 (m, 1H, C14H, maj. + min.), 5.05 – 4.97 (m, 2H, C13H, min.), 5.00 – 4.92 (m, 2H, C13H, maj.), 
4.33 – 4.22 (m, 2H, C11H, maj. + min.), 2.97 – 2.87 (m, 1H, C16Ha, maj. + min.), 2.88 – 2.76 (m, 1H, 
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C16Hb, maj. + min.), 2.33 (td, J = 7.6, 7.2 Hz, 2H, C15H, min.), 2.29 (td, J = 7.6, 7.2 Hz, 2H, C15H, maj.), 
2.06 (dd, J = 1.6, 1.4 Hz, 3H, C23H, min.), 1.94 (dd, J = 1.6, 1.4 Hz, 3H, C23H, maj.), 1.30 (t, J = 7.1 Hz, 
3H, C12H, maj.), 1.27 (t, J = 7.1 Hz, 3H, C12H, min.). 13C NMR (101 MHz, CDCl3): δ 169.9 (C22, maj.), 
169.7 (C22, min.), 162.35 (C10, maj.), 162.31 (C10, min.), 155.1 (C18, maj.), 151.9 (C18, min.), 141.2 (C20, 
min.), 140.9 (C20, maj.), 136.8 (C21, min.), 136.4 (C14, min.), 136.2 (C14, maj.), 135.6 (C21, maj.), 133.4 
(C1, maj.), 133.1 (C1, min.), 132.54 (C5, maj.), 132.50 (C5, min.), 131.50 (C7, maj.), 131.46 (C7, min.), 
123.6 (C4, min.), 123.5 (C4, maj.), 122.4 (C3, maj.), 122.3 (C3, min.), 120.74 (C2, maj.), 120.70 (C2, min.), 
117.1 (C6, min.), 117.0 (C6, maj.), 116.4 (C13, min.), 116.3 (C13, maj.), 114.2 (C17, maj.), 114.0 (C17, 
min.), 111.9 (C9, min.), 111.3 (C9, maj.), 101.1 (C19, maj.), 99.6 (C19, min.), 93.6 (C8, min.), 93.4 (C8, 
maj.), 62.2 (C11, maj. + min.), 33.3 (C15, min.), 33.1 (C15, maj.), 25.3 (C16, min.), 25.2 (C16, maj.), 14.2 
(C12, maj. + min.), 10.8 (C23, min.), 10.6 (C23, maj.). MS (ESI, 70 eV) m/z (%): 441 (M + H+, 100). HRMS 
(ESI, 2 kV): m/z calcd. for C23H21ClN2O5 + H+ 441.1212, found 441.1219. 
8.3.7.4. Synthesis of strigolactone analog 4.2c 
 
The title compound 4.2c was synthesized from ethyl (2E)-2-(5-(but-3-en-1-yl)-7-cyano-6H-
[1,3]dioxolo[4,5-f]isoindol-6-yl)-3-hydroxyacrylate 4.38c (310 mg, 0.875 mmol) following the 
same procedure as outlined for compound 4.2a. The product 4.2c was obtained as yellow 
foam (230 mg, 58%) after purification by automated flash chromatography on C18 silica with 
water/acetonitrile as eluent (gradient from 30% to 100% CH3CN in H2O with steps of 5% per 
1.5 column volumes). The compound 4.2c was characterized as a mixture of two 
interconverting atropisomers as a result of the hindered rotation around the N-C10 bond 
between the isoindole and enol ether moiety (maj./min. 63:37, solution in CDCl3 at 25 °C, 
based on the integration of the enol ether proton (C19H) in 1H NMR). 
Ethyl (2Z)-2-(5-(but-3-en-1-yl)-7-cyano-6H-[1,3]dioxolo[4,5-f]isoindol-6-yl)-3-((4-methyl-5-oxo-
2,5-dihydrofuran-2-yl)oxy)acrylate 4.2c. Yellow foam, yield 58%. IR 
(neat, cm-1): 2191 (C≡N), 1784 (C=O), 1717 (C=O), 1657 (C=C), 1491, 
1429, 1366, 1283, 1244, 1202, 1142, 1080, 1034, 953, 862, 831, 743. 
1H NMR (400 MHz, CDCl3): δ 8.09 (s, 1H, C19H, maj.), 7.80 (s, 1H, C19H, 
min.), 7.02 (dq, J = 1.8, 1.6 Hz, 1H, C21H, min.), 6.91 (dq, J = 1.8, 1.6 Hz, 
1H, C21H, maj.), 6.86 (d, J = 0.7 Hz, 1H, C7H, min.), 6.85 (d, J = 0.7 Hz, 
1H, C7H, maj.), 6.82 (d, J = 0.7 Hz, 1H, C3H, min.), 6.81 (d, J = 0.7 Hz, 1H, C3H, maj.), 6.24 (dq, J = 
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1.8, 1.4 Hz, 1H, C20H, maj.), 6.21 (dq, J = 1.8, 1.4 Hz, 1H, C20H, min.), 5.96 – 5.93 (m, 2H, C5H, maj. + 
min.), 5.80 – 5.64 (m, 1H, C15H, maj. + min.), 5.05 – 4.96 (m, 2H, C14H, min.), 5.00 – 4.92 (m, 2H, C14H, 
maj.), 4.32 – 4.22 (m, 2H, C12H, maj. + min.), 2.86 – 2.76 (m, 1H, C17Ha, maj. + min.), 2.75 – 2.65 (m, 
1H, C17Hb, maj. + min.), 2.29 (td, J = 7.7, 7.1 Hz, 2H, C16H, min.), 2.25 (td, J = 7.7, 7.1 Hz, 2H, C16H, 
maj.), 2.05 (dd, J = 1.6, 1.4 Hz, 3H, C24H, min.), 1.94 (dd, J = 1.6, 1.4 Hz, 3H, C24H, maj.), 1.29 (t, J = 
7.1 Hz, 3H, C13H, maj.), 1.26 (t, J = 7.1 Hz, 3H, C13H, min.). 13C NMR (101 MHz, CDCl3): δ 170.0 (C23, 
maj.), 169.8 (C23, min.), 162.81 (C11, maj.), 162.79 (C11, min.), 154.7 (C19, maj.), 151.1 (C19, min.), 149.3 
(C6, maj.), 149.2 (C6, min.), 146.1 (C4, min.), 146.0 (C4, maj.), 141.5 (C21, min.), 141.0 (C21, maj.), 136.9 
(C22, min.), 136.8 (C15, min.), 136.7 (C15, maj.), 135.6 (C22, maj.), 131.8 (C1, maj.), 131.5 (C1, min.), 
129.21 (C8, maj.), 129.19 (C8, min.), 118.62 (C2, maj.), 118.61 (C2, min.), 116.2 (C14, min.), 116.1 (C14, 
maj.), 115.1 (C18, maj.), 115.0 (C18, min.), 112.4 (C10, min.), 111.9 (C10, maj.), 101.1 (C5, maj. + min., 
C20, maj.), 99.4 (C20, min.), 96.1 (C3, maj.), 96.0 (C3, min.), 94.4 (C7, min.), 94.3 (C7, maj.), 94.0 (C9, 
min.), 93.8 (C9, maj.), 62.11 (C12, maj.), 62.09 (C12, min.), 33.3 (C16, min.), 33.2 (C16, maj.), 25.4 (C17, 
min.), 25.3 (C17, maj.), 14.33 (C13, maj.), 14.32 (C13, min.), 10.9 (C24, min.), 10.7 (C24, maj.). MS (ESI, 
70 eV) m/z (%): 451 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C24H22N2O7 + H+ 451.1500, found 
451.1499. 
8.3.7.5. Synthesis of strigolactone analog 4.2d 
 
The title compound 4.2d was synthesized from ethyl (2E)-2-(1-(but-3-en-1-yl)-3-cyano-5,6-
dimethoxy-2H-isoindol-2-yl)-3-hydroxyacrylate 4.38d (340 mg, 0.918 mmol) following the 
same procedure as outlined for compound 4.2a. The product 4.2d was obtained as yellow 
foam (234 mg, 55%) after purification by automated flash chromatography on C18 silica with 
water/acetonitrile as eluent (gradient from 30% to 100% CH3CN in H2O with steps of 5% per 
1.7 column volumes). The compound 4.2d was characterized as a mixture of two 
interconverting atropisomers as a result of the hindered rotation around the N-C11 bond 
between the isoindole and enol ether moiety (maj./min. 70:30, solution in CDCl3 at 25 °C, 
based on the integration of the enol ether proton (C20H) in 1H NMR).  
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Ethyl (2Z)-2-(1-(but-3-en-1-yl)-3-cyano-5,6-dimethoxy-2H-isoindol-2-yl)-3-((4-methyl-5-oxo-2,5-
dihydrofuran-2-yl)oxy)acrylate 4.2d. Yellow foam, yield 55%. IR (neat, 
cm-1): 2189 (C≡N), 1784 (C=O), 1717 (C=O), 1659 (C=C), 1504, 1433, 
1368, 1254, 1204, 1146, 1082, 951, 862, 824, 737. 1H NMR (400 MHz, 
CDCl3): δ 8.11 (s, 1H, C20H, maj.), 7.82 (s, 1H, C20H, min.), 7.02 (dq, J 
= 1.8, 1.6 Hz, 1H, C22H, min.), 6.91 (dq, J = 1.8, 1.6 Hz, 1H, C22H, maj.), 
6.853 (s, 1H, C8H, min.), 6.848 (s, 1H, C8H, maj.), 6.78 (s, 1H, C3H, 
min.), 6.77 (s, 1H, C3H, maj.), 6.24 (dq, J = 1.8, 1.4 Hz, 1H, C21H, maj.), 6.21 (dq, J = 1.8, 1.4 Hz, 1H, 
C21H, min.), 5.83 – 5.67 (m, 1H, C16H, maj. + min.), 5.07 – 4.98 (m, 2H, C15H, min.), 5.03 – 4.93 (m, 2H, 
C15H, maj.), 4.32 – 4.20 (m, 2H, C13H, maj. + min.), 3.95 (s, 3H, C6H, maj. + min.), 3.92 (s, 3H, C5H, 
min.), 3.91 (s, 3H, C5H, maj.), 2.91 – 2.81 (m, 1H, C18Ha, maj. + min.), 2.80 – 2.70 (m, 1H, C18Hb, maj. 
+ min.), 2.32 (td, J = 7.9, 7.0 Hz, 2H, C17H, min.), 2.28 (td, J = 7.9, 7.0 Hz, 2H, C17H, maj.), 2.05 (dd, J 
= 1.6, 1.4 Hz, 3H, C25H, min.), 1.93 (dd, J = 1.6, 1.4 Hz, 3H, C25H, maj.), 1.30 (t, J = 7.1 Hz, 3H, C14H, 
maj.), 1.26 (t, J = 7.1 Hz, 3H, C14H, min.). 13C NMR (101 MHz, CDCl3): δ 170.0 (C24, maj.), 169.8 (C24, 
min.), 162.8 (C12, maj.), 162.7 (C12, min.), 154.8 (C20, maj.), 151.45 (C20, min.), 151.43 (C7, maj.), 151.42 
(C7, min.), 148.1 (C4, min.), 148.0 (C4, maj.), 141.3 (C22, min.), 141.0 (C22, maj.), 136.8 (C16, min.), 136.7 
(C16, maj.), 136.6 (C23, min.), 135.3 (C23, maj.), 131.3 (C1, maj.), 131.0 (C1, min.), 127.98 (C9, maj.), 
127.95 (C9, min.), 117.42 (C2, maj.), 117.41 (C2, min.), 115.92 (C15, min.), 115.86 (C15, maj.), 115.4 (C19, 
maj.), 115.1 (C19, min.), 112.2 (C11, min.), 111.7 (C11, maj.), 101.0 (C21, maj.), 99.5 (C21, min.), 98.2 (C3, 
maj.), 98.1 (C3, min.), 96.12 (C8, min.), 96.09 (C8, maj.), 92.9 (C10, min.), 92.7 (C10, maj.), 61.9 (C13, maj. 
+ min.), 55.97 (C6, min.), 55.96 (C6, maj.), 55.9 (C5, maj. + min.), 33.1 (C17, min.), 33.0 (C17, maj.), 25.2 
(C18, min.), 25.1 (C18, maj.), 14.2 (C14, maj. + min.), 10.7 (C25, min.), 10.5 (C25, maj.). MS (ESI, 70 eV) 
m/z (%): 467 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for C25H26N2O7 + H+ 467.1813, found 
467.1816. 
8.3.7.6. Synthesis of strigolactone analog 4.2e 
 
The title compound 4.2e was synthesized from ethyl (2E)-2-(1-(but-3-en-1-yl)-3-cyano-2H-
benzo[e]isoindol-2-yl)-3-hydroxyacrylate 4.38e (112 mg, 0.311 mmol) following the same 
procedure as outlined for compound 4.2a. The product 4.2e was obtained as yellow foam 
(52 mg, 37%) after purification by automated flash chromatography on C18 silica with 
water/acetonitrile as eluent (gradient from 30% to 100% CH3CN in H2O over 30 column 
volumes). The compound 4.2e was characterized as a mixture of two interconverting 
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atropisomers as a result of the hindered rotation around the N-C13 bond between the 
benzo[e]isoindole and enol ether moiety (maj./min. 60:40, solution in CDCl3 at 25 °C, based 
on the integration of the enol ether proton (C22H) in 1H NMR). 
Ethyl (2Z)-2-(1-(but-3-en-1-yl)-3-cyano-2H-benzo[e]isoindol-2-yl)-3-((4-methyl-5-oxo-2,5-dihydro-
furan-2-yl)oxy)acrylate 4.2e. Yellow foam, yield 37%. IR (neat, cm-1): 
2201 (C≡N), 1787 (C=O), 1716 (C=O), 1659 (C=C), 1420, 1369, 1283, 
1205, 1166, 1141, 1089, 1042, 1009, 953, 909, 863, 807, 728. 1H NMR 
(400 MHz, CDCl3): δ 8.19 (s, 1H, C22H, maj.), 8.15 (dd, J = 8.1, 1.1 Hz, 
1H, C4H, min.), 8.13 (dd, J = 8.1, 1.1 Hz, 1H, C4H, maj.), 7.92 (s, 1H, C22H, 
min.), 7.81 (dd, J = 8.0, 1.4 Hz, 1H, C7H, min.), 7.80 (dd, J = 8.0, 1.4 Hz, 
1H, C7H, maj.), 7.60 – 7.54 (m, 1H, C5H, maj. + min.), 7.551 (d, 3JAB = 9.0 Hz, 1H, C10H, min.), 7.547 
(d, 3JAB = 9.0 Hz, 1H, C10H, maj.), 7.511 (d, 3JAB = 9.0 Hz, 1H, C9H, min.), 7.508 (d, 3JAB = 9.0 Hz, 1H, 
C9H, maj.), 7.49 – 7.44 (m, 1H, C6H, maj. + min.), 7.00 (dq, J = 1.8, 1.6 Hz, 1H, C24H, min.), 6.88 (dq, J 
= 1.8, 1.6 Hz, 1H, C24H, maj.), 6.26 (dq, J = 1.8, 1.4 Hz, 1H, C23H, maj.), 6.22 (dq, J = 1.8, 1.4 Hz, 1H, 
C23H, min.), 5.95 – 5.81 (m, 1H, C18H, maj. + min.), 5.17 – 5.06 (m, 2H, C17H, min.), 5.14 – 5.02 (m, 2H, 
C17H, maj.), 4.35 – 4.24 (m, 2H, C15H, maj. + min.), 3.26 – 3.15 (m, 1H, C20Ha, maj. + min.), 3.13 – 3.01 
(m, 1H, C20Hb, maj. + min.), 2.51 – 2.32 (m, 2H, C19H, maj. + min.), 2.04 (dd, J = 1.6, 1.4 Hz, 3H, C27H, 
min.), 1.91 (dd, J = 1.6, 1.4 Hz, 3H, C27H, maj.), 1.31 (t, J = 7.1 Hz, 3H, C16H, maj.), 1.27 (t, J = 7.1 Hz, 
3H, C16H, min.). 13C NMR (101 MHz, CDCl3): δ 170.0 (C26, maj.), 169.8 (C26, min.), 162.89 (C14, maj.), 
162.88 (C14, min.), 155.3 (C22, maj.), 151.8 (C22, min.), 141.4 (C24, min.), 140.9 (C24, maj.), 137.0 (C25, 
min.), 136.7 (C18, min.), 136.6 (C18, maj.), 135.7 (C25, maj.), 134.5 (C1, maj.), 134.2 (C1, min.), 131.4 
(C8, min.), 131.3 (C8, maj.), 130.92 (C11, maj.), 130.88 (C11, min.), 129.53 (C7, min.), 129.49 (C7, maj.), 
128.5 (C3, maj. + min.), 128.37 (C9, maj.), 128.35 (C9, min.), 127.5 (C5, maj.), 127.4 (C5, min.), 125.3 
(C6, maj. + min.), 123.03 (C4, maj.), 123.00 (C4, min.), 117.64 (C10, min.), 117.59 (C10, maj.), 117.19 (C2, 
maj.), 117.17 (C2, min.), 116.2 (C17, min.), 116.1 (C17, maj.), 114.4 (C21, maj.), 114.2 (C21, min.), 112.1 
(C13, min.), 111.6 (C13, maj.), 101.1 (C23, maj.), 99.5 (C23, min.), 96.0 (C12, min.), 95.8 (C12, maj.), 62.22 
(C15, maj.), 62.20 (C15, min.), 32.2 (C19, min.), 32.0 (C19, maj.), 27.1 (C20, min.), 27.0 (C20, maj.), 14.4 
(C16, maj.), 14.3 (C16, min.), 10.9 (C27, min.), 10.7 (C27, maj.). MS (ESI, 70 eV) m/z (%): 457 (M + H+, 
100). HRMS (ESI, 2 kV): m/z calcd. for C27H24N2O5 + H+ 457.1758, found 457.1757. 
8.3.7.7. Synthesis of strigolactone analog 4.2f 
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The title compound 4.2f was synthesized from ethyl (2E)-2-(1-(but-3-en-1-yl)-3-cyano-4-
methyl-4H-pyrrolo[3,4-b]indol-2-yl)-3-hydroxyacrylate 4.38f (82 mg, 0.226 mmol) following the 
same procedure as outlined for compound 4.2a. The product 4.2f was obtained as brown-
yellow foam (68 mg, 65%) after purification by automated flash chromatography on C18 silica 
with water/acetonitrile as eluent (gradient from 40% to 100% CH3CN in H2O with steps of 5% 
per 3 column volumes). The compound 4.2f was characterized as a mixture of two 
interconverting atropisomers as a result of the hindered rotation around the N-C11 bond 
between the pyrrolo[3,4-b]indole and enol ether moiety (maj./min. 66:34, solution in CDCl3 at 
25 °C, based on the integration of the enol ether proton (C21H) in 1H NMR). 
Ethyl (2Z)-2-(1-(but-3-en-1-yl)-3-cyano-4-methyl-4H-pyrrolo[3,4-b]indol-2-yl)-3-((4-methyl-5-oxo-
2,5-dihydrofuran-2-yl)oxy)acrylate 4.2f. Brown-yellow foam, yield 65%. 
IR (neat, cm-1): 2189 (C≡N), 1786 (C=O), 1719 (C=O), 1641 (C=C), 1601, 
1464, 1408, 1258, 1206, 1092, 1011, 953, 864, 743. 1H NMR (400 MHz, 
CDCl3): δ 8.11 (s, 1H, C21H, maj.), 7.83 (s, 1H, C21H, min.), 7.70 (d, J = 
7.8 Hz, 1H, C4H, min.), 7.68 (d, J = 7.8 Hz, 1H, C4H, maj.), 7.38 – 7.30 
(m, 1H, C6H, maj. + min.), 7.23 – 7.18 (m, 1H, C7H, maj. + min.), 7.17 – 
7.09 (m, 1H, C5H, maj. + min.), 7.04 (dq, J = 1.8, 1.5 Hz, 1H, C23H, min.), 6.94 (dq, J = 1.8, 1.5 Hz, 1H, 
C23H, maj.), 6.249 (dq, J = 1.8, 1.4 Hz, 1H, C22H, maj.), 6.246 (dq, J = 1.8, 1.4 Hz, 1H, C22H, min.), 5.89 
– 5.72 (m, 1H, C16H, maj. + min.), 5.10 – 4.97 (m, 2H, C15H, min.), 5.06 – 4.92 (m, 2H, C15H, maj.), 4.29 
(q, J = 7.1 Hz, 2H, C13H, maj.), 4.27 (q, J = 7.1 Hz, 2H, C13H, min.), 3.77 (s, 3H, C20H, maj. + min.), 2.95 
– 2.84 (m, 1H, C18Ha, maj. + min.), 2.84 – 2.73 (m, 1H, C18Hb, maj. + min.), 2.46 (td, J = 7.6, 6.8 Hz, 2H, 
C17H, min.), 2.42 (td, J = 7.6, 6.8 Hz, 2H, C17H, maj.), 2.05 (dd, J = 1.5, 1.4 Hz, 3H, C26H, min.), 1.94 
(dd, J = 1.5, 1.4 Hz, 3H, C26H, maj.), 1.31 (t, J = 7.1 Hz, 3H, C14H, maj.), 1.27 (t, J = 7.1 Hz, 3H, C14H, 
min.). 13C NMR (101 MHz, CDCl3): δ 170.1 (C25, maj.), 170.0 (C25, min.), 163.5 (C12, maj. + min.), 155.1 
(C21, maj.), 151.6 (C21, min.), 145.84 (C8, min.), 145.79 (C8, maj.), 143.2 (C9, maj.), 143.1 (C9, min.), 
141.6 (C23, min.), 141.1 (C23, maj.), 136.9 (C16, min.), 136.81 (C24, min.), 136.76 (C16, maj.), 135.6 (C24, 
maj.), 131.5 (C1, maj.), 131.2 (C1, min.), 124.6 (C6, maj. + min.), 120.6 (C4, C3, maj. + min.), 119.53 (C5, 
maj.), 119.48 (C5, min.), 116.1 (C15, min.), 116.0 (C15, maj.), 115.6 (C19, maj.), 115.4 (C19, min.), 114.5 
(C2, maj. + min.), 112.4 (C11, min.), 112.0 (C11, maj.), 108.6 (C7, min.), 108.5 (C7, maj.), 101.0 (C22, 
maj.), 99.4 (C22, min.), 80.5 (C10, min.), 80.4 (C10, maj.), 62.0 (C13, maj. + min.), 32.9 (C17, min.), 32.7 
(C17, maj.), 30.8 (C20, maj. + min.), 26.8 (C18, min.), 26.7 (C18, maj.), 14.4 (C14, maj. + min.), 11.0 (C26, 
min.), 10.8 (C26, maj.). MS (ESI, 70 eV) m/z (%): 460 (M + H+, 100). HRMS (ESI, 2 kV): m/z calcd. for 
C26H25N3O5 + H+ 460.1867, found 460.1855.  
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8.4. Biological evaluation 
8.4.1. Chemical stability assay 
Compounds 4.2a, 4.2c, 4.2e and 4.2f were analyzed for their chemical stability in an aqueous 
solution (methanol/water 1:3) and compared to rac-GR24. Aqueous solutions of the 
compounds (pH 7.4, 0.5 mM) were stored at 22 °C in HPLC vials and analyzed at regular time 
intervals by HPLC-UV-DAD. The samples were prepared from a stock solution of the 
compounds in acetone (5 mM). Of these stock solutions, 120 µL was added to a mixture of 
770 µL phosphate buffer (10 mM, pH 7.4) and 270 µL methanol. Caffeine (40 µL of a 15 mM 
solution in water) was added as internal standard to each sample. All samples were well 
shaken and subsequently analyzed using an Agilent 1200 HPLC system with Supelco Ascentis 
Express C18 (30 mm x 4.6 mm x 2.7 µm) column connected to a UV-DAD detector. At 
74.4 min time intervals, 5 µL of sample was injected, and the compounds were eluted by a 
mixture of acetonitrile in water, with a gradient from 15% to 100% and a flow rate of 1 mL min-1. 
The column was operated at 40 °C. The relative amount of the remaining (nondegraded) 
product was quantified by integration of the UV signals at 220 nm adjusted to the response of 
the internal standard. The data are represented as means of three replicates, including 
standard error intervals. Nonlinear regression and half-life calculations were performed in 
GraphPad Prism 5. The stability experiment was repeated in pure methanol for compounds 
4.2a and 4.2c. The samples were prepared by adding 120 µL of the compound’s stock solution 
(5 mM in acetone) to 1040 µL methanol. Caffeine (40 µL of a 15 mM solution in methanol) was 
added as internal standard to each sample. In this case, one technical replicate of each 
compound was analyzed. 
8.4.2. Seed germination assay in Phelipanche ramosa 
Seeds of Phelipanche ramosa (L.) Pomel were obtained from mature flowering spikes growing 
on winter oilseed rape (Brassica napus L.) in Saint-Martin-de-Fraigneau, France in 2011 and 
provided by the Philippe Delavault lab (Nantes, France). The seeds were subjected to surface 
sterilization using a 12 wt. % sodium hypochlorite solution and subsequently washed 
repeatedly with sterile water. The seeds were kept in the dark and were conditioned at 21 °C 
for seven days in sterile water containing 1 mM of a Na/K phosphate buffer (pH 7.5) at a ratio 
of 10 mg seeds mL-1. For the germination assay, the P. ramosa seeds were transferred to a 
96-well plate and treated by adding a solution of the test chemical in acetone at different final 
molar concentrations. A 0.01% (v/v) acetone solution was used as control treatment. The final 
concentration of acetone was 0.01% (v/v) in all wells. The plates were incubated at 21 °C for 
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five days and microscopically examined for germination. For each compound and 
concentration, over 1200 seeds were evaluated in three independent biological repeats over 
three different plates. Statistical analyses were performed using the one-way ANOVA 
procedure in SAS. Post hoc multiple comparisons were performed using the Tukey’s HSD test. 
8.4.3. Hypocotyl elongation assay in Arabidopsis thaliana 
Seeds of Arabidopsis thaliana (L.) Heynh. (accession Columbia-0) were surface sterilized by 
consecutive treatments with 70% (v/v) ethanol containing 0.05% (w/v) sodium dodecyl sulfate 
(SDS). After rinsing with 95% (v/v) ethanol, the seeds were sown on half-strength Murashige 
and Skoog (1/2 MS) medium containing 1 µM of test chemical. A 0.01% (v/v) acetone solution 
was used as negative control. The plates were stratified for two days at 4 °C to synchronize 
germination between the tested lines. The mutant lines (d14, htl-3, d14/htl-3) used in this study 
are all in the Columbia-0 ecotype background. After stratification, the seeds were exposed to 
white light for 3 h, transferred to the dark for 21 h, and then exposed to continuous red light 
for four days. After scanning of the plates, the hypocotyls were measured using ImageJ 1.45. 
For each combination of mutant line and treatment, three independent biological repeats were 
performed with up to 22 seedlings per repeat. Statistical analyses were performed using the 
one-way ANOVA procedure in SAS. Post hoc multiple comparisons were performed using the 
Tukey’s HSD test. 
8.4.4. SMXL6 protein degradation assay in Arabidopsis thaliana 
All cloning was performed by means of Gateway recombination technology (Thermo Fisher 
Scientific). The coding sequence of SMXL6 was amplified from Arabidopsis thaliana cDNA 
with iProof High-Fidelity DNA Polymerase (Bio-Rad) and Gateway-specific primers (forward: 
GGGGACAAGTTTGTACAAAAAAGCAGGCTCAATGGAGGATCTTACGGCATCG and 
reverse: GGGGACCACTTTGTACAAGAAAGCTGGGTATCACCATATCACATCCACCTTC), 
and then cloned into a pDONR221 entry vector using the BP Clonase II enzyme mix 
(Invitrogen). SMXL6 entry clones were subcloned into the destination vector pH7m24GW2 for 
C-terminal fusions with green fluorescent protein (GFP) under the control of the CaMV 35S 
promoter using the LR Clonase II Plus enzyme mix (Invitrogen). The 35S:SMXL6-GFP 
construct was introduced into the Agrobacterium tumefaciens strain C58C1 (pMP90) for the 
transformation of Arabidopsis thaliana wild-type (Columbia-0) by the floral dip method.186 
Plants were propagated to the T3 generation for the selection of homozygous plants for 
analysis. The roots of 5-day old T3 homozygous seedlings were treated for 30 minutes with 
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either a 10 µM aqueous solution of test chemical or a 0.01% (v/v) acetone solution as control. 
For each treatment, five to eight plants were analyzed. The seedlings were mounted on glass 
slides in a drop of 4 µg mL-1 propidium iodide (PI) solution in water, covered with a coverslip 
and imaged with a Zeiss LSM 710 confocal microscope using a 20x objective (Plan-
Apochromat 20x/0.8 DICII). Excitation of GFP and PI was performed using Argon (488 nm) 
and HeNe (561 nm) lasers, respectively. GFP fluorescence was detected below 555 nm and 
PI above 600 nm. Image processing was performed in Zen2009. 
8.4.5. Yeast transformation and yeast two-hybrid assay 
All cloning was performed using the same techniques as described in section 8.4.4. Two 
pDONR207 entry vectors were constructed, containing the coding sequences of SMXL7 and 
D14. Both entry vectors were subcloned into the destination vectors pGILDA (LexA DNA 
Binding Domain; HIS3 yeast marker) and pB42AD (B42 Activation Domain; TRP1 yeast 
marker) using the LR Clonase II Plus enzyme mix (Invitrogen). The polyethylene glycol 
(PEG)/lithium acetate method was used to co-transform the Saccharomyces cerevisiae yeast 
strain EGY48 (MATα, ura3, his3, trp1, LexAop(x6)-LEU2; p8oplacZ - β-galactosidase reporter 
plasmid with URA3 marker)187 with both bait (BD) and prey (AD) constructs as described by 
Cuéllar et al..188 Transformants were selected on Synthetic Defined media containing 
galactose and raffinose (SD Gal/Raf), and lacking uracil (Ura), tryptophan (Trp) and histidine 
(His) (Clontech). Three individual colonies were grown overnight at 30 °C in liquid cultures (SD 
Gal/Raf-Ura-Trp-His), and 10- and 100-fold dilutions were dropped on control media (SD 
Gal/Raf-Ura-Trp-His) and selective media containing additionally X-Gal (SD Gal/Raf-Ura-Trp-
His + X-Gal; Duchefa). Plates with selective media were supplemented with either 10 µM of 
test chemical or a 0.01% (v/v) acetone solution as control. After incubation for three days at 
30 °C, positive protein interactions were scored based on blue staining of the yeast colonies 
on the selective media. 
8.5. Spectroscopic evaluation 
8.5.1. Fluorescence measurements 
Fluorescence measurements were performed on an Edinburgh Instruments FLSP920 UV-vis-
NIR spectrometer, using a 450 W Xenon lamp as the steady state excitation source (for 
excitation and emission spectra) and an EPLED as the time-resolved excitation source with a 
fixed excitation wavelength of 331 nm (for decay curves). The emission was detected by a 
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Hamamatsu R928P PMT photomultiplier tube. The compounds were dissolved in HPLC grade 
methanol at a concentration of 10-4 M. The samples were measured in quartz cuvettes with a 
path length of 10 mm. Excitation and emission spectra were acquired in the range of 
250-700 nm. All measurements were carried out with a step size of 1 nm in three repetitions. 
The obtained emission spectra were corrected for the spectral sensitivity of the detector 
(detector response curve), whereas the excitation spectra were not corrected. 
The decay curves, measured at the emission maximum λem for each sample, could be well 
fitted using a single exponential function (Equation 4.1) 
 𝐼 = 𝐴 exp (−
𝑡
𝜏
) (4.1) 
where I represents the luminescence intensity, A is a constant, t is time and τ is the 
luminescence lifetime. Origin data analysis software was used for lifetime calculations. 
Absolute fluorescence quantum yields (φf) of the samples were determined using an 
integrating sphere coated inside with BENFLEC, provided by Edinburgh Instruments. For each 
sample, the measured excitation maximum λex was selected as the excitation wavelength. The 
quantum yields were calculated using Equation 4.2 
 𝜑𝑓 =
∫ 𝐿𝑒𝑚𝑖𝑠𝑠𝑖𝑜𝑛
∫ 𝐸𝑏𝑙𝑎𝑛𝑘 – ∫ 𝐸𝑠𝑎𝑚𝑝𝑙𝑒 
 (4.2) 
where ∫Lemission is the integrated area under the emission spectrum, ∫Eblank is the integrated area 
under the “excitation” band of the blank, and ∫Esample is the integrated area under the excitation 
band of the sample. As the sample absorbs part of the light, the resulting area ∫Esample will be 
smaller than ∫Eblank. The error in quantum yield measurements is estimated to be around 10% 
of the obtained value. 
8.5.2. Confocal microscopy 
Seeds of Arabidopsis thaliana (L.) Heynh. (accession Columbia-0) were surface sterilized and 
sown on half-strength Murashige and Skoog (1/2 MS) medium. The plates were stratified for 
two days at 4 °C to synchronize germination. The plates were then incubated at 21 °C and 
exposed to continuous light for five days. For confocal observations, the 5-day old seedlings 
were transferred to 1/2 MS medium containing 100 µM of compound 4.2f. After 20 h, the 
seedlings were mounted on glass slides in a drop of 5 µg mL-1 propidium iodide (PI) solution 
in water, covered with a coverslip and imaged with a Zeiss LSM 710 confocal microscope 
using a 40x water-immersion objective (C-Apochromat 40x/1.2 W Corr M27). The 
fluorochrome of compound 4.2f was excited using a UV diode laser (405 nm). A lambda scan 
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was performed between 445 nm and 605 nm with a 10 nm emission window to determine the 
emission range of the fluorescent dye. The 455-555 nm emission window was chosen to 
visualize the compound in the plant’s roots. PI excitation and imaging were performed at 
561 nm and 580-680 nm, respectively. Confocal images of an untreated seedling using the 
same settings were included as control. Image processing was performed in ImageJ 1.52. 
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CHAPTER V 
RECENT ADVANCES IN ENANTIOSELECTIVE GOLD CATALYSIS: 
LITERATURE OVERVIEW 
1. Introduction 
Over the past decade, the field of homogeneous gold catalysis has advanced tremendously. 
Especially gold(I) complexes have been studied extensively as carbophilic Lewis acids, 
catalyzing a wide variety of transformations that involve the activation of C-C multiple bonds, 
such as alkynes, alkenes, allenes and dienes.135d, 189 In addition, research efforts have been 
devoted to the development of enantioselective variants of gold-catalyzed reactions.190 
However, asymmetric catalysis with chiral gold catalysts is greatly challenged by the linear 
geometry of gold(I) species, which places the substrate and chiral ligand (L*) in remote 
positions. Furthermore, nucleophilic addition to gold-activated π-bonds is generally believed 
to occur through an outer-sphere mechanism (Figure 5.1).12b, 135b, 191 
 
Figure 5.1. Coordination mode of gold(I) complexes. 
In general, three main strategies are applied to increase the steric influence around the 
reactive site, which include the use of binuclear complexes, caved or steric monodentate 
ligands, and chiral counteranions. Of the different approaches, bimetallic gold catalysts are by 
far the most widely employed system to induce enantioselectivity. They are usually 
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constructed from atropisomeric bisphosphine ligands (Figure 5.2a). The proximity of a second 
gold center appears pivotal to establish stereoselectivity in the reaction outcome, although the 
real influence remains unclear. Mononuclear complexes often rely on phosphoramidite ligands 
(Figure 5.2b), which have emerged as highly competent scaffolds for enantioselective gold 
catalysis due to their high level of modularity. Chiral information and steric effects can be 
implemented in the diester part, the amide part or both, and each fragment can be easily tuned 
separately. The diester is commonly derived from the chiral diols BINOL and TADDOL. In 
addition to phosphorus-based mono- and bidentate ligands, chiral carbene ligands have been 
designed for gold (Figure 5.2c), although only moderate levels of enantiodifferentiation have 
been observed for NHC gold(I) complexes.190 As a final strategy, chiral information can also 
be included in the counterion, which potentially acts closer to the metal center than the ancillary 
ligand. This approach was introduced by Toste and coworkers in 2007 and initially 
demonstrated for the enantioselective hydroamination and hydroalkoxylation of allenes.192 
 
Figure 5.2. Privileged scaffolds of chiral ligands in asymmetric gold catalysis. 
In the following literature overview, new developments in homogeneous enantioselective gold 
catalysis over the past two years are reviewed. The discussion is organized according to the 
activated substrate and the effected transformation with focus on the employed chiral catalytic 
system. Reactions in which another chiral additive, distinct from the gold catalyst, sets the 
chiral center are omitted.  
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2. Gold-catalyzed alkyne activation 
2.1. Rearrangement of propargylic esters 
The rearrangement of propargylic esters 5.1 in the presence of a gold catalyst is broadly 
accepted to proceed through vinyl gold intermediates 5.2 or 5.4, which result from respectively 
5-exo-dig and 6-endo-dig nucleophilic attack of the carboxy moiety on the gold-activated triple 
bond (Scheme 5.1). Upon C-O bond cleavage, [2,3]-rearrangement delivers alkenyl gold 
carbenoid 5.3,193 while [3,3]-rearrangement produces the gold-coordinated allene 5.5.194 
Which pathway occurs largely depends on the substituents at either end of the propargylic 
moiety. Both generated gold species can engage in consecutive reactions with nucleophiles 
or unsaturated systems.  
 
Scheme 5.1. Proposed mechanisms of the gold(I)-catalyzed sigmatropic rearrangement of propargylic 
esters. 
In pursuit of a simplified asymmetric total synthesis of hosieine A (5.8), a lupin alkaloid isolated 
from the roots of Ormosia hosiei, Wood and coworkers developed an enantioselective gold(I)-
catalyzed Rautenstrauch rearrangement of the racemic propargylic pivalate ester 5.6 (Scheme 
5.2).195 In this cycloisomerization reaction, the formal 1,2-migration of the acyloxy group is 
followed by an intramolecular cyclization (5.10), yielding cationic intermediate 5.11. 
Elimination of the gold(I) catalyst affords diene 5.12, which is then hydrolyzed to 
cyclopentenone 5.7 (Scheme 5.3). The atropochiral bimetallic catalyst (S)-DTBM-MeO-
Biphep(L6)[AuNCMe]2(SbF6)2 was shown to be highly selective toward (S)-configured 5.7. 
Mirrored selectivity was achieved by using the opposite isomer of the catalyst, which was 
proposed to induce the reversed transition state of 5.10 during electrocyclization. Hence, both 
enantioenriched forms of hosieine A (5.8) could be accessed by simply using antipodal 
catalysts. 
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Scheme 5.2. Rautenstrauch rearrangement of propargylic pivalate 5.6 toward the synthesis of hosieine A. 
 
Scheme 5.3. Proposed mechanism of the gold(I)-catalyzed Rautenstrauch rearrangement of propargylic 
pivalate 5.6. 
In 2011, Toste and coworkers identified chiral acyclic diaminocarbene (ADC) scaffolds as 
superior ligands in the enantioselective gold(I)-catalyzed rearrangement/intramolecular 
hydroalkoxylation of phenol-substituted propargylic esters.196 In a follow-up study, the group 
resorted to computational methods to parameterize this developing ligand class in terms of 
enantioselectivity, and develop a mathematical model to optimize the asymmetric gold(I)-
catalyzed tandem rearrangement/cyclization of propargylic esters 5.13 (Scheme 5.4).197 In this 
reaction sequence, the intermediate gold(I)-allene complex (5.5, Scheme 5.1, vide supra), 
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resulting from the [3,3]-sigmatropic rearrangement of 5.13, is trapped intramolecularly by the 
pendant indole ring. The gold(I)-catalyzed [2+2]-cycloaddition of allenenes (5.15) has been 
earlier proposed to proceed through a reversible stepwise mechanism, involving a series of 
carbocations of which only the cis-configured intermediate 5.18 can ring close to the 
cyclobutane product 5.19 (Scheme 5.5).198 Upon analysis of the molecular features of ADC 
ligands, the authors revealed the distance between the pyridine R’ substituent and the 
hydrogen of the adjacent amine as a primal ligand descriptor, which steers the facial selectivity 
of the reaction. Indeed, hydrogen and oxygen substitution at R’ were shown to induce the 
formation of opposite enantiomers, due to the influence of hydrogen bonding on the R’-H 
distance. Two (S)-H8-BINAM-derived ADC ligands L7 and L8 with differently substituted 
pyridine heterocycles were put forward to compose chiral gold(I) complexes that furnish each 
of the product isomers (5.14). Moderate to high enantioselectivities were obtained for 
propargylic esters 5.13 with aromatic groups in the α-position (R2) and alkyl groups in the 
terminal position of the alkyne (R3). Various electron-donating and -withdrawing groups were 
tolerated at the indole C-5 position (R1), whereas C-4 substitution resulted in nearly racemic 
products.197 
 
Scheme 5.4. Tandem [3,3]-sigmatropic rearrangement/[2+2]-cycloaddition of propargylic esters. 
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Scheme 5.5. Proposed mechanism of the gold(I)-catalyzed intramolecular [2+2]-cycloaddition of 
allenenes. 
2.2. Cycloaddition reactions 
2.2.1. Intermolecular cycloaddition to alkynes 
Echavarren et al. reported the first general enantioselective intermolecular [2+2]-cycloaddition 
of terminal alkynes and alkenes with the formation of enantioenriched cyclobutenes (5.23 and 
5.25) (Scheme 5.6).199 The screening of several chiral non-C2-symmetric JosiPhos digold(I) 
catalysts yielded two effective candidates L9[AuCl]2 and L10[AuCl]2 for the conversion of di- 
and trisubstituted alkenes, respectively. The best results were obtained by generating the 
monocationic complex accompanied by the weakly coordinative counterion [BArF4]- (B[3,5-
(CF3)2C6H3]4-), which afforded enantiomeric ratios up to 94:6 for a wide variety of aryl alkynes 
5.21. Remarkably, no reaction was observed when both chlorides were abstracted from the 
precatalyst L9[AuCl]2 with 5 mol% of silver salt. Neither did the related monogold(I) complex, 
in which the metal center is only coordinated to the trialkylphosphine of L9, yield more than 
trace amounts of racemic 5.23. This suggests that, while only one gold(I) center is directly 
engaged in the activation of the alkyne, the other one is crucial for enantioinduction. The utility 
of this transformation was demonstrated as key step in the nine-step asymmetric synthesis of 
the natural product rumphellaone A (5.20), a cytotoxic sesquiterpenoid isolated from the 
gorgonian coral Rumphella antipathies. 
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Scheme 5.6. Intermolecular [2+2]-cycloaddition of terminal alkynes with alkenes. 
2.2.2. Cycloaddition of 2-(1-alkynyl)-2-alken-1-ones 
Furans and pyrroles are important heterocyclic scaffolds, whose structural units are present in 
numerous bioactive natural products and pharmaceuticals. They are efficiently produced 
through gold-catalyzed cyclization of 2-(1-alkynyl)-2-alken-1-ones and -imines 5.27, as was 
first demonstrated by Larock and coworkers in 2004.200 The furyl/pyrrolyl gold carbocation 5.29 
has been proposed as key intermediate (Scheme 5.7). This 1,3-dipolar species can be 
intercepted by an incoming nucleophile or undergo [3+n]-cycloaddition to access a wide array 
of polysubstituted furan and pyrrole ring systems 5.30.  
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Scheme 5.7. Proposed mechanism of the gold(I)-catalyzed synthesis of polysubstituted furans and 
pyrroles through cyclization of 2-(1-alkynyl)-2-alken-1-ones or -imines. 
Schmalz and coworkers demonstrated that chiral phosphine-phosphite ligands (L11) make 
excellent gold(I) catalysts for the asymmetric synthesis of furo[3,4-d]tetrahydropyridazine 
derivatives 5.33 from 2-(1-alkynyl)-2-alken-1-ones 5.31 and azomethine imides 5.32 (Scheme 
5.8).201 The transformation involves the simultaneous construction of a furan and 
hydropyridazine ring in a single step through tandem cyclization and [3+3]-cycloaddition. The 
phosphite part of the ligand is based on a TADDOL scaffold carrying voluminous 
3,5-dimethylphenyl substituents. As both the phosphine and phosphite core of the ligand 
coordinate gold(I), a binuclear catalyst was generated in situ from (Me2S)AuCl, L11 and silver 
triflate. The reaction proceeded with virtually complete regio- and diastereoselectivity. High 
yields (up to 95%) and excellent ee values (up to 96%) were obtained with a broad range of 
(hetero)aryl-substituted azomethine imides 5.32. In contrast, replacement of the phenyl group 
at the alkyne terminus of 5.31 by an aliphatic substituent resulted in a dramatic decrease of 
enantioselectivity, which defines a limitation in the substrate scope of this method. 
 
Scheme 5.8. Tandem cyclization/[3+3]-cycloaddition of 2-(1-alkynyl)-2-alken-1-ones and azomethine 
imides. 
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Based on a similar mechanism, the gold(I)-catalyzed reaction of 2-(1-alkynyl)-2-alken-1-one 
oxime ethers 5.35 with nitrones 5.36 affords pyrrolo[3,4-d][1,2]oxazines 5.37. The group of J. 
Zhang developed a highly diastereo- and enantioselective approach using the chiral 
bisphosphine ligand (S)-DTBM-MeO-Biphep L6 (Scheme 5.9).202 The substrate scope of the 
reaction extends from oxime ethers 5.35 bearing electron-rich and -deficient aryl groups on 
the alkyne and alkene (R1 and R2) to alkyl and alkenyl substituents on the alkyne (R1). Both 
aryl- and heteroaryl-derived nitrones 5.36 were tolerated. Also, the annulation of cyclic oxime 
5.38 furnished the fused pyrrole 5.39 in high yield and selectivity, demonstrating the generality 
of the method. 
 
Scheme 5.9. Tandem cyclization/[3+3]-cycloaddition of 2-(1-alkynyl)-2-alken-1-one oxime ethers and 
nitrones. 
2.2.3. Tandem cyclization/cycloaddition 
Monogold(I) complexes bearing the BINOL-derived chiral phosphoramidite ligand L12 
efficiently catalyzed the synthesis of optically active bicyclic tetrahydropyridazines 5.42 and 
5.43 (Scheme 5.10).203 The key step involved an asymmetric hetero-Diels-Alder reaction 
between a diazene 5.41 and a cyclic 2-alkoxydiene 5.44. The latter was prepared in situ from 
propargylic alcohols 5.40 through dehydrative cyclization. The gold(I)-catalyzed tandem 
cyclization/cycloaddition proceeded highly efficiently and with moderate to excellent regio- and 
enantioselectivity for a variety of alkyl- and phenyl-substituted diols 5.40. Both five- and six-
membered intermediate cyclic dienes 5.44 readily underwent asymmetric cycloaddition with 
urea-based diazenes 5.41. The 4-chlorophenyl group in 5.41 appeared crucial for the 
stereocontrol of the reaction, as other aryls only resulted in diminished levels of 
enantioselectivity. 
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Scheme 5.10. Tandem dehydrative cyclization/hetero-Diels-Alder reaction of propargylic alcohols with 
diazenes. 
2.3. Cycloisomerization of 1,n-enynes 
The gold-catalyzed cycloisomerization of enynes has been intensively studied in the past.204 
For 1,6-enynes, coordination of cationic gold(I) to the alkyne (5.45) may induce either 5-exo 
or 6-endo cyclization (Scheme 5.11). Subsequent intramolecular cyclopropanation 
respectively gives cyclopropyl gold(I) carbenoids 5.47 and 5.50. The former can undergo ring 
opening through nucleophilic addition to the cyclopropane position to generate alkylidene 
cyclopentanes 5.48 after protodeauration. The second intermediate 5.50 usually evolves into 
functionalized bicyclo[4.1.0]hept-2-ene derivatives 5.51 via a rapid 1,2-hydride shift and 
elimination of the gold fragment. Similarly, 1,5-enynes can yield bicyclo[3.1.0]hexenes through 
gold-catalyzed 5-endo-dig cycloisomerization. 
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Scheme 5.11. Proposed mechanisms of the gold(I)-catalyzed cycloisomerization of 1,6-enynes. 
Gold(I)-catalyzed cycloisomerization and subsequent ring expansion of cyclopropyl-
substituted 1,6-enynes 5.52 provides an easy access to 2-oxocyclobutyl cyclopentane 
derivatives 5.53. Voituriez and coworkers reported the first enantioselective variant of this 
reaction, using a chiral bisphosphine digold(I) catalyst derived from (R)-DTBM-MeO-Biphep 
L6 (Scheme 5.12).205 Preliminary DFT calculations suggested that the reaction proceeds 
through a distorted cyclopropyl gold(I) carbenoid intermediate with high carbocationic 
character 5.54, which rearranges to cyclobutanones 5.53 by ring expansion. The substrate 
scope proved to be relatively broad. Both terminal and substituted alkynes were successfully 
converted into cyclobutanones 5.53, for which the latter solely produced the corresponding (Z) 
isomers. The alkene moiety supported methyl substitution well, while the enyne tether 
tolerated various geminal substitution patterns. Both the major and minor diastereoisomers of 
5.53 were furnished in excellent enantioselectivity. 
 
Scheme 5.12. Tandem cycloisomerization/ring expansion of cyclopropyl-substituted 1,6-enynes.  
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The group of Toste recently developed the first highly enantioselective transformation 
catalyzed by a well-defined gold(III) complex.206 A series of chiral 1,5-enynes 5.55 were 
converted into optically enriched bicyclo[3.1.0]hexenes 5.56 through direct enantioconvergent 
kinetic resolution using a gold(III) catalyst with chiral N-heterocyclic carbene (NHC) ligand L13 
(Scheme 5.13). Whereas the cycloisomerization of enantioenriched 5.55 was shown to 
proceed with a certain degree of chirality transfer in the presence of an achiral gold catalyst, 
the chiral gold(III) complex was able to override this preference, yielding the same (S,S)-
bicyclic adduct 5.56 as major product for both substrate enantiomers, albeit with different 
enantiomeric ratios. As no racemization of the substrate occurred, this cycloisomerization 
belongs to the rare class of direct enantioconvergent transformations.207 Hence, compared to 
standard kinetic resolution, higher product ee was maintained at increased conversion, while 
simultaneously highly enantioenriched starting material 5.55 was obtained. The reaction 
tolerated a variety of aryl and even heteroaryl substituents, however, more sterically 
encumbered substrates generally required higher reaction temperatures. Alkyne substituents, 
on the other hand, were not supported.206 
 
Scheme 5.13. Direct enantioconvergent kinetic resolution of 1,5-enynes. 
2.4. Carboalkoxylation of alkynes 
At the same time of Toste’s report on enantioselective catalysis with chiral gold(III) complexes, 
Wong and coworkers developed a series of stable chiral C,N-cyclometallated BINOL gold(III) 
complexes.208 Instead of the expected O,O’-chelation, X-ray crystallographic analysis of the 
complexes showed that the BINOL moiety adopts an unusual C,O-chelation mode with 
formation of a five-membered ring. The authors synthesized up to 50 catalysts from variously 
substituted BINOLs and both oxazoline- and pyridine-based cyclometallated gold(III) 
dichloride complexes. Remarkably, the coordination of BINOL to gold(III) was characterized 
by a complete axial-to-central chirality transfer, with (S)-BINOL exclusively affording the (R) 
complex and (R)-BINOL the (S) complex. While primarily racemic mixtures of the novel 
RECENT ADVANCES IN ENANTIOSELECTIVE GOLD CATALYSIS 
151 
gold(III) complexes were evaluated for their catalytic activity, enantiopure (R,R)-complex 5.61 
was applied as catalyst in the carboalkoxylation reaction of ortho-ethynylbenzaldehyde 5.57 
(Scheme 5.14). Although the corresponding indanone 5.58 was only obtained in moderate 
yield and ee, the modularity of the complexes leaves plenty of room for improvement through 
extensive catalyst optimization. The addition of (1S)-camphor-10-sulfonic acid 5.62 proved to 
be essential to favor carboalkoxylation over the formation of a six-membered acetal, which 
suggests that the reaction proceeds through acid-promoted acetal formation, followed by 
alkoxylation of the triple bond (5.59) and rearrangement to gold intermediate 5.60. Together 
with Toste’s recent work,206 this research constitutes a major breakthrough in the application 
of well-defined chiral gold(III) complexes in asymmetric catalytic transformations. 
 
Scheme 5.14. Carboalkoxylation of ortho-ethynylbenzaldehyde 5.57. 
2.5. Hydroarylation of alkynes 
N-propargyl tryptamines 5.63 have been reported to undergo cyclization toward azepino[4,5-
b]indoles 5.65 in the presence of gold(I) catalysts.209 The group of Guinchard demonstrated 
that, depending on the nature of the tryptamine spectator N-substituent (R2), the dearomatized 
spiroindolenine 5.64 can be isolated instead.210 More specifically, propargyl, allyl, alkyl and 
benzyl substituents at the amine allowed the synthesis of 5.64 with high regioselectivity 
(5.64/5.65 > 78:22) and yield (up to 86%) in the presence of JohnPhos[AuNCMe](SbF6) 
(Scheme 5.15). The enantioselective spirocyclization of N,N-dipropargyl tryptamine 5.63a was 
achieved using the chiral phosphahelicene-based gold(I) catalyst L14AuCl. 
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Scheme 5.15. Spirocyclization of N-propargyl tryptamines. 
A unique application of alkyne hydroarylation is the conjunction of aromatic rings into ortho-
annulated polycyclic scaffolds or helicenes. The Alcarazo lab designed a series of cationic 
TADDOL-derived phosphonites as ancillary ligands to promote the asymmetric gold(I)-
catalyzed synthesis of substituted [6]carbohelicenes 5.67 from achiral diynes 5.66 (Scheme 
5.16).211 The direct connection of a positively charged imidazolium or triazolium unit to 
phosphorus not only aids the TADDOL framework in establishing an enclosed chiral cavity, 
but also enhances the catalyst activity through increased Lewis acidity at the gold center. 
Spread over two studies, the group optimized both the chiral scaffold and the cationic 
substituent, delivering phosphonites L15-17 as most valuable ligands for the double 6-endo-
dig cyclization of 5.66 into helicene 5.67. Fulvene 5.68, resulting from the 5-exo-dig annulation 
of one of the alkynes, is formed as the major side product. Compared to the imidazolium-
based ligand L15, the triazolium-derived phosphonites L16 and L17 exhibit greatly improved 
regioselectivity toward the helicene product (5.67/5.68 > 92:8). For most substrates, also 
increased enantioselectivity was obtained with ligands L16 and L17. Under the same 
conditions, structurally related phosphoramidite gold(I)-complexes did not display any catalytic 
activity, thus indicating the essential function of the cationic substituent. 
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Scheme 5.16. Enantioselective synthesis of substituted [6]carbohelicenes from diynes. 
In related work of Tanaka et al., [6]carbohelicenes were constructed via gold(I)-catalyzed 
sequential intramolecular hydroarylation of diynones 5.69 (Scheme 5.17).212 As the free 
hydroxy-helicene is air sensitive, the annulation was followed by a methylation step to afford 
methoxy-substituted helicenes 5.70. Screening of several traditional bisphosphine ligands 
indicated that gold catalysts derived from (R)-DifluorPhos L5 induce the highest 
enantioselectivity. While the substrate scope is far more limited compared to Alcarazo’s 
method,211 the protocol could be extended to the quadruple hydroarylation of bis(diyones) 
5.71. The use of (R)-BINAP L1 as a ligand gave double [6]carbohelicenes 5.72 in moderate 
yield and ee, without the formation of meso isomers. 
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Scheme 5.17. Enantioselective synthesis of single and double [6]carbohelicenes from diynones. 
3. Gold-catalyzed allene activation 
3.1. Hydrofunctionalization of allenes 
The gold-catalyzed hydrofunctionalization of allenes is a straightforward method for the 
construction of new C-C, C-N and C-O bonds. In the case of tethered nucleophiles, a wide 
variety of (hetero)cyclic compounds can be accessed. Enantioselective allene hydroarylation 
was employed by Voituriez and coworkers as key step in the short, robust total synthesis of 
(R)-(-)-rhazinilam 5.75, a cytotoxic alkaloid exhibiting strong antimitotic properties.213 The 
6-exo-trig cyclization of the allene-functionalized pyrrole 5.73, catalyzed by the chiral digold(I) 
catalyst (R)-DTBM-MeO-Biphep(L6)[AuCl]2, established the stereogenic quaternary carbon 
center of 5.75 in good enantioselectivity (Scheme 5.18). Tetrahydroindolizine 5.74 was further 
converted to (R)-(-)-rhazinilam 5.75 in seven steps, with retention of the ee.  
 
Scheme 5.18. Hydroarylation of allene-functionalized pyrrole 5.73 in the total synthesis of 
(R)-(-)-rhazinilam. 
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Most enantioselective gold-catalyzed reactions to date, including the aforementioned 
transformations, rely on decelerative asymmetric steric hindrance, in which the reaction to one 
enantiomer is selectively retarded. This approach typically needs higher catalyst loadings due 
to the reduced reaction rates. Ligand-accelerated catalysis, on the other hand, selectively 
boosts the formation of a single isomer. The group of L. Zhang employed this conceptually 
different strategy to the effect the asymmetric gold(I)-catalyzed cyclization of 4-allen-1-ols 5.76 
to 2-vinyltetrahydrofurans 5.77 (Scheme 5.19).214 The key catalyst consists of chiral 
binaphthyl-based ligand L18 containing a remote, asymmetrically positioned amide group. 
This substituent acts as a general base catalyst enhancing the nucleophilicity of the alcohol 
through hydrogen bonding. However, this cooperative ligand-substrate interaction is only 
feasible in one of both possible diastereomeric complexes of 5.76 with the gold catalyst (I 
versus II). In the case of (R)-L18AuCl, this leads to the strong promotion of Re-face attack 
onto the allene, producing (R)-configured 5.77. Both achiral and racemic chiral substrates with 
various substituents on the backbone sp3-carbons were converted with exceedingly high 
enantioselectivity. Regardless of the substrate stereochemistry, excellent allene facial 
selectivity was maintained as expressed by the high diastereomeric excess (de) for each 
enantiomer and cis/trans ratios close to 1:1. Due to the accelerative nature of the catalysis, 
the catalyst loading could be lowered down to 0.01 mol% for several substrates. 
 
Scheme 5.19. Enantioselective cyclization of 4-allen-1-ols. 
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Another catalyst class that depends on ligand-substrate interactions, albeit not catalytically 
accelerative, to induce asymmetric catalysis are metal complexes bearing the chiral xanthene-
based monophosphine ligand L19 with sulfinamide hydrogen bonding site. The J. Zhang group 
designed this structurally novel ligand for the enantioselective gold(I)-catalyzed intramolecular 
cyclization of N-allenamides with tethered indoles 5.78 (Scheme 5.20).215 A sulfonyl protecting 
group on the allenamide nitrogen was crucial to attain high selectivity, as this enabled 
hydrogen bonding with the catalyst ligand. In the adopted allene-gold complex orientation, the 
Re-face of the allenamide is shielded by the aryl substituent of the ligand, directing cyclization 
to the Si-face to yield (R)-tetrahydro-β-carbolines 5.79. The reaction tolerated a variety of 
substituents on the indole ring and in α-position, affording the desired cyclization products 5.79 
in excellent yields and ee values. However, attempts with substituted N-allenamides gave poor 
chemo- and enantioselectivities. The utility of this transformation was demonstrated in the 
asymmetric total synthesis of (R)-debromoarborescidine A 5.80, a derivative of the alkaloid 
arborescidine A produced by the marine tunicate Pseudodistoma arborescens. 
 
Scheme 5.20. Intramolecular cyclization of N-allenamides in the synthesis of tetrahydrocarbolines.  
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3.2. Intermolecular cycloaddition of allenamides 
In contrast to the intramolecular variants, gold-catalyzed intermolecular asymmetric 
cycloaddition reactions with allenes usually require the more reactive N-allenamides 5.81. 
Gold activation of these substrates results in the formation of the resonantly stabilized gold-
allyl cationic intermediate 5.82. Furthermore, delocalization of the positive charge to the 
heteroatom favors nucleophilic attack of the alkene to the distal carbon-carbon double bond 
of the allenamide. The resulting gold-stabilized carbocationic species 5.83 can then participate 
in ring closure reactions, leading to the formal cycloaddition products (Scheme 5.21). 
 
Scheme 5.21. Gold activation and formal intermolecular cycloaddition of N-allenamides. 
In 2012, González and coworkers reported the first asymmetric gold(I)-catalyzed 
intermolecular [2+2]-cycloaddition of N-allenamides with vinylarenes. Optically active 
cyclobutane 5.86 was obtained in high yield and excellent selectivity using the well-
precedented ligand (S)-SiPhos L20, which consists of a 1,1’-spirobiindane backbone (Scheme 
5.22).216 Inspired by this privileged ligand scaffold, the group of K. Ding developed a 
straightforward enantioselective entry toward cyclohexyl-fused chiral spirobiindanes.217 The 
enantioenriched spiro compounds 5.89 were obtained from α,α’-bis(arylidene)cyclohexanones 
5.87 via asymmetric hydrogenation and stereoselective spiroannulation (Scheme 5.23). The 
authors employed the model reaction of González et al. to demonstrate that phosphoramidite 
ligands L21 derived from these cyclohexyl-fused spirobiindanes make equally competent 
gold(I) complexes as the regular spirobiindanes (Scheme 5.22). The easy accessibility of 
these frameworks constitutes a major advantage in chiral ligand design for future 
enantioselective catalysis. 
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Scheme 5.22. Intermolecular [2+2]-cycloaddition of N-allenamide and styrene. 
 
Scheme 5.23. Enantioselective synthesis of cyclohexyl-fused 1,1’-spirobiindanes. 
Rossi and coworkers studied the gold(I)-catalyzed dearomative [4+2]-cycloaddition of 
substituted 2- and 3-vinylindoles with N-allenamides (Scheme 5.24).218 As outlined above, the 
transformation follows a stepwise mechanism, involving the dearomatized cationic 
intermediates 5.95 and 5.96. Intramolecular cyclization then furnishes the corresponding 
formal [4+2]-cycloadducts 5.92 and 5.94 (Scheme 5.25). Gold(I) complexes bearing the axially 
chiral bisphosphine ligand (R)-DTBM-SegPhos L22 induced excellent levels of 
enantioselectivity for a range of 2-vinylindoles 5.90, in addition to complete chemo-, regio- and 
diastereoselectivity. Both alkyl and aryl groups were tolerated at the vinyl moiety (R2), although 
only the latter resulted in enantioenriched products. In contrast, the reaction did not support a 
large phenyl substituent at the indole C-3 position (R3). In the case of 3-vinylindoles, the 
cycloaddition was confined to 2-methyl-substituted substrates 5.93 and yielded the 
tetrahydrocarbazoles 5.94 as a mixture of (Z) and (E) isomers, albeit with high ee. For both 
substrates, the final geometry around the external double bond was controlled by steric 
factors. 
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Scheme 5.24. Dearomative [4+2]-cycloaddition of 2,3-disubstituted vinylindoles with N-allenamides. 
 
Scheme 5.25. Proposed mechanism of the gold(I)-catalyzed dearomative [4+2]-cycloaddition of 
vinylindoles with N-allenamides. 
López and coworkers took this approach one step further, and designed an enantioselective 
gold(I)-catalyzed [2+2+2]-cycloaddition reaction between N-allenamides, alkenes and 
aldehydes.219 Both the phosphoramidite catalyst (R,SN,SN)-L23AuCl and the N-heterocyclic 
carbene (NHC) gold complex (R)-L24AuCl afforded 2,6-disubstituted tetrahydropyrans 5.99 in 
satisfactory diastereo- and enantioselectivity (Scheme 5.26). Compared to the triazole-derived 
catalyst (R)-L24AuCl, reactions with the (R)-VANOL-phosphoramidite (L23) gold(I) complex 
generally yielded lower ee values for the 2,6-cis isomers, while those of the 2,6-trans isomers 
were significantly higher. Also, the proportion of 2,6-trans product was higher. For both 
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catalysts, the reaction proceeded with complete chemoselectivity as the [2+2]-cycloadduct 
was not detected. Mechanistically, the multicomponent reaction is an extension of the two-
component cycloaddition. The vinyl-gold carbocationic species 5.100, composed of the 
allenamide and the alkene, reacts with the carbonyl compound to give oxonium intermediate 
5.101, which subsequently undergoes a Prins cyclization. 
 
Scheme 5.26. Multicomponent [2+2+2]-cycloaddition of N-allenamides, alkenes and aldehydes. 
4. Gold-catalyzed alkene activation 
4.1. Hydroamination of unactivated alkenes 
While enantioselective transformations relying on alkyne and allene activation are rapidly 
emerging, asymmetric gold(I)-catalyzed reactions with alkenes remain challenging, as shown 
by the limited amount of reports in recent years. Widenhoefer and coworkers reported the 
intramolecular hydroamination of unactivated terminal and internal alkenes with 
2-pyridones.220 The cationic gold(I) phosphine complex JohnPhos[AuNCMe](SbF6) efficiently 
catalyzed the conversion of monosubstituted, 1,1- and 1,2-disubstituted 6-(γ-alkenyl)-
2-pyridinones 5.102 into 2,3-dihydroindolizin-5-ones 5.103 (Scheme 5.27). The feasibility of 
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the enantioselective variant of this reaction was demonstrated for the unsubstituted analog 
6-(3-butenyl)-2-pyridinone (5.102a, R1 = R2 = H). The product 5.103a was isolated in high yield 
and enantioselectivity using a digold(I) catalyst with chiral (S)-DTBM-MeO-Biphep ligand L6. 
 
Scheme 5.27. Intramolecular hydroamination of 6-(γ-alkenyl)-2-pyridinones. 
The group of Michon disclosed a solvent-dependent enantiodivergent intramolecular 
hydroamination of alkenes.221 The formation of the cyclic amine 5.105 was efficiently catalyzed 
by a chiral binuclear gold(I) chloride complex based on (S)-DTBM-SegPhos L22 in the 
presence of silver perchlorate and water (Scheme 5.28). Both product enantiomers were 
obtained in good yield and enantioselectivity by simply changing the solvent between toluene 
and methanol. The authors explained the opposite stereochemical outcome of the reaction by 
the formation of silver chloride adducts of the gold(I) perchlorate complex when prepared in 
methanol. X-ray fluorescence analysis indicated the presence of silver and gold in a 1:2 ratio 
in methanol solutions of the catalyst L22[AuOCl4]2, whereas no silver was detected in toluene. 
Furthermore, monocationic silver chloride adducts were also observed by X-ray diffraction 
analysis and mass spectrometry. These oxophilic gold-silver chloride nuclei are proposed to 
interact with the carbamate function of 5.104 in addition to the regular alkene activation by a 
single gold atom. Such proximal and bimetallic activation would favor the positioning of CH2-
Au group on the other face of the N-heterocycle plane, thus inducing enantioinversion during 
the final protodeauration step. Toluene as low polarity solvent, on the other hand, does not 
allow silver chloride adducts to form but rather promotes tight ions pairs and gold-gold 
interaction, affording (S)-5.105 after anion-assisted proton transfer and demetallation. 
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Scheme 5.28. Enantiodivergent intramolecular hydroamination of alkenes. 
4.2. Cycloisomerization of methylenecyclopropanes 
In methylenecyclopropane, the alkene is substituted with a highly strained cyclopropane 
moiety, which allows an additional cycloisomerization process to proceed upon gold-catalyzed 
alkene activation. Shi and coworkers reported the cycloisomerization of ortho-(propargyloxy)-
arenemethylenecyclopropanes 5.106 toward 2,3-dihydrobenzofurans 5.107 under gold(I) 
catalysis (Scheme 5.29).222 The reaction mechanism is proposed to be initiated by the gold(I)-
promoted ring expansion of the cyclopropane unit. Subsequent nucleophilic attack by the 
oxygen atom on the cyclobutenyl cation (5.111) yields oxonium ylide 5.112, which then rapidly 
undergoes [2,3]-sigmatropic rearrangement with release of the gold catalyst (Scheme 5.30). 
The sterically demanding chiral ligand (R)-DTBM-SegPhos L22 gave good to excellent 
enantioselectivities for substrates with halogen substituents on the aromatic core. 
Interestingly, during their exploration of the reactivity of 5.106, the authors found that when a 
sterically bulky substituent, such as tert-butyl or tert-amyl, was placed adjacent to an 
unsubstituted propargyloxy group at the phenyl ring, methylenecyclopropane migration 
products 5.109 were obtained. These 2H-chromenes are likely produced through gold-
catalyzed alkyne cyclization with formation of vinyl gold intermediate 5.108, followed by ring 
expansion and migration of the methylenecyclopropane group. 
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Scheme 5.29. Cycloisomerization of ortho-(propargyloxy)arenemethylenecyclopropanes. 
 
Scheme 5.30. Proposed mechanism of the gold(I)-catalyzed cycloisomerization of 
ortho-(propargyloxy)arenemethylenecyclopropanes. 
5. Gold-catalyzed transformation of diazo compounds 
Diazo compounds are particularly suited species for the formation of metal carbenoids through 
metal-catalyzed decomposition. Carbene transformations, including cyclopropanation, dipolar 
cycloaddition and insertion reactions, have been extensively conducted in the presence of 
transition metals such as rhodium, copper, and palladium.223 While gold carbenoid species are 
frequently proposed intermediates in gold-catalyzed reactions,224 carbene transfer processes 
with diazo-derived gold(I) carbenoids are a relatively unexplored research area, especially with 
respect to enantioselective catalysis.225 Pioneering work was delivered by Davies and 
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coworkers in 2012, who described the first asymmetric gold(I)-catalyzed cyclopropenation of 
alkynes with aryldiazoacetates.226 Recently, the group of Sun reported the regio- and 
enantioselective gold(I)-catalyzed insertion of carbenes into the tautomeric O-H bond of 
2-pyridones 5.113 (Scheme 5.31).227 Even though vinyldiazoacetates 5.114 were used as 
carbenoid source, no vinylogous reactivity was observed employing a chiral digold(I) catalyst 
derived from (R)-DM-SegPhos L25, and a variety of O-alkylation products 5.115 were obtained 
in excellent selectivity. Oxonium ylide 5.117 was proposed as most plausible intermediate, 
producing the insertion product 5.115 through 1,2-hydrogen transfer and deauration.  
 
Scheme 5.31. Vinylcarbene insertion into the tautomeric O-H bond of 2-pyridones. 
6. Gold(I) as σ-Lewis acid 
The majority of enantioselective gold-catalyzed reactions involves the activation and 
transformation of carbon-carbon unsaturated bonds, such as alkynes, alkenes and allenes. In 
contrast to the generally acknowledged activity as a π-acid, only few examples describe the 
use of gold as a σ-Lewis acid catalyst in asymmetric synthesis.8e, 228 Z. Wang and coworkers 
applied this catalysis mode to the asymmetric Mannich reaction of α-diazocarbonyl 
compounds 5.119 with N-sulfonyl cyclic ketimines 5.118 (Scheme 5.32).229 A chiral gold(I) 
catalyst derived from the bisphosphine ligand (S)-BINAP L1 and silver triflate afforded 
β-amino-α-diazoesters 5.120 in satisfactory yield and enantioselectivity. Various electron-
donating and -withdrawing substituents were tolerated on the phenyl ring of 5.118. Preliminary 
mechanistic experiments indicated that the gold(I) complex promoted enolization of the 
α-diazocarbonyl compound 5.119. Subsequent nucleophilic attack of this enol intermediate 
5.122 on the gold(I)-activated ketimine 5.121 in a selective manner was proposed to afford 
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enantioenriched Mannich product 5.120. Remarkably, the authors did not observe the 
formation of gold(I) carbenoids, suggesting the stability of the diazo group in the presented 
catalyst system. 
 
Scheme 5.32. Mannich reaction of α-diazocarbonyls with N-sulfonyl cyclic ketimines. 
7. Conclusion 
Gold catalysis is a powerful synthetic tool to construct complex and highly functionalized 
carbo- and heterocyclic compounds from relatively simple building blocks. Despite the 
unfavorable geometrical constraint inherent to gold(I) catalysts, significant progress has been 
made in asymmetric gold(I) catalysis over the past years. The concise overview of the most 
recent contributions to this field demonstrates the wide variety of transformations that can be 
achieved using chiral gold complexes. Both intra- and intermolecular enantioselective 
cyclization reactions with alkynes, alkenes, and allenes have been accomplished, allowing the 
construction of one or more chiral centers in a stereoselective manner. In addition to the 
commonly exploited π-acid activity, a few papers also reported on the use of chiral gold(I) 
complexes as σ-Lewis acids or as catalysts in carbene transfer reactions of diazo compounds. 
While representing invaluable contributions to method development, several of these gold(I)-
catalyzed asymmetric transformations have also been shown to find direct application in the 
total synthesis of complex natural substances.  
Ongoing research efforts are devoted to the expansion of the current reactivity scope of 
asymmetric gold catalysis. This coincides with a drive to design improved chiral ligands and 
catalysts. Indeed, as evident from the discussed reactions, most transformations currently rely 
on gold(I) complexes derived from the traditional atropisomeric bisphosphine and chiral 
phosphoramidite ligands. Occasionally, novel, interesting ligand scaffolds have been 
CHAPTER V 
166 
introduced, including acyclic diaminocarbenes, phosphahelicenes, chiral phosphines bearing 
a sulfinamide or catalytically cooperative group, and cationic phosphonites. Also, 
enantioselective reactions catalyzed by cationic gold(III) are significantly less explored 
compared to gold(I). Recently, the potential of well-defined gold(III) complexes to induce 
stereoselectivity was demonstrated, opening up a new dimension for asymmetric gold 
catalysis. 
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CHAPTER VI 
DEVELOPMENT OF CHIRAL GOLD(III) COMPLEXES 
AS SELECTIVE LEWIS ACID CATALYSTS 
1. Introduction 
In contrast to homogeneous gold(I) catalysis, which has experienced an extraordinarily rapid 
growth as effective synthetic method to construct new carbon-carbon and carbon-heteroatom 
bonds,135d, 189 gold(III) catalysis is still mainly limited to the use of inorganic gold(III) salts.230 
The development of organometallic gold(III) catalysts is synthetically complicated by the high 
redox potential of gold(III), which renders the associated complexes rather labile and prone to 
reduction to either gold(I) or metallic gold species.11, 231 Moreover, ligands that are capable of 
stabilizing the high-valent gold center often produce catalytically inert complexes.232 
Nevertheless, enantioselective gold catalysis would potentially benefit from the square-planar 
geometry of gold(III) complexes, which places the chiral ligand significantly closer to the 
reactive site compared to the linear gold(I) catalysts (Figure 6.1).  
 
Figure 6.1. Coordination mode of gold(III) complexes. 
As indicated in Chapter V, the first steps have been taken toward the application of well-
defined chiral gold(III) complexes as enantioselective catalysts. While both pioneering 
examples focus on the activation of alkynes, the unique properties of gold(III) species likely 
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impart a new reactivity and selectivity that extends beyond π-activation.233 The fundamental 
differences between gold(I) and gold(III) catalysts should be further exploited in order to 
broaden the scope of asymmetric gold catalysis. In this chapter, preliminary results on the 
synthesis of a novel class of stable chiral gold(III) catalysts are discussed. The complexes 
were subsequently screened in reactions for which chiral gold(I) species exhibited either a 
poor selectivity (alkyne activation reactions) or poor activity (Lewis-acid-catalyzed Diels-Alder 
reaction). This work has been performed during a six-month research stay (October 2016 – 
March 2017) in the laboratory of Prof. F. Dean Toste (University of California, Berkeley, USA). 
2. Preparation of chiral gold(III) complexes 
Gold(III) complexes are generally less stable than gold(I) complexes and other square-planar 
d8 transition metal complexes. Cyclometallation has been proven a reliable strategy to access 
stabilized, yet catalytically active gold(III) species.234 Toste and coworkers recently reported 
on the oxidative addition of strained biphenylene to the cationic form of gold(I) species 6.1 as 
a mild approach to prepare the stable gold(III) catalyst 6.2 (Scheme 6.1).235 They found that 
the bidentate biphenyl ligand with strong Au-C bonding energy efficiently stabilized the cationic 
high-oxidation-state gold(III) complex 6.2. While the initial research employs an N-heterocyclic 
carbene (NHC) as supporting ligand, taking advantage of its generally stabilizing effect on 
transition metal complexes,236 the question arose whether this strategy could be extended to 
gold(III) complexes with electron-rich phosphorus-based ligands. In addition, the incorporation 
of chiral information in the ancillary ligand might produce highly selective gold(III) catalysts. 
Hence, a variety of gold(III)(biphenyl) complexes bearing chiral phosphoramidite and 
phosphine ligands, typically used in asymmetric gold(I) catalysis, were designed as innovative 
catalysts for enantioselective transformations. 
 
Scheme 6.1. Preparation of gold(III) complex 6.3 via oxidative addition of biphenylene 
to cationic gold(I).235  
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2.1. Synthesis of a chiral ligand library 
2.1.1. BINOL-derived phosphoramidites 
Phosphoramidites, first introduced by Feringa as chiral ligands in enantioselective copper 
catalysis,237 are versatile scaffolds that are easily prepared by combining the appropriate diol 
with a trivalent phosphorus reagent and the desired amine. The atropisomeric diol BINOL 6.4 
is a convenient basis for the construction of chiral phosphoramidites. A representative example 
of alkyl as well as aryl 3,3’-disubstituted (R)-BINOL was prepared as described in literature 
(Scheme 6.2).238 Both synthetic pathways started with methoxymethyl (MOM) protection of the 
hydroxyl groups in 6.4. Regioselective metallation with nBuLi followed by iodination gave the 
3,3’-dihalogenated BINOL derivative 6.6. Subsequent Suzuki cross-coupling with 
9-phenanthrylboronic acid yielded the 3,3’-diarylated compound 6.8. The 3,3’-dimethyl 
derivative 6.7 was directly obtained from 6.5 by quenching the corresponding dilithiated 
intermediate with iodomethane. Finally, acid deprotection of the MOM-ethers delivered the 
3,3’-disubstituted (R)-BINOLs 6.9 and 6.10 in good overall yields (69% and 39%, respectively). 
In addition, the 6,6’-disubstituted (R)-BINOL 6.11 was synthesized from the parent compound 
6.4 and 1-adamantanol via acid-catalyzed electrophilic aromatic substitution (Scheme 6.3).239 
 
Scheme 6.2. Synthesis of 3,3’-disubstituted (R)-BINOL derivatives 6.9 and 6.10. 
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Scheme 6.3. Synthesis of (R)-6,6’-di(1-adamantyl)-BINOL 6.11. 
The different (R)-BINOL frameworks were transformed into the corresponding N,N-dimethyl-
substituted phosphoramidites L26a-d by refluxing the compounds with one equivalent of 
tris(dimethylamino)phosphine in dry toluene (Table 6.1).240 Furthermore, (R)-BINOL 6.4 was 
coupled with aminophosphorus dichloride 6.13, which was formed in situ by reaction of chiral 
amine 6.12 with phosphorus trichloride, to yield the sterically encumbered phosphoramidite 
L27 (Scheme 6.4).241 The isolated chiral ligands were purified by column chromatography. 
Table 6.1. Synthesis of BINOL-derived phosphoramidites. 
 
Entry Substrate R1 R2 Product t (h) Yield (%)a 
1 6.4 H H L26a 3 25 
2 6.9 Me H L26b 1 27 
3 6.10 9-phenanthryl H L26c 1 89 
4 6.11 H 1-Adb L26d 1.5 18 
a isolated yield after column chromatography. b 1-adamantyl. 
 
Scheme 6.4. Synthesis of BINOL-derived phosphoramidite L27 with chiral amine moiety.  
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2.1.2. TADDOL-derived phosphoramidites 
Another family of chiral scaffolds frequently used for the formation of phosphoramidite ligands 
are TADDOLs. These tartrate-derived diols consist of two adjacent trans-oriented 
diarylhydroxymethyl groups on a 1,3-dioxolane ring.242 While this skeleton lends itself to 
countless structural variations with respect to the aryl substituents, the dioxolane ring and the 
acetonide bridge, the relatively simple, tetraphenylated TADDOL 6.14 was chosen to prepare 
the corresponding N,N-dimethyl-substituted phosphoramidite L28. As before, the synthesis 
comprised treatment of the chiral diol with tris(dimethylamino)phosphine in boiling toluene 
(Scheme 6.5).243 The ligand L28 was purified by column chromatography, followed by 
crystallization from a mixture of dichloromethane and diethyl ether. 
 
Scheme 6.5. Synthesis of TADDOL-derived phosphoramidite L28. 
2.1.3. Mono- and bisphosphines 
Finally, the series of phosphoramidites was complemented with several axially chiral 
phosphine ligands. The monophosphines (R)-2-(diphenylphosphino)-2’-methoxy-1,1’-
binaphthyl (MOP) L29 and (R)-2-(dicyclopentylphosphino)-2’-(naphthalen-1-ylmethoxy)-1,1’-
binaphthyl L30, together with bisphosphine (R)-BINAP L1, were selected as model ligands for 
this specific class (Figure 6.2). Both (R)-MOP L29 and (R)-BINAP L1 are commercially 
available and were purchased from Merck. Monophosphine L30 was synthesized and 
provided by the Hartwig group.244 
 
Figure 6.2. Axially chiral phosphine ligands (R)-MOP L29, (R)-L30 and (R)-BINAP L1. 
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2.2. Formation of phosphorus gold(III)(biphenyl) complexes 
With a variety of phosphoramidite and phosphine ligands in hand, the corresponding gold(III) 
complexes, containing biphenyl as stabilizing ancillary ligand, were prepared. The envisioned 
strategy involves transmetallation of tin(IV)(biphenyl)(nBu)2 to gold(III), followed by 
coordination of the phosphorus-based ligand. First, the biphenyl-cyclometallated tin(IV) 
complex 6.16 was prepared from 2,2’-dibromobiphenyl 6.15 (Scheme 6.6). Initially, a 
procedure reported by Nagao et al. was followed, which describes a three-step one-pot 
synthesis involving lithium-halogen exchange, reaction with magnesium bromide, and 
coordination to tin(IV) (method a).245 However, the method generated substantial amounts of 
biphenyl side product 6.17, restraining the crude product yield to a meager 12%. Moreover, 
the tin(IV) complex 6.16 could not be fully separated from 6.17 via column chromatography, 
and an additional recrystallization step was required to purify the compound. When an aliquot 
of the reaction, taken after 20 h, was quenched in D2O, a 12:48:40 mixture of tin(IV) complex 
6.16, biphenyl 6.17 and the corresponding dianion was revealed. The little amount of product 
6.16 together with the high level of deprotonated species suggests that lithium-halogen 
exchange is a fast process, but that subsequent reaction with magnesium bromide or the tin 
compound is troublesome, causing the dianion to quench with traces of water over time. 
Indeed, closer analysis of the individual steps learned that dilithiation of 6.15 is complete within 
five minutes at -78 °C, and that reaction with magnesium bromide is essential for subsequent 
transmetallation with tin(IV) as no product was obtained when this reagent was omitted. Extra 
precautions to ensure moist-free conditions, such as the overnight drying of the glassware, 
the use of the Schlenk technique under argon atmosphere, and the transfer of reagents by 
means of a cannula, did not improve the conversion.  
Hence, it was preferred to prepare the Grignard reagent of 2,2’-dibromobiphenyl in the classic 
way by treating 6.15 with magnesium turnings and a few iodine crystals (method b). When all 
magnesium was consumed after approximately 24 h, a solution of Bu2SnCl2 in dry THF was 
added, and the reaction was stirred at room temperature for another 45 h. Only 10% of side 
product 6.17 was present after work-up of the reaction mixture, and tin(IV)(biphenyl)(nBu)2 
6.16 was afforded in 83% yield after recrystallization in ethanol. 
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Scheme 6.6. Synthesis of tin(IV)(biphenyl)(nBu)2 complex 6.16. 
In the next step, tin(IV) complex 6.16 was reacted with AuCl3 bearing a tetrahydrothiophene 
ligand (6.18) to effect transmetallation (Scheme 6.7).235, 246 Sulfur-based ligands are commonly 
used as transient ligand in the synthesis of new gold(I) and gold(III) complexes, as they are 
readily displaced by a neutral or anionic ligand of choice.247 The precursor complex 6.18 was 
easily prepared by mixing an equimolar amount of both components in water/ethanol and 
collecting the formed precipitate by filtration. Exchange of the transient sulfide ligand and two 
chlorides of 6.18 for the bidentate biphenyl resulted in the formation of insoluble gold(III) dimer 
6.19, which was isolated in 45% yield through precipitation in hexane. 
 
Scheme 6.7. Synthesis of gold(III)(biphenyl) chloride complex 6.19. 
When exposed to a coordinating solvent, such as dimethyl sulfoxide (DMSO), the gold(III) 
dimer 6.19 disassembled to furnish two soluble mononuclear complexes 6.20, each bearing 
one chloride and DMSO ligand in addition to the biphenyl metallocycle. The same occurred 
when a relevant ligand was added, and clarification of the solution served as primary visual 
indication for successful precatalyst formation. To a suspension of the gold(III) dimer 6.19 in 
dichloromethane, the appropriate phosphorus-based ligand was added in a 2:1.1 ratio (Table 
6.2).235, 246 The coordination of phosphorus to the gold center was evidenced by a shift of the 
31P NMR signal, and when no remaining free ligand was observed by either TLC or 31P NMR, 
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the slight excess of insoluble gold(III) complex 6.19 was removed by filtration over a silica 
plug. Concentration of the filtrate afforded precatalysts 6.21a-i as off-white to white solids in 
good to excellent yields. 
Table 6.2. Synthesis of phosphorus gold(III)(biphenyl) complexes. 
 
Entry L* Product Yield (%)a 
1 PPh3b 6.21a quant. 
2 L26a 6.21b 77 
3 L26b 6.21c 51 
4 L26c 6.21d 79 
5 L26d 6.21e 83 
6 L27c 6.21f quant. 
7 L28 6.21g 89 
8 L29 6.21h 60 
9 L30 6.21i quant. 
a isolated yield. b achiral ligand. c in CHCl3, 61 °C, 2 h. 
As for the bisphosphine ligand (R)-BINAP L1, which has two metal coordination sites, the 
corresponding gold(III) complex was prepared following the same procedure as outlined 
above, albeit with a ligand/gold(III) dimer ratio of 1:1.1 (Scheme 6.8). While bisphosphines are 
known to form bimetallic complexes with linear gold(I), the steric congestion of the 
gold(III)(biphenyl) species might favor the formation of mononuclear complex 6.22 in which 
both phosphines are coordinated to one gold(III) center.246 Based solely on 1H and 31P NMR 
spectra, the exact nature of the formed complex could not be determined. HRMS analysis, on 
the other hand, detected the cationic and anionic fragment of mononuclear species 6.22 in 
positive and negative ionization mode, respectively. The inactivity of the obtained substance 
as catalyst in enyne cycloisomerization reactions is in agreement with the formation of 
coordinatively saturated complex 6.22 (Table 6.4, vide infra). These findings indicate that 
binucleating ligands are unsuited for the formation of active catalysts when combined with 
cyclometallated gold(III) centers. This contrasts with gold(I) complexes, where bisphosphines 
are highly desired ligands for their favorable effect on asymmetric induction. 
CHIRAL GOLD(III) COMPLEXES AS SELECTIVE CATALYSTS 
175 
 
Scheme 6.8. Synthesis of a gold(III)(biphenyl) complex with (R)-BINAP as ancillary ligand. 
To be able to compare the performance of chiral gold(III) and gold(I) complexes in asymmetric 
catalysis, the gold(I) congener was prepared for each type of ligand. More specifically, achiral 
triphenylphosphine, the BINOL-derived phosphoramidite L26a, the TADDOL-derived 
phosphoramidite L28 and monophosphine L29 were reacted with gold(I) complex 6.24 to 
engage in ligand exchange with the weakly coordinated dimethyl sulfide ligand (Table 6.3).240 
Since the displaced dimethyl sulfide is volatile, the new complexes 6.25 did not require 
additional purification and were readily isolated in quantitative yield upon evaporation of the 
solvent. The precursor complex 6.24 was obtained from AuCl3 through the formation of 
chloroauric acid, followed by a redox reaction with dimethyl sulfide. 
Table 6.3. Synthesis of phosphorus gold(I) complexes. 
 
Entry L* Product Yield (%)a 
1 PPh3b 6.25a quant. 
2 L26a 6.25b quant. 
3 L28 6.25g quant. 
4 L29 6.25h quant. 
a isolated yield. b achiral ligand. 
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3. Stability of cationic gold(III) complexes 
Before the synthesized gold(III) and gold(I) complexes can function as catalysts in organic 
transformations, the cationic, coordinatively unsaturated species have to be generated. The 
activation of gold complexes is usually performed in situ by chloride abstraction using the 
silver(I) salt of a weakly coordinating anion, e.g., silver triflate.135d The process is promoted by 
the precipitation of silver chloride, which is normally filtered out prior to the reaction. As cationic 
gold(III) complexes are often unstable in the presence of electron-rich compounds, such as 
phosphines or amines,248 the behavior of the gold(III)(biphenyl) catalysts in solution was 
examined by 1H NMR (Figure 6.3). The unadorned phosphoramidite-based catalyst 6.21b was 
used as model (Scheme 6.9). 
The treatment of complex 6.21b with one equivalent of silver triflate under ultrasound 
conditions quantitatively replaced the chloride anion by a triflate anion. The ligand exchange 
caused a 0.5 ppm upfield shift of the methyl protons of the coordinated phosphoramidite L26a 
(red to green, Figure 6.3). The activated species 6.26 appeared to be stable at room 
temperature. Even in samples taken after several hours, no biphenylene or free ligand L26a 
was observed, which otherwise would be indicative of the disassembly of the coordination 
complex and possibly reduction to gold(I). Also, 31P NMR showed a single peak corresponding 
to cationic-gold(III)-bound L26a (δ 142.0). The quenching of active gold complexes is 
commonly achieved by the addition of a quaternary ammonium chloride, which regenerates 
the precatalyst containing a chloride ligand.206, 235 Upon addition of one equivalent of 
tetrabutylammonium chloride to cationic gold(III) species 6.26, the triflate anion was indeed 
exchanged for chloride. However, in addition to signals corresponding to the expected 
complex 6.21b, a small fraction of free phosphoramidite ligand L26a was noticed (blue, Figure 
6.3). Moreover, when the ammonium salt was added in excess, L26a was fully displaced and 
anionic gold(III) complex 6.27 was formed. The ability of chloride to force ligand exchange with 
the phosphorus-based ligand was validated by the addition of tetrabutylammonium chloride to 
the precatalyst 6.21b, without preceding activation with silver triflate. Complex 6.27 could also 
directly be generated from the gold(III) dimer 6.19. In this case, the species was isolated in 
79% yield after filtration over a silica plug using dichloromethane with 10% methanol as eluent. 
The structure of 6.27 was confirmed by 1H NMR and HRMS. This anionic type of gold(III) 
species has previously been reported to be obtained from the transmetallation of tin(IV) 
complex 6.16 with nBu4NAuBr4.246 In contrast, the treatment of cationic gold(I) bearing 
phosphoramidite ligand L26a with two equivalents of tetrabutylammonium chloride 
regenerated the precatalyst without any sign of complex decomposition. 
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Figure 6.3. 1H NMR study (in CD2Cl2) of the stability of chiral gold(III)(biphenyl) complex 6.21b in solution. 
The methyl protons of ligand L26a in the different species are indicated in blue, red and green. 
 
Scheme 6.9. Stability of chiral gold(III)(biphenyl) complex 6.21b. 
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Overall, this 1H NMR experiment demonstrates that the novel chiral gold(III) complexes 
bearing phosphorus-based ligands are stable in their active, cationic form. The gold(III) metal 
does not experience reduction to gold(I) nor to metallic gold species. However, the gold-
phosphorus bond is easily broken by strongly coordinating ligands, such as chloride, especially 
in absence of labile ligands or counterions. By the same token, solubilization of gold(III) 
catalyst 6.21b in DMSO led to the decomposition of the complex with formation of DMSO-
ligated gold(III)(biphenyl) chloride 6.20. 
4. Evaluation as selective Lewis acid catalysts 
4.1. Cycloisomerization of 1,6-enynes 
The cycloisomerization of enynes is a classic gold-catalyzed reaction, in which the alkyne is 
selectively activated by the metal while the pendant alkene function acts as nucleophile 
(Scheme 5.11, vide supra). Echavarren and coworkers studied the gold-catalyzed cyclo-
isomerization of 7-alkynyl cycloheptatrienes 6.28.249 For this substrate, 6-endo-dig cyclization 
of the embedded 1,6-enyne leads to the formation of a gold-stabilized barbaralyl cation 6.30a 
(Scheme 6.10). This positively charged hydrocarbon is a highly fluxional molecule, possessing 
the unusual characteristic to rapidly interconvert between different structural isomers through 
pericyclic reactions.250 Eventually, the barbaralyl intermediates 6.30 irreversibly rearrange to 
a homoaromatic 1,4-bishomotropylium cation, which furnishes either 1- or 2-substituted 
indenes upon deauration and restoration of the aromaticity. 
 
Scheme 6.10. Cycloisomerization of 7-alkynyl cycloheptatrienes via gold-stabilized barbaralyl cations. 
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This unique cycloisomerization process was used to evaluate the potential of the chiral gold(III) 
catalysts to control both regioselectivity and enantioselectivity. The active gold(III) species 
were generated through reaction with silver triflate, and the resulting suspension was filtered 
directly into a solution of cycloheptatriene 6.33 in dichloromethane. The isomerization of 6.33 
was allowed to proceed for 30 minutes at room temperature, after which the conversion and 
regioselectivity were analyzed by 1H NMR. The enantioselectivity was determined by chiral 
HPLC after eluting the solution through a short silica column to remove the catalyst (Table 
6.4). 
Table 6.4. Catalyst screening for the cycloisomerization of 7-alkynyl cycloheptatriene 6.33. 
 
Entry Catalyst 
Conversion 
(%)a 
Ratio 
6.34:6.35a 
ee (%)b 
1c - 0 - - 
2d 6.21b 0 - - 
3 6.25a 100 24:76 0 
4 6.25b 100 15:85 -12 
5 6.25g 100 21:79 5 
6 6.25h 100 56:44 -21 
7 6.21a 11 32:68 0 
8 6.21b 100 34:66 -7 
9 6.21c 6 37:63 10 
10 6.21d 100 24:76 -6 
11 6.21e 100 24:76 -8 
12 6.21f 95 36:64 -3 
13 6.21g 100 33:67 9 
14 6.21h 23 65:35 -22 
15 6.21i 100 46:54 -20 
16e 6.22/6.23 0 - - 
a determined by 1H NMR (CD2Cl2). 
b determined by chiral HPLC (Chiralcel OD-H); minus sign denotes the opposite enantiomer. 
c 10 mol% AgOTf. d 10 mol% catalyst, no AgOTf. e 2.5 mol% catalyst.  
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Table 6.4. (continued) 
 
First, two control experiments were conducted, in which either the catalyst or the silver salt 
was excluded from the reaction mixture. Silver triflate was not able to catalyze the conversion, 
which indicates the absence of the “silver effect” for this reaction (entry 1). The lack of activity 
of the precatalyst demonstrates the necessity of chloride abstraction by a silver salt to activate 
the complex (entry 2). In light of the previous section, this experiment also confirms the stability 
of the gold(III) complexes, and in particular the gold-phosphorus bond, in the presence of 
enyne substrate, since 6.33 is not capable of displacing the phosphorus-based ligand and 
initiating catalysis. 
Most cationic gold(III) complexes rapidly catalyzed the cycloisomerization of cycloheptatriene 
6.33 to indene products 6.34 and 6.35, although phosphine-based catalysts in which the 
phosphorus atom is decorated with phenyl groups were generally less active (entries 7 and 
14). Also complex 6.21c performed considerably weaker than the related phosphoramidite-
derived gold(III) species (entry 9). The complex obtained from the reaction of bisphosphine 
(R)-BINAP L1 with gold(III) dimer 6.19 did not show any catalytic activity (entry 16). The ratio 
of the regioisomers 6.34 and 6.35 was sensitive to the type of ligand coordinated to the gold(III) 
catalyst. While 2-substituted indene 6.35 usually was the main product, phosphine-based 
complexes 6.21h and 6.21i (entries 14 and 15) directed the equilibrium toward 1-substituted 
indene 6.34 compared to phosphoramidite-based complexes 6.21b-g (entries 8-13). The ratio 
was even reversed in favor of 6.34 for phosphine complex 6.21h (entry 14). The chiral indene 
6.34 was obtained in low to moderate ee. The best enantioselectivities were obtained with 
catalysts 6.21h and 6.21i (entries 14 and 15). The BINOL-derived catalyst 6.21c (entry 9) as 
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well as the TADDOL-derived catalyst 6.21g (entry 13) induced the formation of the opposite 
enantiomer.  
When comparing the gold(I) and gold(III) catalysts (compare entry 3 with 7, 4 with 8, 5 with 
13, and 6 with 14), the primary differences are found in the activity and regioselectivity of the 
complexes. Gold(I) complexes 6.25 were generally more efficient catalysts, consistently 
reaching full conversion, whereas gold(III) complexes 6.21 occasionally showed reduced 
reactivity. The gold(I) catalysts were also more regioselective compared to their corresponding 
gold(III) species, albeit toward the achiral 2-substituted indene 6.35. The obtained 
enantioselectivities were rather similar, and the coordinated ligand seems to be more 
important than the charge on the gold center in this case. 
Overall, the chiral gold(III) complexes effectively catalyzed the 1,6-enyne cycloisomerization 
of 7-alkynyl cycloheptatriene 6.33. Complexes bearing a chiral phosphine ligand yielded the 
highest fraction of 1-substituted indene 6.34 with a moderate ee of 20-22%. 
4.2. Rautenstrauch rearrangement 
The Rautenstrauch rearrangement, first reported by Valentin Rautenstrauch in 1984,251 refers 
to the cyclization of α-vinyl propargylic esters 6.36 into substituted cyclopentenone derivatives 
6.38 through a 1,2-migration of the ester moiety (Scheme 6.11). 
 
Scheme 6.11. Transition metal-catalyzed Rautenstrauch rearrangement. 
Within the Toste group, there was interest in developing an enantioselective gold(I)-catalyzed 
Rautenstrauch rearrangement in which the cyclopentene-based cationic species 6.41 is 
trapped by a pendant nucleophile (6.42) rather than undergo direct elimination of the gold 
catalyst (6.43) (Scheme 6.12). The simultaneous construction of multiple stereocenters in an 
enantioselective manner represents a valuable synthetic method for the preparation of 
complex carbocyclic systems commonly found in natural products and pharmaceuticals. 
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Scheme 6.12. General outline of the intercepted Rautenstrauch rearrangement. 
The Rautenstrauch-initiated polycyclization was primarily studied with α-vinyl propargylic 
pivalate 6.45, which features a tethered arene.252 The tandem Rautenstrauch/Friedel-Crafts 
reaction yielded hexahydro-1H-indene 6.48 with the two novel chiral centers in the cis 
configuration, as was established by 1H NOE correlation between the hydrogen atom and the 
methyl group on the bridgeheads. The formation of cis-fused product was proposed to arise 
from the stepwise mechanism of the intercepted Rautenstrauch reaction, in which a 
conformational change from 6.47a to 6.47b prior to trapping accounts for the observed 
diastereoselectivity (Scheme 6.13). 
 
Scheme 6.13. Proposed mechanism of cis ring fusion in the Rautenstrauch/Friedel-Crafts cyclization.  
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The optimized conditions, as previously found for chiral gold(I) catalysts,252 were employed to 
evaluate the library of chiral gold(III) complexes. The reaction was performed in benzene at 
room temperature, using AgSbF6 as silver salt to abstract the chloride and activate the catalyst. 
After 1 h, the crude mixture was analyzed by 1H NMR (Table 6.5). In addition to the desired 
fused tricycle 6.48, the major competing products were hydrolysis product 6.49, and 
cyclopentenone 6.50 resulting from the failure to intercept the cationic Rautenstrauch 
intermediate. The conjugated vinyl pivalate esters (6.43) generated in the untrapped reaction 
are much more labile compared to pivalate 6.48 and were not observed. The enantiomeric 
excess of product 6.48 was determined by chiral HPLC after removing the catalyst via filtration 
over a short pad of silica.  
Table 6.5. Catalyst screening for the tandem Rautenstrauch/Friedel-Crafts cyclization of 6.45. 
 
Entry Catalyst 
Conversion 
(%)a 
Product distribution (%)a 
ee (%)b 
6.48 6.49 6.50 
1c - 0 - - - - 
2 6.21b 100 82 8 10 -5 
3 6.21c 79 71 21 8 4 
4 6.21d 100 100 0 0 -5 
5 6.21e 96 77 11 12 -5 
6 6.21f 100 85 11 4 -5 
7 6.21g 100 100 0 0 7 
8 6.21h 41 91 0 9 -1 
9 6.21i 100 100 0 0 -1 
a determined by 1H NMR (C6D6). 
b of 6.48; determined by chiral HPLC (Chiralpak IB);  
minus sign denotes the opposite enantiomer. c 20 mol% AgSbF6. 
Under the applied conditions, most catalysts induced full conversion of the substrate. The only 
exceptions are catalysts 6.21c, 6.21e and 6.21h, for which the decreased activity also led to 
a significant portion of untrapped Rautenstrauch product 6.50 (entries 3, 5 and 8). The 
hydrolysis product 6.49 was only generated in the presence of gold(III) catalysts 6.21b-f 
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bearing a BINOL-derived phosphoramidite ligand (entries 2-6). In contrast to the reasonable 
activity of the complexes, the induced enantioselectivity was generally poor. Overall, this 
screen suggests that the chiral gold(III)(biphenyl) complexes are not suited to selectively 
catalyze Rautenstrauch-type reactions, at least not on the studied substrate under the 
described conditions. 
4.3. Diels-Alder cycloaddition 
The Diels-Alder reaction is a concerted [4+2]-cycloaddition between a conjugated diene and 
a dienophile, commonly a substituted alkene. The formed product is a cyclohexene derivative 
(6.52) containing up to four contiguous asymmetric centers (Figure 6.4). As the reaction 
proceeds through a cyclic transition state (6.51) resulting from the suprafacial-suprafacial 
interaction of the π-systems, the relative stereochemistry present in the diene and dienophile 
is retained in the cycloadduct.253  
 
Figure 6.4. Diels-Alder mechanism and orbital interactions. 
Diels-Alder cycloadditions are characterized by a high regio- and stereoselectivity. The diene 
and dienophile usually arrange themselves in parallel planes to allow full orbital overlap. As 
the endo transition state (6.53) can be further stabilized by secondary orbital interactions, the 
resulting endo isomer 6.54 is often the major product in kinetically controlled cycloadditions. 
The exo isomer 6.56, which is thermodynamically more stable due to decreased steric 
congestion, results from a staggered orientation between the diene and dienophile (6.55) that 
is not favored by secondary interactions (Scheme 6.14).253 
 
Scheme 6.14. Endo versus exo selectivity in Diels-Alder cycloadditions. 
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Toste and coworkers used the Diels-Alder reaction of (E,E)-2,4-hexadienal 6.57 with 
cyclopentadiene 6.58 to evaluate the catalytic reactivity of the originally developed 
gold(III)(biphenyl) complex 6.3 bearing an achiral N-heterocyclic carbene (NHC) ligand 
(Scheme 6.15).235 Although the dienophile 6.57 could possibly undergo cycloaddition at two 
different unsaturated bonds, only γ,δ-functionalization was encountered and bicyclic product 
6.59 was obtained in high yield with good diastereoselectivity (endo/exo 88:12). The observed 
reactivity pattern was unprecedented, as α,β-selectivity normally predominates in such Lewis-
acid-catalyzed reactions.254 The excellent remote selectivity was completely attributed to the 
unique, sterically defined binding pocket of the catalyst.  
 
Scheme 6.15. Remote selectivity in the gold(III)-catalyzed Diels-Alder cycloaddition of 2,4-hexadienal 6.57 
and cyclopentadiene 6.58. 
To investigate if the phosphorus-based gold(III)(biphenyl) complexes 6.21 impart the same 
selectivity as their NHC-based counterpart 6.3, the cycloaddition of 6.58 and 6.57 was 
evaluated employing the same reaction conditions as reported. The used solvent system 
consists of a 4:1 mixture of toluene and nitromethane. As the latter might act as a coordinating 
ligand and induce decomposition of the phosphorus gold(III) complex, the stability of the 
catalyst was first examined. Model complex 6.21b was dissolved in the designated mixture 
and sonicated for 1.5 h at 50 °C. The absence of free phosphoramidite ligand, as verified by 
1H NMR, indicated the compatibility of the catalyst with the solvent system. Thereupon, a 
solution of cationic gold(III) complex, generated through the reaction of precatalyst 6.21 with 
silver triflimide, was added to hexadienal 6.57. A total of 15 equivalents of cyclopentadiene 
6.58, produced by the cracking of dicyclopentadiene, was added to the mixture spread over 
three portions. In addition to room temperature, the cycloaddition process was evaluated at 
0 °C in an attempt to minimize potential background reactions. Whereas 2,4-hexadienal 6.57 
was observed to only react with the γ,δ-bond, the remaining α,β-unsaturated bond in the 
obtained cycloadduct 6.59 was prone to a second cycloaddition reaction. As a direct 
consequence of the large excess of cyclopentadiene used in the reaction, the double Diels-
Alder adduct 6.60 was observed as a minor side product. After 18 h, the yield and 
diastereoselectivity of the reaction were determined by 1H NMR using 1,4-dinitrobenzene as 
internal standard. Upon isolation of product 6.59 by preparative TLC, the enantiomeric purity 
of the endo isomer was analyzed by chiral HPLC (Table 6.6). 
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Table 6.6. Catalyst screening for the Diels-Alder cycloaddition of 2,4-hexadienal with cyclopentadiene. 
 
Entry Catalyst T (°C) 
Conversion 
(%)a 
Yield 6.59 
(%)a 
endo/exoa,b ee (%)c 
Yield 6.60 
(%)a 
1 - 0 71 0 - - 0 
2 6.21b 0 74 0 - - 0 
3 6.21c 0 34 0 - - 0 
4 6.21d 0 34 14 92:8 -76 2 
5 6.21e 0 8 0 - - 0 
6 6.21f 0 21 0 - - 0 
7 6.21g 0 55 32 71:29 -48 4 
8 6.21h 0 70 0 - - 0 
9 6.21i 0 15 10 76:24 26 0 
10 - 20 97 0.7 ND - 0 
11 6.21d 20 78 25 86:14 -59 13 
12 6.21g 20 84 33 70:30 -37 10 
a determined by 1H NMR (CDCl3) of the crude mixture using 1,4-dinitrobenzene as internal standard. 
b endo and exo isomers were assigned by 2D-NOE experiments on the purified compounds. 
c of endo product; determined by chiral HPLC (Chiralpak AS-H); minus sign denotes the opposite enantiomer. 
The reaction is characterized by a significant degree of unwanted background reactions, as 
can be deduced from the silver tests (entries 1 and 10). Both at 0 °C and 20 °C, substrate 6.57 
was largely consumed, although the Diels-Alder cycloaddition itself was not catalyzed. In fact, 
at low temperature, the majority of the catalysts failed to catalyze the reaction at hand. 
Nevertheless, in those cases where reactivity was observed, cycloadduct 6.59 was obtained 
in excellent endo/exo selectivity and moderate to high ee (entries 4, 7 and 9). 
Phosphoramidite-based catalyst 6.21d, possessing bulky 9-phenanthryl substituents on the 
ligand, induced the same level of diastereoselectivity as NHC-based complex 6.3 and, 
additionally, yielded the endo product 6.59 in 76% ee (entry 4). TADDOL-derived complex 
6.21g showed the highest activity of the evaluated catalysts, producing bicycle 6.59 in 32% 
yield (entry 7). Finally, also phosphine complex 6.21i catalyzed the reaction, albeit with only 
moderate enantioselectivity (entry 9). According to what was anticipated, performing the 
reaction at room temperature enhanced the reactivity of the catalysts, but at the same time led 
to an overall decline in selectivity (entries 11 and 12). As complexes of each ligand type were 
variably able or unable to induce cycloaddition, the catalytic activity was not decided by the 
primary scaffold of the ligand, but rather by the substitution pattern. This opens the possibility 
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to further improve the yield and selectivity by synthesizing related catalysts, decorated with 
functional groups of different steric and electronic nature. Altogether, chiral phosphorus-based 
gold(III)(biphenyl) complexes are promising candidates for the development of regio-, enantio- 
and diastereoselective [4+2]-cycloaddition reactions of α,β-γ,δ-diunsaturated aldehydes with 
cyclopentadiene. 
5. Conclusion 
A series of well-defined gold(III)(biphenyl) complexes bearing chiral phosphoramidite and 
phosphine ligands was prepared. This type of catalysts is unprecedented in literature, as 
hitherto only neutral or electron-deficient nitrogen-containing compounds, such as pyridines, 
N-heterocyclic carbenes, Schiff bases, and triazole derivatives, have been used as ligands in 
auric complexes.206, 255 The stabilizing effect of the bidentate biphenyl ligand on the high-valent 
gold(III) center permits the formation of reliable cationic complexes that are not prone to 
reduction or decomposition by redox processes. However, the strength of the gold-phosphorus 
bond is only mediocre, and the ligand can be displaced by strongly coordinating substrates or 
anions. The ability of chloride to exchange with the phosphorus-based ligand implies that 
catalyst regeneration through the addition of ammonium chloride is not possible.  
The complexes were highly active in different alkyne cyclization reactions, such as the 
cycloisomerization of 1,6-enynes and the Rautenstrauch rearrangement, though only low to 
moderate enantioselectivity was achieved. In contrast, high diastereo- and enantioselectivity 
was obtained when catalyzing Diels-Alder cycloaddition reactions. Consequently, the 
observed reactivity profile of the phosphorus-based gold(III)(biphenyl) complexes is in line with 
the hard, oxophilic Lewis acidity exhibited by the related complex 6.3 with N-heterocyclic 
carbene ligand, which was earlier developed by Toste and coworkers.235  
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6. Perspectives 
This preliminary work on chiral organogold(III) complexes has opened the way to further 
in-depth research with respect to the unique catalyst structure and the potential applications 
in asymmetric catalysis. 
As the developed catalysts comprise a novel type of coordination complexes, analysis by X-ray 
diffraction is desired to obtain unambiguous confirmation of the expected phosphorus-gold 
connection. Furthermore, additional information on their structure, such as bond distances and 
angles, will also provide increased insight into the coordination chemistry via which the 
complexes impart selectivity.  
During the initial research, only a limited number of catalysts were prepared and screened. 
The selected complexes represent simplified examples of various ligand types, and the 
catalyst library should be further expanded to explore the different possibilities in structural 
diversity. Each of the three main parts of the catalyst – the chiral ligand, the bidentate biphenyl 
and the counterion – is amendable to modifications and can be used to tailor the activity and 
Lewis acidity of the gold complex to the needs of a specific catalytic application (Figure 6.5).  
 
Figure 6.5. Possible structural variations in the chiral gold(III)(biphenyl) complexes. 
The modularity of phosphoramidite ligands allows the facile alteration of the substituents at 
both the oxygen and nitrogen atoms, which in turn provides control over the electronic and 
steric properties of the ligand. Besides phosphoramidites and phosphines, stronger 
π-acceptors, e.g., phosphites, could be examined as chiral ancillary ligand as well. The strong 
σ-donating biphenyl ligand is essential for the stabilization of the cationic gold(III) complex and 
cannot be omitted. Nevertheless, the structure is perfectly suited for modifications with 
electron-donating or -withdrawing substituents. The presence of such groups may attenuate 
the σ-donor properties of the ligand and as a consequence the electronic nature of the gold 
center, while maintaining the stabilizing effect of the metallocycle. Additionally, the introduction 
of bulky substituents onto the ortho positions of the biphenyl core would constitute a 
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straightforward way to amplify chiral induction through steric effects. Finally, also the employed 
counterion can significantly influence the selectivity of the reaction. Different weakly 
coordinative anions are easily introduced by variating the silver salt. In addition to 
commercially available achiral silver salts, chiral silver salts can be used to enhance 
stereocontrol. Importantly, the choice of counterion may affect the stability of the complex, and 
their compatibility should be verified in future studies. 
In terms of reactivity, the exceptional architecture and higher metal oxidation state of the 
developed gold(III) complexes undoubtedly lead to a diverged catalytic activity compared to 
related gold(I) complexes. While only examined briefly in the preliminary study, it would be 
interesting to thoroughly investigate the difference in characteristics between both catalyst 
types. Asymmetric gold(I)-catalyzed reactions in literature for which only low to moderate 
selectivity is obtained are particularly qualified for this kind of study, as this would allow to 
identify superior performance of the novel catalytic species. 
At the same time, to complement the extensive number of transformations relying on the soft, 
carbophilic Lewis acid properties of gold(I) catalysts, further research efforts should be 
directed to the exploitation of the hard, oxophilic Lewis acidity observed for the gold(III) species 
(Scheme 6.16). The promising activity in the Diels-Alder cyclization of an all-carbon diene and 
dienophile could be extended to the catalysis of hetero-Diels-Alder reactions for the 
construction of heterocycles (6.63) with high diastereo- and enantioselectivity. Other 
synthetically interesting asymmetric reactions that could benefit from catalysis by the strongly 
Lewis acidic chiral gold(III) complexes are for example the allylation of aldehydes 6.64 with 
allylsilanes 6.65, the Mannich reaction of enolizable carbonyls 6.69 with imines 6.68, the 
1,3-dipolar cycloaddition of nitrones 6.71 to olefins 6.72, and the carbonyl-ene reaction.  
To conclude, also the remote γ,δ-selectivity exhibited by the gold(III) complexes is an 
interesting concept that should be further elaborated. In particular, the enantio- and 
regioselective catalysis of conjugate additions could be investigated, e.g., the Mukaiyama-
Michael addition of silyl enol ethers 6.77 to α,β-unsaturated aldehydes 6.76 (Scheme 6.17). 
Moreover, a comparison study of gold(III) versus gold(I) will likely reveal significant differences 
in reactivity and selectivity, and may be highly elucidative regarding the catalytic features of 
both systems. 
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Scheme 6.16. Proposed asymmetric reactions to be catalyzed by the Lewis acidic gold(III) complexes. 
 
Scheme 6.17. Proposed gold(III)-catalyzed Mukaiyama-Michael Aldol reaction.  
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7. Experimental details 
7.1. General methods 
Unless otherwise noted, all commercial reagents were used without further purification. 
Tetrahydrofuran, dichloromethane, and toluene were dried by passage through an activated 
alumina column under argon. Thin layer chromatography (TLC) analysis of reaction mixtures 
was performed using Merck silica gel 60 F254 TLC plates, and visualized under UV light 
(254 nm) or by using ceric ammonium molybdate, KMnO4 or vanillin stain. Flash column 
chromatography was carried out on Merck Silica Gel 60 Å, 230 X 400 mesh. Nuclear magnetic 
resonance (NMR) spectra were recorded on Bruker AV-600, AV-500, DRX-500, AVB-400 and 
AVQ-400 spectrometers at 20 °C, unless otherwise stated. 1H and 13C chemical shifts are 
reported in ppm downfield of tetramethylsilane and referenced to the (residual) solvent peak 
(CDCl3 δH = 7.26 and δC = 77.16; CD2Cl2 δH = 5.32 and δC = 53.84; DMSO-d6 δH = 2.50 and 
δC = 39.52; benzene-d6 δH = 7.16 and δC = 128.06). Coupling constants (J) are reported in 
Hertz (Hz). Multiplicities are listed using the following abbreviations: s = singlet, d = doublet, t 
= triplet, q = quartet, p = quintet, h = sextet, m = multiplet, br = broad resonance. Reaction 
conversions were determined by the integration of 1H NMR spectra of the crude product prior 
to purification. NMR yield was calculated using 1,4-dinitrobenzene as internal standard. The 
enantiomeric excess (ee) was verified by chromatographic separation using a Shimadzu 
Prominence HPLC system equipped with a Chiralcel OD-H (250 mm x 4.6 mm x 5 µm), 
Chiralpak IB (250 mm x 4.6 mm x 5 µm) or Chiralpak AS-H (250 mm x 4.6 mm x 5 µm) column. 
High resolution mass spectral (HRMS) data were collected on a PerkinElmer AxION 2 time-
of-flight mass spectrometer (ESI mode, 3500 V). This instrument is part of the Catalysis 
Facility of Lawrence Berkeley National Laboratory. 
7.2. Safety 
By analogy with section 8.2 of chapter IV, a brief overview of the category 1 chemicals 
employed in this research, as classified according to the European Regulation (EC) No 
1272/2008, is given below, along with the hazards and precautions for the specific hazard 
class. Substances listed in the aforementioned section are not repeated. The information was 
retrieved from the respective safety data sheets (SDS), which can be found on the website of 
the supplier. 
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Barium hydroxide. Causes severe skin burns and eye damage. Wear protective gloves and 
clothing. 
Benzene. May be fatal if swallowed and enters airways. May cause genetic defects. May 
cause cancer. Causes damage to organs through prolonged or repeated exposure. Harmful 
to aquatic life with long lasting effects. Wear protective gloves and clothing. 
2,2’-Dibromo-1,1’-biphenyl. Very toxic to aquatic life with long lasting effects. Avoid release 
to the environment. 
Dibutyltin dichloride. Fatal if inhaled. Causes severe skin burns and eye damage. May cause 
an allergic skin reaction. May damage fertility. May damage the unborn child. Causes damage 
to organs through prolonged or repeated exposure and to lungs if inhaled. Very toxic to aquatic 
life with long lasting effects. Wear protective gloves and clothing. 
1,4-Dinitrobenzene. Fatal if in contact with skin. Very toxic to aquatic life with long lasting 
effects. Avoid release to the environment. Wear protective gloves and clothing. 
(E,E)-2,4-Hexadienal. Causes severe skin burns and eye damage. May cause an allergic skin 
reaction. Wear protective gloves and clothing. 
Iodine. Causes damage to organs (thyroid) through prolonged or repeated exposure if 
swallowed. Very toxic to aquatic life. Avoid release to the environment. Wear protective gloves 
and clothing. 
Magnesium. Flammable solid. Self-heating, may catch fire. Keep away from heat, hot 
surfaces, sparks, open flames and other ignition sources. Protect from sunlight. 
Magnesium bromide ethyl etherate. Flammable solid. Keep away from heat, hot surfaces, 
sparks, open flames and other ignition sources. 
Organic bases (Et3N, TMEDA). Cause severe skin burns and eye damage. Wear protective 
gloves and clothing. 
Organolithium reagents. Pyrophoric liquids. Catch fire spontaneously if exposed to air. In 
contact with water release flammable gases which may ignite spontaneously. May be fatal if 
swallowed and enter airways. Cause severe skin burns and eye damage. Do not allow contact 
with air or water. Handle and store under inert gas. Protect from moisture. Wear protective 
gloves and clothing. 
Pentane. May be fatal if swallowed and enters airways. Avoid breathing vapors. 
Phosphorus trichloride. Causes severe skin burns and eye damage. Reacts violently with 
water. Contact with water liberates toxic gas. Wear protective gloves and clothing.  
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Solvents in general. (Highly) flammable liquid and vapor. Harmful if swallowed, in contact 
with skin or if inhaled. Keep away from heat, hot surfaces, sparks, open flames and other 
ignition sources. Avoid inhalation. Wear protective gloves and clothing. 
Transition metal salts. May cause an allergic skin reaction. Cause severe skin burns and 
eye damage. May cause respiratory irritation. Very toxic to aquatic life (with long lasting 
effects). Wear protective gloves and clothing. 
Tris(dimethylamino)phosphine. May cause genetic defects. May cause cancer. Wear 
protective gloves and clothing. 
7.3. Synthetic procedures and spectral data 
7.3.1. Synthesis of a chiral phosphorus ligand library 
The chiral phosphine ligands (R)-2-(diphenylphosphino)-2’-methoxy-1,1’-binaphthyl (MOP) 
L29 and (R)-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (BINAP) L1 were purchased from 
Merck and used without further purification. The ligand (R)-2-(dicyclopentylphosphino)-2’-
(naphthalen-1-ylmethoxy)-1,1’-binaphthyl L30 was synthesized and provided by the Hartwig 
group.244 
7.3.1.1. Synthesis of BINOL-derived phosphoramidites L26 
Enantiopure (R)-1,1’-binaphthyl-2,2’-diol (BINOL) 6.4 was purchased from Merck and used 
without further purification. The 3,3’-disubstituted BINOLs (R)-3,3’-dimethyl-1,1’-binaphthyl-
2,2’-diol 6.9 and (R)-3,3’-di(9-phenanthryl)-1,1’-binaphthyl-2,2’-diol 6.10 were synthesized 
according to literature procedures reported by Xu et al.238a and Rueping et al..238b, 238c The 
6,6’-disubstituted BINOL (R)-6,6’-di(1-adamantyl)-1,1’-binaphthyl-2,2’-diol 6.11 was 
synthesized as reported by Yang et al..239 The spectroscopic data of the obtained products are 
in agreement with the reported literature values.  
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The BINOL-derived phosphoramidites L26 were synthesized via a procedure reported by 
González et al..240 An oven-dried 10 mL round-bottom flask equipped with a Teflon-coated 
magnetic stirrer and a reflux condenser was charged with (R)-BINOL 6.4 or a derived diol 
(0.600 mmol) and dry toluene (4 mL, 0.15 M), and placed under nitrogen atmosphere. To this 
solution, tris(dimethylamino)phosphine (0.11 mL, 0.600 mmol) was added and the mixture 
was heated to reflux (110 °C). When TLC analysis of the reaction mixture indicated complete 
consumption of the starting material, the solution was concentrated under reduced pressure. 
Purification by flash column chromatography on silica gel yielded the desired ligands L26 as 
white solids. 
(R)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a:3,4-a′]dinaphthalen-4-yl)dimethylamine L26a. The 
compound was synthesized from diol 6.4 (R1 = R2 = H). Reaction time 3 h. White 
solid, yield 25%. Rf (SiO2) = 0.46 (hexane/EtOAc 9:1). 1H NMR (600 MHz, CDCl3): 
δ 7.97 (d, J = 8.8 Hz, 1H), 7.93 – 7.89 (m, 3H), 7.51 (d, J = 8.6 Hz, 1H), 7.44 – 
7.40 (m, 3H), 7.39 (d, J = 8.7 Hz, 1H), 7.35 (d, J = 8.5 Hz, 1H), 7.30 – 7.23 (m, 
2H), 2.56 (d, 3JHP = 9.0 Hz, 6H). 13C NMR (151 MHz, CDCl3): δ 150.1 (d, 2JCP = 4.9 Hz), 149.6, 133.0, 
132.7, 131.5, 130.9, 130.4, 130.1, 128.5, 128.4, 127.13, 127.05, 126.2 (2C), 124.9, 124.7, 124.1 (d, JCP 
= 4.9 Hz), 122.9 (d, JCP = 2.2 Hz), 122.2, 122.1 (d, JCP = 2.0 Hz), 36.1 (d, 2JCP = 20.9 Hz, 2C). 31P NMR 
(162 MHz, CDCl3): δ 148.70. HRMS (ESI, 3.5 kV): m/z calcd. for C22H18NO2P + H+ 360.1148, found 
360.1137. The spectroscopic data are in agreement with the previously reported literature values.240 
(R)-(2,6-Dimethyl-3,5-dioxa-4-phosphacyclohepta[2,1-a:3,4-a']dinaphthalen-4-yl)dimethylamine 
L26b. The compound was synthesized from diol 6.9 (R1 = Me, R2 = H). Reaction 
time 1 h. White solid, yield 27%. Rf (SiO2) = 0.30 (hexane/CH2Cl2 3:1). 1H NMR 
(400 MHz, CDCl3): δ 7.85 – 7.80 (m, 3H), 7.76 (s, 1H), 7.40 – 7.35 (m, 2H), 7.34 
(d, J = 8.3 Hz, 1H), 7.25 (d, J = 8.6 Hz, 1H), 7.23 – 7.13 (m, 2H), 2.61 (s, 3H), 
2.53 (d, 3JHP = 9.0 Hz, 6H), 2.51 (s, 3H). 13C NMR (126 MHz, CDCl3): δ 149.2 (d, 2JCP = 3.9 Hz), 148.8 
(d, 2JCP = 1.6 Hz), 131.8 (d, JCP = 1.3 Hz), 131.6, 131.3, 130.8, 130.5 (d, JCP = 1.6 Hz), 130.0, 129.8, 
129.5, 127.6, 127.5, 127.0, 126.9, 125.18, 125.15, 124.8, 124.6, 124.1 (d, JCP = 5.1 Hz), 122.9 (d, JCP 
= 2.1 Hz), 35.7 (d, 2JCP = 21.4 Hz, 2C), 17.75 (d, 4JCP = 2.4 Hz), 17.67. 31P NMR (162 MHz, CDCl3): δ 
145.92. HRMS (ESI, 3.5 kV): m/z calcd. for C24H22NO2P + H+ 388.1461, found 388.1441.  
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(R)-(2,6-Di(9-phenanthryl)-3,5-dioxa-4-phosphacyclohepta[2,1-a:3,4-a']dinaphthalen-4-yl)-
dimethylamine L26c. The compound was synthesized from diol 6.10 (R1 = 
9-phenanthryl, R2 = H). Reaction time 1 h. Isolated as a mixture of two isomers 
(maj./min. 65:35). White solid, yield 89%. Rf (SiO2) = 0.35 (hexane/CH2Cl2 2:1). 
1H NMR (600 MHz, CDCl3): δ 8.73 (d, J = 8.4 Hz, 4H, maj.), 8.71 (d, J = 8.5 Hz, 
4H, min.), 8.13 (s, 1H, maj.), 8.11 (s, 1H, min.), 8.04 – 7.99 (m, 2H, maj. + min.), 
7.98 (d, J = 7.9 Hz, 1H, maj.), 7.96 (d, J = 7.7 Hz, 1H, min.), 7.93 – 7.81 (m, 4H, 
maj. + min.), 7.79 (d, J = 8.8 Hz, 2H, min.), 7.78 (d, J = 8.7 Hz, 2H, maj.), 7.74 – 
7.38 (m, 14H, maj. + min.), 1.88 (d, 3JHP = 8.9 Hz, 6H, min.), 1.85 (d, 3JHP = 9.0 
Hz, 6H, maj.). 13C NMR (151 MHz, CDCl3): δ 148.8 (d, 2JCP = 1.4 Hz, min.), 148.6 (d, 2JCP = 1.6 Hz, 
maj.), 148.5 (d, 2JCP = 2.9 Hz, min.), 148.4 (d, 2JCP = 3.3 Hz, maj.), 136.63 (maj.), 136.61 (min.), 135.2 
(maj.), 134.7 (min.), 134.2 (d, JCP = 1.5 Hz, maj.), 134.1 (maj.), 134.0 (min.), 133.9 (d, JCP = 1.7 Hz, 
min.), 133.24 (d, JCP = 1.1 Hz, maj.), 133.15 (min.), 133.12 (maj.), 133.0 (min.), 132.3 – 126.3 (complex 
region of 32C, maj. + min.), 125.3 (maj.), 125.2 (min.), 125.1 (maj. + min.), 124.9 (d, JCP = 4.9 Hz, min.), 
124.7 (d, JCP = 5.0 Hz, maj.), 123.7 (d, JCP = 1.7 Hz, maj.), 123.4 (d, JCP = 3.3 Hz, min.), 122.9 (maj. + 
min.), 122.7 (2C, maj. + min.), 122.60 (min.), 122.58 (maj.), 35.1 (d, 2JCP = 20.3 Hz, 2C, min.), 35.0 (d, 
2JCP = 20.3 Hz, 2C, maj.). 31P NMR (243 MHz, CDCl3): δ 149.04 (min.), 148.84 (maj.). 
(R)-(9,14-Di(1-adamantyl)-3,5-dioxa-4-phosphacyclohepta[2,1-a:3,4-a′]dinaphthalen-4-yl)-
dimethylamine L26d. The compound was synthesized from diol 6.11 (R1 
= H, R2 = 1-adamantyl). Reaction time 1.5 h. White solid, yield 18%. Rf 
(SiO2) = 0.40 (hexane/EtOAc 95:5). 1H NMR (500 MHz, CDCl3): δ 7.92 (d, 
J = 8.8 Hz, 1H), 7.85 (d, J = 8.8 Hz, 1H), 7.78 (s, 1H), 7.76 (s, 1H), 7.45 (d, 
J = 8.7 Hz, 1H), 7.43 – 7.32 (m, 5H), 2.55 (d, 3JHP = 8.9 Hz, 6H), 2.13 (s, 
6H), 2.01 (d, J = 6.4 Hz, 12H), 1.84 – 1.75 (m, 12H). 13C NMR (126 MHz, 
CDCl3): δ 149.5 (d, 2JCP = 4.7 Hz), 149.0, 147.7, 147.4, 131.5, 131.1 (d, JCP = 1.2 Hz), 130.9 (2C), 130.3, 
130.0, 126.9, 126.8, 124.5, 124.4, 123.9 (d, JCP = 4.9 Hz), 123.3, 123.2, 122.7 (d, JCP = 1.7 Hz), 121.9, 
121.8, 43.17 (3C), 43.16 (3C), 37.0 (6C), 36.3 (2C), 36.2 (d, 2JCP = 21.0 Hz, 2C), 29.0 (6C). 31P NMR 
(162 MHz, CDCl3): δ 148.22. 
7.3.1.2. Synthesis of BINOL-derived phosphoramidite L27 with chiral amine moiety 
 
The title compound L27 was synthesized via a procedure reported by Chapsal et al..241 An 
oven-dried 10 mL round-bottom flask was charged with triethylamine (0.35 mL, 2.500 mmol), 
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and placed under nitrogen atmosphere. The flask was cooled to 0 °C and phosphorus 
trichloride (44 µL, 0.500 mmol) was added dropwise. Subsequently, a solution of bis[(R)-1-
phenylethyl]amine 6.12 (114 µL, 0.500 mmol) in dry tetrahydrofuran (1 mL, 0.5 M) was added, 
and the mixture was stirred at room temperature (20 °C) for 3 h. The reaction was then cooled 
again to 0 °C and a solution of (R)-BINOL 6.4 (143 mg, 0.500 mmol) in dry tetrahydrofuran 
(1 mL, 0.5 M) was added, after which stirring was continued at room temperature (20 °C) for 
another 12 h. After addition of diethyl ether (1 mL), the resulting solid was filtered off on a short 
silica column and washed with excess diethyl ether. The filtrate was concentrated under 
reduced pressure. The product L27 was purified by flash column chromatography on silica gel 
with hexane/dichloromethane 3:1 as eluent and was obtained as a white solid (219 mg, 81%). 
(R,R,R)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a:3,4-a′]dinaphthalen-4-yl)bis(1-phenylethyl)amine 
L27. White solid, yield 81%. Rf (SiO2) = 0.35 (hexane/CH2Cl2 3:1). 1H NMR 
(400 MHz, CDCl3): δ 8.00 (d, J = 8.8 Hz, 1H), 7.92 (d, J = 8.2 Hz, 1H), 7.81 
(dd, J = 8.3, 1.2 Hz, 1H), 7.73 (d, J = 8.9 Hz, 1H), 7.57 (dd, J = 8.8, 1.0 Hz, 
1H), 7.41 (ddd, J = 8.2, 6.5, 1.5 Hz, 1H), 7.38 – 7.32 (m, 3H), 7.28 – 7.19 (m, 
3H), 7.19 – 7.15 (m, 10H), 4.41 (dq, 3JHP = 10.8 Hz, J = 7.0 Hz, 2H), 1.68 (d, J 
= 7.1 Hz, 6H). 31P NMR (162 MHz, CDCl3): δ 150.39. The spectroscopic data are in agreement with the 
previously reported literature values.256 
7.3.1.3. Synthesis of TADDOL-derived phosphoramidite L28 
 
Enantiopure (4R,5R)-2,2-dimethyl-α,α,α’,α’-tetraphenyl-1,3-dioxolane-4,5-dimethanol 6.14 
was purchased from Merck and used without further purification. The title compound L28 was 
synthesized via a procedure reported by Alexakis et al..243 An oven-dried 10 mL round-bottom 
flask equipped with a Teflon-coated magnetic stirrer and a reflux condenser was charged with 
(4R,5R)-TADDOL 6.14 (467 mg, 1.00 mmol) and dry toluene (4 mL, 0.25 M), and placed under 
nitrogen atmosphere. To this solution, tris(dimethylamino)phosphine (0.24 mL, 1.30 mmol) 
was added and the mixture was heated to reflux (110 °C) for 19 h. The solution was 
concentrated under reduced pressure and the crude product was purified by flash column 
chromatography on silica gel with hexane/ethyl acetate 95:5 + 1% Et3N as eluent. Subsequent 
crystallization from a mixture of dichloromethane and diethyl ether yielded product L28 as 
white crystals (81 mg, 15%). 
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(3aR,8aR)-(2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxa-
phosphepin-6-yl)dimethylamine L28. White crystals, yield 15%. Rf (SiO2) = 
0.44 (hexane/EtOAc 95:5 + 1% Et3N). 1H NMR (600 MHz, CDCl3): δ 7.75 (d, J 
= 7.3 Hz, 2H), 7.62 (d, J = 7.2 Hz, 2H), 7.49 (d, J = 7.2 Hz, 2H), 7.44 (d, J = 7.3 
Hz, 2H), 7.35 – 7.29 (m, 6H), 7.28 – 7.23 (m, 5H), 7.22 – 7.18 (m, 1H), 5.20 (dd, 
J = 8.5 Hz, 4JHP = 3.1 Hz, 1H), 4.84 (d, J = 8.5 Hz, 1H), 2.75 (d, 3JHP = 10.6 Hz, 
6H), 1.29 (s, 3H), 0.31 (s, 3H). 13C NMR (151 MHz, CDCl3): δ 147.0, 146.7 (d, 3JCP = 1.7 Hz), 142.3 (d, 
3JCP = 1.8 Hz), 142.0 (d, 3JCP = 1.2 Hz), 129.1 (2C), 128.92, 128.89, 128.2 (2C), 127.8 (2C), 127.60 
(2C), 127.59, 127.4, 127.3 (4C), 127.24 (2C), 127.19 (2C), 111.9, 82.6 (d, 3JCP = 3.7 Hz), 82.5 (d, 3JCP 
= 19.6 Hz), 82.1, 81.4 (d, 2JCP = 7.6 Hz), 35.5 (d, 2JCP = 19.6 Hz, 2C), 27.7, 25.5. 31P NMR (162 MHz, 
CDCl3): δ 139.33. HRMS (ESI, 3.5 kV): m/z calcd. for C33H34NO4P + H+ 540.2298, found 540.2297. The 
spectroscopic data are in agreement with the previously reported literature values.243 
7.3.2. Synthesis of phosphorus gold(III)(biphenyl) complexes 
7.3.2.1. Synthesis of tin(IV) complex 6.16 
 
An oven-dried 100 mL three-neck round-bottom flask equipped with a Teflon-coated magnetic 
stirrer and a reflux condenser was charged with dried magnesium turnings (535 mg, 
0.022 mol) and 2-3 iodine crystals. The flask was placed under nitrogen atmosphere and a 
small amount of dry tetrahydrofuran (5 mL) was added, as well as 1 mL of a 1 M solution of 
2,2’-dibromo-1,1’-biphenyl 6.15 (3.12 g, 0.010 mol) in dry tetrahydrofuran (10 mL). The 
reaction was stirred vigorously under heating until the purple iodine color disappeared. 
Subsequently, the rest of the 2,2’-dibromo-1,1’-biphenyl 6.15 solution was added dropwise at 
room temperature (20 °C), after which the reaction was heated to 50 °C for 24 h. The mixture 
was then cooled again to room temperature (20 °C) and a solution of dibutyltin dichloride 
(3.04 g, 0.010 mol) in dry tetrahydrofuran (10 mL, 1 M) was added slowly. The reaction was 
stirred for 45 h, diluted with diethyl ether (20 mL) and quenched with a saturated aqueous 
solution of NaCl (25 mL). The aqueous layer was extracted with diethyl ether (3 x 50 mL) and 
the combined organic phases were dried over MgSO4, filtered and concentrated. The product 
6.16 was recrystallized in ethanol and obtained as white crystals (3.21 g, 83%).  
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9,9-Dibutyl-9-stannafluorene 6.16. White crystals, yield 83%. Rf (SiO2) = 0.24 (hexane/Et3N 40:1). 
1H NMR (600 MHz, CDCl3): δ 7.97 (d, J = 7.8 Hz, 2H), 7.64 (dd, J = 7.0, 1.4 Hz, 2H), 
7.40 (td, J = 7.6, 1.5 Hz, 2H), 7.28 (t, J = 7.0 Hz, 2H), 1.66 – 1.60 (m, 4H), 1.39 – 1.32 
(m, 8H), 0.88 (t, J = 7.3 Hz, 6H). 13C NMR (126 MHz, CDCl3): δ 148.8 (2C), 141.3 (2C), 
136.7 (2C), 129.0, 128.9, 127.4, 127.3, 122.6 (2C), 29.2 (2C), 27.3 (2C), 13.8 (2C), 12.1 
(2C). The spectroscopic data are in agreement with the previously reported literature values.245 
7.3.2.2. Synthesis of precursor gold(III) complex 6.18 
 
The title compound 6.18 was synthesized via a modification of a procedure reported by Usón 
et al..247c To a suspension of AuCl3 (1.69 g, 5.600 mmol) in a 1:6 mixture of water and ethanol 
(14 mL, 0.40 M) was added dropwise tetrahydrothiophene (0.50 mL, 5.600 mmol). The 
resulting mixture was stirred at room temperature (20 °C) for 10 minutes, after which the 
formed yellow precipitate was filtered through a fine fritted funnel, washed with cold ethanol (2 
x 5 mL) and dried under high vacuum (1.50 g, 68%). 
Trichloro(tetrahydrothiophene)gold(III) 6.18. Yellow solid, yield 68%. 1H NMR (600 MHz, CDCl3): δ 
3.60 – 3.22 (m, 4H), 2.37 – 1.99 (m, 4H). 13C NMR (126 MHz, CDCl3): δ 40.5 (2C), 30.6 
(2C). 
7.3.2.3. Synthesis of gold(III) dimer 6.19 
 
The title compound 6.19 was synthesized via a procedure reported by Wu et al..235 A 100 mL 
round-bottom flask was charged with 9,9-dibutyl-9-stannafluorene 6.16 (963 mg, 2.500 mmol) 
and dichloromethane (25 mL, 0.1 M), and the resulting solution was cooled to 0 °C in an ice 
bath. Subsequently, trichloro(tetrahydrothiophene)gold(III) 6.18 (979 mg, 2.500 mmol) was 
added, and the color of the reaction mixture immediately changed from yellow to black. The 
reaction was stirred for 10 minutes at 0 °C and for another 10 minutes at room temperature 
(20 °C), followed by concentration under reduced pressure to a volume of approximately 
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1.5 mL. The remaining solution was passed through celite and added dropwise to stirred 
hexane (200 mL). The white precipitate was collected by centrifuge, washed with hexane (3 x 
25 mL) and diethyl ether (3 x 25 mL), and dried under high vacuum (437 mg, 45%). The title 
compound 6.19 was not soluble in non-coordinating solvents. 
(Biphen-2,2’-diyl)chlorogold(III) 6.19. White solid, yield 45%. 1H NMR (400 MHz, DMSO-d6): δ 7.82 
(d, J = 7.9 Hz, 1H), 7.45 – 7.39 (m, 3H), 7.19 (t, J = 7.6 Hz, 1H), 7.16 (t, J = 7.6 Hz, 1H), 
7.00 (t, J = 7.6 Hz, 1H), 6.92 (t, J = 7.7 Hz, 1H). 13C NMR (151 MHz, DMSO-d6): δ 156.2, 
151.6, 150.5, 147.4, 133.2, 128.5, 128.2, 128.1, 126.8, 126.7, 122.0, 121.6. HRMS (ESI, 
3.5 kV): m/z calcd. for C12H8AuCl + Cl- 418.9674, found 418.9699. The spectroscopic 
data are in agreement with the previously reported literature values.235 
7.3.2.4. Synthesis of chiral gold(III)(biphenyl) complexes 6.21 
 
The gold(III) complexes 6.21 were synthesized via a modification of a procedure reported by 
Wu et al..235 An oven-dried 4 mL screw-top vial was charged with (biphen-2,2’-diyl)-
chlorogold(III) dimer 6.19 (42 mg, 0.055 mmol) and dry dichloromethane (0.4 mL), and the 
resulting suspension was cooled to 0 °C in an ice bath. A solution of the desired ligand 
(0.100 mmol) in 1.0 mL of dry dichloromethane (final concentration of 0.07 M) was added 
dropwise, and the reaction mixture was allowed to warm to room temperature (20 °C) and 
stirred for 1 h. The mixture was then passed through a short silica column and concentrated 
under reduced pressure to yield the desired gold(III) complexes 6.21 as off-white to white 
solids. 
Triphenylphosphinegold(III)(biphenyl) chloride 6.21a. White solid, quant. yield. 1H NMR (600 MHz, 
CDCl3): δ 8.36 (t, J = 8.3 Hz, 1H), 7.72 – 7.67 (m, 5H), 7.54 – 7.38 (m, 11H), 7.36 – 7.30 
(m, 1H), 7.19 (t, J = 7.5 Hz, 1H), 7.13 – 7.08 (m, 1H), 7.02 (t, J = 7.5 Hz, 1H), 6.75 (d, J 
= 7.6 Hz, 1H), 6.37 (t, J = 7.8 Hz, 1H). 13C NMR (151 MHz, CDCl3): δ 166.5 (d, 2JCP = 
131.1 Hz), 154.7 (d, JCP = 4.6 Hz), 154.3 (d, JCP = 7.5 Hz), 152.5, 135.5, 135.4 (d, 2JCP = 
11.3 Hz, 6C), 133.5, 131.9 (d, 4JCP = 2.8 Hz, 3C), 128.9 (d, 3JCP = 11.0 Hz, 6C), 128.21 (d, 1JCP = 49.1 
Hz, 3C), 128.15, 127.5, 127.4 (d, JCP = 9.9 Hz), 126.7 (d, JCP = 2.9 Hz), 121.9, 121.4 (d, JCP = 7.0 Hz). 
31P NMR (243 MHz, CDCl3): δ 41.20.  
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((R)-L26a)gold(III)(biphenyl) chloride 6.21b. White solid, yield 77%. 1H NMR (500 MHz, CDCl3): δ 
8.28 (dd, 4JHP = 13.4 Hz, J = 7.7 Hz, 1H), 8.12 – 8.06 (m, 2H), 8.00 (d, J = 8.1 
Hz, 1H), 7.96 – 7.91 (m, 1H), 7.89 (d, J = 8.2 Hz, 1H), 7.63 (d, J = 8.9 Hz, 1H), 
7.53 (ddd, J = 8.1, 6.7, 1.2 Hz, 1H), 7.47 – 7.41 (m, 3H), 7.39 – 7.33 (m, 3H), 
7.32 – 7.24 (m, 2H), 7.21 (t, J = 7.3 Hz, 1H), 7.19 – 7.15 (m, 1H), 7.11 (tdd, J = 
7.4, 5.6, 1.5 Hz, 1H), 6.99 (t, J = 7.7 Hz, 1H), 2.80 (d, 3JHP = 11.5 Hz, 6H). 
13C NMR (126 MHz, CDCl3): δ 164.0 (d, 2JCP = 188.8 Hz), 154.9 (d, JCP = 10.5 
Hz), 154.3 (d, JCP = 6.9 Hz), 152.7 (d, JCP = 1.9 Hz), 147.8 (d, JCP = 11.5 Hz), 147.5 (d, JCP = 5.5 Hz), 
134.4, 132.7 (d, JCP = 3.3 Hz), 132.4 (d, JCP = 1.4 Hz), 132.3 (d, JCP = 1.2 Hz), 132.0 (d, JCP = 1.0 Hz), 
131.7, 131.5, 131.2, 128.7 (2C), 128.4, 128.2, 127.7 (d, JCP = 3.1 Hz), 127.22 (d, JCP = 14.3 Hz), 127.19, 
127.1, 127.0, 126.7, 126.1, 125.9, 122.8 (d, JCP = 1.4 Hz), 122.4 (2C), 121.5, 121.4 (d, JCP = 10.0 Hz), 
120.6, 37.7 (d, 2JCP = 10.2 Hz, 2C). 31P NMR (202 MHz, CDCl3): δ 149.44. 
((R)-L26b)gold(III)(biphenyl) chloride 6.21c. Off-white solid, yield 51%. 1H NMR (400 MHz, CDCl3): δ 
8.30 (dd, 4JHP = 13.6 Hz, J = 7.5 Hz, 1H), 7.92 – 7.85 (m, 3H), 7.79 (d, J = 8.2 
Hz, 1H), 7.75 (s, 1H), 7.48 (ddd, J = 8.1, 6.5, 1.3 Hz, 1H), 7.42 – 7.34 (m, 3H), 
7.33 – 7.24 (m, 2H), 7.21 – 7.07 (m, 5H), 6.79 (t, J = 7.6 Hz, 1H), 2.75 – 2.64 
(m, 9H), 2.58 (s, 3H). 13C NMR (151 MHz, CDCl3): δ 164.1 (d, 2JCP = 189.8 Hz), 
155.2 (d, JCP = 10.9 Hz), 154.1 (d, JCP = 7.2 Hz), 152.8 (d, JCP = 2.0 Hz), 147.1 
(d, JCP = 7.0 Hz), 147.0 (d, JCP = 13.2 Hz), 133.7, 133.1 (d, JCP = 3.2 Hz), 131.9, 
131.8, 131.5 (d, JCP = 1.9 Hz), 131.35 (d, JCP = 1.1 Hz), 131.32, 130.8, 129.7 
(d, JCP = 2.6 Hz), 129.2, 128.4, 128.2, 127.9, 127.7, 127.5 (d, JCP = 2.7 Hz), 127.2 (d, JCP = 14.8 Hz), 
127.03, 127.00, 126.09, 126.06, 125.83, 125.76, 123.2 (d, JCP = 2.7 Hz), 122.6 (d, JCP = 2.3 Hz), 122.2, 
121.4 (d, JCP = 10.0 Hz), 37.5 (2C), 19.4, 17.3. 31P NMR (162 MHz, CDCl3): δ 147.79. 
((R)-L26c)gold(III)(biphenyl) chloride 6.21d. Isolated as a mixture of three isomers (51:27:22). White 
solid, yield 79%. 1H NMR (600 MHz, CDCl3): δ 8.80 (d, J = 8.1 Hz), 8.79 (d, J 
= 8.1 Hz), 8.74 (d, J = 8.4 Hz), 8.70 (d, J = 8.4 Hz), 8.68 (d, J = 8.5 Hz), 8.64 
(d, J = 8.0 Hz) (2H, combined); 8.49 – 8.43 (m), 8.38 (s), 8.36 (s), 8.31 (s), 
8.27 – 8.20 (m) (3H, combined); 8.15 – 8.04 (m, 2H); 8.01 – 7.72 (m, 6H); 
7.72 – 7.39 (m, 14H); 7.35 (br s), 7.18 – 7.13 (m) (1H, combined); 7.07 – 6.64 
(m, 5H); 6.52 (br s), 6.23 – 6.13 (m) (2H, combined); 5.59 (br s), 5.38 – 5.32 
(m) (1H, combined); 2.32 – 2.02 (m), 1.82 – 1.57 (m) (6H, combined). 
31P NMR (243 MHz, CDCl3): δ 150.18 (51%), 149.62 (22%), 148.64 (27%). 
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((R)-L26d)gold(III)(biphenyl) chloride 6.21e. Off-white solid, yield 83%. 1H NMR (400 MHz, CDCl3): δ 
8.27 (dd, 4JHP = 13.3 Hz, J = 7.7 Hz, 1H), 8.09 (d, J = 7.7 Hz, 1H), 8.02 (d, 
J = 8.8 Hz, 1H), 7.89 (d, J = 8.0 Hz, 1H), 7.84 (s, 1H), 7.74 (s, 1H), 7.56 
(d, J = 8.8 Hz, 1H), 7.45 (s, 2H), 7.41 (d, J = 7.4 Hz, 1H), 7.37 – 7.27 (m, 
4H), 7.22 – 7.14 (m, 2H), 7.13 – 7.07 (m, 1H), 6.96 (t, J = 7.5 Hz, 1H), 
2.79 (d, 3JHP = 11.5 Hz, 6H), 2.15 (s, 3H), 2.10 (s, 3H), 2.03 (d, J = 3.0 Hz, 
6H), 1.96 (d, J = 3.0 Hz, 6H), 1.87 – 1.72 (m, 12H). 13C NMR (151 MHz, 
CDCl3): δ 164.0 (d, 2JCP = 189.1 Hz), 154.9 (d, JCP = 10.5 Hz), 154.4, 152.7 
(d, JCP = 2.0 Hz), 149.0, 148.8, 147.3 (d, JCP = 13.0 Hz), 147.0 (d, JCP = 5.4 Hz), 134.5, 132.8 (d, JCP = 
3.2 Hz), 132.2, 131.9, 131.4, 131.1, 130.7, 130.5, 128.3, 128.1, 127.7 (d, JCP = 3.0 Hz), 127.2 (d, JCP = 
14.6 Hz), 127.0, 126.8, 125.4, 125.0, 123.6, 123.5, 122.6, 122.3, 122.2, 121.4, 121.3 (d, JCP = 9.9 Hz), 
120.3, 43.13 (3C), 43.07 (3C), 37.7 (d, 2JCP = 10.3 Hz, 2C), 36.90 (3C), 36.89 (3C), 36.5, 36.3, 29.01 
(3C), 28.99 (3C). 31P NMR (162 MHz, CDCl3): δ 148.73. 
((R,R,R)-L27)gold(III)(biphenyl) chloride 6.21f. The compound was synthesized in chloroform instead 
of dichloromethane. The reaction mixture was heated to reflux (61 °C) for 2 h. 
Isolated as a mixture of two isomers (maj./min. 57:43). Off-white solid, quant. 
yield. 1H NMR (600 MHz, CDCl3): δ 8.46 (dd, 4JHP = 13.6 Hz, J = 7.6 Hz, 1H, 
maj.), 8.31 (d, J = 9.0 Hz, 1H, maj.), 8.17 (dd, 4JHP = 14.1 Hz, J = 7.8 Hz, 1H, 
min.), 8.13 (d, J = 8.9 Hz, 1H, min.), 8.03 (d, J = 7.1 Hz, 1H, maj.), 8.02 (d, J = 
7.1 Hz, 1H, min.), 7.98 (d, J = 9.0 Hz, 1H, maj.), 7.93 (d, J = 8.8 Hz, 1H, maj.), 
7.87 (d, J = 8.2 Hz, 1H, maj.), 7.85 (d, J = 8.1 Hz, 1H, min.), 7.77 (d, J = 7.5 Hz, 1H, min.), 7.76 (d, J = 
7.9 Hz, 1H, min.), 7.63 (d, J = 9.0 Hz, 1H, min.), 7.54 (d, J = 7.4 Hz, 1H, maj.), 7.53 (d, J = 7.4 Hz, 1H, 
maj.) 7.45 – 7.29 (m, 5H, maj. + min., 1H, min.), 7.24 (d, J = 7.0 Hz, 1H, maj.), 7.22 (d, J = 7.0 Hz, 1H, 
min.), 7.20 – 7.05 (m, 9H, maj. + min.), 7.05 – 7.01 (m, 1H, maj.), 6.96 (dd, J = 7.9, 3.5 Hz, 1H, min.), 
6.86 (br s, 4H, min.), 6.83 (d, J = 9.0 Hz, 1H, maj.), 6.77 (d, J = 7.7 Hz, 4H, maj.), 6.74 (t, J = 7.6 Hz, 
1H, maj.), 6.52 (d, J = 8.8 Hz, 1H, min.), 6.39 (t, J = 7.7 Hz, 1H, min.), 5.29 (br s, 2H, min.), 5.04 (dq, 
3JHP = 14.6 Hz, J = 7.1 Hz, 2H, maj.), 1.87 (d, J = 7.2 Hz, 6H, maj.), 1.45 (br s, 6H, min.). 31P NMR (243 
MHz, CDCl3): δ 151.93 (min.), 151.38 (maj.). 
((R,R)-L28)gold(III)(biphenyl) chloride 6.21g. White solid, yield 89%. 1H NMR (400 MHz, CDCl3): δ 
8.11 (ddd, 4JHP = 13.6 Hz, J = 7.8, 1.3 Hz, 1H), 7.86 (d, J = 7.7 Hz, 2H), 7.69 
(d, J = 7.3 Hz, 2H), 7.47 (t, J = 7.6 Hz, 2H), 7.40 – 7.23 (m, 14H), 7.14 – 7.06 
(m, 2H), 7.03 (tdd, J = 7.4, 5.7, 1.6 Hz, 1H), 6.96 – 6.91 (m, 2H), 6.90 – 6.84 
(m, 1H), 6.79 (td, J = 7.6, 1.6 Hz, 1H), 5.84 (d, J = 7.9 Hz, 1H), 5.47 (d, J = 7.9 
Hz, 1H), 2.31 (d, 3JHP = 11.4 Hz, 6H), 0.56 (s, 3H), 0.48 (s, 3H). 13C NMR (151 
MHz, CDCl3): δ 163.9 (d, 2JCP = 199.7 Hz), 155.5 (d, JCP = 11.5 Hz), 154.1 (d, 
JCP = 6.7 Hz), 152.4 (d, JCP = 2.2 Hz), 144.2, 140.8 (d, 3JCP = 6.8 Hz), 140.2 (d, 3JCP = 8.2 Hz), 139.7, 
132.8 (d, JCP = 3.3 Hz), 131.4 (d, JCP = 9.5 Hz), 129.5 (2C), 129.35, 129.27 (2C), 128.8 (2C), 128.7 
(2C), 128.53, 128.49 (2C), 127.9, 127.7, 127.5, 127.43 (2C), 127.38, 127.18 (2C), 127.16 (2C), 127.0 
(d, JCP = 2.8 Hz), 126.6 (d, JCP = 15.2 Hz), 121.7, 120.8 (d, JCP = 10.4 Hz), 115.8, 91.3 (d, 2JCP = 20.9 
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Hz), 89.2, 79.5 (d, 3JCP = 2.5 Hz), 77.8 (d, 3JCP = 2.0 Hz), 36.9 (d, 2JCP = 11.0 Hz, 2C), 26.8, 26.3. 
31P NMR (162 MHz, CDCl3): δ 123.07. 
((R)-L29)gold(III)(biphenyl) chloride 6.21h. White solid, yield 60%. 1H NMR (400 MHz, CDCl3): δ 8.17 
(td, J = 8.2, 1.0 Hz, 1H), 8.00 – 7.97 (m, 2H), 7.95 (d, J = 8.5 Hz, 1H), 7.67 – 7.61 
(m, 2H), 7.58 (d, J = 9.1 Hz, 1H), 7.53 (ddd, J = 8.0, 6.9, 1.0 Hz, 1H), 7.39 – 7.16 
(m, 10H), 7.15 – 7.09 (m, 3H), 7.06 – 6.91 (m, 4H), 6.89 (td, J = 7.5, 1.1 Hz, 1H), 
6.76 – 6.71 (m, 2H), 6.66 (d, J = 8.5 Hz, 1H), 6.21 (td, J = 7.6, 1.6 Hz, 1H), 3.41 
(s, 3H). 13C NMR (101 MHz, CDCl3): δ 166.0 (d, 2JCP = 131.4 Hz), 155.2, 155.0 (d, 
JCP = 7.7 Hz), 154.0 (d, JCP = 4.6 Hz), 152.3, 143.0 (d, JCP = 9.4 Hz), 137.4 (d, 2JCP 
= 12.7 Hz, 2C), 135.7 (d, 2JCP = 9.6 Hz), 135.5 (d, 2JCP = 10.6 Hz, 2C), 134.6 (d, JCP = 1.9 Hz), 134.0 
(d, JCP = 9.5 Hz), 133.9, 133.1, 131.7 (d, 3JCP = 12.1 Hz), 131.3 (d, 4JCP = 2.1 Hz), 131.1, 130.5 (d, 4JCP 
= 2.8 Hz), 128.72, 128.71 (d, 1JCP = 46.0 Hz), 128.24 (d, 3JCP = 10.9 Hz, 3C), 128.18 (2C), 127.52 (d, 
3JCP = 10.8 Hz), 127.47 (d, 3JCP = 11.7 Hz, 2C), 127.4, 127.3, 127.2, 127.1, 126.84, 126.83 (d, JCP = 
10.1 Hz), 126.5, 126.1 (d, JCP = 3.0 Hz), 125.8 (d, 1JCP = 46.5 Hz), 125.7, 123.3, 121.3, 120.9 (d, JCP = 
7.2 Hz), 118.3 (d, JCP = 5.1 Hz), 112.4, 55.0. 31P NMR (162 MHz, CDCl3): δ 40.84. 
((R)-L30)gold(III)(biphenyl) chloride 6.21i. White solid, quant. yield. 1H NMR (600 MHz, CDCl3): δ 
8.04 (t, J = 8.7 Hz, 2H), 8.00 (d, J = 8.6 Hz, 1H), 7.96 (d, J = 8.3 Hz, 1H), 7.93 (d, 
J = 9.1 Hz, 1H), 7.71 (d, J = 8.2 Hz, 1H), 7.66 (d, J = 8.2 Hz, 1H), 7.61 (br s, 1H), 
7.55 (t, J = 7.5 Hz, 1H), 7.46 (br s, 1H), 7.30 (t, J = 7.5 Hz, 1H), 7.27 – 7.21 (m, 
4H), 7.19 (t, J = 7.5 Hz, 1H), 7.17 (d, J = 8.7 Hz, 1H), 7.11 (t, J = 7.4 Hz, 1H), 
7.09 – 6.98 (m, 4H), 6.89 (t, J = 7.2 Hz, 2H), 6.73 (br s, 2H), 6.41 – 6.35 (m, 1H), 
5.36 (d, 2Jgem = 12.3 Hz, 1H), 5.19 (br s, 1H), 3.02 (br s, 1H), 2.89 (br s, 1H), 2.03 
– 1.85 (m, 3H), 1.82 – 1.73 (m, 1H), 1.67 – 1.51 (m, 3H), 1.48 – 1.34 (m, 5H), 
1.31 – 1.23 (m, 3H), 1.00 (br s, 1H). 13C NMR (151 MHz, CDCl3): δ 165.9 (d, 2JCP = 129.1 Hz), 155.2 
(d, JCP = 6.8 Hz), 154.7, 154.0 (d, JCP = 4.3 Hz), 152.1, 141.5 (d, JCP = 8.9 Hz), 134.3, 134.1, 134.0 (d, 
JCP = 8.8 Hz), 133.7, 133.5, 132.6, 132.1, 131.3, 131.0, 130.4, 129.5, 128.6, 128.3, 128.1, 128.0 (2C), 
127.91, 127.88, 127.3, 127.2, 127.1, 126.8, 126.7 (d, JCP = 9.7 Hz), 126.3 (d, JCP = 2.6 Hz), 126.1, 
125.9, 125.8 (2C), 125.7, 125.0, 123.9, 123.5, 121.4, 120.7, 120.6 (d, JCP = 7.1 Hz), 114.9, 69.0, 35.8 
(d, 1JCP = 23.1 Hz, 2C), 31.4 (2C), 30.4 (2C), 26.4, 25.9, 25.7, 25.2 (d, JCP = 12.5 Hz). 31P NMR (162 
MHz, CDCl3): δ 35.50.  
CHIRAL GOLD(III) COMPLEXES AS SELECTIVE CATALYSTS 
203 
7.3.2.5. Synthesis of bisphosphine gold(III)(biphenyl) complex 6.22 
 
The title compound 6.22 was synthesized from (biphen-2,2’-diyl)chlorogold(III) dimer 6.19 
(42 mg, 0.055 mmol) following the same procedure as outlined for gold(III) complexes 6.21, 
though only one equivalent of ligand ((R)-BINAP L1, 31 mg, 0.050 mmol) was added. Upon 
completion of the reaction, the mixture was passed through a short silica column using 
dichloromethane/methanol 9:1 as eluent. Evaporation of the solvent under reduced pressure 
yielded complex 6.22 as a yellow solid (68 mg, 97%). 
((R)-BINAP)(biphen-2,2’-diyl)gold(III) (biphen-2,2’-diyl)dichloroaurate(III) 6.22. Yellow solid, yield 
97%. 1H NMR (400 MHz, CD2Cl2): δ 8.17 (dd, J = 7.9, 1.2 
Hz, 2H), 7.88 – 7.76 (m, 4H), 7.64 (d, J = 8.7 Hz, 4H), 7.58 
(dd, J = 8.2, 6.5 Hz, 2H), 7.51 – 7.44 (m, 7H), 7.43 – 7.38 
(m, 3H), 7.30 – 7.19 (m, 10H), 7.06 (td, J = 7.4, 1.3 Hz, 
3H), 7.01 (t, J = 7.5 Hz, 5H), 6.91 (td, J = 7.6, 1.6 Hz, 2H), 
6.73 (dd, J = 8.6, 1.0 Hz, 2H), 6.60 – 6.53 (m, 2H), 6.38 – 
6.32 (m, 2H). 31P NMR (162 MHz, CD2Cl2): δ 34.65. HRMS 
(ESI, 3.5 kV): m/z calcd. for C56H40AuP2+ 971.2265, found 971.2296; m/z calcd. for C12H8AuCl2- 
418.9674, found 418.9675. 
7.3.2.6. Synthesis of anionic gold(III)(biphenyl) complex 6.27 
 
The title compound 6.27 was synthesized from (biphen-2,2’-diyl)chlorogold(III) dimer 6.19 
(42 mg, 0.055 mmol) following the same procedure as outlined for gold(III) complexes 6.21. 
Instead of ligand, a solution of tetrabutylammonium chloride (28 mg, 0.100 mmol) in dry 
dichloromethane was added. Upon completion of the reaction, the mixture was passed through 
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a short silica column using dichloromethane/methanol 9:1 as eluent. Evaporation of the solvent 
under reduced pressure yielded complex 6.27 as a white solid (52 mg, 79%). 
Tetrabutylammonium (biphen-2,2’-diyl)dichloroaurate(III) 6.27. White solid, yield 79%. 1H NMR 
(400 MHz, CD2Cl2): δ 8.15 (dd, J = 7.9, 1.2 Hz, 2H), 7.29 (dd, J = 7.6, 1.6 Hz, 
2H), 7.11 (td, J = 7.4, 1.2 Hz, 2H), 6.94 (td, J = 7.6, 1.5 Hz, 2H), 3.16 – 3.10 
(m, 8H), 1.60 – 1.50 (m, 8H), 1.40 – 1.30 (m, 8H), 0.94 (t, J = 7.3 Hz, 12H). 
13C NMR (101 MHz, CD2Cl2): δ 156.0 (2C), 152.6 (2C), 133.2 (2C), 127.5 (2C), 
126.9 (2C), 121.2 (2C), 59.3 (4C), 24.3 (4C), 20.0 (4C), 13.8 (4C). HRMS (ESI, 3.5 kV): m/z calcd. for 
C16H36N+ 242.2842, found 242.2836; m/z calcd. for C12H8AuCl2- 418.9674, found 418.9702. The 
spectroscopic data are in agreement with the previously reported literature values.257 
7.3.3. Synthesis of phosphorus gold(I) complexes 
7.3.3.1. Synthesis of precursor gold(I) complex 6.24 
 
A flame-dried 50 mL round-bottom flask was charged with AuCl3 (500 mg, 1.648 mmol) and 
methanol (11 mL, 0.15 M), and placed under nitrogen atmosphere. The resulting red 
suspension was cooled to 0 °C and concentrated HCl (12 M, 0.14 mL, 1.648 mmol) was added 
dropwise under vigorous stirring until the solution became yellow and homogeneous. 
Subsequently, dimethyl sulfide (0.24 mL, 3.297 mmol) was added dropwise to the solution 
under vigorous stirring. Each drop of dimethyl sulfide resulted in a red color which faded away 
with stirring. Once a drop of dimethyl sulfide hit without resulting in a visible red color, the 
addition was halted. The reaction was warmed to room temperature (20 °C) and stirred for 
0.5 h. The formed suspension was diluted with dichloromethane (40 mL), filtered through a 
fine fritted funnel to remove any gold(0) impurities, and washed with excess dichloromethane. 
The filtrate was concentrated slowly until chloro(dimethylsulfide)gold(I) 6.24 began to crash 
out of solution. At this point, methanol was added to induce further precipitation. The obtained 
solid was filtered and dried briefly in vacuo. The filtrate was reconcentrated and diluted with 
methanol to yield a second crop of product 6.24 (393 mg, 81%, combined yield). 
Chloro(dimethylsulfide)gold(I) 6.24. White to gray powder, yield 81%. 1H NMR (600 MHz, CD2Cl2): δ 
2.74 (s, 6H). 13C NMR (151 MHz, CD2Cl2): δ 25.2 (2C).  
CHIRAL GOLD(III) COMPLEXES AS SELECTIVE CATALYSTS 
205 
7.3.3.2. Synthesis of chiral gold(I) complexes 6.25 
 
The gold(I) complexes 6.25 were synthesized via a procedure reported by González et al..240 
An oven-dried 4 mL screw-top vial was charged with chloro(dimethylsulfide)gold(I) 6.24 
(29 mg, 0.100 mmol) and dry dichloromethane (0.5 mL), and the resulting solution was cooled 
to 0 °C in an ice bath. A solution of the desired ligand (0.100 mmol) in 0.5 mL of dry 
dichloromethane (final concentration of 0.1 M) was added dropwise, and the reaction mixture 
was allowed to warm to room temperature (20 °C) and stirred for 1.5 h. The reaction solution 
was concentrated under reduced pressure to yield the desired gold(I) complexes 6.25 as white 
solids. 
Triphenylphosphinegold(I) chloride 6.25a. White solid, quant. yield. 1H NMR (600 MHz, CDCl3): δ 
7.55 – 7.50 (m, 9H), 7.49 – 7.45 (m, 6H). 13C NMR (151 MHz, CDCl3): δ 134.3 (d, 2JCP 
= 13.8 Hz, 6C), 132.1 (d, 4JCP = 2.7 Hz, 3C), 129.4 (d, 3JCP = 11.8 Hz, 6C), 128.9 (d, 
1JCP = 62.3 Hz, 3C). 31P NMR (243 MHz, CDCl3): δ 33.19. The spectroscopic data are 
in agreement with the previously reported literature values.258 
((R)-L26a)gold(I) chloride 6.25b. White solid, quant. yield. 1H NMR (400 MHz, CDCl3): δ 8.07 (d, J = 
8.8 Hz, 1H), 8.01 (d, J = 8.8 Hz, 1H), 7.97 (t, J = 7.3 Hz, 2H), 7.58 (dd, J = 8.8, 
1.3 Hz, 1H), 7.54 – 7.48 (m, 2H), 7.43 (dd, J = 8.8, 1.1 Hz, 2H), 7.37 – 7.30 (m, 
3H), 2.78 (d, 3JHP = 12.0 Hz, 6H). 13C NMR (151 MHz, CDCl3): δ 147.6 (d, 2JCP = 
13.1 Hz), 146.7 (d, 2JCP = 6.1 Hz), 132.5 (d, JCP = 2.0 Hz), 132.3 (d, JCP = 1.5 Hz), 
132.2 (d, JCP = 1.4 Hz), 131.8 (d, JCP = 1.2 Hz), 131.6 (d, JCP = 1.1 Hz), 131.4 (d, JCP = 1.3 Hz), 128.8, 
128.6, 127.1 (2C), 127.02, 126.98, 126.1, 126.0, 122.7 (d, JCP = 3.2 Hz), 122.2 (d, JCP = 2.7 Hz), 121.0 
(d, JCP = 3.0 Hz), 120.4 (d, JCP = 2.1 Hz), 37.5 (d, 2JCP = 12.0 Hz, 2C). 31P NMR (162 MHz, CDCl3): δ 
128.36. The spectroscopic data are in agreement with the previously reported literature values.240 
((R,R)-L28)gold(I) chloride 6.25g. White solid, quant. yield. 1H NMR (600 MHz, CDCl3): δ 7.54 (dd, J 
= 6.5, 3.0 Hz, 2H), 7.51 (dd, J = 7.8, 1.5 Hz, 2H), 7.45 (d, J = 7.4 Hz, 2H), 7.44 
– 7.42 (m, 3H), 7.39 (t, J = 7.5 Hz, 2H), 7.36 – 7.31 (m, 4H), 7.31 – 7.26 (m, 5H), 
5.65 (d, J = 8.1 Hz, 1H), 5.08 (d, J = 8.2 Hz, 1H), 2.72 (d, 3JHP = 13.0 Hz, 6H), 
0.93 (s, 3H), 0.41 (s, 3H). 13C NMR (151 MHz, CDCl3): δ 144.6 (d, 3JCP = 3.3 
Hz), 143.5, 140.2 (d, 3JCP = 6.6 Hz), 139.6 (d, 3JCP = 6.0 Hz), 129.2, 129.1 (2C), 128.9 (2C), 128.5 (2C), 
128.45 (2C), 128.39, 128.36, 128.04 (2C), 128.01, 127.7 (2C), 127.5 (2C), 127.0 (2C), 114.2, 89.0 (d, 
2JCP = 12.0 Hz), 86.6 (d, 2JCP = 1.0 Hz), 80.7 (d, 3JCP = 2.2 Hz), 80.2 (d, 3JCP = 7.1 Hz), 36.9 (d, 2JCP = 
12.6 Hz, 2C), 27.0, 26.0. 31P NMR (243 MHz, CDCl3): δ 109.12.  
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((R)-L29)gold(I) chloride 6.25h. White solid, quant. yield. 1H NMR (400 MHz, CDCl3): δ 8.13 (d, J = 
9.0 Hz, 1H), 7.93 (d, J = 8.7 Hz, 2H), 7.88 (d, J = 8.2 Hz, 1H), 7.56 (ddd, J = 8.1, 6.8, 
1.3 Hz, 1H), 7.51 – 7.45 (m, 3H), 7.44 – 7.36 (m, 3H), 7.35 – 7.19 (m, 9H), 6.95 (ddd, 
J = 8.3, 6.8, 1.3 Hz, 1H), 6.56 (dd, J = 8.4, 1.0 Hz, 1H), 3.44 (s, 3H). 13C NMR (151 
MHz, CDCl3): δ 155.0, 143.4 (d, JCP = 15.4 Hz), 134.6 (d, JCP = 2.1 Hz), 134.32 (d, 
2JCP = 14.1 Hz, 2C), 134.30 (d, 2JCP = 14.1 Hz, 2C), 133.8, 133.7 (d, JCP = 10.4 Hz), 131.43, 131.36 (d, 
4JCP = 2.6 Hz), 131.3 (d, 4JCP = 2.6 Hz), 130.1 (d, 1JCP = 61.1 Hz), 129.9 (d, 1JCP = 61.4 Hz), 129.1, 
128.92 (d, 3JCP = 11.7 Hz, 2C), 128.88 (d, 3JCP = 11.7 Hz, 2C), 128.8 (d, JCP = 7.2 Hz), 128.7, 128.4, 
128.3 (d, JCP = 9.3 Hz), 128.1, 127.4, 127.3 (d, JCP = 1.9 Hz), 126.9, 125.8 (d, 1JCP = 64.4 Hz), 124.4, 
123.6, 118.9 (d, JCP = 8.6 Hz), 113.0, 55.3. 31P NMR (162 MHz, CDCl3): δ 24.80. 
7.3.4. Procedure of the gold-catalyzed cycloisomerization of 7-alkynyl cycloheptatrienes 
 
The substrate 7-((4-methoxyphenyl)ethynyl)cyclohepta-1,3,5-triene 6.33 was synthesized as 
reported by McGonigal et al..249 A mixture of AgOTf (1.0 mg, 0.004 mmol) and phosphorus 
gold(III)(biphenyl) chloride complex or phosphorus gold(I) chloride complex (0.004 mmol) was 
suspended in 200 µL of dichloromethane-d2 in a sealed, screw-top vial, and sonicated for 15 
minutes at room temperature. The resulting suspension was filtered through a glass microfiber 
plug directly into a solution of substrate 6.33 (17.8 mg, 0.080 mmol) in 200 µL of 
dichloromethane-d2 (final concentration of 0.2 M). The reaction was stirred at room 
temperature (20 °C) for 30 minutes, after which the crude mixture was analyzed by 1H NMR. 
Prior to HPLC analysis, the catalyst was removed by passage through a short silica column 
using pentane/dichloromethane 3:1 as eluent (Rf product = 0.45). The enantiomeric excess 
was determined using a Chiralcel OD-H column (hexane/isopropanol 99:1, 0.5 mL min-1, 
220 nm) to separate the enantiomers (Figure 6.6). The spectroscopic data of the obtained 
products 6.34 and 6.35 are in agreement with the previously reported literature values.249 
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Figure 6.6. Representative HPLC trace of indene 6.34. First enantiomer tr = 19.9 min; second enantiomer tr 
= 21.8 min. 
7.3.5. Procedure of the gold-catalyzed Rautenstrauch/Friedel-Crafts cyclization 
 
The substrate (E)-7-(3,5-dimethoxyphenyl)-4-methylhept-4-en-1-yn-3-yl pivalate 6.45 was 
synthesized as reported by Sethofer, and the reaction was performed following a procedure 
reported by the same author.252 A mixture of AgSbF6 (0.7 mg, 0.002 mmol) and phosphorus 
gold(III)(biphenyl) chloride complex (0.002 mmol) was suspended in 200 µL of benzene-d6 in 
a sealed, screw-top vial, and sonicated for 30 minutes under gentle heating (40-50 °C). The 
resulting suspension was filtered through a glass microfiber plug directly into a solution of 
substrate 6.45 (6.9 mg, 0.020 mmol) in 200 µL of benzene-d6 (final concentration of 0.05 M). 
The reaction was stirred at room temperature (20 °C) for 1 h, after which the crude mixture 
was analyzed by 1H NMR. Prior to HPLC analysis, the catalyst was removed by passage 
through a short silica column using dichloromethane/hexane 3:1 as eluent (Rf product = 0.53). 
The solvent was removed under a stream of nitrogen, and the residue was dissolved in 
hexane/isopropanol 10:1. The enantiomeric excess was determined using a Chiralpak IB 
column (hexane/isopropanol 99.5:0.5, 0.5 mL min-1, 215 nm) to separate the enantiomers 
(Figure 6.7). The spectroscopic data of the obtained product 6.48 are in agreement with the 
previously reported literature values.252 
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Figure 6.7. Representative HPLC trace of pivalate 6.48. First enantiomer tr = 16.4 min; second enantiomer 
tr = 17.8 min. 
7.3.6. Procedure of the gold-catalyzed Diels-Alder cycloaddition 
 
The substrate (E,E)-2,4-hexadienal 6.57 was purchased from Merck and used without further 
purification. Cyclopentadiene 6.58 was freshly prepared from dicyclopentadiene by cracking 
and fractional distillation.259 The reaction was performed following a procedure reported by Wu 
et al..235 A mixture of AgNTf2 (1.4 mg, 0.0036 mmol) and phosphorus gold(III)(biphenyl) 
chloride complex (0.0036 mmol) was suspended in 125 µL of toluene/nitromethane 4:1 in a 
sealed, screw-top vial, and sonicated for 10 minutes at room temperature. The resulting 
suspension was filtered through a glass microfiber plug. To this mixture, 4 Å molecular sieves 
(25 mg, not dried) and (E,E)-2,4-hexadienal 6.57 (4 µL, 0.036 mmol) were added, and, 
depending on the desired temperature, the mixture was cooled to 0 °C or kept at room 
temperature (20 °C). Subsequently, cyclopentadiene 6.58 (45 µL, 0.543 mmol) was added in 
three equal portions of 15 µL at the interval of 3 h each. The reaction was stirred for 18 h at 
the designated temperature (0 °C or 20 °C). The crude mixture was passed through a short 
silica column using dichloromethane as eluent. The solvent was removed under a stream of 
nitrogen, and the residue was dissolved in 0.5 mL of a 1.0 mg mL-1 solution of 
1,4-dinitrobenzene in chloroform-d and analyzed by 1H NMR. Prior to HPLC analysis, the 
product was isolated by preparative TLC using hexane/ethyl acetate 6:1 as eluent (Rf product 
= 0.35). The solvent was removed under a stream of nitrogen, and the residue was dissolved 
in hexane. The enantiomeric excess of the endo product was determined using a Chiralpak 
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AS-H column (hexane/isopropanol 99.5:0.5, 0.5 mL min-1, 225 nm) to separate the 
enantiomers (Figure 6.8). The spectroscopic data of the obtained product 6.59 are in 
agreement with the previously reported literature values.235 
 
Figure 6.8. Representative HPLC trace of cycloadduct 6.59. First enantiomer tr = 29.1 min; second 
enantiomer tr = 32.8 min. 
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Over the past decade, gold catalysis has emerged as one of the most powerful and 
straightforward synthetic tools in modern organic chemistry for the atom-economical 
construction of cyclic skeletons. This late transition metal has the unique ability to selectively 
activate unsaturated C-C bonds, even in a complex polyfunctional framework, and catalyze 
subsequent intra- or intermolecular nucleophilic addition under mild conditions. 
In the first part of this thesis, the gold-catalyzed cyclization of alkynes was devised as a key 
step in the synthesis of fluorescent strigolactone (SL) analogs. SLs are a family of terpenoid 
allelochemicals that were recognized as plant hormones only a decade ago. They influence a 
myriad of both above- and belowground developmental processes, and are an important 
survival strategy for plants in nutrient-deprived soils. While the knowledge on the biochemical 
processes behind SL perception and signaling has extensively improved since their discovery, 
the distribution and transportation of SLs within the plant is still an unresolved topic. The 
application of fluorescently labeled derivatives is an increasingly popular method to study the 
dynamic process involved in the spatiotemporal regulation of plant hormones.  
In the past, the labeling of SLs has mainly been achieved by the conjugation of a known 
fluorescent dye, such as fluorescein or BODIPY, to the tricyclic core of natural SLs, e.g., strigol 
i, or their synthetic derivatives. The major drawback of this approach is the substantial increase 
of the molecular weight and overall size of the hormone, which accounts for the reduced 
biological activity observed for this type of tracers. Therefore, a novel class of labeled SL 
analogs (ii) was constructed, where the original tricyclic lactone moiety of natural SLs was 
replaced by a fluorescent cyanoisoindole ring system (Figure I). The biologically essential 
α,β-unsaturated furanone ring and connected enol ether bridge were untouched. 
 
Figure I. Molecular structure of natural SLs and cyanoisoindole-labeled SL analogs.  
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In total, six new cyanoisoindole strigolactone analogs (CISA) with various substitution patterns 
and fused 5- or 6-membered rings were prepared. The synthetic pathway consisted of five 
major steps, starting from a selection of ortho-brominated arylaldehydes iii (Scheme I). The 
first step involved a Sonogashira cross-coupling, implementing a TMS-capped alkyne onto the 
aromatic ring. Silyl deprotection of the intermediate proceeded smoothly in the presence of 
potassium carbonate in methanol. In the second step, a Strecker reaction was carried out to 
transform aldehyde iv into α-amino nitrile vi. The fluorescent 1-cyanoisoindole core vii was 
then generated through annulation of the amino moiety with the earlier introduced terminal 
alkyne. The reaction was gold- (vie) or acid-catalyzed (vif), and proceeded through a cascade 
5-exo-dig cyclization and [3,3]-sigmatropic Claisen rearrangement. For the CISA derivatives 
with nonaromatic substituents (iva-d), cyclization also occurred spontaneously under Strecker 
reaction conditions at elevated temperatures. To introduce the essential 2-furanone ring to the 
cyanoisoindole fragment vii, the α-position of the ester was formylated and coupled with 
bromobutenolide ix. Formylation was performed under neat conditions in the presence of a 
base and a large excess of ethyl formate. After optimization of the reaction conditions, the 
analogs were prepared in overall yields of 10-20%. 
 
Scheme I. Synthetic pathway of the fluorescent cyanoisoindole-based SL analogs. 
Functional tracer molecules are characterized by a suitable combination of biological activity 
and fluorescent properties. The potency of the CISA analogs to function as SL agonists was 
evaluated in both parasitic and autotrophic plants. A germination assay on seeds of the root 
parasite Phelipanche ramosa revealed a strong activity as germination stimulants. In 
Arabidopsis thaliana seedlings, the CISA analogs proved to be equally active as the commonly 
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used standard GR24 in inhibiting hypocotyl elongation, which demonstrates their role as 
phytohormone in higher plants. Additionally, via a SMXL6 protein degradation and a yeast two-
hybrid assay, molecular evidence was provided that the compounds operate through the 
natural SL signaling cascade.  
All CISA analogs were shown to emit fluorescent light in solution, though some differences 
exist between the derivatives resulting from the variations in the cyanoisoindole core. Most 
prominently was the strong redshifted emission maximum of analog iif, owing to the increased 
conjugation with a nitrogen-containing heterocycle. Moreover, the quantum yield of iif was 
significantly higher compared to the other analogs. These favorable spectroscopic properties 
also enabled in vivo visualization of CISA-7 (iif) in plants. In contrast to the previously reported 
fluorescent analogs, CISA-7 (iif) displays a large similarity in shape and structure with the 
natural hormone, which renders the analog a promising tracer to investigate the mobility of 
SLs in plants and fungi.  
Complementary to the application-oriented first part, the second part of this thesis focused on 
the more fundamental aspects of gold catalysis, including catalyst design and methodology 
study. In particular, the research centered on the development of a novel type of 
enantioselective catalysts that combine a cationic gold(III) center with a chiral phosphorus-
based ligand. The primary advantage of gold(III) over gold(I) for enantioselective catalysis is 
its square-planar geometry, which places the chiral information significantly closer the reactive 
site. However, the development of organometallic gold(III) catalysts is greatly challenged by 
the high redox potential of gold(III), which leads to the facile reduction of the associated 
complexes to either gold(I) or metallic gold species. To address this issue, the high-valent 
gold(III) center was endowed with a cyclometallated biphenyl ligand, as the strong Au-C 
bonding energy exhibits a stabilizing effect on the auric complex.  
A variety of gold(III) catalysts xiii were prepared through transmetallation of the bidentate 
biphenyl ligand of tin(IV) complex xi to gold(III), followed by coordination of a phosphorus-
based ligand. The attached chiral ligands can be classified into three groups according to their 
structure: BINOL-derived phosphoramidites, TADDOL-derived phosphoramidites, and 
phosphine ligands (Scheme II). 
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Scheme II. Synthesis of chiral phosphorus gold(III)(biphenyl) complexes. 
The catalysts were evaluated for their activity and selectivity in two types of alkyne cyclization 
reactions and a Diels-Alder cycloaddition. In the 1,6-enyne cycloisomerization of 7-alkynyl 
cycloheptatriene xiv, the catalysts exhibited good to excellent activity, mostly inducing 
quantitative conversion of the substrate (Scheme III-a). However, only low to moderate 
enantioselectivity was obtained for the 1-substituted indene xv. Interestingly, the ratio of the 
regioisomers was sensitive to the type of ligand coordinated to the gold(III) catalyst. Whereas 
phosphoramidite-based catalysts favored the formation of 2-substituted indene xvi, phosphine 
complexes were able to pull the ratio in favor of the chiral product xv. The gold(III)-catalyzed 
alkyne activation of α-vinyl propargylic ester xvii containing a tethered arene induced a tandem 
Rautenstrauch/Friedel-Crafts cyclization, leading to the formation of fused tricycle xviii 
(Scheme III-b). Similar to the previous reaction, excellent activity yet poor selectivity was 
observed for the different complexes. Last but not least, the gold(III) catalysts were employed 
as σ-Lewis acids in the Diels-Alder cycloaddition of (E,E)-2,4-hexadienal xix and 
cyclopentadiene xx (Scheme III-c). While the majority of the complexes failed to catalyze the 
reaction, those catalysts that were active furnished cycloadduct xxi in high diastereo- and 
enantioselectivity. The catalytic efficacy of the complexes was not ligand-related, as 
complexes of each ligand type were variably capable or incapable of inducing cycloaddition. 
The superior performance of xiii as selective catalyst in the Diels-Alder cycloaddition 
compared to alkyne activation reactions suggests that the chiral gold(III) complexes display a 
hard, oxophilic Lewis acidity, rather than the soft, carbophilic Lewis acidity encountered in 
gold(I) species. Consequently, the unprecedented gold(III)(biphenyl) complexes bearing chiral 
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phosphorus-based ligands are promising catalysts to extend the scope of enantioselective 
gold(I) catalysis to asymmetric syntheses involving carbonyl activation. 
 
Scheme III. Evaluation of the novel gold(III) complexes as selective Lewis acid catalysts. 
 
  
 
 
 
SAMENVATTING 
SAMENVATTING 
221 
In de afgelopen tien jaar is goudkatalyse uitgegroeid tot één van de meest krachtige en directe 
synthesemethoden binnen de moderne organische chemie om op een atoomeconomische 
wijze cyclische verbindingen te bereiden. Dit transitiemetaal bezit het unieke vermogen om, 
zelfs in complexe meervoudig gefunctionaliseerde moleculen, selectief onverzadigde C-C-
bindingen te activeren en vervolgens intra- of intermoleculaire nucleofiele additie te 
katalyseren onder milde omstandigheden. 
In het eerste deel van deze thesis werd de goud-gekatalyseerde ringsluiting van alkynen 
gebruikt als centrale stap in de synthese van fluorescente strigolacton (SL) analoga. 
Strigolactonen zijn een familie van terpenoïde allelochemische stoffen die amper tien jaar 
geleden erkend werden als plantenhormonen. Ze staan in voor de regeling van zowel boven- 
als ondergrondse groeiprocessen en vormen een belangrijke strategie voor de overleving van 
planten op nutriëntarme bodems. Desondanks de biochemische kennis omtrent SL-binding 
en -signaaltransductie aanzienlijk is toegenomen sinds hun ontdekking, blijven de distributie 
en het transport van strigolactonen in de plant een relatief onbekend terrein. Het gebruik van 
fluorescerende derivaten is een populaire techniek om de dynamische processen achter de 
spatiotemporele regulatie van plantenhormonen te bestuderen. 
Het labelen van strigolactonen gebeurde voorheen hoofdzakelijk door de conjugatie van een 
gekende fluorescerende verbinding, zoals fluoresceïne of BODIPY, met de tricyclische kern 
van natuurlijke strigolactonen, bijvoorbeeld strigol i, of hun synthetische derivaten. Het 
belangrijkste nadeel van deze methode is de sterke toename van de moleculaire massa en 
de grootte van het hormoon, wat leidt tot een verminderde biologische activiteit voor dit type 
tracers. Bijgevolg werd een nieuwe klasse van gelabelde SL-analoga (ii) ontwikkeld, waarbij 
het tricyclische lacton van natuurlijke strigolactonen vervangen werd door een fluorescente 
cyaanisoindoolring (Figuur I). De biologisch essentiële α,β-onverzadigde furanonring en 
geconnecteerde enolether-brug bleven ongewijzigd. 
 
Figuur I. Moleculaire structuur van natuurlijke strigolactonen en cyaanisoindool-gelabelde SL-analoga. 
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In totaal werden zes nieuwe cyaanisoindool strigolacton analoga (CISA) met verschillende 
substitutiepatronen en gefuseerde 5- of 6-ringen bereid. De syntheseroute bestond uit vijf 
opeenvolgende stappen en startte van een reeks ortho-gebromeerde arylaldehyden iii 
(Schema I). De eerste stap omvatte een Sonogashira-koppelingsreactie, waarbij een TMS-
beschermd alkyn werd ingevoerd op de aromatische ring. Ontscherming van het gesilyleerd 
tussenproduct verliep vlot met behulp van kaliumcarbonaat in methanol. In de tweede stap 
werd een Strecker-reactie uitgevoerd om aldehyde iv om te zetten in α-aminonitril vi. De 
fluorescente 1-cyaanisoindoolkern vii werd vervolgens gesynthetiseerd door ringsluiting van 
het tertiair amine met het eerder geïntroduceerde eindstandige alkyn. De reactie was goud- 
(vie) of zuur-gekatalyseerd (vif) en verliep via een 5-exo-dig cyclisatie, gevolgd door een 
[3,3]-sigmatrope Claisen-omlegging. In het geval van de CISA-derivaten met niet-aromatische 
substituenten (iva-d) trad ringsluiting ook spontaan op onder Strecker-condities bij verhoogde 
temperaturen. Om de essentiële 2-furanonring aan het cyaanisoindoolfragment vii toe te 
voegen, werd de α-positie van het ester geformyleerd en gekoppeld met broombutenolide ix. 
De formyleringsreactie werd uitgevoerd onder solventvrije omstandigheden in de 
aanwezigheid van een base en een grote overmaat ethylformiaat. Na optimalisatie van de 
reactiecondities werden de analoga bereid met een globaal rendement van 10-20%. 
 
Schema I. Syntheseroute van de fluorescente cyaanisoindool-gebaseerde SL-analoga. 
Functionele tracermoleculen worden gekenmerkt door een optimale combinatie van 
biologische activiteit en fluorescerende eigenschappen. De activiteit van de CISA-analoga als 
SL-agonisten werd geëvalueerd in zowel parasitaire als autotrofe planten. Uit een kiemingstest 
op zaden van de wortelparasiet Phelipanche ramosa bleek een sterke activiteit als 
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kiemingsstimulantia. In zaailingen van Arabidopsis thaliana waren de CISA-analoga even 
actief als de veelgebruikte standaard GR24 in het afremmen van de elongatie van het 
hypocotyl, wat hun rol als hormoon in de plant aantoont. Bovendien werd door middel van de 
afbraak van SMXL6-eiwit en een gist twee-hybride analyse bewijs aangeleverd op moleculair 
niveau dat de verbindingen werken via de natuurlijke SL-signaalcascade. 
Alle CISA-analoga vertoonden fluorescerende eigenschappen in oplossing, waarbij de 
variaties in de cyaanisoindoolkern aanleiding gaven tot verschillen tussen de derivaten. Het 
meest opvallend was de sterke roodverschuiving van het emissiemaximum van analogon iif 
ten gevolge van de toegenomen conjugatie met een stikstofhoudende heterocyclische 
component. Bovendien was de kwantumopbrengst van iif significant hoger in vergelijking met 
de andere analoga. Deze gunstige spectroscopische eigenschappen maakten dan ook in vivo-
visualisatie van CISA-7 (iif) in de plant mogelijk. In tegenstelling tot de eerder gerapporteerde 
fluorescente analoga vertoont CISA-7 (iif) een grote structurele gelijkenis met het natuurlijk 
hormoon, waardoor het analogon een veelbelovende tracer is om de mobiliteit van 
strigolactonen in planten en schimmels te onderzoeken. 
Als aanvulling op het toepassingsgerichte eerste deel concentreerde het tweede deel van 
deze thesis zich op de meer fundamentele aspecten van goudkatalyse, waaronder het 
ontwerp en de synthese van katalysatoren en de studie van de methodologie. Het onderzoek 
was specifiek gewijd aan de ontwikkeling van een nieuw type enantioselectieve katalysatoren, 
waarbij een kationisch goud(III) metaalcentrum gecombineerd wordt met een chiraal fosfor-
houdend ligand. Het belangrijkste voordeel van goud(III) ten opzichte van goud(I) in 
enantioselectieve katalyse is de vierkant planaire geometrie, die ervoor zorgt dat de chirale 
informatie zich beduidend dichter bij de coördinatiesite bevindt. De ontwikkeling van 
organometaalverbindingen op basis van goud(III) wordt echter sterk bemoeilijkt door het hoge 
redoxpotentieel van het goudion, waardoor de geassocieerde complexen gemakkelijk 
gereduceerd worden tot goud(I) of metallisch goud. Dit probleem werd omzeild door het 
centrale goud(III)atoom uit te rusten met een chelerend bifenylligand, aangezien de sterke 
energie van de Au-C-binding een stabiliserend effect heeft op het goudcomplex. 
Een reeks goud(III)katalysatoren xiii werd bereid door transmetallatie van het bidentaat 
bifenylligand van tin(IV)complex xi naar goud(III), gevolgd door coördinatie van een 
fosforhoudend ligand. De aangewende chirale liganden kunnen onderverdeeld worden in drie 
groepen naargelang hun structuur: BINOL-afgeleide fosforamidieten, TADDOL-afgeleide 
fosforamidieten en fosfineliganden (Schema II). 
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Schema II. Synthese van chirale fosfor-goud(III)(bifenyl)-complexen. 
De katalysatoren werden gescreend op hun activiteit en selectiviteit in twee verschillende 
alkyncyclisatiereacties en een Diels-Alder-cycloadditie. In de 1,6-enyncycloisomerisatie van 
7-alkynylcycloheptatrieen xiv vertoonden de katalysatoren een goede tot uitstekende 
activiteit, met veelal kwantitatieve omzetting van het substraat (Schema III-a). De 
enantioselectiviteit voor het 1-gesubstitueerde indeen xv was echter laag tot matig. De 
verhouding van de regio-isomeren was afhankelijk van het type ligand dat gecoördineerd was 
met het goud(III)centrum. Terwijl de op fosforamidiet gebaseerde katalysatoren de vorming 
van 2-gesubstitueerd indeen xvi bevorderden, wijzigden fosfinecomplexen de verhouding ten 
voordele van het chirale product xv. De goud(III)-gekatalyseerde alkynactivering van 
α-vinylpropargylester xvii met aangebonden aromatische ring leidde tot een tandem 
Rautenstrauch/Friedel-Crafts-ringsluitingsreactie met vorming van de gefuseerde tricyclische 
verbinding xviii (Schema III-b). In analogie met de vorige reactie werd een uitstekende 
activiteit doch slechte selectiviteit bekomen voor de verschillende complexen. Finaal werden 
de goud(III)katalysatoren ook toegepast als σ-lewiszuren in de Diels-Alder-cycloadditie van 
(E,E)-2,4-hexadienal ix en cyclopentadieen xx (Schema III-c). Hoewel de meerderheid van de 
complexen geen reactiviteit vertoonden, leverden de actieve katalysatoren cycloadduct xxi in 
hoge diastereo- en enantioselectiviteit. De katalytische activiteit van de complexen was niet 
ligandgebonden, vermits complexen van elk ligandtype al dan niet in staat waren om de 
cycloadditie te katalyseren. De superieure prestatie van xiii als selectieve katalysator in de 
Diels-Alder-cycloadditie ten opzichte van de alkynactiveringsreacties suggereert dat de chirale 
goud(III)complexen harde, oxofiele lewiszure eigenschappen vertonen in plaats van de 
zachte, carbofiele eigenschappen aangetroffen in goud(I)complexen. De nieuwe 
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goud(III)(bifenyl)-complexen met chirale fosforhoudende liganden zijn aldus veelbelovende 
katalysatoren om het toepassingsgebied van enantioselectieve goud(I)katalyse uit te breiden 
tot asymmetrische syntheses waarin de activatie van een carbonylgroep vereist is. 
 
Schema III. Evaluatie van de nieuwe goud(III)complexen als selectieve lewiszuren. 
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